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Preface 
Performing a PhD research project is like participating in a North Pole 
expedition. Because of his enormous enthusiasm, the expedition leader, my 
promoter Pascal Verdonck, easily convinced me to join the research group at the 
Hydraulics Laboratory.  
As happens with all expeditions, the preparation of years is much more important 
than those final steps towards the goal. From the moment it was decided that I 
would follow the trail of ‘hemodialyzers’, it was time to meet the other 
participants with different backgrounds, like medical doctors and their staff. One 
of the first persons I ran into was Jean-Yves, who introduced me in the world of 
dialysis, and helped me with an inexhaustible passion and patience with most of 
the experiments.  
Once a starting knowledge was gathered and the trail was roughly traced out, it 
was time to look for good technical equipment. From this respect I especially 
have to thank the technicians Stefaan, Marcel, Martin, Chris, Jurgen, Hichem, 
and Johan, for their work behind the scenes. Thanks to them I could profit by 
pulling a well-sliding sledge instead of carrying all heavy stuff in a backpack. 
But a successful expedition does not only depend on knowledge and excellent 
technical materials. Already from the start, a good physical condition is 
indispensable and helps you through the moral rock bottoms and the long cold 
nights. I was surely not standing alone with my ever-stating motto ‘a sound mind 
in a sound body’. Therefore, special thanks go to Kris and Koen for joining me 
when swimming numerous lengths, and to Annie, Henk, Chris and Christian for 
the countless kilometers jogging at the riverside. I must honestly say that I also 
took a lot of courage from the memories on previous ‘expeditions’ on the ice of 
Svalbard and Greenland, and the moral support and deep friendship from the 
other participants: thank you Margreet, Ole, and Jakob! 
On my long way to go, I was lucky to meet other researchers and medical doctors 
who gave a critical evaluation of the covered trail with suggestions for the future. 
Some of them even joined my expedition and enlarged in that way the chance for 
success. For the various and interesting projects I am most indebted to Dr 
Hombrouckx, Prof Vanholder, Prof De Bisschop, Prof Dhondt, Rita, Stefaan, 
Yves, and Pieter. 
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In spite of a good preparation, obstacles like ice-holes might always block the 
initial plans. Luckily I could always count on a number of persons that helped me 
solving the problems I could not handle alone. Thank you Jan, Kris, Dirk, Guy, 
and Ilse for all the advices with respect to numerical modeling. I am also grateful 
to Peter, Veerle, and Prof De Bisschop for solving numerous questions related to 
chemistry, and to Jean-Yves and Rita for keeping me well informed about the 
clinical practice. 
After each stage during the final months, different colleagues helped me in the 
evaluation of the performed work. Pascal, Patrick, Dirk, Stijn, Guy, and Tom 
wrestled with kilos of paperwork. But also people from outside the lab, Jan and 
Prof Vanholder, never argued when I came along with another version of the 
text. They all contributed, each in his way, to the final version of my dissertation. 
I was also strengthened by the encouragements from the other colleagues in the 
lab who were not actively joining the expedition. Ronny, Manuella, and the 
youngsters followed the progressions through different channels with great 
interest. 
Although it looked like if the last months were a lonesome struggle far away 
from home, having a satellite phone for calling the home front gave me a strong 
feeling. Especially during the last tracks when I started counting every single 
progression, and when it felt like I sank deeper in the snow for every further step, 
I was only able to persist thanks to the moral support of my family and friends. I 
especially want to thank my parents for having me learned to define goals in my 
life and to strive for them. Finally, I must honestly say that, although I will be the 
only person getting the credits, this was not at all a solo expedition. My husband 
Bruno was like the leader of my dog team, leading me through the wide white 
landscape straight to the goal. 
The day that I will finally plant my flag on the North Pole, I will feel great for 
having reached another challenge in my life. But as ice is always drifting away 
from the pole, research must go on while striving for another goal: never stop 
exploring! 
 
Thanks to all, 
 
Sunny, 
August 2004 
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Nomenclature 
Symbols 
a Particle diameter m  
A Area  m²  
Af Gross frontal area m²  
c Particle volume fraction -  
cp Specific heat capacity J/kg/K  
C Concentration  kg/m³ mol/m³ 
d Width m  
D Diameter  m  
Deq Equivalent diameter m  
D Diffusive dialysance m³/s mL/min 
DS Solute diffusivity m²/s  
DDC Dimensionless drag coefficient -  
E Extraction ratio -  
F Free energy J  
FP Plasma water fraction -  
FRBC Red blood cell fraction -  
hm Hydraulic permeability m/s/Pa  
GS Solute generation rate kg/s mol/s 
h Heat transfer coefficient W/m²/K  
H Hematocrit % - 
J Solute flux kg/s mol/s 
Ju Volumetric flux m³/s mL/min 
k  Porous medium permeability m²/s/Pa  
k = K/t Kinetic parameter 1/s  
k= f(h) Thermal transport velocity 1/s  
K Diffusive clearance m³/s mL/min 
K’ Total clearance m³/s mL/min 
Kblood Total blood-side clearance m³/s mL/min 
Kdialysate Total dialysate-side clearance m³/s mL/min 
KUF Ultrafiltration coefficient m³/s/Pa mL/h/mmHg 
K0 Mass transfer coefficient m/s  
K12 Inter-compartmental clearance m³/s mL/min 
L Length m  
m&  Mass flow rate kg/s  
M Mass  kg  
n Lerche parameter -  
P Pressure  Pa mmHg 
Nomenclature 
 viii 
PF Summation of perimeters of all fibers m  
PT  Perimeter of the tubing m  
Pe Péclet number -  
Q Flow rate m³/s mL/min 
QUF Ultrafiltration rate m³/s mL/min 
r Radial distance m  
R Radius  m  
R Universal gas constant = 8.314 J/kg/K  
R0 Total resisitance s/m  
Re Reynolds number -  
Rep Particle Reynolds number -  
S Sieving coefficient -  
St Stokes number -  
t Time  s  
T Absolute temperature K  
T Torque N·m  
TMP Transmembrane pressure Pa mmHg 
Tr  Transmittance coefficient -  
u Axial velocity m/s  
V Volume  m³  
V1 Perfused volume L  
Vmax Maximum velocity m/s  
Vmean Mean flow velocity m/s  
Vtot Total distribut ion volume L  
 
Greek symbols 
e Porosity -  
g Shear rate 1/s  
gsl, gpl, gps Solid- liquid, particle- liquid, particle-
substrate interfacial energy 
J/m²  
gd Dispersion force J/m²  
k Dean number -  
m Dynamic viscosity Pa·s  
mp Dynamic plasma viscosity Pa·s  
mapp Apparent blood viscosity Pa·s  
mw Dynamic water viscosity Pa·s  
n Kinematic viscosity m²/s  
Dp  Oncotic pressure Pa  
r Density kg/m³  
t Shear stress  Pa  
w Angular velocity rad/s  
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Abbreviations 
ADMA Asymmetric dimethylarginine 
AN Acrylonitrile 
AV Arterio-venous 
BW Body weight 
CA Cellulose acetate 
CAPD Continuous ambulatory peritoneal dialysis 
CC Co-current  
CCPD Continuous cyclic peritoneal dialysis 
CDA Cellulose diacetate 
CFD Computational fluid dynamics 
Ci Curie 
CMPF 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid 
CT (imaging) Computer tomography 
CT (solute) Creatine 
CTA Cellulose triacetate 
CTC Counter current 
CTN Creatinine  
DAPD Daytime ambulatory peritoneal dialysis 
DMSA Dimercaptosuccinic acid 
FDM Finite difference method 
FEM Finite element method 
FVM Finite volume method 
G Guanidine 
GAA Guanidinoacetic acid 
GSA Guanidinosuccinic acid 
HMW High molecular weight 
HLA Human leukocyte antigen 
IAA Indole-3-acetic acid 
IS In series 
IP In parallel 
IPD Intermittent peritoneal dialysis 
LMW Low molecular weight 
MAA Macro aggregated albumin 
MCV Mean cell volume 
MG methylguanidine 
MMR Middle molecule reduction ratio 
MMW Middle molecular weight 
MRI Magnetic resonance imaging 
MW Molecular weight 
NIPD Nightly intermittent peritoneal dialysis 
PAN Polyacrylonitrile 
PET Positron emission tomography 
PMMA Polymethylmethacrylate 
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Nomenclature 
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PVC Polyvinylchloride 
RBC Red blood cell 
RO Reverse osmosis 
RR Reduction ratio 
SMC Saponified modified cellulose 
SPECT Single photon emission computed tomography 
Tc Technetium 
URR Urea reduction ratio 
 
Overview and Rationale 
Nowadays, a broad range of hollow fiber dialyzers is available on the market, 
differing from each other in membrane type, surface area and/or filtration 
characteristics. The rationale of this work was therefore not the design of a new 
device or the examination of a particular commercially available dialyzer. The 
primary goal of the research summarized in this dissertation was to develop new 
tools, which allow quantifying dialysis. From this respect, numerical models 
were developed to investigate dialyzer performance and patient clearance. By 
combining those implementations, a better comprehension is obtained of the 
intervening phenomena during dialysis. 
The first chapter is intended to introduce the reader in the medical as well as 
mathematical background of this dissertation. After a general introductive 
paragraph about renal failure and the potential renal replacement therapies, the 
biophysics in a hemodialyzer is discussed by focusing on the characteristics of 
blood, dialysate and the semi-permeable membrane. This allows better 
understanding of the transport phenomena that determine the efficiency of a 
dialyzer. Emphasizing the long period of dialyzer developments in the past, a 
review of the major milestones in the history of hemodialyzer and associated 
devices is presented. The chapter is completed with an overview of the research 
techniques applied within the scope of this dissertation. Distinction is hereby 
made between experimental and mathematical approaches. 
Because blood and dialysate flow distributions are important determinants of the 
efficiency of mass transport, the dialyzer overall flow was investigated 
experimentally and numerically, and described in chapter II. The experimental 
results of the SPECT (single photon emission computed tomography) technique 
were combined with the numerical results obtained with a macro model of the 
blood and dialysate compartment. 
Because detailed flow information and fluid specific characteristics cannot be 
derived from the macro model, chapter III highlights the flow in a single fiber. 
First, a technique is described to investigate particle transport in an impermeable 
microcapillary. A feasibility study was made for using this technique to 
investigate blood flow in a dialyzer fiber. However, because of some drawbacks 
of this experimental technique for blood flow modeling, it was decided to switch 
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to computational modeling combined with in vitro, in vivo, and ex vivo 
experiments. The validated micro model renders detailed information about fluid 
dynamics and blood behavior over the entire dialyzer length, allowing to perform 
parameter studies related to geometrical and/or flow variations. 
In chapter IV the influence of flows and flow distributions on mass transfer 
efficiency was investigated using a theoretical, experimental, and numerical 
approach. Distinction was made between the removal of small (MW<500) and 
middle molecules (MW>500). Two different in vitro setups were built to 
investigate the impact of flow, flow direction and dialyzer surface area on the 
overall clearance. With the numerical analysis, the developed micro model of the 
dialyzer fiber was further extended to study especially the diffusive mass transfer 
of small and middle molecules. Finally, the SPECT results were used as input 
data in order to calculate the overall dialyzer efficiency. 
Instead of concentrating on the dialyzer clearance, chapter V considers the 
patient clearance for small water-soluble compounds as well as protein-bound 
solutes. Therefore, a two-pool kinetic model was developed and parameters like 
distribution volumes and inter-compartmental clearance were derived from in 
vivo concentration measurements during dialysis. The model is especially useful 
to define the intra-dialytic kinetic behavior of solutes that are distributed 
according a two-pool configuration, and allows comparison with the kinetic 
behavior of urea. This is of special interest since the latter is used as marker for 
dialysis adequacy. 
Deviating from a standard dialysis setup, chapter VI discusses some major 
parameters for adequate dialysis with the single-pass Genius batch system. The 
system consists of a closed circuit and dialysate container in which fresh, as well 
as spent dialysate are stored. Since the separation of both fluids is based on 
density differences, the impact of two influencing parameters, i.e. temperature 
and concentration, was studied theoretically, with experiments, and by 
computational fluid dynamics. 
Finally, chapter VII summarizes the major conclusions as drawn from the 
previous chapters, and discusses some drawbacks of the presented modeling 
techniques. Consequently, suggestions are given to further improve the discussed 
models in order to have an optimal tool available for overall dialysis 
quantification. 
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1. Chapter overview 
After a general introduction to the dialysis therapy and the artificial kidney, the 
biophysics in a hemodialyzer is discussed. Hereby, special attention is drawn to 
the fluid properties of blood and dialysate, the membrane characteristics, and the 
different transport phenomena determining dialysis efficiency.  
Furthermore, a review is given of the milestones performed in the development 
and enhancement of dialysis therapy. This includes the design of dialyzers, the 
dialyzer system, and the vascular access.  
Finally, the research techniques as used within the scope of this dissertation are 
described. Experimental as well as mathematical modeling techniques are 
explained and the necessity of combining both types of techniques is discussed.  
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2. Introduction to dialysis and artificial kidney†  
2.1. Function of the healthy kidneys 
The urinary system consists of two kidneys that filter blood and deliver the 
produced urine into the two ureters. From the ureters the urine is passed to the 
urinary bladder, which is drained via the urethra during urination. The kidneys 
are bean-shaped organs of about 11cm long, 4 to 5cm wide and 2 to 3cm thick, 
and lie bilaterally in the retroperitoneum in the abdominal cavity. The smallest 
functional unit of the kidney is the uriniferous tubule, each containing a nephron 
and a collecting tubule. There are approximately 1 to 1.3 million nephrons in 
each kidney. One nephron is composed of a vascular part (glomerulus), a 
drainage part (Bowman's capsule), a proximal tubule, Henle’s loop and a distal 
tubule (Fig. I-1). Several nephrons are drained by one collecting tubule, which 
enlarges downstream until it becomes a duct of Bellini and perforates the renal 
papilla [1]. 
The major function of the kidneys is removing toxic by-products of the 
metabolism and other molecules smaller than 69000Da (i.e. smaller than 
albumin) by filtration of the blood flowing through the glomerulus. They also 
regulate body fluid composition and volume. Specifically resorption of salts 
(Na+, K+, Cl-), glucose, creatine, proteins, and water takes place in the tubular 
parts. Because of these eliminating and conserving functions, the kidneys also 
contribute to the regulation of the blood pressure, hemodynamics, and the acid-
base balance of the body. Additionally, kidneys have an endocrine function: they 
produce the hormone renin, erythropoietin and prostaglandines (derivatives of 
essential fatty acids to maintain homeostasis) and help in converting vitamin D to 
dihydroxycholecalciferol, a substance which controls calcium transport [1].  
 
                                                     
† The contents of this section was submitted for publication 
Modeling of transport phenomena in an artificial kidney 
S. Eloot and P. Verdonck 
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Fig. I-1: The urineferous tubule, the smallest functional unit of the kidney 
2.2. The uremic syndrome 
Renal insufficiency can be subdivided into three categories according to the 
duration that the kidneys loose their ability to purify the blood: acute (hours to 
days) [2], subacute (months) and chronic (years) renal failure. In contrast with the 
subacute and chronic form, acute renal failure is often reversible. The uremic 
syndrome is the result of the retention of compounds, normally cleared by 
healthy kidneys, and of a disorder in the hormonal and enzymatic homeostasis [3]. 
As renal failure progresses, glomerular filtration rate as well as the amount of 
nephrons decreases. The main causes of end stage renal disease are diabetes and 
hypertension, while the most important symptoms are found in the cardiovascular 
[4-6], neurological [7,8], hematological [9,10] and immunological [11-13] status. 
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2.3. Renal replacement therapies 
The diagnosis of chronic renal failure is based on the indication of a decreased 
renal function or a disorder in urine sedimentation. In daily practice, creatinine 
clearance (95±20mL/min for women and 120±25mL/min for men) [14] is used as 
a measure of the glomerular ultrafiltration rate and quantifies the remaining renal 
function. In contrast with creatinine, the urea blood level is strongly dependent 
on the protein intake and the catabolic state of the patient, and furthermore, urea 
clearance is dependent on the urine flow rate. Nevertheless, the increase of serum 
ureum is a useful additional marker of chronic renal failure. 
As renal replacement therapy, two treatment modalities are available: a natural 
one (kidney transplantation from cadaver or living donors), and an artificial one 
(dialysis), which has two sub-modalities: peritoneal dialysis and hemodialysis.  
2.3.1. Transplantation 
The introduction of the chirurgical ‘end-to-end’ anastomosis technique [15], the 
revelation of the secrets of the HLA (Human Leukocyte Antigen) [16,17] and the 
availability of immunosuppressiva [18], opened the way to successful 
transplantations. The implantation of the donor kidney occurs usually in one of 
the fossae iliacae (cavity at the intestinal bone). The venous anastomosis consists 
of a ‘side-to-end’ connection of the vena renalis with the vena iliaca 
communis/externa. The arteria renalis is anastomosed with the arteria iliaca 
interna (‘end-to-end’) or with the arteria iliaca communis/externa (‘side-to-end’). 
Last but not least, the donor ureter must be fixed at the supralateral side of the 
bladder roof after performing an anti-reflux channel at the bladder wall.  
Possible rejections of transplanted organs can be subdivided into two groups: 
hyperacute rejections, which are serological processes based on preformed 
antibodies, and the rejections caused by cellular reactions between T-
lymphocytes and HLA. The latter can be acute or chronic. In spite of those 
complications, kidney transplantation can be called the solution for chronic renal 
failure with immense advantages for the patient: no limitation concerning water 
intake, less restricted diet, no suffering from anemia, normalization of the bone 
metabolism and return to a dynamic life with a social and professional 
reintegration. Only a small percentage of patients are on the waiting list, and only 
a small percentage of patients on the waiting list are actually transplanted (27% 
for West Europe – Eurotransplant 2003).  
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2.3.2. Peritoneal dialysis 
With peritoneal dialysis [19], a hypertonic, mostly, glucose dialysis fluid [20] is 
injected in the peritoneal cavity by means of a permanent peritoneal catheter [21-
25]. The peritoneal cavity is an intra abdominal space, which is surrounded by a 
serous membrane called the peritoneum (1-1.5m²). It is a semi-permeable 
membrane that contains mesothelial cells on an interstitium that consists of 
connective tissue with capillaries and lymphatic vessels. In between the 
mesothelial cells, intercellular gaps (range 50 nm) are responsible for the major 
solute transport between the dialysis fluid and the blood in the capillaries [14]. 
Peritoneal dialysis can be performed continuously (CAPD = Continuous 
Ambulatory Peritoneal Dialysis [26], CCPD = Continuous Cyclic Peritoneal 
Dialysis [27,28]), or intermittently (DAPD = Daytime Ambulatory Peritoneal 
Dialysis, IPD = Intermittent Peritoneal Dialysis [29], NIPD = Nightly Intermittent 
Peritoneal Dialysis). 
2.3.3. Hemodialysis 
Hemodialysis is a blood purifying therapy in which the blood of a patient is 
circulated through an artificial kidney, also called hemodialyzer. This is realized 
in an extracorporeal circuit (Fig. I-2) where one or two needles (or catheters) can 
be used as the patient’s vascular access. A general hemodialysis therapy lasts 
about 9-15 hours a week, mostly spread over three sessions. It can take place in 
the hospital, in a low care unit or at home.  
 
Fig. I-2: The extracorporeal circuit in hemodialysis 
Two types of hemodialyzers are in use: plate and hollow fiber dialyzers [30]. In a 
plate dialyzer, membrane sheets are packed together and blood and dialysate 
flow in subsequent layers. The priming volume is around 30% larger than in a 
hollow fiber dialyzer. The latter (Fig. I-3) consists of thousands of small 
blood pump
dialyzer
fresh dialysate
waste dialysate
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capillaries (inner diameter in the range of 200µm and wall thickness of 8-40µm). 
Blood flows inside the capillaries whereas dialysate flows counter currently 
around them. Typical blood flow rates are in the range of 200 up to 350mL/min 
[31], while dialysate flows are preferably twice the blood flow [32]. Besides the 
advantage of a small blood volume, these dialyzers suffer from problems like 
clotting in and clogging of the capillaries. With respect to the membrane 
characteristics, distinction can be made between low, medium, and high flux 
dialyzers on one hand (ultrafiltration coefficient lower than 15, between 15 and 
40, and higher than 40mL/h/mmHg, respectively), and low and high area 
dialyzers on the other (membrane surface lower and higher than 1.5m², 
respectively).  
 
Fig. I-3: The hollow fiber dialyzer 
Already from the start of hemodialysis, the challenge for nephrologists was to 
obtain an adequate vascular access. The Quinton-Scribner shunt [33] with the use 
of an external access is nowadays, if used, only utilized in patients with acute 
renal failure and important vascular problems. More often, catheters are used for 
acute short phase of renal failure. The original subcutaneous internal arterio-
venous fistula, described by Brescia and Cimino [34], between the arteria radialis 
and the vena cephalica is still the most successful angioaccess method [35]. In the 
latter, arterial flow and pressure dilates the vein, facilitating repetitive puncture. 
In case vessel conditions are inadequate or fail to dilate (10-30% of the patients), 
bridge grafts between an artery and a suitable vein are used. Several types of 
graft material are used, including autologous veins [36-39], allografts [40], and 
synthetic grafts [41,42]. As more elderly people with peripheral vascular disease are 
recruited on dialysis, the central venous catheter, which was initially introduced 
for acute dialysis, is gaining popularity in long-term dialysis treatment [43-45].  
blood inflow 
blood outflow 
dialysate inflow 
dialysate outflow 
fiber bundle
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As hemodialysis implies a repeated and compulsory contact of blood with 
foreign materials, biocompatibility problems are unavoidable. Traditionally, 
biocompatibility is defined as the absence of functional and/or biochemical 
reaction during or after the contact of the body, a body fluid or an organ with an 
artificial device or a foreign material [46,47]. Dialysis related biocompatibility 
problems are mainly due to the intermittent nature, the application of high blood 
flows, and the use of dialysis fluid and of semi-permeable membranes. They can 
be summarized as problems related to clotting phenomena [48-50], complement and 
leukocyte activation [51,52], susceptibility to bacterial [53] and tuberculosis 
infection [54], leaching [55], surface alterations [56], allergic reactions [57,58], shear 
[59], and inverse transfer of electrolytes [60] or endotoxins from the dialysate 
towards the blood [61]. 
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3. Biophysics of a hemodialyzer† 
In hemodialysis therapy, the dialyzer succeeds in purifying the blood and 
extracting the excess water due to basic transport phenomena, such as diffusion, 
ultrafiltration, and osmosis. As transport takes place between the blood and 
dialysate compartment over a semi-permeable membrane, fluid characteristics 
and membrane properties should also be considered. 
3.1. Blood characteristics 
3.1.1. Blood constitution and major functions 
An average adult has a total blood volume of about 5L, which is approximately 
7% of total body weight. Blood is a dark red, viscous, slightly alkaline 
suspension (pH 7.4) of cells - erythrocytes (red blood cells), leukocytes (white 
blood cells) and thrombocytes (platelets) - suspended in a fluid (plasma). The 
amount of cells (45% for male, 43% for female) is better known as the 
hematocrit [14]. 
The main functions of blood include transportation of nutrients from the 
gastrointestinal system to all cells of the body and subsequently delivering waste 
products of these cells to organs for elimination. Oxygen (O2) is carried from the 
lungs to all cells of the organism by the hemoglobin in the erythrocytes, whereas 
carbon dioxide (CO2) is transported back to the lungs for elimination both by the 
hemoglobin and the plasma. Besides nutrients, numerous other metabolites, 
cellular products, and electrolytes are transported by the bloodstream. 
Additionally, blood has also a function of regulating the body temperature and 
maintaining the acid-base and osmotic balance of the body fluids. 
Plasma consists of water (90%), proteins (9%) and inorganic salts, ions, 
nitrogens, nutrients and gases (1%) [14]. There are several plasma proteins with 
different origin and function, e.g. albumin (69000Da), α- and β-globulins (0.08-
1·E+6Da), γ-globulins, clotting proteins, complement proteins (C1 to C9) and 
plasma lipoproteins. 
                                                     
† The contents of this section was submitted for publication 
Modeling of transport phenomena in an artificial kidney 
S. Eloot and P. Verdonck 
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Erythrocytes are non-nucleated, biconcave-shaped disks, 7.5µm in diameter and 
1-2µm thick. Their large surface-volume proportion benefits the exchange of 
gases. Erythrocytes are packed with hemoglobin, a large protein (68000Da) 
composed of four polypeptide chains, which are covalently bound to an iron 
containing heme. In regions of high oxygen concentration, the hemoglobin part 
releases CO2 while the iron binds to O2. Leukocytes use the bloodstream as a 
means for traveling and only fulfill their function after diapedesis (leaving the 
blood vessels and entering the surrounding connective tissue). Within the 
bloodstream, leukocytes are round while they are pleomorphic in connective 
tissue. Their main function is to defend the human body against foreign 
substances. They can be classified into two main groups: granulocytes (60-70% 
neutrophiles, 4% eosinophiles and 1% basophiles) and agranulocytes (20-25% 
lymphocytes and 3-8% monocytes). Thrombocytes are small (2-4µm in 
diameter), disk-shaped, non-nucleated cell fragments, containing several tubules 
and granules. They function in limiting hemorrhage of blood vessel endothelium 
in case of injury [14].  
3.1.2. Bloodrheology 
Blood is a non Newtonian fluid characterized by a non-linear relationship 
between shear stress τ (Pa) and shear rate γ = ∂u/∂y (1/s) [62]: 
 m
m
γµ
y
uµτ ⋅=



∂
∂⋅=  Eq. I-1 
With µ the dynamic viscosity (Pa·s), u the velocity in axial direction (m/s), y the 
direction perpendicular to the flow direction (m), and m a coefficient (-) equal to 
unity for Newtonian fluids, and smaller than 1 for shear thinning fluids like 
blood.  
The shear thinning behavior as well as the dependence of the blood viscosity µ 
on the hematocrit H (-) and the plasma viscosity µp, is described among others by 
Quemada [63] (Fig. I-4): 
 ( )2p Hk211
µ
µ
⋅−
=  Eq. I-2 
Parameter k is function of the intrinsic viscosities k0(H), characterizing the red 
blood cell aggregation at zero shear stress, k∝(H), describing the orientation and 
deformation of red blood cells at important shear stress, and the shear rate γ [64]: 
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32
c
32
32
0
H3.697H25.600H27.9236.1508ln γ
H0.6479H2.711H2.8031.3435kln 
H6.738H13.800H10.4103.874kln 
 Eq. I-4 
For a fixed hematocrit, viscosity decreases with increasing shear rate, whereas 
for a fixed shear rate, viscosity increases with hematocrit. 
 
Fig. I-4: Dynamic viscosity µ as a function of hematocrit H and shear rate, as described by 
Quemada 
Blood flowing through small capillaries exhibits a redistribution of the red blood 
cells creating a plasma-skimming layer that can be observed near the wall while 
red blood cells are concentrated in the centre. Fahraeus and Lindqvist [65] 
described the effect of this non-uniform cell distribution on the flow by defining 
an apparent blood viscosity µapp (Pa·s) for use in the Haegen-Poiseuille equation, 
describing laminar flow in a circular tube [62]: 
 P128
Dπ
Lµ
1Q
4
app
∆⋅⋅⋅⋅=  Eq. I-5 
With Q the flow rate (m³/s) through a tube with diameter D (m), and ∆P the 
pressure drop over the tube length L (m). 
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The radial variation of the hematocrit was deduced by Lerche et al. [66] using a 
parameter n, which describes the degree of plasma skimming: non-uniformity of 
cell distribution increases with decreasing n (Fig. I-5): 
 
( ) ( ) ( )
( ) ( )
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−⋅−⋅−−+−
⋅−

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 −⋅+⋅−⋅=
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n
r                      
.
2
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2n1nn
0
 Eq. I-6 
With H0 the mean hematocrit (-), r the relative radial position in the capillary (-), 
and n the dimensionless Lerche parameter. 
 
Fig. I-5: The radial variation of the hematocrit over the fiber radius, described by Lerche 
3.2. Dialysis fluid characteristics 
The hemodialysis fluid should be considered as a temporary extension of the 
patient's extracellular fluid because of the bi-directional transport process when 
blood and dialysate are flowing through the dialyzer. Therefore, the composition 
of dialysis fluid is critical in achieving the desired blood purification and body 
fluid and electrolyte homeostasis. It contains reverse osmosis water, dextrose and 
different electrolytes like calcium-, magnesium-, potassium- and sodium chloride 
and sodium acetate or -bicarbonate. The latter two fulfill the function of dialysate 
buffer, responsible for the correction of metabolic acidosis in the uremic patient. 
Hydrogen ions (H+) are, soon after their production, buffered by plasma 
bicarbonate, and can only be removed by the diffusive flux of alkaline from the 
dialysate into the blood replacing the blood buffers [67].  
H(r) / H0
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Besides the chemical composition, also the physical and microbiological 
characteristics are important. As the use of highly permeable membranes in 
hemodialysis is responsible for backfiltration and/or backdiffusion (filtration 
and/or diffusion from the dialysate compartment towards the blood 
compartment), toxic and pyrogenic substances can move from the dialysate 
towards the blood resulting in febrile reactions [61].  
Nowadays, the composition of dialysis fluid is prescribed for each single patient 
to individualize the dialysis therapy according to the personal needs [68]. The 
actual dialysis machines guarantee accurate proportioning of treated water and 
concentrated salts, continuous monitoring of the final composition and a constant 
maintenance of the required conductivity values [69]. 
The hemodialysis system is the end point of a hydraulic circuit where tap water is 
changed into reverse osmosis water through water supply, water pre-treatment, 
water purification [70], and dialysis fluid preparation. The pre-treatment consists 
of flowing tap water through filters, softener, carbon filter and microfilters. The 
subsequent treatment concerns flow through one or two reverse osmosis 
membranes [71] and a deionizer [72], closing the purification chain with 
ultrafiltration and submicrofiltration. 
3.3. Membrane properties 
Hemodialysis membranes vary in chemical compositional structure, transport 
properties and biocompatibility. Polymers can be categorized in three major 
groups [73,74]: regenerated and modified cellulose membranes, and synthetic 
membranes. Regenerated cellulose membranes replaced collodion, the first 
polymer to be used as an artificial membrane, and showed a better performance 
and mechanical stability. Cuprophan, for example, is a polysaccharide with the 
same chemical but other physical characteristics than the original cellulose 
because of a chemical modification. These membranes are very hydrophilic and 
form a hydrogel when absorbing water. Solute diffusion occurs through highly 
water-swollen amorphous regions. 
Examples of synthetically modified cellulose are cellulose (di) (tri) acetate and 
hemophan. In the first, one, two, respectively, three hydroxyl groups are changed 
by an acetate group making it more hydrophobic than cellulose. With hemophan, 
1% of the hydrogen (H+) in the hydroxyl (OH-) groups is changed by an amino 
ligand. The majority of cellulose and modified cellulose membranes have a 
thickness of 5-11µm and a surface of 0.8-2.5m². 
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Polysulphone (PSu), polyamide (PA) and polyacrylonitrile polyvinylchloride 
copolymer (PAN-PVC) are membranes prepared from synthetic engineered 
thermoplastics and are hydrophobic, asymmetric and anisotropic with solid 
structures and open void spaces [74]. These membranes are also characterized by a 
thin skin layer, determining the hydraulic permeability and solute retention 
properties, and a bulk spongy region, which provides mechanical strength (Fig. 
I-6). Synthetic materials are usually less activating complement cascade and are 
less restrictive to the transport of middle and large molecules. The AN69 
(acrylonitrile) is different from the other synthetic membranes due to its 
symmetric structure. The well-chosen proportion of the hydrophilic sulphonate 
groups and the hydrophobic nitrile groups makes it a membrane with good 
permeability and biocompatible characteristics. 
 
Fig. I-6: Synthetic polysulphone membrane 
Due to varying polymer compositions, membranes with the same polymer names 
may differ in their hemocompatibility, flux properties and adsorption 
characteristics [75,76]. The phenomenon that dialysis membranes differently adsorb 
proteins like beta2-microglobulin, fibrinogen, and coagulation factors, 
complement proteins or hormones like parathormone and erythropoietin, 
contributes to the removal characteristics [77].  
3.4. Basic transport phenomena 
Diffusion refers to the net transport of matter from one region to another due to 
random thermal motion. First and foremost, the driving force for the net diffusion 
of an uncharged solute is a concentration difference. Because the thermal energy, 
responsible for the random molecular motion, is high enough, diffusion is often 
called downhill or passive transport. Adolf Fick derived the first law of diffusion 
of uncharged particles [78]: 
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∆x
∆CADJ S ⋅⋅−=  Eq. I-7 
With J the net solute flux (mol/s), DS the solute diffusivity (m²/s) being a unique 
property of the solute-solvent at a specific temperature, A the area of diffusion 
(m²) and ∆C/∆x the concentration difference (mol/m³) over the membrane 
thickness (m). 
Ultrafiltration is a mode of convective transport with a pressure difference as 
driving force. Because the fluid conveys solutes, it can be seen as passive 
transport of solutes. Darcy’s law gives a general equation for ultrafiltration: 
 PAhJ mu ∆⋅⋅=  Eq. I-8 
With Ju the volumetric flux (m³/s), hm the hydraulic permeability (m/s/Pa), A the 
area of ultrafiltration (m²), and ∆P the pressure difference (Pa). 
Osmosis can be described as diffusive transport. The difference with diffusion, 
however, is that the dissolved particles cannot pass the membrane (e.g. albumin). 
Thus, water passes the membrane in opposite direction to tend to equalize the 
concentrations. The osmotic pressure ∆π is given by the expression of Van 't 
Hoff [79]: 
 ∆CTRσ∆π ⋅⋅⋅=  Eq. I-9 
With σ the reflection coefficient of the membrane (-), R the universal gas 
constant (8.314J/mol/K), T the absolute temperature (K) and ∆C the 
concentration difference (mol/L). 
In hemodialysis, diffusion is the major transport phenomenon, while the term 
hemofiltration is used for the therapy in which solutes are mainly cleared by 
convection [80,81]. In the latter, the excess water and vital solute removal are 
counterbalanced by adding a dilution fluid at the dialyzer inlet (pre dilution [82]) 
or outlet (post dilution technique [83]). In hemodiafiltration therapy, toxic agents 
are removed by a combination of diffusion and convection resulting in a better 
clearance of high molecular weight (HMW) solutes (MW>12000Da) while 
maintaining the performance for low molecular weight (LMW) solutes 
(MW<300Da) [84]. 
3.5. Mass transfer in hemodialyzers 
The practical application of the diffusion law (Eq. I-7), requires the definition of 
different coefficients that can help in either dialyzer design or clinical practice. 
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From this point of view the overall mass transfer coefficient K0 (m/s) can be 
defined transforming Eq. I-7 into: 
 CAKJ 0 ∆⋅⋅−=  Eq. I-10 
The reciprocal of K0 can be seen as the resistance to diffusive transport, which is 
the sum of blood side, membrane and dialysate side resistances [85]. Therefore, 
dialyzer efficiency can be increased best by reducing the largest resistance. The 
blood and dialysate side resistances are mainly covered by the diffusion distance 
from the main fluid stream to and from the membrane. The membrane resistance, 
however, is depending on membrane thickness as well as diffusivity in the 
membrane, varying with the chemical composition of it. 
The diffusive dialysance D (mL/min) is defined as the change in solute content in 
the blood inflow per unit of concentration driving force [86]: 
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−⋅=D  Eq. I-11 
With QBi the inlet blood flow rate (mL/min) and CBi, CBo, CDi, CDo the blood inlet 
and outlet concentrations, respectively, dialysate inlet and outlet concentrations. 
As the dialysate inlet concentration is zero in the case of hemodialysis, Eq. I-11 
can be simplified to the definition of the diffusive clearance K (mL/min), a 
definition that is analogical to the physiological kidney clearance [87]: 
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In case ultrafiltration takes place, the diffusive clearance K is increased by net 
contribution of ultrafiltration QUF (mL/min) to the flux: 
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Because these relations hold for aqueous solutions, a correction factor should be 
added, counting for the heterogeneous nature of blood. The influence of the 
hematocrit H (%), plasma water and solute protein binding is considered by 
replacing QBi by QE in the conventional formulas [88]: 
 ( )

 ⋅⋅−⋅−⋅= φk'FF
100
HFQQ RBCPPBiE  Eq. I-14 
Where FP is the plasma water fraction, FRBC the red blood cell water fraction, k’ 
the equilibrium distribution coefficient and ϕ the red blood cell water fraction 
that participates in solute transfer during blood flow through the dialyzer. 
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In clinical practice, clearance index, K·t/Vurea, equal to 1.2-1.4 is used as gold 
standard for adequate dialysis [89]. This indicator is larger for better clearance, K, 
longer dialysis time, t, and/or for a smaller patient distribution volume, Vurea. In 
general, an increase of K·t/Vurea by 0.1 is associated with a substantially 
decreased risk of death from cardiac, cerebrovascular and infectious diseases [90]. 
K·t/Vurea, however, measures only removal of low molecular weight substances, 
which occurs predominantly by diffusion, and does not consider clearance of 
larger molecules. Babb et al. [91] introduced as first the term middle molecular 
weight solutes (300-12000Da) [84], playing an important role in uremic toxicity, 
especially in processes related to inflammation, malnutrition, and atherogenesis 
(start of degeneration of the inner vessel wall). Moreover, he defined their 
clearance as the product of overall mass transfer coefficient K0 and membrane 
area A, the proportion factor in Eq. I-10. Both described parameters (i.e. K·t/Vurea 
and K0A) are linked by the Michaels equation [85] stating that diffusive clearance 
K is a function of blood and dialysate flow rates and of the dialyzer specific 
parameter K0·A: 
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Eq. I-15 
Besides the mass transfer to and from the patient, described by dialysance D or 
clearance K, there is also a transfer of water towards and/or from the dialysate 
compartment to control the patient’s distribution volume. In analogy with 
Darcy’s law (Eq. I-8), the ultrafiltration coefficient KUF (mL/min/mmHg) can be 
defined as [92]: 
 
TMP
Q
πP
QK UFUFUF =∆−∆=  Eq. I-16 
With QUF the ultrafiltration flow rate (mL/min) and ∆P the hydraulic pressure 
difference (mmHg) between blood and dialysate compartment. The latter can be 
defined as the sum of transmembrane pressure TMP and oncotic pressure ∆π 
exerted by the proteins present at dialyzer blood side. While low flux dialyzers 
were originally designed as diffusive exchangers [93], high flux dialyzers have the 
therapeutic advantage of an increased solute removal by ultrafiltration. Their 
open pore structure results in high rates of small molecule diffusion [94] and 
middle molecule diffusion and convection [92,94]. 
Backfiltration may occur whenever the transmembrane pressure becomes 
negative [95]. The existence and importance of backfiltration during high flux 
hemodialysis have been extensively demonstrated performing hydrostatic and 
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oncotic pressure measurements [61,96-99]. The main problem related to 
backfiltration is the bacterial contamination by liquid bicarbonate concentrate 
and the passage of endotoxins towards the blood compartment [61]. Ronco et al. 
[100], however, demonstrated the positive influence of high forward filtration in 
the proximal and backfiltration in the distal segment of the dialyzer for the 
removal of large molecules. 
After the membrane is exposed to proteins, diffusive transport as well as 
hydraulic permeability decreases significantly due to protein adsorption [56]. 
Moreover, these plasma proteins exert an oncotic pressure ∆π of 20-30mmHg 
opposing the applied hydrostatic pressure [30,101]. Furthermore, the ultrafiltration 
flow deviates from linearity for high TMP values due to concentration 
polarization of high molecular weight substances in the blood which are not 
freely filtrated through the membrane pores [101,102].  
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4. Milestones in the history of dialysis 
Thomas Graham (1805-1869) can be called the father of modern dialysis [103]. 
With his hoop dialyzer (a semi-permeable membrane coated with albumin and 
stretched over a wooden hoop), he demonstrated that solutes are removed by 
diffusion from fluids containing colloids and crystalloids (1861). Although he 
predicted that his findings might be applied in medicine, he never proceeded into 
this field. 
In 1913, John Abel (1857-1938) et al. developed a vividiffusion apparatus, which 
they coined the name artificial kidney. Their original dialyzer, consisting of 8 
parallel collodion tubes of 8 mm diameter and 40 cm long, was soon after 
extended to 32 parallel tubes. The making of those fragile collodion tubes and the 
non-availability of heparin as an anticoagulant were the hardest difficulties they 
had to deal with. Nevertheless, they succeeded in preparing a non-toxic hirudin 
as anticoagulant and in extending the dialyzing capacity with 192 parallel tubes 
for use in human patients. It would however last even more than 30 years before 
the use of an artificial kidney saved the first patient with acute renal failure. 
Meanwhile, the problems of anticoagulation and a suitable membrane were well 
investigated by different researchers all over the world. Von Hess and McGuigan 
(1914) prevented clotting and the formation of stagnant layers by creating a 
pulsatile blood flow and a turbulent dialysate flow, respectively. Love (Chicago, 
1920) started preparing dialysis membranes from chicken intestines while 
Heinrich Necheles (Hamburg, 1923) used semi-permeable tubes made from 
goldbeater’s skin (membrane isolated from calf appendix) [104]. In order to keep 
the blood volume small, these tubes were compressed between metal wire grids. 
Georg Haas (1886-1971) performed the first human dialysis in 1924. He 
constructed a collodion tube (1.2m long) dialyzer with a surface area of 1.5-
2.1m². He reported on improvements in a male patient recovering from uremic 
coma to full consciousness, however deteriorating later again. Moreover, during 
dialysis extended to 60 minutes, the anticoagulant caused bleeding from the 
surgical cannulation wounds. During later in vivo experiments in 1928, using 
heparin as anticoagulant and Ringer solution as dialysis fluid, Haas reported the 
phenomenon of ultrafiltration from positive pressure.  
During the following years (1928-1937), two important advances were made: 
purified heparin became available for human application and a new type of 
membrane named cellophane became commercially.  
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A real break-through happened in 1943 when Willem Kolff constructed the 
rotating drum dialyzer (Fig. I-7), originally made from a wooden core. A 30 to 
40m cellophane tube (diameter 2.5cm) was wound around the cylinder and was 
perfused with the patient's blood by means of a water pump copied from a Ford 
automobile. The lower half of the drum was immersed in a stationary tank 
containing 70-100L dialysis fluid. After some life saving intermittent dialysis 
sessions using one needle for draining and reinfusing the blood, Kolff changed to 
continuous dialysis using two needles. After making punctures in the main 
arteries and veins he had to use surgical cut-downs into the vessels, which 
frequently caused bleeding during heparinization. The problem with achieving 
repeated access to the bloodstream was the major reason why chronic uremic 
patients didn't survive for a long time. Focusing on acute renal failure patients, 
Kolff celebrated his first survivor, a 67 years old female, in 1945.  
 
Fig. I-7: Kolff’s original rotating drum (1943) 
Stimulated by the work of Kolff and his first successes, Nils Alwall (Sweden, 
1946) constructed the first dialyzer with controllable ultrafiltration by applying 
negative pressures to the dialysate reservoir. His dialyzer consisted of cellophane 
tubing wrapped around a stationary vertical metal drum, which was surrounded 
by a second screen and placed in a glass reservoir filled with dialysate. 
Unaware of the work of Kolff and Alwall, Murray et al. (Canada, 1946) 
constructed a static coil, which they used in human patients, using a pulsatile 
blood pump. To attach the patient to their apparatus, they passed a catheter 
through a saphenous vein into the vena cava and another catheter into the 
opposite femoral vein, a method that is still frequently used in patients with acute 
renal failure. 
Von Garrelts (Sweden, 1947) developed a dialyzer, which was more or less the 
precursor of the coil type in which cellophane tubing is wrapped together with a 
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spacer. The spacer was meant to support the membrane but also to allow the 
dialyzer to get perfused by the dialysate. 
Meanwhile, MacNeill (USA, 1947) built a parallel flow dialyzer made from 28 
short flattened cellophane tubes, which were separated by a nylon mesh. This 
prototype was portable but not disposable and had to be sterilized for each 
dialysis session. Skeggs and Leonards (USA, 1948) changed the design of this 
prototype by using two sheets of cellophane and two grooved rubber pads. The 
blood is flowing between the sheets while dialysate flows in the grooves outside 
the cellophane sheets. It is also important to mention that they were the first to 
use counter current flow. 
At the first meeting of the American Society for Artificial Internal Organs 
(ASAIO) in 1955, Kolff presented his twin coil dialyzer (Fig. I-8).  
 
Fig. I-8: Twin coil dialyzer, developed by Kollf (1955) 
Two parallel cellophane tubes (10m long) and fibreglass with spacers were 
wrapped together around a metal core. This type of coil dialyzer was compact 
and could be sterilized in advance by steam or ethylene oxide. Moreover, it was 
disposable and could be mass-produced. However, several disadvantages could 
be remarked: a blood pump was still required, the high pressures in the 
extracorporeal circuit could damage the membrane, a high priming volume was 
needed and, in addition, there was a high incidence of bacterial contamination 
caused by the open tank system. Nevertheless, the survival rate of patients with 
acute renal failure who were dialyzed with this twin coil was rather high. The 
hardest bottleneck to overcome was still the problem of vascular access. 
The studies of Alwall (Sweden, 1949) formed a new approach to the latter 
problem. During animal experiments, he created an arterio-venous shunt between 
the carotid artery and the jugular vein by means of a siliconized heparinized glass 
tube. But the major break-through was the invention of an exterior Teflon bypass 
by Quinton, Dillard and Scribner (USA, 1960) (Fig. I-9). Two Teflon cannules, 
being bent over 180° beneath the skin, were inserted in the radial artery 
respectively the cephalic vein near the wrist of the patient. This device was a 
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landmark in the history of dialysis because it opened the door for the treatment of 
chronic renal failure patients. 
 
Fig. I-9: Prototype of the arterio-venous shunt, developed by Quinton et al. in 1960 
The Kiil dialyzer, developed by Frederik Kiil (Norway, 1960) formed an answer 
to the different problems of that time. The two-layer cuprophan dialyzer 
consisted of a small volume of the blood compartment, which made priming with 
donor blood unnecessary. In addition, the combination of the low flow resistance 
in the blood compartment and the use of an arterio-venous cannule system made 
the use of a blood pump superfluous. 
To avoid problems with dialysate contamination, the single pass technique was 
introduced (1963). This technique was actually the first step in the development 
of a central dialysate supply system. A second step was the substitution of acetate 
for bicarbonate in the dialysis fluid. Sodium acetate, in contrast to the 
precipitating bicarbonate, could be readily mixed with other salts and dextrose in 
the appropriate concentration. Babb developed a multi-patient dialysate 
proportioning system in 1964. 
As a consequence of all these available facilities, an enormous increase of regular 
dialysis treatments occurred. As an answer on the problems of the financing and 
the training of doctors and nurses, Shaldon (UK, 1963) introduced the self-
dialysis, which was soon after extended to home dialysis. 
Although the predecessor of the current hollow fiber dialyzer was described by 
Stewart already in 1968, the Achilles heel of chronic patients remained the 
arterio-venous (A-V) shunt. Therefore, Brescia, Cimino, et al. (USA) created a 
surgically A-V fistula. Because some patients had recurrent problems, May 
introduced in 1969 the saphenous vein autograph as a loop or straight bridge 
between an artery and a vein. 
In the 70's further developments were performed on other domains: increasing 
the dialysis efficiency, shortening the dialysis time, increasing the quality of life 
and the comfort of the chronic patient, amelioration of the biocompatibility and 
miniaturization of the equipment.  
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The middle molecule hypothesis, reported by Babb in 1971, suggested that 
inadequate removal of the middle molecules causes complications such as 
peripheral neuropathy and pericarditis. To provide high diffusive and convective 
transport of middle and large molecules, high flux devices for use in 
hemodialysis were developed. 
The introduction in 1972 of synthetic membranes (e.g. polyacrylonitrile PAN, 
polymethylmethacrylate PMMA, polysulphone PSu), which are far more 
biocompatible than cellulose membranes, prevented activation of the 
complement cascade. 
To control the ultrafiltration flow, a direct control or a control based on a 
differential flow measurement was used until Schultheis (Germany, 1975) 
described the volumetric control method relying on balancing chambers that 
equalize the flow of fresh and spent dialysate [105].  
As an alternative for the classical Brescia-Cimino bridged arterio-venous fistula, 
Baker and Kaplan introduced in 1976 the expanded polytetrafluoroethylene 
(ePTFE, Gore-tex) self-sealing conduit. 
In the 80's, the suspicion arose that acetate, used to prepare the dialysis fluid, 
could accumulate in the blood and tissues, leading to acetate toxicity with 
vascular instability and hypotension. For this reason the use of bicarbonate 
containing dialysate was reborn in 1982. 
The modern machines for hemodialysis permit a complete manipulation of the 
dialysate composition, temperature, flows, and pressures to improve problems of 
metabolic acidosis and electrolyte imbalances [67]. Although most hollow fiber 
dialyzers today resemble to those devices over 30 years ago, a number of 
variations in design have been established in order to optimize dialyzer 
performance. These performance-enhancing designs will be discussed more in 
detail in Chapter II. 
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5. Research techniques  
For the investigation of transport phenomena and fluid properties, experimental 
as well as mathematical techniques were applied for the projects reported in this 
dissertation. While physical properties of fluid and flow were effectively 
measured with experiments, they were described by equations in a mathematical 
model.  
One can distinguish between in vitro, in vivo, and ex vivo experiments. While in 
vivo experiments are initially achieved at the patient’s bedside, in vitro and ex 
vivo experiments can be performed in the laboratory. In vitro and ex vivo 
experiments allow using the exact same equipment as it is used in the clinical 
setting (e.g., dialyzer, pressure monitors), and they even permit the use of 
uncommon measuring approaches, such as medical imaging of dialyzer flows. 
The experimental results were further used either as input or as a validation tool 
for the mathematical model. With the validated model, detailed three-
dimensional predictions of transport phenomena and fluid properties were 
provided. Furthermore, a validated mathematical model offered the opportunity 
to investigate different design and flow parameters in a non-destructive way with 
minimal cost. 
5.1. In vitro testing 
In vitro experiments were useful to investigate specific dialyzer, flow and/or 
fluid characteristics. For this purpose, basic measuring equipment and water-like 
fluids, such as reverse osmosis water or dialysis fluid, were used. Using water 
instead of blood, flow rates were adapted according to dynamic similarity, 
keeping the Reynolds number in the model equal to that in reality [62]: 
  
ν
DVRe mean ⋅=  Eq. I-17 
With Vmean the mean flow velocity (m/s), D a characteristic geometry parameter 
(m) (e.g. diameter), and ν the kinematic viscosity (m²/s). 
The in vitro setups used to study dialyzer related aspects, consisted of an 
upstream reservoir from which the fluid was pumped with a roller pump through 
the dialyzer under study towards a downstream reservoir. The semi-pulsatile flow 
pattern was often attenuated by the use of air chambers.  
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In order to describe flow properties, flow rate and pressure measurements were 
performed. Using a downstream reservoir, the flow rate was determined 
gravimetrically as the mass change (registered by a balance) over a time interval 
(registered by a chronometer). In order to characterize flow at an intermediate 
position in the in vitro setup, clamp-on probes were applied to determine the flow 
rate with ultrasound (Transonic Systems Inc, Ithaca, NY). The probes were 
however calibrated by gravimetrical flow measurements, as the ultrasound 
propagation and derived flow rates are dependent on the fluid properties and the 
tubing material and wall thickness. 
Local pressure was measured with fluid filled strain gauge transducers (Ohmeda, 
Gent, Belgium). The filling and purging of the transducers was achieved using 
capillary fluid lines, connected perpendicular to the tubing wall. To compare 
local pressures as measured with several pressure transducers, static pressure 
differences due to height were taken into account. To measure a pressure 
difference directly, e.g. pressure drop over a dialyzer, a differential pressure 
transducer was used (Fuji Electrics FCX, Coulton, UK). With either type of 
transducer the pressure is translated into a voltage signal that has to be 
conditioned and amplified, thus requiring calibration of the whole system. 
Density and viscosity are important fluid characteristics when performing flow 
measurements. The density of an aqueous fluid was measured with a density-
hydrometer-aerometer (Assistant, Germany). The densimeter, a long sealed 
capillary, was placed in a glass container filled with the fluid under study. 
Depending on the fluid density, the densimeter floats on the fluid, characterized 
by a certain submerged height. The denser the fluid is, the smaller the submerged 
height. 
The viscosity of an aqueous fluid was measured with a capillary Ubbelohde 
viscometer (Schott, Germany). This glass tube with a partial capillary was fixed 
in a thermostatic bath and was filled with the fluid under study. Viscosity is 
derived from the time interval that the fluid needs to pass the capillary. To obtain 
an absolute value, the instrument was calibrated and characterized by an 
apparatus constant K (m²/s²): 
 tKν ⋅=  Eq. I-18 
With ν the kinematic fluid viscosity (m²/s) and t the passage time of the fluid (s). 
For laboratory measurements, dialysis fluid was prepared on the spot by 
proportional mixing of reverse osmosis water with electrolytes and bicarbonate. 
The conductivity of the final mixture should be constant at 14mS/cm and was 
controlled using a conductivity probe (LF340-WTW, Weilheim, Germany). 
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Conductivity is a measure of the ability of the fluid to carry an electric current. 
Conductivity meters function by measuring the amount of ionized substances in 
the fluid, such that a change in conductivity occurs when there is a change in the 
total concentration of ionized solutes. 
5.2. In vivo testing 
Patient data was in particular cases indispensable for the input and/or validation 
of mathematical models. While pressure and flow rates were set and read from 
the hemodialysis machine monitor, blood properties were mainly investigated by 
blood sampling from the arterial and/or venous blood line. The samples were 
analyzed in the clinical laboratory to determine specific blood properties, i.e., 
solute concentrations and hematocrit. 
Techniques that require aspiration of a blood sample for hematocrit (H) 
determination change the sample status and introduce three potentially significant 
errors: dilution errors (caused by blood anticoagulation), mean cell volume errors 
(caused by red blood cell shrinkage due to anticoagulation), and technique errors 
(e.g. contamination or hemolysis of the sample, equipment related errors, or 
inappropriate sampling time). In general, the overall potential error for human 
blood samples is as high as +/-5H units. 
To counter this problem, hematocrit, together with blood volume and oxygen 
saturation, were monitored on line during in vivo dialysis using a Critline 
system (Inline Diagnostics, US). The Critline sensors were placed in the blood 
line and register the in vivo hematocrit Hiv by optical trans-illumination of blood: 
 
plasmaRBC
RBC
iv VV
V
H +=  Eq. I-19 
With VRBC and Vplasma the red blood cell and plasma volume, respectively. The 
Critline is calibrated to standard hemodialysis patient’s blood with a mean cell 
volume (MCV) of 91µm³. 
5.3. Ex vivo testing 
The term ‘ex vivo’ refers to the simulation of the clinical dialysis setup, however, 
without a patient – as if the fluid is taken out of the body. Using a standard 
dialysis machine, a blood substitute flow and dialysate flow were generated in 
the dialyzer. As blood substitute, bovine blood from the slaughterhouse was used 
in the blood compartment. 
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Flow rate and pressure measurements were performed as described in paragraph 
5.1. The viscosity of non-Newtonian blood was evaluated with a plate and cone 
viscometer (Rheolyst AR 1000-N Rheometer, TA Instruments, UK), where 
viscosity is registered as a function of shear rate by assessing the torque 
necessary to spin the cone. For blood measurements, an acrylic cone (176°) with 
a diameter of 6cm was applied. The distance between cone and plate was set to 
56µm and the plate was heated to body temperature 37°C. The dynamic blood 
viscosity for a given shear rate was derived using: 
 ωF
F
γ
τµ
rate
stress
⋅
⋅== T  Eq. I-20 
With τ the shear stress (Pa), γ the shear rate (1/s), T the torque (N·m), and ω the 
angular velocity (rad/s). The instrument constants Fstress and Frate are equal to 
18000m-3 and 28.5, respectively. By increasing the shear rate from 10 to 800s-1 
during the experiments, the shear thinning behavior of blood (viscosity 
decreasing with shear rate) can be adequately visualized. 
5.4. Medical Imaging techniques 
5.4.1. Overview of available imaging techniques 
According to the purpose, different medical imaging techniques are clinically 
applied: computer tomography (CT), magnetic resonance imaging (MRI), 
positron emission tomography (PET), and single photon emission computed 
tomography (SPECT). CT and MRI are morphological imaging techniques 
resulting in anatomical information with a high resolution (~1mm). PET and 
SPECT, however, provide information about functional processes and are nuclear 
techniques with a limited resolution (~5-12mm in patients). 
With CT, a thin and efficiently collimated X-ray bundle is passing radially 
through the patient’s body, while a detector measures the different attenuation 
values of the cross section. Because the obtained intensity profile is actually a 
projection, the instrument is rotated over 180° in 1° increments. From all 
projections, the computer calculates a two-dimensional attenuation distribution 
corresponding to the scanned object. 
MRI is based on the fact that hydrogen atoms act as little magnets in an overall 
magnetic field. By registering, after external excitation, the movement of these 
magnets in the patient, cross sectional images of the patient’s body are obtained. 
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The image forming variable with PET is the distribution in the structure under 
study of a radionuclide, a radioactive indicator of physiological processes. The 
latter is administered in the form of a pharmaceutical prior to the imaging 
procedure, and decays by the emission of positrons. The reconstruction is 
analogous to that used in conventional CT. 
The medical imaging technique used in this dissertation was SPECT, and will 
therefore be explained more in detail in the following paragraph. 
5.4.2. SPECT imaging 
SPECT, or single photon emission computed tomography, aims to visualize the 
regional concentration of a radionuclide within a specific organ as a function of 
time. Such a radionuclide (e.g. 99m-Tc) is normally injected in the patient’s 
body, where it emits a single gamma ray photon. This photon has 141keV energy 
and a half-life of about 6h, and is easily detected by gamma cameras. In order to 
obtain reliable images, collimation of the gamma rays is necessary. A collimator 
contains thousands of parallel channels, and is connected directly on top of a 
single crystal (NaI) present in every gamma camera (Fig. I-10). Gamma rays 
passing unabsorbed through the collimator interact with the crystal and create 
light. Behind the crystal, a grid of photomultiplier tubes collect the light for 
processing. By analyzing these light signals, SPECT images are produced. 
In order to obtain a three-dimensional activity distribution, the two-dimensional 
projections, as taken at each view angle by camera rotation, must be 
reconstructed with a filtered backprojection algorithm [106]. Here, the Fourier 
transform of a projection is related to the Fourier transform of the object along a 
single radial according to the Fourier slice theorem [107]. Given the Fourier 
transform of a projection at enough angles, the projections can be assembled into 
a complete estimate of the two-dimensional transform. 
Filtered backprojection is performed in four steps: first, measuring of the 
projection; second, finding the Fourier transform of the projection; third, 
performing a filter operation by multiplying the Fourier transform by a weighing 
function that is linear in frequency; and fourth, completing a backprojection by 
summation of the Fourier transforms of the filtered projections over the image 
plane. This procedure is repeated for the projections taken at each view angle. 
There are two advantages to the filtered backprojection algorithm over a 
frequency domain interpolation scheme. Most importantly, the reconstruction 
procedure can be started as soon as the first projection was measured. Secondly, 
interpolation in the space domain is more accurate than in the frequency domain. 
Introduction to modeling of dialysis 
 31
 
Fig. I-10: The detection system in a SPECT camera 
5.5. Kinetic modeling 
The human body can be considered as a biological system, consisting of different 
compartments, which are separated by semi-permeable membranes. Around 58% 
of the human body consists of water, which is divided over the extracellular 
compartment (plasma water and interstitial water) and the intracellular 
compartment. Transport between the different compartments can happen 
passively by free diffusion of non-loaded particles (e.g. water, oxygen, urea) or 
loaded particles (ions), and by forced diffusion via carriers or channels. The 
transport can also occur as an active process where the energy is supplied by the 
ATP (adenosine triphosphate) hydrolysis ATPase, or as a secondary active 
transport according to an electrochemical gradient. 
In order to investigate the efficiency of hemodialysis, a kinetic model, 
incorporating fluid mechanics and mass transport, can describe the entire patient-
dialyzer system. In general, kinetics describes the variation in time (characterized 
by a time constant) of a physical entity (e.g. mass, energy) according to a driving 
force.  
Geometrically evaluated, a kinetic model may consist of a single pool, two pools 
or even more compartments. Each compartment is characterized by an internal 
solute concentration (C) and a volume (V). Different transport processes can 
change the solute concentration and volume: input (I) and output (O), and solute 
generation (GS) and/or elimination (E) (Fig. I-11). 
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Fig. I-11: Single pool model characterized by its solute concentration (C), volume (V), and the 
different transport processes: input (I), output (O), solute generation (GS), and elimination (E). 
Depending on how the mass transfer is related to the solute concentration, we can 
distinguish between a zero, first, or higher order process. In a zero order process, 
a constant amount of mass (A) is added or extracted. This transport process, 
independent on the solute concentration, might however be time dependent, and 
can be described as follows in a single pool model: 
 
( ) A
dt
dCV
dt
dVC
dt
CVd =⋅+⋅=⋅  Eq. I-21 
In a first order process, the mass input and output is proportional with the 
concentration itself or, in the case of two compartments, with the concentration 
difference. The proportionality factor is then often called the clearance (K) and 
inter-compartmental clearance (K12), respectively. A first order process in a 
single pool can be formulated as: 
 
( ) CK
dt
dCV
dt
dVC
dt
CVd ⋅=⋅+⋅=⋅  Eq. I-22 
In the case the volume change can be neglected, solving Eq. I-22 gives:  
 ( )tkexpCt
V
KexpCC 00 ⋅−⋅=

 ⋅−⋅=  Eq. I-23 
With C0 the solute concentration at t=0, and k a kinetic parameter. The reciprocal 
of the latter is the time constant of this first order process, indicating the time it 
takes to decrease concentration by 63% [as C/C0 = exp(-1) = 0.37]. 
With a higher order process, the mass input and output varies non-linearly with 
the solute concentration. 
A two-pool model is a logical extension of the single pool model. There are two 
well distinguishable parts, such that the physical entities have different values in 
both compartments. In analogy with a single pool model, a mass balance is 
written for each compartment separately, resulting in two differential equations. 
Furthermore, as mass transport takes place in between the two pools, the 
differential equations are coupled and must be solved simultaneously. 
C, VI O
GS E
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5.6. Numerical modeling 
Besides experimental and theoretical approaches, computational fluid dynamics 
(CFD) can be seen as a virtual way of investigating complex flow situations. 
With CFD, the flow situation in a specific structure is analyzed by dividing the 
geometry in numerous non-overlapping small cells for which the basic flow 
dynamics can be calculated and related to the neighboring cells. The results are 
calculated in some discrete points of the cells, also called nodes. Cells can be of 
different shape (e.g. triangular, quadrilateral), and can be part of a structured or 
non-structured grid. The meshes used in the scope of this work were created 
using Gambit (Sheffield, UK). The cornerstones of CFD are the fundamental 
governing equations of fluid dynamics: continuity, momentum and energy 
equations. These mathematical statements are based on the fundamental physical 
principles mass conservation, Newton's second law respectively energy 
conservation, which can be written in a differential or an integral form.  
These equations are replaced by algebraic equations using one of the three 
known discretizing techniques: Finite Difference Method (FDM), Finite Element 
Method (FEM), or Finite Volume Method (FVM). The FDM replaces the 
derivatives in the differential equations by differences, and needs therefore a 
structured grid. The FEM does not look for a solution of the differential 
equations itself, but looks for a solution of some integral form of the equations, 
obtained from a weighted residual formulation. With the FVM the integral form, 
and not the differential form is discretized.  
By replacing the equations with numbers, which are advanced in space and/or 
time, a final numerical description of the complete flow field of interest was 
obtained.  
5.6.1. Governing equations 
The governing equations were calculated using the software package Fluent 
(Sheffield, UK). 
5.6.1.1. Fluid dynamic equations 
The continuity and momentum equations are also known as the steady Navier-
Stokes equations and are expressed as: 
 
τpuuρ
0u
∇=∇+∇•⋅
=•∇
 Eq. I-24 
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With u the local mass average fluid velocity vector (m/s), ρ the local density 
(kg/m³), p the local pressure (Pa), and τ  the deviatoric stress tensor (Pa). ∇  is 
the gradient operator in three-dimensional Cartesian coordinates: 
 



∂
∂
∂
∂
∂
∂=∇
z
,
y
,
x
 Eq. I-25 
The stress tensor, σ , consists of two parts, i.e. the pressure p and deviatoric 
stress tensor τ : 
 τIpσ +⋅−=  Eq. I-26 
With I  being the unity tensor. 
To model the stress tensor, it is necessary to add the constitutive equation, 
expressing the rheological properties of the fluid: 
 ( ) ( )Tuuuµτ ∇+∇⋅∇=  Eq. I-27 
µ denotes the dynamic viscosity (Pa·s) and the superscript T is the transpose of 
the tensor. The choice of ( )uµ ∇  defines the model and is constant for a 
Newtonian fluid. 
5.6.1.2. The convection-diffusion equation 
The equations of continuity for two chemical species (e.g. A and B) in a binary 
fluid mixture can be established by making a mass balance over an arbitrary 
differential fluid volume. The insertion of the expression for the mass flux results 
in the convection-diffusion equation. The stationary convection-diffusion 
equation for mass transport of species A in a binary fluid mixture with species A 
and B, can be described as: 
 ( ) rCuCD AAAB =∇•+∇⋅∇−  Eq. I-28 
With DAB the diffusion coefficient of species A in B (m²/s), CA the solute 
concentration of species A (mol/m³), u  the macroscopic fluid velocity vector of 
species B, and r a reaction term (source or sink). 
In case the diffusion coefficient DAB is constant, Eq. I-28 can be written as: 
 rCu∆CD- AAAB =∇•+⋅  Eq. I-29 
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With ∆ the Laplace operator in three-dimensional Cartesian coordinates: 
 2
2
2
2
2
2
zyx
∆ ∂
∂+∂
∂+∂
∂=  Eq. I-30 
5.6.2. Boundary conditions 
The fluid dynamic equations (Eq. I-24) must be solved using appropriate 
boundary conditions for the limits of the flow field. Because Eq. I-24 is a system 
of second order differential equations in space, it is necessary to prescribe 
boundary conditions for each velocity component and pressure at the complete 
domain boundary.  
At the inlet, a Poiseuille or uniform velocity distribution is assumed. The outlet 
boundary can be modeled as a pressure outlet or an outflow. The latter can 
specify, in the case of multiple outlets, how much of the total inlet flow will 
leave the geometry by this particular outlet.  
The domain boundaries are modeled either as a wall where no-slip occurs or as 
symmetry planes when only a part of a symmetric structure is modeled. There are 
no velocity components perpendicular (n direction) to the symmetry plane (un = 
0), and the tangential stress is zero (σt = 0). At fixed walls, no-slip conditions at 
the wall are applied ( u =0). 
The concentration can be prescribed on some part of the domain boundary, while 
at symmetry planes a zero perpendicular variation is prescribed: 0
n
CA =∂
∂
. 
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1. Chapter overview 
This chapter starts with focusing on the importance of investigating blood and 
dialysate flow distributions in hemodialyzers (paragraph 2). A literature 
overview deals with the different techniques that have been used in the past in 
order to assess the flow distribution in the blood and/or dialysate compartment. 
At once, the results of the investigated dialyzers will be discussed as well as 
some new dialyzer designs to improve any flow mismatch (paragraph 3).  
In paragraph 4, our study is presented in which we combined a medical imaging 
technique (i.e. single photon emission computed tomography: SPECT) and 
computational fluid dynamics (CFD) for the assessment of flow distributions in a 
low flux polysulphone hollow fiber dialyzer (Fresenius F6HPS). The SPECT 
results were further applied to validate the CFD model (paragraph 5). By 
implementing the local results in a computer model of one single fiber, the 
influence on mass transfer of different flow distributions can be quantified 
(Chapter IV). 
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2. The importance of flow modeling 
Diffusion is the major transport phenomenon in hemodialysis. Low molecular 
weight solutes are removed primarily by diffusion, while larger molecules are 
transported by diffusion as well as with the convective ultrafiltration flow. As a 
consequence, the efficiency of the diffusion process plays an important role in 
the removal of small uremic solutes from the patient’s blood. Since it has been 
proven in the early 70’s that the removal of larger molecules also plays an 
important role in uremic toxicity [91], optimization of convective transport 
efficiency gained more attention. 
The driving force for diffusive transport is the concentration difference over the 
membrane between the blood and dialysate. The blood and dialysate flow rates, 
and the membrane surface area and thickness mainly influence this gradient. 
Although the surface area and membrane thickness are theoretically constant for 
a particular dialyzer type, disturbances in flow can influence the effective value 
of those parameters, and are therefore of special interest. 
The driving force for convective transport is the pressure difference over the 
membrane between the blood and dialysate. This difference is primarily 
influenced by the blood and dialysate flow rates and the geometrical dimensions. 
The pressure profile in both compartments also determines the location of 
forward and backfiltration. Because internal filtration enhances overall mass 
transfer, the knowledge of pressure and, with it, of flow distributions is 
significant. 
Ideally, the flow distributions in both the blood and dialysate compartment 
should be uniform over the entire dialyzer geometry to ensure optimal solute 
removal [108]. Blood should flow uniformly inside the lumen of the fibers, while 
dialysis fluid should flow uniformly around the fibers. When each fiber is 
completely bathed in the dialysis fluid, the surface area that effectively 
contributes to the solute removal is then optimal. It is evident that any mismatch 
in flow distributions, e.g. caused by dialysate channeling and/or fluid stagnation, 
plays a negative role in solute clearance efficiency. 
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3. Literature overview 
In the early 70's, several dialyzer innovations were achieved increasing dialysis 
adequacy. The introduction of synthetic membranes was a real breakthrough in 
favor of a better biocompatibility. The development of high flux devices 
ameliorated the removal of middle and large molecules, decreasing the risk of 
long-term effects on mortality and morbidity [109,110]. And furthermore, control 
systems were developed to adjust ultrafiltration rate, especially important when 
using high flux dialyzers [105]. 
Until the 90’s, the concept of hollow fiber dialyzers was not changed and 
dialyzers only differed from each other regarding the membrane type and the 
geometrical dimensions on fiber as well as dialyzer level. Since it was proven 
during the last decennium, however, that flow distributions have an important 
impact on dialyzer efficiency, different performance-enhancing designs were 
developed.  
3.1. Flow distributions in the original dialyzer concept 
Nordon et al. [111] investigated the blood flow distribution in an axi-symmetrical 
two-dimensional CFD model of hollow fiber systems used for affinity cell 
separation. In the inlet and outlet header, the Navier-Stokes equations 
(conservation of mass and momentum) were solved for steady incompressible 
laminar flow. The hollow fibers were modeled as a porous medium with a radial 
permeability a factor thousand less than the axial permeability. They found a 
uniform blood flow, and stated that this is mainly influenced by the radial-to-
axial hydraulic permeability ratio. In the inlet header, boundary layer separation 
occurred at the point of channel divergence causing the formation of a separation 
bubble. This phenomenon can be avoided ensuring a lower inlet Reynolds 
number (<200), or changing the inlet header geometry, i.e. decreasing the length 
within the inlet and the fiber bundle interface, and adapting the shape of the 
header. 
Performing in vitro measurements using whole blood, blood flow distributions 
were shown to be hematocrit dependent. Ronco et al. [112] found that the 
peripheral regions (near the dialyzer outer shell) are less perfused for higher 
hematocrits compared to the central region of a dialyzer. With a pre-dialysis 
hematocrit of 25%, the central and peripheral velocities were 13% higher and 
23% lower than the average calculated flow velocity, respectively. For a start 
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hematocrit of 40%, deviations from the average velocity were even more 
pronounced, i.e. 42% higher and 53% lower in the central and peripheral regions, 
respectively. Furthermore, in vivo studies illustrated that diffusion of several 
solutes is hampered for higher hematocrits [113,114]. Urea transfer is not 
significantly affected by the hematocrit, because it diffuses freely through the red 
cell membrane and is almost in equilibrium (99%) at the dialyzer outlet [115,116]. 
Creatinine, however, only hardly diffuses from the red blood cell to plasma 
during blood transit through the dialyzer (2%) [115,116]. As a consequence, solute 
clearances that are confined to plasma water are more influenced by changes in 
hematocrit. 
Osuga et al. [117] determined dialysate pressure isobars in a low flux hollow fiber 
dialyzer (Toray B2-2.0) by combining the results of magnetic resonance imaging 
(MRI) and a numerical simulation of a contrast solution injected in the dialysate 
flow. Comparing the results of both measuring techniques, the fiber compartment 
was regarded as a porous medium with a radial-to-axial hydraulic permeability 
ratio in the range 0.114-1.14. Because the pressure isobars only vary in the axial 
direction, dialysate flow was assumed uniform with no local non-uniformities of 
the fiber bundle density. 
Using computed tomography (CT), Takesawa et al. [118], however, found a non-
uniform dialysate flow in dialyzers of different membrane types (i.e. cuprophan, 
regenerated cellulose, cellulose diacetate, and polymethylmethacrylate) and 
different manufacturers (i.e. Senko, Asahi Medical and Terumo, Baxter, and 
Toray Medical, respectively). It was found that the wetting of the cellulose fibers 
causes breaking and twisting of the fiber bundle resulting in a markedly increase 
of local dialysate velocity. With the polymethylmethacrylate membranes 
(PMMA), dialysate flow towards the inner regions of the dialyzer was delayed 
causing part of the surface area ineffective when it comes to solute removal. The 
presence of spacing yarns, however, avoids fiber twisting and makes the PMMA 
membranes more efficient compared to cellulose membranes (see paragraph 
3.2.1). 
Zhang et al. [119] determined the blood and dialysate flow distributions 
simultaneously using magnetic resonance Fourier velocity imaging. Equal but 
counter current blood and dialysate flow rates were applied with cellulose acetate 
(CA), cellulose triacetate (CTA), and polysulphone (PSu) membranes. The flow 
distribution within the fibers was relatively uniform in all studied dialyzers. 
Dialysate flow distribution, however, was strongly non-uniform with regions of 
high flow either outside the fiber bundle (CA and CTA) or dispersed in a patchy 
way (PSu).  
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In conclusion, the standard hollow fiber dialyzer design, with thousands of fibers 
randomly packed and encapsulated inside a dialyzer housing, results in a 
decreased mass transfer efficiency compared to theoretical assumptions based on 
the entire membrane surface area. In the search for enhancing mass removal to 
ameliorate the quality of life and comfort of the chronic renal patient, several 
new designs were developed in the recent years. 
3.2. New dialyzer designs optimizing flow distributions 
Different strategies were followed in order to obtain homogeneously distributed 
dialyzer flows. Some attempts were related to the fiber bundle, while others were 
focused on the design of the dialyzer housing. 
3.2.1. Improvements on the fiber bundle 
Using a helical CT scan, Ronco et al. evaluated the use of spacing yarns in a 
polyacrylonitrile (PAN) membrane (Asahi Medical 65SF) [112,120,121]. Spacing 
yarns are placed within the fiber bundle to separate the fibers, increasing the 
effective surface area (Fig. II-1 left and middle panel). They also investigated 
dialysate flow around hollow fibers with a Moiré structured wave design in a 
cellulose diacetate (CDA) membrane (Nissho-Nipro FB130) [112,121] (Fig. II-1 
right panel). Flow distributions were most homogeneous in the dialyzer with the 
fibers waved to give Moiré structure, while spacing yarns gave a result 
intermediate to the Moiré structure and a standard PAN hemodialyzer (Asahi 
Medical 65DX). Both techniques were found effective in preventing fiber 
twisting and excessive packing of the fibers in some regions, hereby resulting in 
an idealized dialysate flow pattern without dialysate channeling.  
The positive effect of spacing yarns on dialysate flow distribution was also 
studied by Poh et al., by using MRI [122]. 
  
Fig. II-1: Spacing yarns (left and middle panel) and Moiré structured fibers (right panel) in a 
dialyzer, adapted from Ronco et al. [121] and Uhlenbusch et al. [123] 
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Gastaldon et al. [124] reported that the use of a special fiber cutting technology 
contributes to an improved blood flow distribution in the PSu Diacap 15 (Braun). 
This is because accidental obstructions of the fiber lumen are prevented and a 
smooth interface at the fiber inlets is created decreasing cell activation [125]. 
Furthermore, the undulation of the fibers reduces dialysate channeling, 
comparable to what happens with Moiré structured fibers. 
As an alternative to spacing yarns and undulated fibers, a special fiber crossing 
with a certain angle can be applied (e.g. Gambro polyamide Polyflux) [126]. 
Furthermore, fin-like structures at the outer surface of each fiber have also been 
developed to ensure fiber separation [123]. The effectiveness of the latter technique 
could however not be proven [127].  
The dimensions of the fiber itself also affect diffusive and/or convective 
transport. Because thicker membrane increases the diffusion length, hereby 
reducing the diffusion driving force (Eq. I-7), a higher urea mass transfer area 
coefficient (K0·A) was found using a CTA membrane (15µm) compared to a PSu 
membrane (40µm) [128]. Keeping the total surface area constant, a reduction of the 
fiber diameter does not affect diffusive transport, while the convective removal 
of middle [129] and large molecules [130] is enhanced. Furthermore, increasing the 
fiber length results in a larger pressure drop over the dialyzer, ameliorating 
filtration and/or internal filtration [131]. As a consequence, larger molecules are 
transported more efficiently by convection, while the diffusive transport is not 
altered for equal surface areas. 
Finally, it should be remarked that the optimum dialyzer dimensions and related 
fiber packing density should be determined for each dialyzer individually [132]. 
The use of different fiber bundles in the same dialyzer housing may lead to low 
packing densities, resulting in flow channeling, or dense packed fibers, resulting 
in fluid stagnation, thereby also inducing flow channeling.  
3.2.2. Improvements on the dialyzer housing 
In order to avoid the non-uniform blood flow distribution as found with higher 
hematocrits [112], new blood header designs were developed. In the arterial 
header, blood stagnation should be avoided as well as irregularities. The conic-
shape distributor with a very thin space between the inlet and the fiber bundle 
interface [113] was many years considered as the most efficient flow distributor. 
This was previously confirmed by the calculations of Nordon et al. [111]. 
Recently, the manufacturers Fresenius Medical Care and Hospal introduced a 
new header, in which the blood is entering through a laterally positioned inlet 
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nozzle. For the FX-class of dialyzers (Fresenius), the radial inflow together with 
the internal helicoidal distributor enhances the radial blood velocity and the 
homogeneous access to all fibers. With the Arylane and CDA dialyzers (Hospal), 
blood inlet is tangential rather than radial [123]. 
  
Fig. II-2: Flow baffles in a hemodialyzer: semi rounded flow baffle (left panel) and internally 
finned flow baffle (right panel), adapted from Poh et al. [133] 
With respect to the dialysate side, flow distribution was originally enhanced 
using distribution rings within the dialyzer housing. Related to this, Poh et al. 
[122,133] investigated with MRI the effect of different designs of flow baffles 
(pieces of plastics) in the dialysate inlet and outlet header (Fig. II-2). The semi 
rounded flow baffle (Fig. II-2 left panel) prevents a high velocity impact onto the 
fiber bundle. Although these flow baffles are commonly used in a hemodialyzer, 
both designs were found ineffective to guarantee a uniform dialysate flow. Wang 
et al. [134] reported an increased mass transfer in a double-segmented baffled 
module compared to conventional modules (Fig. II-3). 
  
Fig. II-3: A double segmental baffled module, adapted from Wang et al. [134] 
Recently, a pinnacle structure of the ends of the dialyzer housing (Fig. II-4) was 
considered as another innovative construction to promote a homogeneous 
dialysate flow distribution (Helixone, Fresenius) [123,135]. 
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Fig. II-4: Pinacle structure in the dialyzer housing, adapted from Uhlenbusch et al. [123] 
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4. Combining SPECT and CFD for analyzing flow 
distributions in a low flux dialyzer† 
4.1. Abstract 
For a better insight in dialyzer efficiency with respect to local mass transport in a 
low flux dialyzer (Fresenius F6HPS), blood and dialysate flow distributions were 
visualized with computational fluid dynamic (CFD) simulations, which were 
validated with single photon emission computed tomography (SPECT) imaging. 
To visualize blood-side flow while avoiding transport through the fiber 
membrane, a bolus of 99m-Technetium labeled MAA (Macro Aggregated 
Albumin) was injected in the flow using an electronic valve. Water was used to 
simulate blood, but flow rate was adjusted according to laws of dynamic 
similarity to account for the viscosity difference (factor 2.75). For the 
visualization of dialysate flow, a bolus of 99m-Technetium labeled DMSA 
(Dimercaptosuccinic Acid) was injected, while pressurized air in the blood 
compartment avoided transmembrane flow. For each test series, 3D acquisitions 
were made on a two respectively three-headed SPECT camera. By evaluating the 
images at different time steps, dynamic 3D intensity plots were obtained, which 
were further used to derive local flow velocities. Additionally, three-dimensional 
CFD models were developed for simulating the overall blood and dialysate flow, 
respectively. In both models, the whole fiber compartment was defined as a 
porous medium with overall axial and radial permeability derived theoretically 
and from in vitro tests.  
With the imaging as well as with the computational technique, a homogeneous 
blood flow distribution was found, while vortices and fluid stagnation were 
observed in the dialyzer inlet manifold. The non-homogeneous dialysate 
distribution, as found with SPECT imaging, implies the occurrence of non-
efficient sites with respect to mass transfer. The discrepancy between the 
dialysate results of both techniques indicated that the assumption of a constant 
fiber bundle permeability in the CFD model was too optimistic.  
                                                     
† The contents of this section was submitted for publication 
Combining SPECT medical imaging and computational fluid dynamics for analyzing blood and 
dialysate flow in hemodialyzers 
S. Eloot, Y. D’Asseler, P. De Bondt, and P. Verdonck 
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In conclusion, medical imaging techniques like SPECT are helpful to validate 
CFD models, which can be further applied for dialyzer design and optimization.  
4.2. Background 
The flow distribution in both the blood and dialysate compartment of a hollow 
fiber dialyzer determines the efficiency of the mass transfer. A uniform flow 
distribution benefits local mass transfer, and any mismatch caused by non-
uniform flow in either the blood or dialysate compartment results in an inferior 
uremic solute removal from the blood [108]. It has been demonstrated that a 
significant increase in mass transfer area coefficient (K0·A) can be obtained by 
augmenting the dialysate flow rate from 500 up to 800mL/min [128,136]. This 
benefit in dialyzer efficiency can be ascribed to an increase in effective 
membrane surface area [137], as fiber bundle perfusion is enhanced, and 
preferential flow channeling and fluid stagnation are impeded with the use of 
higher dialysate flows. Due to the high economical cost of using increased 
dialysate flow rates, alternative solutions were sought by developing new 
dialyzer designs, either targeting the fiber bundle (the use of spacing yarns 
[112,121,122]), the fiber itself (fiber undulations [112,124]), the dialyzer manifolds 
(radial inflow [135], or the use of flow baffles [133]). 
These dialyzer designs were evaluated using experimental medical imaging 
techniques like helical computed tomography (CT) scanning [112,120,121], magnetic 
resonance imaging (MRI) [117,119,122,133], and X-ray CT scanning [118]. These 
techniques have been proven to be adequate for a global description of flow and 
pressure distributions in hemodialyzers, but their accuracy is however limited 
due to restricted resolution of the medical images.  
Recently, computational fluid dynamics (CFD) has become an important tool in 
the design process of artificial organs [138,139]. Although CFD can provide a 
detailed three-dimensional evaluation of flow and mass transport in complex 
geometries, it should be noted that the numerical results are only as valid as the 
physical models incorporated in the implemented governing equations and 
boundary conditions. As a consequence, the simulations should be validated 
using experimental techniques, such as, for instance, flow visualization by 
medical imaging. 
The main objective of this study was to assess the local flow in hemodialyzers by 
combining experimental and numerical techniques. The flow distributions in a 
low flux dialyzer were visualized using single photon emission computed 
tomography (SPECT) imaging, a different imaging technique then those 
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previously described in literature. A CFD model was developed for the 
simulation of the transport processes in a hemodialyzer, providing detailed 
quantitative information about local velocities and fiber bundle permeabilities. 
The combination of the SPECT images and the CFD simulations are used to 
assess the transport in hemodialyzers. 
4.3. Materials and methods 
4.3.1. Experimental SPECT measurements 
4.3.1.1. In vitro setup 
A new in vitro setup (Fig. II-5) was built to visualize blood or dialysate flow 
through a low flux polysulphone F6HPS hemodialyzer (Fresenius Medical Care, 
Bad Homburg, Germany) with SPECT imaging. Using an upstream overflow 
reservoir, a steady state flow was accomplished in the compartment under study 
either the blood or the dialysate compartment. At the dialyzer outlet, flow rates 
were measured gravimetrically. A controlled injection system using an electronic 
valve was used for radioactive bolus injection in the dialyzer supply tubing.  
 
Fig. II-5: In vitro setup for SPECT measurements. 
As radioactive tracer we utilized Technetium, which is a radionuclide with a half-
life of 6.01hours and an energy of 141keV. The F6HPS dialyzer (ultrafiltration 
coefficient 8.5mL/h/mmHg, fiber inner diameter 200µm, membrane thickness 
40µm, 9200 fibers) was horizontally and centrally positioned inside a SPECT 
camera (IRIX, Marconi-Phillips, Cleveland Ohio). For blood and dialysate flow 
visualizations, the SPECT camera contained two respectively three single-crystal 
NaI low energy high-resolution detectors with parallel hole collimators. Images 
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System Computer
Overflow Reservoir
ntroll
Dialyzer
γ CameraSPECT C mera
z
x
Modeling of flow in a hollow fiber dialyzer 
 49
of the projection of the bolus activity distribution were taken at different time 
steps. 
4.3.1.2. SPECT blood flow visualization 
Using water instead of blood in the dialyzer blood compartment, flow rates were 
adjusted to account for the difference in dynamic viscosity and density. To obey 
dimensional similarity between in vivo blood and in vitro water flow, Reynolds 
numbers Re (-) were kept equal in both models: 
 
fAεµ
DQρRe ⋅⋅
⋅⋅=  Eq. II-1 
With ρ fluid density (kg/m³), Q flow rate (m³/s), D fiber diameter (m), µ dynamic 
viscosity (Pa·s), ε porosity (-), and Af gross frontal area (m²). Human anemic 
blood at 37°C has a density of 1054kg/m³ and a dynamic viscosity of 2.96mPa·s 
derived from [140]: 
 ( )H0.0235expµµ p ⋅⋅=  Eq. II-2 
With plasma viscosity µp=1.3mPa·s and hematocrit H=35%. The experimental 
water flow rates at room temperature (µw = 1.02mPa·s and ρw = 998kg/m³) had to 
be lowered by a factor 2.75. As a consequence, to simulate a blood flow of 
300mL/min, a water flow rate of 109mL/min was used in the in vitro setup. 
During investigation of the flow pattern in the blood compartment, the dialysate 
side was filled with fresh tap water at room temperature and hermetically closed. 
Radioactive transport through the semi-permeable membrane (cut-off 69000Da) 
from the blood towards the dialysate compartment would trouble the images and 
results, and was avoided by injecting 10mL boluses of 200000Da 99m-
Technetium labeled MAA (Macro Aggregated Albumin).  
Preliminary viscosity measurements of the macro aggregate suspension were 
performed using an Ubbelohde capillary (Schott, Germany). The viscosity of a 
water solution with 0.01% MAA mass fraction showed no significant differences 
compared to 0.005% solution (P=0.69) and compared to fresh water (P=0.71). As 
a result, the injected boluses containing only 0.007% MAA mass fraction did not 
differ the water fluid properties. With respect to radioactivity, the 10mL boluses 
contained 10mCi each. 
With the dialyzer fixed under a two-headed SPECT camera and using a dynamic 
acquisition mode, 128 planar 2D images of intensity distribution were taken of 
the bolus passage each 0.7s. The result is a 2D matrix per time interval with 
prescribed dimensions (128 by 128). Each element of the matrix shows the 
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amount of photon counts along a line perpendicular to the camera (spatial 
superposition). Owing to the axi-symmetrical housing and nozzle construction of 
the blood compartment, an axi-symmetric blood flow was assumed a priori. 
Within this respect, the planar images were considered identical for each view 
angle. After performing a filtered backprojection reconstruction to calculate a 3D 
image of the activity distribution [106], and after a replication of the images over 
360°, a three-dimensional dynamic image was reconstructed of the bolus passage 
through the dialyzer fibers.  
The in vitro experiments with bolus injection in the blood compartment were 
repeated four times to investigate reproducibility.  
4.3.1.3. Extracting blood velocity from the SPECT 
measurements 
The passage of the bolus through the blood compartment took at least 61 
timeframes (total time of 43s). The images were evaluated each 6 timeframes 
corresponding to a time step of 4.2s. The first assessed timeframe corresponded 
with a bolus front at the dialyzer axis at 14mm from the blood inlet. Furthermore, 
according to the radial spatial resolution (2.34mm), each axial section was 
subdivided in 16 slices (Fig. II-6).  
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Fig. II-6: Calculation procedure of dialyzer velocity. 
Due to the a priori made assumption of axi-symmetrical blood-side flow, images 
will be identical in every axial section. For each slice and for each time step, the 
intensity profile along the total dialyzer length was assessed. By analyzing the 
axial bolus intensity shift (∆z) in between two considered timeframes (∆t=4.2s), 
the local velocity was calculated as ∆z/∆t (Fig. II-6). Three different velocities 
were examined: vpeak, velocity corresponding with the shift of the intensity peak; 
vslope, velocity derived from the budge of the bolus intensity slope, characterized 
by an intensity of one third of maximum bolus intensity; and vfront, velocity of the 
bolus front (Fig. II-6). From the four performed experiments of blood flow 
visualization, a mean velocity with standard deviation was obtained for each 
slice, after normalization of the velocities for the average water flow rate, as 
measured gravimetrically during each bolus injection.  
4.3.1.4. SPECT dialysate flow visualization 
Because the 99m-Tc-MAA tracer, as used for the blood experiments, was 
adhered to the dialyzer housing, the intensity images obtained with preliminary 
measurements were unreliable. Therefore instead, 10mL boluses of 99m-Tc-
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DMSA (Dimercaptosuccinic Acid, MW 281Da) tracer were injected in the 
500mL/min dialysate flow, while pressurized air at 6bar was forced 
simultaneously and counter currently through the blood compartment. The latter 
technique was useful to avoid water filtration and Technetium diffusion through 
the dialyzer membrane, and yet no air bubbles were forced through the 
membrane.  
3D acquisitions of flow in the dialysate compartment were made by rotating the 
three-headed SPECT camera over 120° in 12° increments. Thus the three heads 
together covered a 360° range in 10 measurements, with each one bolus 
injection. Consequently, 10 bolus injections were used for the 3D reconstruction 
of one bolus passage. For each angular position, 2D planar intensity pictures of 
the bolus passage through the dialysate compartment were taken by each camera 
head as 128 by 128 images every 0.4s. By evaluating the images of the 10 
measurements at different time steps during 128 time frames, and by performing 
a filtered backprojection [106], a dynamic 3D image was constructed of the bolus 
propagation in the dialysate compartment. 
4.3.1.5. Extracting dialysate velocity from the SPECT 
measurements 
The images taken at every second timeframe (every 0.8s) were studied to derive 
local dialysate flow velocities. In the first considered timeframe, the bolus front 
was distributed and observed over the entire dialyzer radial section. Analogous to 
the blood experiments, velocities of the bolus peak (vpeak), slope (vslope), and front 
(vfront) were calculated for each axial slice of 2.34mm in width.  
4.3.2. CFD modeling 
4.3.2.1. CFD blood flow simulation 
The blood flow inside the fiber lumen was modeled with a three-dimensional 
finite volume model (Fluent 6, Sheffield, UK). Due to symmetry reasons, only a 
quarter part of the dialyzer needed to be simulated (Fig. II-7). Blood was 
modeled as a Newtonian fluid with a dynamic inlet viscosity of 2.96mPa·s and 
density of 1054kg/m³. As blood thickening due to ultrafiltration occurs along the 
dialyzer length, blood viscosity was assumed to increase linearly up to 
4.10mPa·s, which corresponds to an overall ultrafiltration flow of 2L/h [141].  
Conservation of mass and momentum, expressed by the Navier-Stokes equations, 
was defined in the inlet and outlet nozzles and dialyzer manifolds. Instead of 
including the geometry of the 9200 fibers individually, the fiber compartment 
was modeled as one porous entity, characterized by a given resistance to the flow 
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(Darcy’s law) (Fig. II-7). This resistance should be adapted such that pressure 
drop over the porous medium is comparable to flow inside the fiber lumen. 
Because the fibers are elongated along the dialyzer length and because the 
ultrafiltration flow rate can be ignored as compared to the applied blood flow 
rate, the radial blood-side porous medium permeability kB_radial (reciprocal of the 
resistance to flow) can be neglected. The axial blood-side porous medium 
permeability kB_axial, however, was derived from the theoretical flow-pressure 
drop relation in circular tubes (Poiseuille’s law), and was found equal to 
8.1·E-8m²/s/Pa. 
A parabolic velocity profile at the inlet nozzle (i.e., matching with an overall 
blood flow of 300mL/min), and a relative zero outlet pressure at the outlet nozzle 
were set as boundary conditions. The boundaries of the dialyzer housing, were 
defined as no-slip walls. The internal planar boundaries were specified as 
symmetry planes characterized by zero radial velocities (Fig. II-7). 
 
 
Fig. II-7: CFD model for blood flow (upper left panel), dialysate flow (upper right panel), and in 
vitro setup in order to determine the dialysate-side radial permeability kD_radial (bottom panel). 
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Dialysate flow distribution was investigated using a 3D finite volume model of 
the entire dialyzer due to the asymmetrically placed inlet and outlet nozzles 
(Fluent 6, Sheffield, UK) (Fig. II-7). The dialysate properties at 37°C were a 
dynamic viscosity of 0.687mPa·s and density of 1008kg/m³, as derived in a 
previous performed clinical study [141]. Moreover, it was previously demonstrated 
that dialysate properties are not influenced by dialysis over the dialyzer length, 
and can be assumed constant at least for ultrafiltration flow rates limited to 2L/h 
[141]. 
In analogy with the blood-side simulations, the Navier-Stokes equations were 
calculated in the inlet and outlet nozzles and dialyzer manifolds, each consisting 
of a distribution ring. 
Due to the three-dimensional dialysate flow around the hollow fibers, the porous 
medium of the fiber compartment was characterized by an axial permeability as 
well as a non-negligible radial permeability. The latter were obtained from in 
vitro experiments performing flow and pressure measurements in the dialysate 
compartment [142]: 
 
f
UF
A
d
∆P
Qk ⋅=  Eq. II-3 
With k the porous medium permeability (m²/s/Pa), QUF the filtration flow rate 
(m³/s), ∆P the pressure drop (Pa) over the width d (m), and Af the considered 
gross frontal area (m²).  
The axial dialysate-side permeability of the fiber bundle was investigated by 
flowing dialysate at room temperature through the dialysate compartment and by 
registration of the flow rate (range 300-800mL/min) and inlet and outlet 
pressures (range 14-27mmHg). With this procedure, an axial dialysate-side 
porous medium permeability kD_axial of 91.0·E-8m²/s/Pa was found. 
For the study of the radial permeability, the dialyzer was extended with two 
sidelong capsules in opposite position (Fig. II-7, bottom panel). The latter were 
connected to the fiber compartment by 15 rectangular side holes (2.5mm x 
8.0mm) in the dialyzer housing. Dialysate was then squeezed radially through the 
dialyzer using flows in the range 0-650mL/min. The water flow was measured 
gravimetrically, while inlet and outlet pressures were measured in both capsules 
with fluid-filled pressure transducers (Ohmeda, Gent, Belgium). During the 
dialysate-side permeability tests, the blood compartment was filled with dialysate 
and closed hermetically. The radial dialysate-side permeability showed a linear 
relation for flow rates limited to 200mL/min, while further increasing of the flow 
resulted in a non-linear increase of flow resistance. In the lower radial flow 
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range, a permeability kD_radial of 4.16·E-8m²/s/Pa was found. As a consequence, 
an axial to radial permeability ratio of 22 was found in the dialysate 
compartment, which assumes a preferential axial dialyzer flow. 
The overall dialysate flow of 500mL/min was defined as a parabolic velocity 
profile at the inlet nozzle. At the outlet nozzle, pressure was set to zero while all 
other boundaries of the dialyzer housing were defined as no-slip wall.  
4.3.3. Statistical analysis 
Data are expressed as mean ± standard deviations. Correlations between 
parameters were investigated by performing linear regression analysis (Pearson). 
Statistical analyses were carried out using the Student t-Test for unpaired 
samples on normally distributed populations, with P<0.05 as the limit of 
significant difference (Sigmastat, Jandel Scientific Corporation).  
4.4. Results 
4.4.1. SPECT blood flow visualization 
Velocities of the bolus intensity peak, slope, and front were derived from 
evaluation of intensity plots at different time steps (Fig. II-6). For each axial 
dialyzer slice, mean velocities with standard deviations, averaged over the 
dialyzer length, are shown in Fig. II-8 for a mean blood flow rate of 
297±5mL/min. The overall mean velocity was 12.1±1.6mm/s for the bolus peak, 
21.5±2.8mm/s for the bolus slope, and 28.6±1.2mm/s and 24.8±1.8mm/s for the 
bolus front at the dialyzer axis and near the dialyzer housing, respectively. While 
the mean velocity of the bolus peak was significantly smaller than the theoretical 
mean velocity of 17.3mm/s (P<0.001), the velocity of the bolus slope and front 
were significantly larger (P<0.001). 
Fig. II-9 illustrates the radial distribution of axial velocity in a dialyzer radial 
section for different positions along the dialyzer length (z-values). The latter 
were derived from the mean axial position of the bolus intensity peak within two 
consecutive considered time frames. For z equal to 70, 89, and 107mm (Fig. 
II-6), no significant differences were found between the local bolus peak 
velocities and the mean bolus peak velocity of 12.1mm/s. Near the dialyzer inlet 
and halfway the dialyzer, however, local bolus peak velocities were found 
significant higher than (P<0.001 for z=47mm), and lower than 12.1mm/s 
(P<0.001 for z=121mm and z=140mm, and P=0.011 for z=154mm), respectively. 
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Fig. II-8: Mean axial blood velocity of the bolus peak, slope, and front at different radial 
positions, as obtained with SPECT. 
 
Fig. II-9: Mean radial distribution of axial blood velocity of the bolus peak for 7 different axial 
z positions compared to average, as obtained with SPECT. 
4.4.2. SPECT dialysate flow visualization 
The mean bolus peak and slope velocities were derived in the axial section 
tangential to the dialysate inlet and outlet nozzles (yz-plane) and in the axial 
section perpendicular to the latter (xz-plane) (Fig. II-6). 
For the yz-plane, bolus peak and slope velocities are illustrated in Fig. II-10. 
Velocities were not homogeneously distributed over the radial section, but 
showed maximum values near the nozzles-side housing, while a minimum value 
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was located down the dialyzer axis (at 23-25mm vertical distance from the inlet 
nozzle, corresponding with slice 6). An overall mean velocity of 17.9±13.1mm/s 
and 28.7±10.0mm/s was found for the peak and slope velocities, respectively. 
There was no significant difference between the mean measured peak velocity 
and the mean theoretical value of 17.0mm/s (P=0.985), while the mean measured 
slope velocity was significantly larger (P<0.001). Furthermore, peak and slope 
velocities were strongly correlated (R=0.95; P<0.001). The maximum velocity of 
the bolus front was equal to 39.2±2.2mm/s and occurred at 7-9mm vertical 
distance from the inlet nozzle (slice 13) (Fig. II-10).  
 
Fig. II-10: Mean axial dialysate velocity of the bolus peak, slope, and front at different radial 
positions in the axial yz-plane, as obtained with SPECT. 
 
In the xz-plane, overall mean bolus peak and slope velocities were 
16.8±13.0mm/s and 26.0±11.9mm/s, respectively, and strong correlation between 
both velocities was observed (R=0.94; P<0.001). The mean bolus peak and slope 
velocity did not (P=0.985), respectively, did differ significantly (P<0.001) from 
the mean theoretical velocity 17.0mm/s. Again, a non-homogeneous velocity 
distribution over the radial section was measured (Fig. II-11), with maximum 
values near one side of the dialyzer housing, and a minimum velocity at a quarter 
radial distance between the dialyzer axis and the opposed dialyzer housing (slice 
6). In addition, no significant differences were found between the mean bolus 
peak velocities respectively mean bolus slope velocities as measured in the yz-
plane compared to those found in the xz-plane.  
4.4.3. CFD blood flow simulation 
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A homogeneous blood velocity of 17.5±0.2mm/s was found over the complete 
dialyzer radial section. Due to boundary layer separation at the point of channel 
divergence, and due to the impact of the inflowing blood on the fiber 
compartment inlet surface with a velocity in the order of 300-400mm/s, vortices 
were developed in the inlet manifold. Moreover, near the outer regions of the 
inlet and outlet manifolds, stagnant fluid layers were observed.  
 
 
Fig. II-11: Mean axial dialysate velocity of the bolus peak, slope, and front at different radial 
positions in the axial xz-plane, as obtained with SPECT. 
4.4.4. CFD dialysate simulation 
Fig. II-12 shows the axial velocities in the yz-plane for a constant overall porous 
medium permeability, corresponding with perfectly distributed fibers. In the 
radial sections near the nozzles (z=42mm and z=184mm), minimum velocities 
were found near the dialyzer axis and were 19-23% lower than the mean velocity 
in the radial section. Velocities near the housing were 24-29% higher compared 
to the mean value. In the radial sections located more centrally (z=89mm and 
z=137mm), however, minimum axis velocities were only 3% lower and distal 
maximum velocities were 3-4% higher compared to the radial sectional mean 
velocity. Furthermore, no significant differences were found with the velocity 
profile as averaged over the dialyzer length and which is illustrated in Fig. II-12 
(average). The axial velocities in the xz-plane show a similar distribution as 
found in the yz-plane, such that no differences were found in the considered 
radial sections z=42mm (P=0.956), z=89mm (P=0.543), z=137mm (P=0.635), 
and z=184mm (P=0.889). 
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Fig. II-12: Radial distribution of axial dialysate velocity as computed with CFD for 4 different 
axial z positions compared to average. The CFD results are also compared to mean bolus peak 
velocity (bars) as measured with SPECT. 
4.5. Discussion 
The present study combines experimental and numerical tools in order to 
quantify blood and dialysate flow distributions in a low flux polysulphone 
dialyzer. For this purpose, planar dynamic SPECT images were taken from bolus 
passages in the blood, respectively, the dialysate compartment. Local fluid 
velocities were then derived from time-varying bolus intensity plots in the axial 
section under study. Although this medical imaging technique offered us an 
overall analysis of velocity distributions in a hemodialyzer, detailed information 
and flow paths in the nozzles and dialyzer manifolds, could however not be 
obtained with this technique. Therefore, both fluid flows were further 
investigated in depth using CFD. The fiber bundle was modeled as a porous 
medium with permeability characteristics depending on the considered flow 
direction and fluid. 
The most striking results of this study are: first, the SPECT as well as CFD 
results showed a fully homogeneously distributed blood flow; second, medical 
images of the dialysate flow indicated preferential flow paths, while the CFD 
results for a constant porous medium permeability showed a symmetrical 
dialysate velocity distribution.  
Blood velocity calculations from the SPECT images taken at different time steps, 
resulted in bolus peak velocities, which were lower than theoretically predicted. 
The bolus slope and front velocities were however significantly larger than the 
mean velocity. Because this phenomenon implies that axial diffusion and, more 
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important, convective transport of the radioactive bolus are non-negligible, care 
should be taken drawing the conclusions of the SPECT measurements. However, 
as the bolus diffuses forward as well as backward in the same degree, our results, 
revealing a homogeneous blood flow distribution, are reliable. Moreover, 
correspondence was found with earlier published data concerning blood flow 
visualizations in a different dialyzer [119].  
Due to the radial dialysate inflow, it was expected that the bolus would show an 
asymmetrical profile while flowing through the dialyzer. A declined bolus front, 
however, does not necessarily imply a radially distributed dialysate flow. 
Because of the occurrence of preferential flow channeling due to fiber twisting, 
however, a non-homogeneous dialysate flow was found. While former 
experiments [118-120] reported a radially distributed dialysate flow in the axial 
section tangential to the dialysate inlet and outlet nozzles (yz-plane), we found 
flow non-homogeneities as well in all other axial sections (e.g. demonstrated for 
the xz-plane in Fig. II-11).  
The mismatch between blood and dialysate flow distribution, as found with the 
SPECT measurements, has a pernicious effect on mass transfer efficiency of 
small molecules. This is because diffusion is, for a constant surface area and 
membrane thickness, mainly dependent on the concentration gradient between 
blood and dialysate, which is, on its turn, strongly affected by the flows and their 
distribution. 
To obtain more accurate quantitative data of both dialyzer flows, two CFD 
models were developed for each compartment under study. The outer regions of 
the inlet and outlet nozzles, where blood flow was stagnating, form a potential 
risk with respect to blood clotting.  
While the fiber bundle permeability at blood-side could be derived easily from 
Poiseuille’s theory, an alternative method was sought to determine the flow 
resistance in the dialysate compartment. Osuga et al. [117] combined the results of 
MRI and CFD by evaluating the dialysate pressure isobars until correspondence 
between both techniques was found for a given radial-to-axial hydraulic 
permeability ratio of the fiber bundle. In the present study, however, we preferred 
to derive the characteristics of the porous medium independently by performing 
in vitro experiments.  
The fact that large discrepancies were found between the SPECT and CFD 
results for dialysate flow indicated that the hypothesis of a constant fiber bundle 
permeability is not correct. As a consequence, permeabilities, as defined in the 
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CFD model, should be adapted locally until the velocity profiles obtained with 
both techniques do match. 
In conclusion, medical imaging offers a non-destructive method to gain insight in 
flow distributions and transport characteristics in hemodialyzers. Moreover, 
those techniques play a key role in the validation of numerical models. The latter 
are, on their turn, important to examine regions of interest, which are smaller 
than the spatial resolution of the imaging techniques, and to further optimize 
dialyzer design. 
4.6. Conclusion 
Flow distribution in a low flux dialyzer was visualized using single photon 
emission computed tomography (SPECT) imaging. The experimental results 
were compared to computational fluid dynamic (CFD) simulations. With both 
techniques, a fully homogeneously distributed blood flow was found, while a 
discrepancy was observed for the dialysate flow in the case a constant fiber 
bundle permeability was modeled numerically. The SPECT results can be 
applied for validation of the CFD model with respect to the fiber bundle 
permeabilities, such that the validated CFD model can be further used for new 
dialyzer design and optimization. 
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5. Validation of the CFD model used for 
analyzing flow distributions 
5.1. Background 
When using computational fluid dynamics, one should keep in mind that the 
simulation results are only as valid as the equations, boundary conditions, and 
fluid and membrane properties that are implemented in the model. As a 
consequence, validation of the CFD model is necessary. Comparison of the CFD 
results with the results of the SPECT measurements is hereby a useful tool. 
In the previous study (paragraph 4), a discrepancy was found for the axial 
dialysate velocities in the fiber compartment between CFD and SPECT. This 
implies that some formulated assumptions in the CFD calculations are not yet 
suitable.  
Because it is not feasible, with the available computer capacity, to model each 
fiber in the bundle separately, we cannot drop the modeling of the fiber bundle as 
a porous medium using Darcy’s law (Eq. I-8). In the latter equation, however, the 
permeability factor is a parameter that was derived and implemented by us. 
Although a radial and axial component for the permeability was derived from in 
vitro tests, those proportion factors were assumed constant over the entire fiber 
compartment. Because many previously performed studies reported the incidence 
of dialysate channeling [118,119,121], the assumption of a uniform permeability was 
too optimistic. Furthermore, the phenomenon of dialysate channeling implies the 
variation of the axial permeability rather than the radial one. Finally, because no 
radial velocities were obtained from the SPECT measurements, a local radial 
permeability cannot be implemented in the CFD model by direct comparison of 
both results. 
In this section, the local axial permeabilities are derived for implementation in 
the CFD model. This will result in analogous flow distributions with SPECT and 
with CFD, such that the CFD model can be further applied when investigating 
other parameters, as for instance proportional dialyzer dimensions. 
5.2. Methods 
Using Darcy’s law (Eq. I-8) and the definition of the permeability of a porous 
medium (Eq. II-3), the mean axial velocity Vmean (m/s) in the fiber bundle can be 
written as a function of the pressure drop ∆P (Pa) over the fiber length d (m): 
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 ∆Pd
k∆Ph
A
QV meanm
F
UF ⋅=⋅==mean  Eq. II-4 
With kmean the mean porous medium permeability (m²/s/Pa), QUF the filtration 
flow rate (m³/s), and Af the gross frontal area (m²).  
As the pressure drop over the fiber bundle is constant, the local permeability k 
(m²/s/Pa) can be derived from the mean fiber bundle permeability kmean, and the 
local and mean axial velocities, v and Vmean, respectively: 
 mean
mean
k
V
vk ⋅=  Eq. II-5 
v represents the local velocities measured with SPECT and shown as peak 
velocities in Fig. II-10 and Fig. II-11 in the yz-plane and xz-plane, respectively. 
5.3. Results 
Fig. II-13 shows the axial permeabilities in the yz-plane and the xz-plane, as 
calculated with Eq. II-5 compared to a constant axial permeability. 
 
Fig. II-13: Radial distribution of axial permeabilities in the yz-plane and xz-plane compared to a 
constant axial permeability. 
The assumption of a constant axial permeability of 91·E-8m²/s/Pa resulted in an 
overestimation of the permeability with 58% (yz-plane) and 75% (xz-plane) near 
the dialyzer axis (slice 6). Near the dialyzer outer shell, however, permeability 
was underestimated with 103% (yz-plane) and 130% (xz-plane) (slice 16). 
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5.4. Conclusion 
Dialysate flow channeling can be observed easily from the local axial velocities 
as calculated with SPECT measurements. In order to simulate this phenomenon 
using CFD, local axial permeabilities were derived from the local SPECT 
velocities. The calculated permeability distribution can now be implemented in 
the computer model for further parameter investigation. 
 Chapter III Modeling of flow in a single 
hemodialyzer fiber 
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1. Chapter overview 
In contrast with investigating the macroscopic flow in the entire dialyzer 
(Chapter II), we focus now on the flow (Chapter III) and mass transport (Chapter 
IV) in one single fiber of a dialyzer. 
First, a measuring technique is described for quantitative evaluation of cell or 
particle convective transport in capillary tubes (paragraph 3). The proposed 
technique was applied to investigate the transport of 10µm spherical particles in 
non-permeable capillary tubes of various diameters, lengths, and internal 
coatings. Considering a capillary of 220µm in diameter and 0.3m in length, a link 
can be drawn with red blood cell transport in a hollow fiber. There are however 
some important limitations to the measuring technique when it comes to the 
radial blood cell distribution in a dialyzer fiber. Due to the high reproducibility of 
the measurements, the technique was found effective for particle transport in 
microcapillaries, which might be of interest in future artificial organ devices 
design. 
Radial blood cell distribution will be studied intensively in the second part of this 
chapter. Abstraction is made of the fiber packing in the dialyzer to isolate one 
fiber with its surrounding membrane and dialysate compartment. In order to 
implement this blood-dialysate interface in a numerical model, characteristics of 
the three compartments must be known. Therefore, in vivo tests were done to 
study the influence of dialysis on the dialysate properties (paragraph 4.3). The 
membrane permeability was investigated in vitro (paragraph 4.4) for different 
membrane types (paragraph 4.5) and with different filtration fluids (paragraph 
4.6). Furthermore, theoretical formulations were obtained from literature to 
describe blood behavior in small fibers (paragraph 4.7). With those input data, 
numerical simulations give information about the ultrafiltration profile and the 
radial and axial variation of blood properties by flowing through the dialyzer. 
The third part of this chapter deals with the validation of the numerical model. 
With an in vivo study blood properties were examined, while an ex vivo study 
was set out using bovine blood as patient’s blood substitute. Flow and fluid 
properties were measured and compared to the results of the numerical 
simulations. 
Finally, the numerical model was optimized in order to remove the remaining 
drawbacks, and the influence of ultrafiltration on the blood-side pressure drop 
was calculated and compared to the theoretical Poiseuille law. 
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2. Introduction 
In continuation of the macroscopic blood and dialysate flow investigation in a 
hemodialyzer, some important aspects like radial distribution of blood properties, 
ultrafiltration, and convection-diffusion are investigated microscopically in a 
single fiber. 
The in vitro measurements investigating particle transport in a microcapillary 
were a first attempt to learn more about capillary (blood) flow. The technique is 
based on a bolus injection of particles at the capillary entrance, while the particle 
outflow is registered using an electronic gate detector. Assuming a capillary 
Poiseuille flow, a preferential radial position of particle transport can be derived 
from the particle transit time.  
To simulate the blood flow through a dialyzer fiber, the in vitro settings were 
adapted as much as possible. It should be remarked however that, although this 
adaptation, a considerable difference remains between particles transported in a 
convective capillary flow and a high concentrated cell suspension (blood) flow in 
a hollow fiber. 
2.1. Assessment of the experimental settings 
To generate in vitro flow conditions (particle transport in a capillary) that are 
dynamically similar to the ones in vivo (blood cell transport in a hollow fiber), 
the dimensionless Reynolds number (Eq. I-17) for flow and particles should be 
similar in vivo and in vitro. 
Restricted by the available characteristics of particle and microcapillary 
dimensions, those settings were a priori decided matching as much as possible 
the dialyzer and blood cell dimensions. The experiments were done i.e. in a 
220µm diameter capillary using spherical particles with a diameter of 10µm. 
Furthermore, a physiological solution (0.9%NaCl) with an electrical conductivity 
of 66mS/cm was used as carrier liquid to obtain an adequate signal to noise ratio 
(-70dB) during particle detection at the gate. 
An overview of the in vivo and in vitro characteristics is shown in Table III-1 for 
a low flux Fresenius F6 or high flux F60 dialyzer with 9200 fibers. For different 
dialyzer blood flows (QB), the in vivo flow Reynolds numbers are calculated 
from the kinematic blood viscosity (νblood), fiber diameter (Dfiber) and fluid 
velocity in a single fiber (vfiber). The in vitro fluid velocity (vcap) can then be 
derived using the calculated in vivo Reynolds value (Rein vivo), the a priori known 
Chapter III 
 68
diameter of the capillary (Dcap), and the kinematic viscosity of the physiological 
solution (νphys) (Table III-1). 
Table III-1: Dynamic similarity between blood flow in a dialyzer fiber and particle flow 
in a microcapillary. 
In vivo: dialyzer fiber In vitro: microcapillary 
QB 
mL/min 
vfiber 
mm/s 
Dfiber 
µm 
νblood 37°C 
mm²/s 
Rein vivo 
- 
Dcap 
µm 
νphys 
mm²/s 
vcap 
mm/s 
150 8.6 200 3.42 0.51 220 0.995 2.3 
250 14.4 200 3.42 0.85 220 0.995 3.8 
350 20.2 200 3.42 1.18 220 0.995 5.3 
 
Besides the flow Reynolds number, dynamic similarity should also be obtained 
for the particles and cells. The particle Reynolds number (Rep) is defined as [143]: 
 
Dν
aVRe
2
max
p ⋅
⋅=  Eq. III-1 
With a the particle radius (m), ν the kinematic fluid viscosity (m²/s), D the 
capillary diameter (m), and Vmax the maximum velocity, as it takes place at the 
capillary axis (r=0), derived from the Poiseuille velocity profile: 
 


 

−⋅⋅=
2
mean R
r1V2v  Eq. III-2 
With v the local velocity (m/s) at radial position r (m) from the axis, Vmean the 
mean velocity (m/s), and R the capillary radius (m). 
The comparison between the in vitro and in vivo particle Reynolds numbers is 
shown in Table III-2 for a low flux F6 or high flux F60 dialyzer. For the in vivo 
particle diameter, the maximum diameter of a red blood cell (7µm) is used. The 
maximum Poiseuille velocity for capillary flow is derived from the mean 
velocities as calculated with the flow Reynolds number (Vmax = 2·Vmean). 
Using in vitro flow rates derived from the flow Reynolds number and counting 
for the in vitro particle and fluid properties, the particle Reynolds number was 
found of the same order of magnitude in vitro and in vivo (Table III-2), varying 
with a factor 1.7. 
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Table III-2: Comparison between the particle Reynolds number for blood flow in a 
dialyzer fiber and particle flow in a microcapillary. 
In vivo: dialyzer fiber In vitro: microcapillary 
Qblood 
mL/min 
Vmax 
mm/s 
a 
µm 
Dfiber 
µm 
νblood 
mm²/s
Rep in vivo
- 
Vmax 
mm/s
a 
µm 
Dcap 
µm 
νphys 
mm²/s 
Rep in vitro 
- 
150 17.3 3.5 200 3.42 3.1 E-4 4.6 5 220 0.995 5.2 E-4 
250 28.8 3.5 200 3.42 5.2 E-4 7.6 5 220 0.995 8.7 E-4 
350 40.4 3.5 200 3.42 7.2 E-4 10.7 5 220 0.995 12.2 E-4 
 
The cell concentration in blood (hematocrit) is taken as a criterion to derive the 
required particle concentration of the bolus in vitro. Table III-3 shows the 
calculation of the number of particles per bolus injection of 20µL, taking into 
account the volume of one single sphere (529.6µm³). The total number of 
particles is of the order 1000-2000 in the hematocrit range 25-50%. 
Table III-3: Particle concentration in a bolus injection 
Hematocrit 
% 
Cell volume  
µl 
Number of particles 
- 
25 5 955 
30 6 1146 
35 7 1337 
40 8 1528 
45 9 1719 
50 10 1910 
 
In conclusion, with the available capillaries and particles, both the flow rate and 
the injected number of particles can be adapted to obtain dynamic similar 
conditions as in vivo. 
2.2. Differences between blood flow and particle transport 
With the applied measuring technique, we are, however, not able to adequately 
simulate blood flow in a hollow fiber by investigating particle transport in 
microcapillaries, due to different flow phenomena. 
It has been shown in several studies that blood behaves as a strongly non-
Newtonian fluid. Besides the dependency on hematocrit [144-146], blood viscosity 
is also affected by the shear rate and the tube diameter. At higher shear rates, red 
blood cells start to deform and will align in the flow, resulting in a lower 
apparent viscosity [144]. Blood viscosity will further decrease for blood flowing in 
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tubes between 300-30µm in diameter [65,147]. Microscopic observations showed a 
central core of red blood cells and a marginal plasma layer. With the proposed 
measuring technique, however, rigid particles are used. 
Furthermore, blood flow is a continuous flow of cells suspended in plasma, 
characterized by a volume percentage equal to the hematocrit. In the 
experiments, however, a bolus of 20µL of suspended particles is injected in an 
aqueous Poiseuille flow at the capillary inlet. Although the bolus concentration 
can be well chosen such that it matches the corresponding hematocrit, a bolus is 
always subject to dilution, resulting in a lower concentration at the capillary 
outlet. 
Particle buoyancy is an important aspect when investigating particle transport in 
microcapillaries. With the present technique, the particles are lagging the fluid 
with a buoyancy of 0.6%. In blood, however, the buoyancy of cells in plasma is 
5.8%. 
As blood is flowing through the dialyzer, ultrafiltration causes blood thickening 
and changes the flow rate along the fiber length. With the non-permeable 
capillaries, ultrafiltration and related flow phenomena are not taken into account. 
2.3. Conclusion 
Because of the differences between blood flow in a hollow fiber of a dialyzer and 
particle transport in a non-permeable microcapillary, the aim of the next 
paragraph is to present the developed measuring technique rather than to draw a 
direct relation between blood and particle flow. The proposed technique presents 
unprecedented possibilities for quantitative evaluation of cell or particle adhesion 
at solid-liquid interfaces; of interest in future artificial organs design. Moreover, 
it offers possibilities of cell or particle separation with particle size, density and 
adherence as the discriminating parameters. 
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3. Particle transport in a microcapillary† 
3.1. Abstract 
Convective transport of 10µm nearly neutrally buoyant spherical particles 
(polystyrene vinyl dibenzene) is studied in 220µm and 530µm diameter 
capillaries using an on-line particle detector of the electronic gate type. The 
detector, connected to the capillary outlet, monitors the elution and translates the 
passage of individual particles into pulsed signals. The measuring technique 
requires the use of an electrically conductive carrier liquid, such as physiological 
saline (0.9%NaCl). Passage times are registered for discrete capillary lengths 
varying between 0.25m and 5m. Mean particle and fluid velocities are used to 
calculate the preferential radius of particle transport.  
The equilibrium position of the particles is found to shift towards the capillary 
wall for higher Reynolds numbers, for longer and smaller capillaries, and for 
more dilute suspensions. However, the higher the particle to capillary diameter 
ratio, the more pronounced wall effects are. Moreover, as the Stokes number is 
small (E-2), adhesion at the capillary walls turns out to be non-negligible and to 
have an impact on the final quantitative results. 
3.2. Background 
Spherical particles injected in a convective (Poiseuille) flow are subjected to 
forces like lift, drag [148,149] and the Archimedes gravity. The combination of 
these might result in particle migration towards preferential streamlines.  
Most studies in this context describe the motion of a single particle in shear flow. 
The linearized Navier-Stokes equations, describing creeping motion by 
neglecting acceleration, ignore the existence of radially directed motion [150]. 
Segré and Silberberg [151], however, experimentally demonstrated the occurrence 
of radial particle displacements that are attributed to the inertia of the moving 
fluid. In order to describe this migration theoretically, several investigators 
considered the contribution of inertial effects for a particle that translates and 
rotates in an unbounded flow, by defining lift forces due to particle rotation [152] 
and shear [153]. Although Saffman [153] took into account the wall effect slowing 
                                                     
† The contents of this section was published in Phys Fluids 2004;16:2282-2293. 
Experimental evaluation of the migration of spherical particles in three-dimensional Poiseuille flow 
S. Eloot, F. De Bisschop, and P. Verdonck 
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down a particle due to the extra drag, he did not consider the change of the flow 
field surrounding any particle near the wall. In summary, none of those viscous 
theories, accepting lift force to be linear in the carrier velocity and to be viscosity 
dependent, explains the observations by Segré and Silberberg [151] to a satisfying 
degree.  
3.2.1. Neutrally buoyant particle 
Cox and Brenner [154] were the first to consider all influences exerted by a wall, 
as well as the non-uniformity of shear in three-dimensional Poiseuille flow. Their 
inertial theory, however, did not allow drawing any conclusions regarding the 
direction of lateral forces, nor did it explain the occurrence of preferential flow 
paths and their location. Based on the theory of Cox and Brenner [154] and by 
reducing the problem to two-dimensional flow between two parallel plates, Ho 
and Leal [155] were able to evaluate the magnitude and direction of the lateral 
force on a neutrally buoyant particle in both simple shear and Poiseuille flow. 
They concluded that lateral migration originates from shear stresses acting on the 
sphere, rather than from wall-induced lag and/or angular velocities. Moreover, 
they defined lift as a function of the disturbance flow created by the wall on one 
hand and of the migration velocity due to an unbounded shear field on the other. 
In general, for two-dimensional Poiseuille flow, three particle positions are found 
where lift is vanishing: an unstable one at the centerline and two stable ones at 20 
and 80%, respectively, of the channel width [155]. These equilibrium positions 
agree well with the preferential flow paths in two- and three-dimensional flow 
experiments performed by Tachibana [156] and Segré and Silberberg [151]. For 
vertical Poiseuille flow, Vasseur and Cox [157] defined stable equilibrium 
positions at 19 and 81% of the channel width for freely rotating particles. These 
equilibrium points shift to 26 and 74%, respectively, whenever particles are 
prevented from rotating. Despite fair agreements of their findings with the lateral 
migration theories for spheres in the bulk region, closer to the wall, Ho and Leal 
[155] overestimated the lateral migration velocity as derived by Vasseur and Cox 
[157] and Cox and Hsu [158]. The latter focused on the migration of a neutrally 
buoyant particle in the vicinity of a single plane wall. It should be noticed finally, 
that particle size plays an important role, as reported by Karnis et al. [159]. In the 
limit, a particle with a diameter closely matching the channel width travels by 
definition on the axis, while smaller particles travel further away from the axis.  
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3.2.2. Non-neutrally buoyant particle 
A non-neutrally buoyant spherical particle with a velocity greater than the 
undisturbed local fluid velocity migrates towards the nearest wall. A particle that 
lags the carrier liquid, on the contrary, experiences larger inertial lift and 
migrates towards the center plane in a rectangular duct (2D) [160,161] or towards 
the axis in a circular conduit [151,162,163]. Moreover, the migration rate increases 
with particle size, carrier liquid flow rate, and/or particle-fluid density difference 
[157]. Numerical simulations by Feng et al. [143] are in good agreement with the 
preceding theories, at least for small particle-fluid density differences in a 
Poiseuille flow. For larger density differences, the equilibrium position shifts 
towards the centerline, irrespective of whether the particle is more or less dense 
than the fluid. However, particles never are able to stabilize exactly on the 
centerline. 
3.2.3. Dependence on Reynolds number 
One of the main parameters controlling the position of the equilibrium 
streamlines is the tube or channel Reynolds number (-): 
 
ν
DVRe meantube
⋅=  
ν
LVRe maxchannel
⋅=  Eq. III-3 
With Vmean and Vmax the mean and maximum flow velocity (m/s), respectively, D 
the tube diameter (m), L the channel width (m) and ν the kinematic fluid 
viscosity (m²/s). The formerly mentioned theories [155,157] were derived for low 
Rechannel (<<1), and indicated that the equilibrium streamline is the result of two 
effects. One is caused by the interaction with the wall and the shear there, 
producing migration towards the axis, while the other is linked to the shear and 
the curvature of the Poiseuille flow, producing migration towards the wall. 
Schonberg et al. [164], however, investigated, based on Saffman’s theory, the 
migration of neutrally buoyant particles in 3D Poiseuille flow for the case 
convective terms are equal (Rechannel ≈ 1) or more important than the viscous 
terms (Rechannel > 1). For Rechannel ≤ 15, they found migration profiles in good 
agreement with those predicted by Vasseur and Cox [157]. However, for higher 
Rechannel (> 30) and particles not too close to the walls ( channelReL/> ), lateral 
migration velocities (scaled by particle diameter a and mean fluid velocity Vmean) 
decrease and equilibrium positions are closer to the wall [165], as also observed by 
Segré and Silberberg [151]. Extending Saffman’s theory for shear flow (lower Re), 
Mc Laughlin [166] found lift forces to be much smaller than predicted [153], at least 
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for unbounded shear flow. On the basis of numerical simulations for a neutrally 
buoyant particle in a 2D Poiseuille flow and for Rechannel of 40 and higher, Feng 
et al. [143] found an equilibrium position at 25.2% of the channel width and closer 
to the wall, respectively. For Rechannel in the range 100 up to 3000, Asmolov [167] 
described lift on neutrally as well as non neutrally buoyant spheres as a function 
of Rechannel, distance to the wall, and slip velocity. His results for Rechannel = 100 
and non-neutrally buoyant spheres were similar to those obtained by Hogg [168]. 
These reported results indicate the importance of the tube or channel Reynolds 
number. 
3.2.4. Particle transport near the wall 
For effectively bounded domains, Ho and Leal [155] defined a lift force 
determined by inertia alone, without explicit dependence on viscosity. In more 
recent studies of a shear flow in systems bounded by one single [169] or two 
infinite flat planes [170], lift is derived from the superposition of migration 
velocity due to the unbounded shear field on one hand, and, to the disturbance 
flow created by the wall on the other. Whereas former theories were derived for 
distances between the sphere and the wall larger than the particle radius, an 
extension of such theories was formulated by Cherukat et al. [171] for a wall lying 
within the inner region of a particle (i.e. the region in which viscous effects 
dominate). For spherical particles colliding with the wall in a shear flow, 
Leighton and Acrivos [172] found that lift is directed away from the wall and that 
its magnitude is proportional with the fourth power of the particle radius and the 
square of the velocity gradient at both sides of the sphere. Gondret et al. [173] 
experimentally investigated the bouncing of spherical particles onto a wall and 
found that no rebound occurs if the Stokes number (St) remains lower than a 
critical value (Stc) of about 10. The Stokes number is here defined as the ratio of 
particle inertia to viscous forces: 
 µ
Vaρ
9
2St p
⋅⋅⋅=  Eq. III-4 
ρp represents the particle density (kg/m³), a the particle radius (m), V the impact 
velocity (m/s), and µ the dynamic fluid viscosity (Pa·s). 
In this experimental study, the migration of approximately neutrally buoyant 
spherical particles is investigated in three-dimensional microcapillary Poiseuille 
flow. The main parameters investigated are the Reynolds number, the particle to 
capillary diameter ratio, the internal capillary coating, and the injected particle 
volume fraction. 
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3.3. Experimental method 
3.3.1. In vitro setup 
Silica capillary (Achrom) of varying length and of internal diameters of 530µm 
and 220µm, respectively, is horizontally coiled-up (coil radius is about 100mm) 
(Fig. III-1). The capillary is coated at its inside with methyl, methyl-phenyl or 
glycol groups, resulting in different adhesive behavior. A piston pump driven by 
a stepping motor generates convective transport in the capillary. The step rate of 
the motor, fixed by a resistance-capacitance RC time constant, is set by means of 
a potentiometer.  
At the capillary inlet, a sampling valve connected to a storage column (530µm 
diameter and 90.65mm in length) allows a bolus injection of a 20µL suspension 
of particles of various concentrations. By repeatedly transporting the particle 
suspension in between the loading syringes, the storage column is loaded by a 
homogeneous suspension and can be subsequently unloaded when opening the 
sampling valve (Fig. III-1). 
 
Fig. III-1: Scheme of the in vitro setup with a detail of the gate geometry. 
The capillary outlet is connected to an on-line detection apparatus [174] with a gate 
of 50µm aperture and 50µm in length (see detail in Fig. III-1). In front of the 
gate, the streamlines of the suspension are made to converge, using a secondary 
surrounding carrier liquid flow, in order to avoid recirculation of particles and 
with it, the generation of false counts [175]. As capillary passage times are of the 
order 8-400s, and particles are only 0.04-0.13s in the transitional phase in front 
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of the gate (i.e. 0.01-1.6%), particle track times are not influenced by it. Transit 
of particles through the electronic gate is signaled as a variation of the gate’s 
resistance, in proportion to the particle size [176]. Resistance-to-voltage 
conversion is then effectuated by operating the gate in a measuring bridge that is 
actuated by a low-frequency signal of high spectral purity [175]. Further handling 
of the pulsed gate signal remains a matter of selective amplification and base-line 
restoration [175]. 
A 0.9% sodium chloride physiological solution with density of 1024kg/m³ and 
dynamic viscosity of 1.02mPa·s is used as carrier liquid. For the different 
potentiometer settings, the flow rates of the carrier are calibrated in advance by 
gravimetric flow measurements. The suspended particles are polystyrene vinyl 
dibenzene spheres of 10µm nominal diameter, calibration standards of uniform 
density (1030kg/m³) (Coulter-PN6602796). The particle size distribution is 
derived on the basis of pulse-height measurements (sizing resolution better than 
0.10µm) and is found being Gaussian with a standard deviation of 0.15µm. 
Considering particle to carrier densities, the particle is lagging the fluid with a 
buoyancy of 0.6%. 
3.3.2. Elution diagrams 
The electronic coaxial gate detector at the capillary outlet translates the passage 
of individual particles into pulsed signals and monitors the elution rate, i.e. the 
number of particles leaving the capillary per unit of time: 

 t,
dt
dn  plot (Fig. 
III-1). As monitoring starts at the moment of bolus injection at capillary inlet, the 
onset of detection of elution is a measure for the velocity of the fastest particles 
(capillary length divided by passage time). Moreover, an elution peak reflects the 
velocity of the majority of particles, also indicating the occurrence of a 
preferential pathway of transport (Segré-Silberberg phenomenon). Broadening 
and tailing of elution peaks reflect particle retardation due to adhesion and/or 
particle collisions.  
From the elution diagram, the cumulative number of particles detected per time 
step is derived and normalized for the total particle number: 

 ∫ t,dtdn  plot (Fig. 
III-1). Cumulative elution diagrams, less sensitive to statistical variations in the 
elution rate, allow more reliable comparisons between subsequent tests with the 
same and different parameters, respectively. Moreover, in a normalized 
cumulative elution plot, the area below the curve (i.e. the integral) constitutes a 
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measure of occurring retardation: the lower the area, the more important 
adhesion and collision phenomena are. Whether adhesion is irreversible or not 
can be investigated by comparing the number of injected and detected particles. 
3.3.3. Measuring protocol 
Main parameters in this study are capillary diameter, length, and internal coating, 
carrier liquid flow rate, and number of particles injected (Table III-4). The same 
methyl coated capillary, either of 530µm or 220µm diameter, was cut to 
decreasing lengths, stepwise. For each length and flow rate, elution rates were 
registered 2 up to 4 times, in order to investigate reproducibility. Poor 
reproducibility indeed may result from effects of irreversible adhesion. During 
repeated tests with the 220µm diameter methyl coated capillary, already 
shortened to a length of 0.9m, irreversible adhesion of particles to the capillary 
wall started disturbing the subsequent test series. Therefore, a fresh 220µm 
diameter capillary was used so that reliable results were obtained for the shorter 
capillary lengths (0.5m and 0.25m). 
Table III-4: Overview of the test parameters 
Parameters 530µm diameter capillary 220µm diameter capillary 
Capillary length L (m) 5 - 2 - 1.5 - 1 - 0.5 - 0.3 2.7 - 1.7 - 0.9 - 0.5 - 0.3 
Internal coating methyl / methyl-phenyl / glycol methyl 
Flow rate Q (mm³/s) 6.82 - 3.23 0.90 - 0.31 
Mean velocity Vmean (mm/s) 31 - 15 24 - 8 
Mean sedimentation Vsed (mm/s) 3.2·E-4 3.2·E-4 
Sedimentation ratio α (-) 0.006 – 0.200 0.018 – 0.490 
Reynolds number Retube (-) 16 - 8 5 - 2 
Number of particles n (-) 15000 - 25000 1000 - 10000 
Injected volume fraction (-) E-4 E-5 - E-4 
Injection time (s) 3 - 6 22 - 64 
 
To investigate the adhesion phenomenon more in detail, the results for 530µm 
diameter capillaries with different internal coatings, i.e. methyl, methyl-phenyl, 
and glycol groups, are compared. The adhesiveness of these groups is dissimilar 
for reasons of molecular polarity. Moreover, for a constant capillary length (5m) 
and constant number of injected particles, the influence of carrier flow rate on 
adhesion is studied.  
As the tube Re numbers are of the order 1.8-5.2 (D=220µm) and 7.8-16.5 
(D=530µm) for flow rates varying from 0.3 up to 0.9mm³/s and from 3.2 up to 
Chapter III 
 78
6.8mm³/s, respectively (Table III-4), the capillary flow is laminar with the 
characteristic velocity profile as described by Poiseuille’s law: 
 ( ) 


 

−⋅⋅=
2
R
r1V2rv mean  Eq. III-5 
With v(r) the axial velocity (m/s) at a radial position r from the axis (m), Vmean 
the mean fluid velocity (m/s) and R the capillary radius (m). 
The curvature ratio δ of the coiled capillaries (capillary radius R divided by the 
curvature radius) is very small, i.e. 0.00265 and 0.00110, giving rise to a Dean 
number κ in the range of 0.06-0.85. The latter is defined [177] as a function of 
mean velocity Vmean (m/s), capillary radius R (m) and kinematic viscosity ν 
(m²/s): 
 
δ
ν
RV2
κ mean ⋅⋅⋅=  Eq. III-6 
The Poiseuille velocity profile, in such conditions, remains undisturbed by 
capillary curvature [177,178].  
As for the presented test results particle volume fractions were only of the order 
E-4, fluid viscosity [179,180] is never affected by the bolus injection. The 
preferential flow path (r/R) is then derived from Poiseuille’s law: 
 
meanV2
v
1
R
r particle
⋅−=  Eq. III-7 
Owing to the finite bolus volume (20µL) and the relative small flow rates, 
injection times (22-64s for D=220µm and 3-6s for D=530µm) cannot be 
neglected and should be taken into account while interpreting elution diagrams. 
As for the 530µm capillary the particle injection produces a short bolus of high 
particle concentration, and since elution starts with a steep peak, track times 
effectively correspond to the detected time interval (Fig. III-2 top panel). This 
however is no longer the case with the 220µm capillary: the fastest particles 
anyhow leave the storage column as first. For the majority of particles (i.e. for 
the elution peak), track times are more accurately derived from a start time 
corresponding with the number of particles as detected at the peak of the elution 
(shaded area in Fig. III-2 bottom panel). 
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Fig. III-2: A typical bolus injection and elution plot with the 530µm diameter capillary for a 
flow rate of 6.823mm³/s (top panel) and with the 220µm diameter capillary for a flow rate of 
0.779mm³/s (bottom panel). 
3.4. Experimental results 
The migration of nearly neutrally buoyant spherical particles is investigated 
experimentally. An overview of the average positions of the preferential flow 
path r/R (%) for the fastest particles in the 530µm diameter methyl coated 
capillary is given in Table III-5 and Fig. III-3. The equilibrium position shifts 
towards the capillary wall at higher flow rates and for longer capillaries. Table 
III-6 shows the derived r/R values for a 220µm diameter capillary for the fastest 
particles on one hand (Fig. III-3), and for the majority of particles on the other. 
For higher flow rates (>0.77mm³/s) and shorter capillaries (<0.5m), the velocity 
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of the fastest particles is higher (20-60%) than the mean carrier liquid flow 
velocity, while it is slightly lower (0-10%) for lower flow rates (<0.41mm²/s) and 
longer capillaries (>1m).  
Table III-5: Mean values of preferential flow path r/R (%) for the fastest particles in the 
530µm diameter capillary for the applied flow rates and capillary lengths. 
Q(mm³/s)  \  L(m) 5.0 2.0 1.5 1.0 0.5 0.3 
6.823 46 45 47 42 29 37 
5.151 42 43 39 42 28 16 
4.190 43 44 42 39 13 19 
3.231 40 40 38 34 16 19 
 
 
Fig. III-3: Illustration of preferential pathways in 3D Poiseuille flow for the 530µm and the 
220µm diameter capillary compared with literature results. 
 
The distance traveled by the fastest particles as a function of elution peak time 
for the different carrier liquid flow rates, is shown in Fig. III-4 (530µm diameter) 
and Fig. III-5 (220µm diameter). The slope of these curves, derived from a linear 
regression, is a measure of the speed of Segré-Silberberg transport. Due to 
transitional phenomena and finite bolus injection times, the regression curves do 
not pass the origin.  
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Table III-6: Mean values of preferential flow path r/R (%) for the fastest 
particles/majority of particles in the 220µm diameter capillary for the applied flow rates 
and capillary lengths. 
Q(mm³/s)  \  L(m) 2.7 1.7 0.9 0.5 0.25 
0.895 48 / 66 55 / 71 77 / 79 66 / 83 49 / 77 
0.779 66 / 80  51 / 78 76 / 78 62 / 79 53 / 75 
0.407 73 / 80 77 / 84 73 / 74 60 / 72 46 / 77 
0.311 68 / 77 77 / 81 73 / 74 44 / 63 40 / 71 
 
 
Fig. III-4: Distance covered by the particles as a function of the track time at various flow rates 
of the carrier liquid in the 530µm diameter capillary. 
 
Fig. III-6 shows the normalized cumulative elution obtained with a 220µm 
diameter capillary of 0.9m long, and at a flow rate of 0.407mm³/s, before and 
after contamination of the capillary with irreversible adhering particles. For a 
standard capillary, the preferential flow path is found at r/R = 73±1%, while the 
radius of transport is closer to the centerline, i.e. r/R = 41±1% when permanent 
adhesion has occurred.  
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Fig. III-5: Distance covered by the fastest particles as a function of track time at various flow 
rates of the carrier liquid in the 220µm diameter capillary. 
 
 
Fig. III-6: Cumulative elution plots before (bold line) and after (thin line) irreversible adhesion 
in the 220µm diameter and 0.9m long capillary for a carrier liquid flow rate of 0.407mm³/s.   
The curves are numbered from 1 up to 6 in order of successive performed measurements. 
 
Fig. III-7 shows the normalized cumulative elution plots for 530µm diameter and 
5m long capillaries with different internal coatings, i.e. methyl, methyl-phenyl 
and glycol, and for a flow rate of 4.190mm³/s. Taking the results of the methyl 
capillary as reference and normalizing the elution curves for the total number of 
detected particles, the area in between the curves is a measure for the extra 
adhesion occurring in the methyl-phenyl and glycol capillaries, respectively. The 
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ratio of the enclosed area to the total area below the cumulative elution curve of 
the methyl coated capillary (%) is a measure for the extra appearing adhesion and 
is given in Table III-7 for the different applied flow rates. Adhesion seems more 
important in the methyl-phenyl coated capillary and for lower flow rates. 
 
Fig. III-7: Cumulative elution plots in 530µm diameter and 5m long capillaries with different 
internal coating: methyl, methyl-phenyl, and glycol. The carrier liquid flow rate is 4.190mm³/s. 
 
Table III-7: Extra adhesion (%) in the methyl-phenyl and glycol capillaries, compared 
with the methyl coated one (530µm diameter and 5m in length), for the different applied 
flow rates. 
Q(mm³/s)   methyl-phenyl glycol 
6.823 0.6 0.06 
5.151 0.8 0.2 
4.190 2.5 0.7 
3.231 5.3 4.1 
3.5. Discussion 
Most former studies investigated either the transport of a single particle 
theoretically [143,157,164,168,170], or the motion of a continuous dilute suspension of 
particles experimentally in relatively wide tubes [151,156]. This study, however, 
aims to quantify particle suspension transport in long microcapillaries by 
evaluating the elution at the capillary outlet after bolus injection at the inlet. The 
main distinctions between the different approaches are given in Table III-8. With 
respect to the carrier liquid fluid, Poiseuille flow conditions are assumed since 
tube Reynolds numbers are low (<20) and the velocity profile is not influenced 
by capillary curvature [177,178].  
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Table III-8: Parameters and results of the presented study compared with those of an 
experimental [151] and theoretical [143] study. 
Parameters Eloot et al. 
D = 530µm 
Eloot et al. 
D = 220µm 
Segré et al. 
Experimental 
Feng et al. 
Numerical 
Capillary position horizontal horizontal vertical horizontal 
Capillary length L (m) 0.3 - 5 0.3 - 2.7 0.31 - 1.20 - 
Capillary diam D (mm) 0.530 0.220 11.2 8·a 
Particle diam a (mm) 0.010 0.010 0.32 - 1.71 a 
Ratio a/D (-) 0.019 0.045 0.029 – 0.153 0.125 
(ρp - ρf) / ρf (%) + 0.6 + 0.6 0 -10 - +10 
Velocity Vmean (mm/s) 31 - 15 24 - 8 50 - 900 0.625·ν·L/a² 
Re number Retube (-) 16 - 8 5 - 2 3 - 700 40 - 120 
Number of particles (#/cm³) 7·E+5 – 10·E+5 5·E+4 – 50·E+4 0.33 - 4 single particle
Injection time (s) 3 - 6 22 - 64 7 - 134 - 
Flow path r/R (%)      
Neutrally buoyancy 16 - 47 40 – 77 40 / 60 60 
Strong buoyancy - - - → 0 
3.5.1. Particle buoyancy 
The buoyancy parameter is only 0.6% and might inspire the reader to make 
comparisons with the results for neutrally buoyant particles. For the intermediate 
case between neutrally and non-neutrally buoyant particles, Vasseur and Cox [157] 
described a theory (originally derived for Retube<<1 but found to be valid [164] for 
Retube< 15) based on the dimensionless parameter B: 
 2
mean
particle
R2
a
V
v
B 


⋅⋅=  Eq. III-8 
B is equal to zero for neutrally buoyant particles migrating to the equilibrium 
flow path at r/R=62%. Positive values of B result in preferential flow paths 
nearer to the wall, while negative values result in particle migration towards the 
axis [157]. Deviations from the equilibrium streamline only become important for 
absolute values of B equal to E-1. As we are dealing with B values E-4 (220µm 
capillary) and E-5 (530µm capillary), buoyancy seems not to be important. 
However, in long microcapillaries, particle sedimentation plays a non-negligible 
role. Using Stokes’ law and considering hydrodynamic interactions between 
particles, Batchelor [181] defined the average sedimentation velocity in a dilute 
random suspension Vsed (m/s) as: 
 ( )( )2Stsed cOc6.551VV +⋅−⋅=  Eq. III-9 
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with c as the particle volume fraction (-) and VSt as the Stokes velocity (m/s): 
 ( )
g
µ9
ρρa2
V fp
2
St ⋅⋅
−⋅⋅=  Eq. III-10 
The latter is a function of particle radius a (m), dynamic fluid viscosity µ (Pa·s), 
the particle and fluid density ρp and ρf (kg/m³), respectively, and the gravitational 
acceleration g (m/s²). As the suspension is rather dilute, sedimentation velocity is 
found constant and equal to 0.32µm/s (Table III-4). The ratio of sedimentation 
distance to capillary inner diameter, α (-), a relevant measure for buoyancy, 
becomes important (α=0.49) for low flow rates (Vmean=8mm/s) in long 
(L=2.96m) and small (D=220µm) capillaries (Table III-4): 
 
mean
sedsed
VD
LV
D
tV
α ⋅
⋅=⋅=  Eq. III-11 
As a consequence, particles tend to migrate to the bottom of longer capillaries, 
which makes adhesion more likely to occur. 
3.5.2. Preferential flow paths 
There is a significant difference between the preferential flow paths found with 
the 530µm (range r/R = 16-47%) and with the 220µm diameter capillary (range 
r/R = 40-77%), respectively (Fig. III-3). Causes of that might be multiple. First, 
the particle to capillary diameter ratio, 2·a/2·R, (0.019 in the 530µm versus 0.045 
in the 220µm diameter capillary) appears to have an important influence on 
particle transport. As occurring differences in axial velocities at both sides of the 
particle are higher in smaller capillaries for a fixed mean velocity, particles will 
experience stronger negative pressure at the lower velocity side, stimulating 
migration towards the wall. Secondly, due to dissimilar flow rates applied in both 
capillaries, we are dealing with different injection times and, hence, with 
different elution curves. For capillaries of relatively large diameter and for higher 
flow rates, bolus injection can be considered as instantaneous, such that the 
elution diagrams are characterized by a steep frontal peak (Fig. III-2). In the 
smaller capillary, however, and for lower flow rates applied, injection as well as 
elution spread out (Fig. III-2), resulting in a lower detected volume fraction. 
Moreover, to avoid contamination resulting in capillary and/or gate blockage, the 
injected bolus particle volume fraction was reduced by a factor 10 with the 
220µm diameter capillary, compared to the tests with the wider capillary. As a 
consequence, the elution measured with the 220µm diameter capillary is more 
the result of single particles passing the gate, less influenced by preceding or 
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chasing particles. This might be the reason why preferential flow paths derived 
from those elution curves are better matching former experimental and 
theoretical results [143,151].  
The equilibrium streamlines in the 530µm capillary shift towards the wall for 
higher Reynolds numbers (higher flow rates), as was experimentally and 
numerically pointed out by Segré et al. [151] and Feng et al. [143]. In general, higher 
Reynolds numbers correspond to higher fluid velocities, larger channel width, or 
less viscous fluids. For a particle flowing e.g. beneath the axis in a horizontal 
Poiseuille flow, the velocity curvature, more expressed for higher flow rates, 
creates a higher velocity of the fluid relative to the particle on the bottom side. 
This stronger local flow causes low pressure on this side such that the particle is 
sucked away from the centerline [143]. Moreover, for wider channels, the wake of 
a particle no longer fills the channel width, in such a way that the inertial 
interaction with the wall and, with it, wall repulsion decreases. As a 
consequence, radial migration velocity is related to three dimensionless variables 
[151,157,165,166]: particle to capillary radius ratio, a/R, radial position to capillary 
radius ratio, r/R, and the Reynolds number.  
As Segré and Silberberg did not consider the lower Re range (i.e. Retube<16.2) in 
their experiments with long (L=1.2m) wide tubes (r/R=60%), the influence of 
Reynolds number on particle transport as found with our experiments is 
compared to their results for a shorter tube (L=0.31m). For a high number of 
injected particles (7·E+5 - 40·E+5 particles/cm³) in the longest capillary (L=5m), 
our experimental findings gave an r/R varying from 40 to 46% for tube Reynolds 
numbers increasing from 7.8 up to 16.5 (Table III-5). These results appear in 
good agreement with the experimental data as measured by Segré and Silberberg 
for an injection of 2 particles/cm³ (particle diameter 1.21mm) in a tube with 
diameter D=11.2mm and length L=0.31m. They found an r/R varying from 40 to 
46% for a Reynolds number in the range 3.2-16.2. However, it should be 
remarked, that both experiments are performed in totally different ranges with 
respect to particle/tube sizes and particle volume fractions. As a consequence, 
this comparison is more an evidence of the phenomenon rather than a 
quantitative verification. 
For the longest 530µm diameter capillaries (2m-5m), a stable equilibrium is 
found at 27-30% of the capillary width (i.e. the capillary diameter) while 20% 
width is predicted on the basis of single particle tracking [151,155-157] (Fig. III-3). 
The observed equilibrium streamline for slightly buoyant (0.6%) injected 
particles is the result of two competing effects: particle sedimentation towards 
the bottom wall, and migration of the lagging particles towards the centerline 
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[160,161]. With shorter capillaries (<1m) particles are moving with velocities more 
approaching the maximum fluid velocity. This can be explained by the fact that 
the shorter the capillary passage time is, the lower the axial particle diffusion and 
bolus dilution are. And, as a consequence, the higher the bolus volume fraction, 
the more important the interaction between particles is. Han et al. [182] reported 
mutual particle collisions for volume fractions of 0.06, resulting in a smooth 
particle distribution around the equilibrium in between the centre and the wall. 
Dealing with much smaller volume fractions (e.g. order E-4) does, however, not 
necessarily imply that indirect particle interactions can be ignored. For the case 
the distance in between two neighbouring particles is not too close but still small 
compared to the channel width, the disturbance flow in the inviscid region (far 
enough from the wall) is influenced by both particles. This results in a lift force 
on each particle twice as high as found for a single particle [183]. Furthermore, 
mutual particle collisions between a flowing and an adhered particle are more 
likely to occur with the more concentrated suspension in the 530µm diameter 
capillaries. As a consequence, adhered particles are enabled to be released again 
and to migrate towards regions of higher fluid velocities [184]. 
For the 220µm capillary, the fastest particles move along streamlines at 10-30% 
of the capillary width, which is in quite good agreement with previous results 
[151,155-157]  (Fig. III-3). Although good reproducibility for measurements with the 
same test conditions was found, it is hard drawing clear conclusions with respect 
to capillary lengths and Reynolds numbers. For the larger capillary lengths 
(>1.5m), equilibrium streamlines shift towards the wall for lower flow rates 
(lower Reynolds numbers) as sedimentation becomes more expressed (Eq. 
III-11). However it should be remarked that a considerable experimental 
variability (high standard deviation) was found for the transport radii at higher 
flow rates (>0.779mm³/s) compared with the lower ones (<0.407mm3/s).  
Of decisive importance for the applicability of the present measuring technique is 
the rate of establishment of Segré-Silberberg transport immediately after 
injection of the bolus. Relevant information in that context was obtained by 
measuring track times in capillaries cut to decreasing lengths and at various flow 
rates of the carrier liquid (Fig. III-4 and Fig. III-5). For the 530µm capillaries, the 
slopes deviate from linearity only for capillary lengths smaller than 0.5m (Fig. 
III-4). As the negative x-intercept diminishes for higher flow rates, the transition 
phenomenon is more expressed with lower axial velocities. In general, this entry 
effect is caused by the fact that fluid from the storage column, entering the mouth 
of the capillary, will not immediately transform into the laminar Poiseuille 
profile. Moreover, the initial homogeneous particle distribution will transform to 
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transport along preferential streamlines. Using the shear-induced-diffusion 
hypothesis of Leighton and Acrivos [185], the timescale for reaching fully steady 
state flow [186], tss, is function of the mean radial distance the particles must 
travel, R: 
 
D⋅≈ 4
Rt
2
ss  Eq. III-12 
With D the shear-induced diffusivity (m²/s) defined as: 
 ( ) 2aγd ⋅⋅= φD  Eq. III-13 
γ being the shear rate (1/s), a the particle radius (m), and d(φ) a non-dimensional 
function of particle volume fraction, φ, obtained from extrapolation of 
experimental data with high concentrated suspensions [187]: 
 ( ) ( )[ ]φφφ ⋅⋅+⋅⋅= 7exp9.015.0d 2  Eq. III-14 
The shear rate is estimated for Poiseuille flow at the radial position 
corresponding with mean axial velocity: 2.83·Vmean/R. Eq. III-12 can be 
expressed equivalently as the length required to reach steady state, Lss (m): 
 
( )[ ] 2
3
2ss a
R
7exp9.0166.5
1L ⋅⋅⋅+⋅⋅= φφ  Eq. III-15 
Although this theory was originally derived from experiments using a totally 
different range for particle and tube sizes, particle volume fractions, and shear 
rates, Eq. III-15 might still give an indication about transition phenomena. For 
our dilute suspension and small particle to capillary ratio, a transition length of at 
least E+6m is found. This implies that no fully developed flow is reached in the 
considered capillaries. In addition, investigation of transport of dilute particle 
suspensions in microcapillaries requires the use of extremely long capillaries. 
However, regarding the relatively short lengths investigated, the presented results 
are only slightly influenced by the transition phenomenon. As a consequence, 
cautiously, the results can be considered valuable within the experimental range. 
Moreover, the good correlation of the linear curves observed in Fig. III-4, clearly 
indicates that transition effects mainly manifest in the first 0.5m and are rather 
negligible for capillary lengths between 0.5-2m. With the 220µm capillaries, 
curves derived for the fastest particles correlate less well (R² = 0.88-0.99) and, 
even worse, a positive x-intercept is found for the highest flow rate (0.9mm³/s) 
(Fig. III-5). The latter implies that besides entrance effects, particle transport 
along the capillary, characterized by wall adhesion and release, also plays an 
important role. 
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3.5.3. Adhesion 
Both adhesion and removal of particles to/from a substrate are influenced by 
mechanical properties of the materials (Young’s moduli and yield strength), by 
their chemical nature and texture, and by characteristics of the flow near the 
surface of the substrate. As the influence of different coatings is investigated in 
this study at a constant temperature, at preset flow rates (constant shear stress at 
the surface), and with suspensions of similar concentrations, only differences in 
chemical constitution have to be considered. Adhesion and disruption are 
assumed to take place at constant temperature, without any volume change of the 
materials involved, and in the absence of chemical processes. 
Thermodynamically speaking, spontaneous and reversible adhesion may occur in 
such circumstances whenever the system’s free energy F (Joule) is decreasing 
[188]: 
 0σZγγγ
A
∆F
plslps <⋅+−−=∆  Eq. III-16 
With γps, γsl, and γpl the particle/substrate, substrate/liquid, and particle/liquid 
interfacial energies (J/m² or N/m), respectively, ∆A the contact surface change 
(m²), Z the electric potential at the shear surface, and σ the surface charge density 
(Clb/m²). As the polystyrene vinyl dibenzene spheres are uncharged (σ∼0) and 
the sodium chloride solution has a high ion concentration (Z∼0), the last term in 
Eq. III-16 can be ignored.  
Interfacial energies of the types γsl and γpl on the ground of Young’s law are 
related to solid/liquid contact angles: 
 


⋅−=
⋅−=
pllvppl
sllvssl
cosθγγγ
cosθγγγ
 Eq. III-17 
Where γlv (also referred to in literature as γl) represents the surface tension of the 
liquid. 
Molecular interaction between materials such as polystyrene vinyl dibenzene 
latex and the adhesive substrates of the present experiments (methyl, methyl-
phenyl, and glycol coated) mainly takes place as a consequence of dispersion 
forces (γd). This allows the interfacial energy, γps, to be formulated as [189]:  
 ( ) 21dsdpspps γγ2γγγ ⋅−+=  Eq. III-18 
Substituting Eq. III-17 and Eq. III-18 in Eq. III-16, one obtains: 
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 ( ) ( ) 0γγ2cosθcosθγ 21dsdpplsllv <⋅−+⋅  Eq. III-19 
The dispersion terms, dsdp  γand γ , can be determined by measuring the contact 
angle of a fluid with known surface tension, γl, with the corresponding solid, e.g.: 
 
l
d
ld
ssl γ
γ
γ2-1cosθ ⋅⋅+=  Eq. III-20 
The governing equation (Eq. III-19) regarding occurrence of adhesion, is 
transformed in: 
 ( ) 0
γγ2
1cosθ
.
γγ2
1cosθ
2cosθcosθγ
l
d
l
pl
l
d
l
sl
plsllv <



⋅
+




⋅
+⋅−+⋅  Eq. III-21 
Because methyl groups have the second lowest free surface energy [190] 
(≈20mN/m), it is taken in this study as the reference. Free surface energy is 
increased in alcohols [190] (such as glycol) because of an increased molecular 
polarity as the oxygen group enlarges the contact angle. For similar reasons 
actually, progressively higher surface energies are found for aliphatic chains and 
aromatic rings (such as methyl-phenyl) [190]. So the order of ranking the coatings 
for increasing free surface energy becomes methyl, glycol, and methyl-phenyl. 
Because substrate surface free energy γs is related to the contact angle θsl (Eq. 
III-17), higher energies correspond to lower values for Eq. III-21. 
To investigate the degree of adhesion, the load Ps needed to effect a 
particle/substrate separation is also an interesting tool, and was defined by 
Johnson, Kendall, and Roberts [191]: 
 aπw
2
3P As ⋅⋅⋅−=  Eq. III-22 
With a the particle radius (m) and wA the thermodynamic work of adhesion 
(J/m²), related to the surface energies, γp and γs, of any particle and substrate and 
their interfacial energy, γps: 
 psspA γγγw −+=  Eq. III-23 
Combining Eq. III-18, Eq. III-22, and Eq. III-23, the separation load can be 
rewritten as: 
 ( ) aπγγ3P 21dsdps ⋅⋅⋅−=  Eq. III-24 
The separation load, Ps, decreases in absolute value for a decreasing dispersion 
force, ds γ . This is reached using a substrate material, such as methyl, with a lower 
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free surface energy, γs, and, thus, characterized by a lower contact angle. Our 
experimental findings, i.e. increasing importance of adhesion in methyl, glycol, 
and methyl-phenyl coated capillaries, respectively, are in agreement with the 
here presented theory describing adhesion phenomena. 
Particles transported by rolling over the wall in the absence of any adhesion, are 
characterized by a flow path of r/R=0.95. Higher values, as found for the slowest 
particles in the 220µm diameter capillary, at least indicate the presence of 
adhesion with subsequent release of particles. By flushing the capillary at high 
flow rates (exerting higher shear stresses at the surface) once a measurement at 
the lowest flow rates was done, around 5% of the total number of particles, 
adhering to the wall, was released again. As the Stokes number in our 
experiments with the 220µm capillary (of the order E-2) is much lower than the 
critical Stokes number [173], rebound appears impossible. As a consequence, a 
release of adhering particles can be effectuated only by extra acceleration 
obtained from a moving particle colliding with an adhered one. This 
phenomenon was also observed in a previous study [183,192] where adhesion in the 
530µm capillary was less pronounced for increasing particle concentrations.  
After irrevocable deposition of particles on the capillary wall, so as observed in 
the 0.9m long 220µm diameter capillary, elution starts earlier and lasts even 
longer (Fig. III-6) in such a way that it is hard to distinguish an isolated elution 
peak. On one hand we speculate that contamination at the capillary wall causes 
the approaching particles to migrate towards the centerline, resulting in a higher 
transport velocity. This wall repulsive phenomenon was described earlier by 
Feng et al. [143] for particles initially released near the wall. On the other hand, 
wall contamination might cause particles to be trapped; in such a way that 
temporarily or even irreversible adhesion occurs. 
3.5.4. Experimental limitations 
Finally, it should be remarked that although reliable quantitative results are 
obtained, we have to deal with some limitations. First, the bolus injection times 
are non-negligible so that interpretation of the elution curves is more difficult. 
Secondly, as the used microcapillaries are nontransparent, microscopic 
observations of steady state conditions, particle collisions and adhesion cannot be 
performed and results should be considered as black box output. 
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3.6. Conclusion 
The described measuring technique allows quantitative evaluation of the 
transport of a particle suspension in microcapillaries. Critical parameters like 
carrier liquid flow rate, bolus volume fraction, particle-to-liquid density ratio, 
particle-to-capillary diameter ratio, and capillary length were investigated.  
For more concentrated dilute suspensions in wider capillaries, indirect particle 
interactions cause preferential flow paths to lie closer to the centerline than 
obtained from experimental and numerical studies concerning a single particle or 
more dilute suspensions. In small capillaries, however, the idea of particles 
following a specific flow path parallel to the capillary axis might be too 
optimistic even for dilute suspensions. It is more realistic to conclude that 
sedimentation and temporary wall adhesion cause retardation, which, in turn, 
causes deviations from the ideal flow path. 
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4. Flow modeling at the blood-dialysate interface 
of a hemodialyzer fiber 
4.1. Importance of microscopic flow modeling 
Pressure values in the blood, as well as in the dialysate compartment determine 
the ultrafiltration profile in hemodialyzers. This pressure profile can be 
theoretically calculated, assuming a constant fluid viscosity and a linear pressure 
drop over the fiber length in blood and dialysate. Due to ultrafiltration, however, 
flow rates are changing over the fiber length and may cause the pressure drop 
deviating from linearity. Moreover, blood viscosity is varying along the length of 
the dialyzer, causing blood thickening. Besides this axial variation, blood 
viscosity will also vary in radial direction due to the Fahraeus-Lindqvist effect. 
Blood viscosity will approach plasma viscosity near the dialyzer membrane, 
while the high concentration of cells near the fiber axis causes a local viscosity 
increase. 
As a consequence, the influence of ultrafiltration on fiber flow and fluid 
properties must be investigated at the fiber level rather than the dialyzer level. 
Therefore, a numerical model was developed of the blood-dialysate interface. 
Fluid characteristics and membrane properties were investigated in advance in 
order to implement them properly in the numerical model. 
After a short literature overview, the following studies are reported: in vivo 
evaluation of the dialysate properties, in vitro evaluation of the membrane 
permeability, influence of the dialyzer membrane type, and influence of the 
filtration fluid. 
4.2. Literature overview† 
Whereas one can investigate and compute (macroscopically) blood and dialysate 
flow in a dialyzer assuming flow in a permeable medium, it should be noted that 
some important aspects like ultrafiltration, concentration polarization, particle 
accumulation or protein adsorption at the membrane surface and the multiphase 
blood flow should be investigated with a microscopic model. Computational 
fluid dynamics (CFD) is a useful tool for flow visualization at both macroscopic 
                                                     
† The contents of this section was published in Artif Organs 2002;26(7):590-599. 
Computational flow modeling in hollow-fiber dialyzers 
S. Eloot, D. De Wachter, I. Van Tricht, and P. Verdonck 
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and microscopic level. However, the numerical results should at least be 
validated with analytical solutions and/or experimental measurements. 
4.2.1. Ultrafiltration versus Haegen-Poiseuille 
Ultrafiltration, generated by osmotic and hydrostatic pressure drops over a 
porous membrane, was originally numerically described by Kedem and 
Katchalsky [193] using thermodynamics of irreversible processes. The membrane 
properties were described in terms of filtration, reflection and permeability. 
Rather than using thermodynamics, Kargol [194] redefined those coefficients 
assuming a membrane with randomly distributed pore sizes. Using a theoretical 
model validated with experiments, Wupper et al. [195] described the profile of 
ultrafiltration and concentration along the axis of high flux hollow fiber 
dialyzers. It was found that the hydrostatic pressure profile could be 
approximated as linear even in the presence of a non-linear concentration profile 
for impermeable solutes. As a result, changes in fiber radius and membrane 
permeability can be studied using the Darcy and Haegen-Poiseuille laws. 
Karode [196] derived analytical expressions for the pressure drop in a permeable 
tube as a function of wall permeability, channel dimensions, axial position and 
fluid properties by differentiating the Haegen-Poiseuille formula and applying it 
locally to infinitesimal sections. Moreover, to benchmark the expression for 
constant wall permeability, a CFD model was developed and verified by 
comparing the results for constant wall velocity with Berman’s solution [197]. 
4.2.2. Concentration-polarization 
In the presence of ultrafiltration, particles within the main stream are subjected to 
a drag force and accumulate near the membrane surface, while the accumulated 
particles tend to migrate to the feeding stream driven by the concentration 
gradient. The boundary layer concentration modifies the solute and/or solvent 
properties like viscosity, density and solute molecular diffusivity [198]. Due to 
particle accumulation, ultrafiltration flow decreases with time and a steady state 
value, described as a function of the concentration ratio near the membrane and 
in the main stream and of the mass transfer coefficient, was derived by Michaels 
[199] using the one-dimensional convection-diffusion equation. Backfiltration, 
caused by the oncotic effect, induces a shear stress, which was incorporated by 
Zydney et al. [200] by using the shear-induced hydrodynamic diffusion coefficient 
analyzed experimentally by Eckstein et al. [201]. Moreover, the shear stress, 
maximal at the membrane on the fluid-like concentrated layer, causes this layer 
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to get fluidized. This shear-induced hydrodynamic diffusion process was 
implemented by Romero et al. [202] taking into account the two-dimensional 
characteristics of ultrafiltration by integrating the axial momentum equation into 
the one-dimensional convection-diffusion equation. 
Lee et al. [203] used the two-dimensional convection-diffusion equation to 
describe, using an iterative algorithm, the ultrafiltration flow decline caused by 
concentration polarization. They found that the concentration as well as the 
thickness of the boundary layer increases with axial distance but decreases for 
higher diffusion coefficients and axial velocities.  
For computational modeling of such a thin boundary layer in which the solute 
concentration changes intensively, a very dense grid should be used. To enable 
the use of a large grid, Miranda et al. [198] applied a simple natural logarithmic 
variable transformation, a procedure described earlier by Zidney et al. [204], in the 
solute transport equation attenuating the concentration derivatives inside the 
boundary layer. Other studies [205,206] refer to the use of CFD to model 
concentration polarization in the fluid phase adjacent to the membrane without 
taking into account the selective permeation through the membrane fluid phase. 
4.2.3. Particle accumulation 
As the characteristics of the particle layer on the membrane are directly related to 
the hydraulic permeability, numerous algorithms (e.g. based on a simple Monte 
Carlo simulation [207] or a discrete stochastic model [208]) exist for simulating the 
particle packing. Kawakatsu et al. [209] performed a three-dimensional analysis of 
boundary layer formation and porosity assuming mono-dispersed particles 
moving according to Brownian motion. Emphasizing the non-equal sized 
character of accumulating particles, Yoon et al. [210] developed a three-
dimensional simulation for the microfiltration of colloidal particles considering 
the particle back transport velocity, which was found to be dominantly controlled 
by particle-surface interactions. The particle transport towards the membrane 
surface was determined considering the ensemble of forces (lift, drag, van der 
Waals attraction and charge repulsion) and torques acting on the moving particle. 
Moreover, the flux is calculated using the concept of a resistance in series model 
considering pore blocking as well as layer resistance. For non-flocculating 
particle conditions, the latter is the major flux controlling parameter. 
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4.2.4. Multiphase flow 
The unidirectional shear flow of highly concentrated fluid-particle suspensions, 
showing particle migration from regions of high shear to regions of low shear, 
has been investigated using a two-dimensional [211] and axi-symmetric [212] 
numerical model. The suspension, treated as a Newtonian fluid, is modeled using 
the momentum and continuity equation, whereas the particle motion is governed 
by a modified transport equation accounting for the effects of shear-induced 
particle migrations. Although the parameters of rigid neutrally buoyant particles 
[212] are far from matching those of the deformable red blood cells, the numerical 
results, in good agreement with analytical predictions of Phillips et al. [213], may 
contribute to a better understanding of the possible local variations of the 
hematocrit. 
4.3. In vivo evaluation of the dialysate properties† 
4.3.1. Objective 
The influence of ultrafiltration and solute removal on the dialysate viscosity and 
density was investigated in vivo. Dialysate samples were taken at the inlet and 
outlet dialysate line at different time points during the dialysis session. 
4.3.2. Patients and methods 
4.3.2.1. Patients and dialysis strategies 
The study was performed in three stable female dialysis patients without native 
kidney function. Two-needle conventional hemodialysis was performed during 
210±30 minutes using low flux dialyzers. The main characteristics of the patients 
and their dialysis sessions are shown in Table III-9. The composition of the 
dialysate was: 37mmol/L bicarbonate, 140mmol/L sodium, 107.5mmol/L 
chloride, 3.0mmol/L acetate, 1.5g/L glucose, 1.25mmol/L calcium, 1.0mmol/L 
potassium, and 0.5mmol/L magnesium. A constant dialysate flow rate of 
500mL/min was applied using a Bellco Multimat dialysis machine. Blood flow 
of 227±25mL/min and ultrafiltration rates of 0.72±0.13L/h were obtained (Table 
III-9). 
                                                     
† The contents of this section was adapted from the report published in 2001 
Assessment of the impact of bloodviscosity on the flow through a hollow fiber dialyzer 
S. Eloot, D. De Wachter, and P. Verdonck 
This study was financially supported by Fresenius Medical Care - Bad Homburg - Germany. 
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Table III-9: Main characteristics of the dialysis patients. 
Patient 
 
Age 
years 
QB 
mL/min 
BW* 
kg 
H* 
% 
UF 
L 
Dialysis 
min 
Dialyzer KUF 
mL/h/mmHg
1 67 200 53.7 28 3.48 240 Nipro FB 210H 15 
2 67 230 35.2 34 2.17 210 Renak MA 18U 8.8 
3 77 250 76.0 28 1.98 180 Fresenius F6 HPS 8.5 
MEAN 70 227 55.0 30 2,54 210 - 10.8 
SD 6 25 20.4 3 0,82 30 - 3.0 
*pre-dialysis; blood flow QB; body weight BW; hematocrit H; ultrafiltration UF; standard deviation SD 
 
In the water pre-treatment system of the hospital, well water is subsequently 
percolated over a rough sediment filter, iron filter, softener, activated carbon 
filter and two reverse osmosis membranes. The characteristics of the obtained 
reverse osmosis (RO) water correspond to the demands as described by the 
European Best Practice Guidelines [214]. After water distribution towards the 
dialysis unit, a Bellco Multimat dialysis machine prepared the dialysis fluid just 
before it flows through the hollow fiber dialyzer. The ultra pure water is first 
mixed with automatic self-made bicarbonate in order to obtain a conductivity of 
3mS/cm. Finally it was mixed with industrial made acid concentrate. The mixing 
is based on a constant conductivity of 14mS/cm and doesn't count with constant 
volumes of RO water, bicarbonate and acid. 
4.3.2.2. Dialysate sampling and analyses 
In order to investigate viscosity, dialysate was sampled (20mL) for each patient 
at the inlet and outlet dialysate line at the start, halfway and at the end of the 
dialysis session. The dialysate viscosity was measured at 37°C with a capillary 
Ubbelohde viscometer. The measuring technique was described in Chapter I, 
paragraph 5.1. Each sample was measured three times to check reproducibility.  
For the density measurements, 500mL samples were needed. The number of 
samples was limited owing to the risk of getting the dialysis machine in leak 
alarm during sampling. Only one sample was taken at the inlet dialysate line, 
while dialysate outlet samples were taken when the patients were halfway in the 
dialysis treatment. The density of the dialysate was measured with a density-
hydrometer-aerometer (Assistant, Germany). The measuring technique was 
described more in detail in Chapter I, paragraph 5.1.  
4.3.3. Experimental results 
The mean inlet and outlet dialysate viscosity (with standard deviation) at the 
start, halfway, and at the end of the dialysis session, is for the three different 
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patients given in Table III-10. The viscosity variation by flowing through the 
dialyzer is indicated as % increment.  
Table III-10: Results of the viscosity measurements. 
Patient Inlet viscosity 
mPa·s 
Outlet viscosity 
mPa·s 
Increment 
% 
Start of dialysis 
1 0.665 ± 0.003 0.684 ± 0.006 2.9 
2 0.670 ± 0.004 0.680 ± 0.003 1.5 
3 0.675 ± 0.006 0.679 ± 0.003 0.5 
Halfway dialysis 
1 0.676 ± 0.008 0.685 ± 0.006 1.3 
2 0.679 ± 0.003 0.686 ± 0.001 1.1 
3 0.684 ± 0.001 0.681 ± 0.003 -0.4 
End of dialysis 
1 0.720 ± 0.010 0.713 ± 0.005 -1.0 
2 0.712 ± 0.003 0.699 ± 0.001 -1.8 
3 0.695 ± 0.010 0.693 ± 0.002 -0.3 
 
Performing three measurements with each dialysate sample resulted in a small 
standard deviation on the measured viscosity. By flowing through the dialyzer, 
dialysate viscosity is increased at the start of dialysis, while it is decreased at the 
discontinuation of the dialysis session. It must be remarked, however, that the 
changes are not significant (1-2%). The overall mean viscosity was calculated 
and was found 0.687±0.200mPa·s. 
The evolution over the dialysis session of the inlet and outlet dialysate viscosities 
is presented in Fig. III-8. A significant rise (range 3.0-6.3%) in the viscosity of 
fresh dialysate was observed. 
The results of the dialysate density measurements are shown in Table III-11. 
Because the densimeter was calibrated at 25°C, the samples were cooled to room 
temperature before registration of the density. No significant difference was 
found between the density of the inlet and outlet samples. Furthermore, the 
density of the dialysate can be considered equal for the three patients (1008g/L). 
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Fig. III-8: Variation of dialysate viscosity during the dialysis session at the dialyzer inlet (left 
panel) and dialyzer outlet (right panel) for patient 1 (rhombs), patient 2 (squares), and patient 3 
(triangles) 
 
Table III-11: Results of the density measurements. 
Dialyzer inlet  Dialyzer outlet 
Density  
(g/L) 
Temperature 
(°C) 
Patient Density  
(g/L) 
Temperature  
(°C) 
1 1008 29.5 
2 1009 26.0 1008 24.5 
3 1008 26.5 
4.3.4. Discussion 
The present study aimed at investigating whether the mass transport in the 
dialyzer influences the dialysate viscosity and density properties. Therefore, 
dialysate samples were taken in vivo at the inlet and outlet line, and were 
examined with a viscometer and densimeter, respectively.  
The main conclusions of this study are: first, dialysate viscosity is only slightly 
influenced (1-2%) by flowing through the dialyzer; second, the viscosity of fresh 
dialysate increased towards the end of the dialysis session; third, dialysate 
density is not influenced by dialysis and can be assumed constant (1008g/L).  
Hoping to find an explanation for the unexpected rise of fresh dialysate viscosity, 
dialysate glucose measurements were achieved at different time points during a 
standard dialysis day. In Fig. III-9, three different mixing procedures are 
presented: first, RO water mixed with industrial acid and self-made bicarbonate 
with an overall conductivity of 14.5mS/cm; second, RO water mixed with 
industrial acid and industrial bicarbonate with a resulting conductivity of 
14mS/cm; and third, RO water mixed with industrial acid and industrial 
bicarbonate with a resulting conductivity of 14.5mS/cm. While both latter 
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mixtures can be considered constant for each conductivity value 14mS/cm 
(162.7±0.6mg%) and 14.5mS/cm (183.7±2.9mg%), the mixing method as used 
during our experiments, RO water mixed with self-made bicarbonate and 
industrial made acid, describes important fluctuations in glucose concentration 
(161.5±9.5mg%).  
Because of variations in the preparation of self-made bicarbonate, the final 
mixing will contain variable proportions of acid and bicarbonate in order to keep 
the conductivity at the prescribed rate. Varying proportions of the two solutes 
results in varying glucose concentrations, which is an important parameter for the 
viscosity [215]. The increasing difference between glucose concentration in 
dialysate and blood can lead to higher glucose diffusion towards the blood. This 
phenomenon explains the decrease of dialysate viscosity (inflow versus outflow) 
at the end of a dialysis treatment.  
 
Fig. III-9: Variation in time of dialysate glucose concentration (mg%) using different mixtures: 
industrial acid with self-made bicarbonate to 14.5mS/cm (asterisks), industrial acid with 
industrial bicarbonate to 14mS/cm (triangles), and industrial acid with industrial bicarbonate to 
14.5mS/cm (squares). 
4.3.5. Conclusion 
Dialysate viscosity shows no significant variation (1-2%) by passing through the 
dialyzer and has a mean value of 0.687±0.200mPa·s. Due to a non-constant 
volume mixing of the RO water with bicarbonate and acid, there is an evolution 
in the fresh dialysate viscosity during dialysis. From this respect, it is 
recommended for future tests to combine viscosity and glucose measurements or 
to use dialysis fluid prepared with industrial made solutes. 
With the applied measuring technique, dialysate density was found constant 
(1008g/L) and not influenced by dialysis. 
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4.4. In vitro evaluation of the membrane permeability† 
4.4.1. Abstract 
An in vitro setup has been designed to study the hydraulic permeability of hollow 
fiber dialyzers. Forward and reverse dialysate filtration were determined using 
both sterile dialyzers and samples with a protein layer settled on the membrane 
(Fresenius F6, F8, F60 and F80). 
The ultrafiltration coefficient KUF (mL/h/mmHg) was calculated as the ratio of 
volumetrically flow (QUF) and transmembrane pressure (TMP) measurements. 
The protein layer on the membrane was induced either by recirculation of human 
plasma through the dialyzers (in vitro) or by a standard hemodialysis session (in 
vivo). 
KUF is largely independent of TMP up to 600mmHg (low flux) and 60mmHg 
(high flux) for forward and reverse flow. In sterile dialyzers, backfiltration yields 
a significantly different KUF except for the F80. An in vitro induced protein layer 
on the membrane decreases KUF with 15-30% (forward) and 4-12% (backward) 
in low flux and 45-70% (forward) and 65-73% (backward) in high flux dialyzers. 
4.4.2. Introduction 
Hollow fiber dialyzers were originally designed as multi-pipe diffusive 
exchangers using low permeable membranes. They could be safely utilized 
without serious risks of excessive ultrafiltration [92]. High flux dialyzers, on the 
other hand, have the therapeutic advantage of an increased solute removal. Their 
open pore structure results in high rates of small molecule diffusion [93] and 
middle molecule diffusion and convection [93,94]. Ronco et al. [100] demonstrated 
the importance of high forward filtration in the proximal and backfiltration in the 
distal segment of the dialyzer for the removal of large molecules. 
The overall water flux QUF (mL/min) [100] in a dialyzer can be written as a 
function of the difference in hydraulic (∆P) and oncotic pressure (∆π) between 
the blood and dialysate compartment: 
 ( )∫∫ ∆∆=
A
UFUF .dA.K'π-PQ  Eq. III-25 
                                                     
† The contents of this section was published in Int J Artif Organs 2002;25(3):210-216 
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Assuming the ultrafiltration coefficient of the membrane K'UF (mL/h/mmHg/m²) 
to be constant over the surface area A and ∆P to be identical at any point in a 
cross section of the dialyzer, Eq. III-25 can be simplified to: 
 ( ) .TMPK
L
dx.π-P.KQ UF
L
xUFUF =∆∆= ∫  Eq. III-26 
With L the dialyzer length, KUF the ultrafiltration coefficient of the dialyzer 
(mL/h/mmHg) and TMP the transmembrane pressure (mmHg). 
The ultrafiltration flow of pure water through a membrane increases linearly 
(proportionality factor KUF) with the average transmembrane pressure [92]. After 
exposure to proteins however, the diffusive transport as well as the hydraulic 
permeability of the membrane decreases significantly due to protein adsorption 
[56]. Moreover, these plasma proteins exert an oncotic pressure of 20-30mmHg 
opposing the applied hydrostatic pressure, but which is not responsible for the 
permeability decrease [30,101]. Furthermore, the ultrafiltration flow deviates from 
linearity for high TMP values due to concentration polarization of high molecular 
weight substances in the blood which are not freely filtrated through the 
membrane pores [101,102]. Because blood cells are 2000 times larger than pores of 
a high flux polysulphone membrane, one single blood cell may block several 
pores, reducing the effective membrane area and ultrafiltration flow. Individual 
variations in the hematocrit, plasma protein concentration and coagulation may 
lead to significant variation in the ultrafiltration flow at a given TMP. 
Furthermore, in vivo ultrafiltration coefficients are 10-25% lower than the values 
reported by manufacturers because of the used in vitro test setup and differences 
between the test solution and a patient's blood [92]. 
Backfiltration may occur whenever the local pressure drop over the membrane 
( )xπ-P ∆∆  becomes negative [95]. The existence and importance of backfiltration 
during high flux hemodialysis have been extensively demonstrated performing 
hydrostatic and oncotic pressure measurements [61,96-99]. Moreover, several 
theoretical models have been developed, whether or not relying on extensive 
knowledge of the properties of blood and the dialysis membrane [216-219]. 
Forward and backfiltration coefficients are different in vitro and even more 
different in vivo because of the protein layer in the blood compartment and the 
structure of the membrane [100]. The main problem related to backfiltration is the 
bacterial contamination by liquid bicarbonate concentrate. Moreover, endotoxins 
may pass the dialysis membrane barrier.  
In this study, the hydraulic permeability of dialyzers for both forward and reverse 
ultrafiltration flow is investigated in a newly built in vitro setup. Moreover, the 
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permeability influence of a protein layer on the membrane is studied. These data 
are a necessary intermediate step (parameter identification) in a numerical model 
study where the blood, dialysate and ultrafiltration flow through a hollow fiber 
dialyzer will be computed. 
4.4.3. Experimental method 
4.4.3.1. In vitro setup  
To measure the forward ultrafiltration in sterile dialyzers as well as in dialyzers 
with a deposited protein layer, the inlet and outlet of the blood compartment were 
used as fluid inlet, while the inlet and outlet of the dialysate compartment were 
used as fluid outlet (Fig. III-10).  
 
Fig. III-10: In vitro setup;  Configuration for forward filtration with dialysis fluid;    
 Parallel circuit to induce an in vitro protein layer while the filtration circuit is closed. 
The fluid was squeezed through the membrane by means of a roller pump (Bellco 
BL 760\D). A buffer chamber upstream the dialyzer served to damp the pulsatile 
character of the flow. Downstream the dialyzer the fluid was collected in a 
reservoir on a balance for mass measurement. For backfiltration measurements, 
the inlet and outlet connections were reversed. 
4.4.3.2. Filtration fluid  
Reverse osmosis (RO) water from the renal unit was transported easily to the lab 
without changing its properties. Because of the possible precipitation of 
bicarbonate, the dialysis fluid was prepared just in time. It consisted of RO water, 
1:27 bicarbonate and 1:35 acid (producer: Sterima n.v., distributor: Fresenius 
T T
TT
buffer
dialyzer
pressure 
transducer
balanceplasma 
reservoir
dialysate 
reservoir
pump
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Medical Care, Belgium). Accuracy of mixing was monitored by measuring the 
conductivity of the mixture (JENWAY 4200, Spectronic, UK). During the entire 
measurement session, the conductivity was kept constant at 14mS/cm. 
4.4.3.3. Tested dialyzers  
We tested several types of polysulphone hollow fiber dialyzers (Fresenius F6, F8, 
F60 and F80). The characteristics of the dialyzers are given in Table III-12, also 
showing the ultrafiltration coefficients as given by the manufacturer (Fresenius 
Medical Care, Bad Homburg, Germany) and obtained from in vitro tests 
imitating the clinical setup and using a counter current flow of dialysate and 
blood with a specific composition.  
Table III-12: Manufacturer's data for the four tested hollow fiber dialyzers. 
 Membrane 
Dialyzer Surface 
m² 
Thickness 
mm 
# fibers 
- 
KUF 
mL/h/mmHg 
F6 1.3 0.04 9 200 5.5 
F8 1.8 0.04 12 300 7.5 
F60 1.3 0.04 9 200 40 
F80 1.8 0.04 12 300 55 
 
In our study, both forward and backfiltration coefficients were derived for three 
sterile samples (identical lot number) of each dialyzer type. An in vitro protein 
layer was induced in two of the three samples. In addition, two clinically used 
dialyzers (F6 and F8) were tested to investigate the influence of in vivo induced 
protein adhesion. 
4.4.3.4. In vitro protein layer  
To induce the build-up of an in vitro protein layer, the blood compartment of the 
dialyzer was circulated in advance with human plasma using a parallel circuit 
(Fig. III-10). The deep frozen human plasma was warmed to room temperature in 
a bain-marie. Looking at intra-dialytic metabolic reactivity of polymorphonuclear 
cells, a marked suppression in reactivity versus pre-dialysis was observed 15 
minutes after the start of the dialysis session [220]. This down regulation of the 
response to complement factors can be seen especially with cuprophan, and 
gives an indication of the presence of a protein layer in general. Therefore, it was 
assumed that a protein layer is formed during the first 15 minutes of a dialysis 
session and the plasma (800-1000mL) was recirculated in the in vitro setup for 
20 minutes at a flow rate of about 250mL/min. The measurements with an in 
vitro protein layer were started with the blood compartment filled with plasma.  
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4.4.3.5. In vivo protein layer  
The influence of an in vivo protein layer was tested with dialyzer samples (F6 
and F8), which were used during a standard dialysis therapy of about four hours. 
They were flushed and filled with physiological water after the dialysis session in 
preparation to the in vitro experiments. 
4.4.3.6. Pressure and flow measurements  
The pressure was measured at both inlet and both outlets with fluid filled 
pressure transducers (Ohmeda, Gent, Belgium) calibrated prior to each test 
series. Additionally, a differential pressure transducer (Fuji Electrics FCX, 
Coulton, UK) was used as an independent measurement for validation. The flow 
was measured gravimetrically (mass change on the balance per time interval). 
4.4.3.7. Test procedure 
The measurements were done for a cycle of increasing and decreasing 
ultrafiltration rates. Once a constant ultrafiltration rate was achieved, the four 
pressures (at blood inlet PBi and outlet PBo and dialysate inlet PDi and outlet PDo) 
were registered during 120s to obtain a time-averaged transmembrane pressure, 
while the mass flow rate ∆M/∆t was measured during about 300s with an 
electronic balance (accuracy 1g) and a chronometer. To calculate the volume, a 
density value ρ of 1008g/L for dialysate fluid (measured at room temperature 
with a density-hydrometer-aerometer) was used. The mean transmembrane 
pressure TMP (mmHg) was derived from the recorded values over an integer 
number of pump revolutions.  
4.4.3.8. Calculation of ultrafiltration and permeability  
Ultrafiltration flow QUF (mL/min) and hydraulic pressure difference ∆P (mmHg) 
were calculated by standard formulae: 
 
∆tρ
∆MQUF ⋅=  Eq. III-27 
 πTMP
2
PP
2
PP
P DoDiBoBi ∆+=+−+=∆  Eq. III-28 
The ultrafiltration coefficient KUF (mL/h/mmHg) and the permeability k 
(nm²/s/Pa), using the membrane thickness d (mm) and total membrane surface A 
(m²), were defined as : 
 
TMP
QK UFUF =   (device characteristic) Eq. III-29 
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A
dKk UF ⋅=   (membrane characteristic) Eq. III-30 
Plotting the ultrafiltration flow QUF (mL/min) as a function of transmembrane 
pressure TMP (mmHg), a mean value for the ultrafiltration coefficient KUF 
(mL/h/mmHg) was derived as the slope of the fitted regression line (Fig. III-11). 
The permeability k, calculated from the KUF value, is a measure to distinguish 
between low and high flux membranes and was expected to be equal for 
dialyzers with a similar membrane type. 
 
Fig. III-11: Forward ultrafiltration flow QUF as a function of TMP for tests without and with an 
in vitro induced protein layer in a F80 dialyzer; -ο- sterile dialyzer (y=2.73x+0.02; R²=0.999);   
-×- ∆P-QUF for dialyzer with in vitro protein layer (y=1.04x-29.13; R²=0.948; oncotic pressure 
∆π=28mmHg); -+- TMP-QUF for dialyzer with in vitro protein layer (y=1.04x; R²=0.948). 
The oncotic pressure ∆π was estimated from the x-intercept of the ∆P-QUF curve 
(Fig. III-11) in the presence of plasma proteins. 
4.4.3.9. Statistical Analysis  
A general linear model (GLM) multivariate procedure was used for simultaneous 
assessment of the influence of the hydrostatic and measuring error (intercept) and 
ultrafiltration coefficient KUF (slope) in the experimental model. The GLM 
multivariate procedure provides regression analysis and analysis of variance for 
multiple dependent variables by one or more factor variables. An F-value was 
calculated to determine the overall significance of the model. Moreover, for each 
term, the standard error, t-value and significance were estimated. 
The data points of different measurement series were combined if no significant 
difference was found for the ultrafiltration coefficient KUF (slope) as obtained 
from one series. Moreover, different measurement conditions, as the performance 
of forward versus backfiltration, were compared considering the KUF value. 
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4.4.4. Results 
Mean values and standard deviations of the forward ultrafiltration coefficient KUF 
(mL/h/mmHg), the permeability of the sterile membrane k (nm²/s/Pa), the x-
intercept (mmHg) and the correlation R² are given in Table III-13 for all samples 
of the different hollow fiber dialyzers. Backfiltration yields a different (P<0.05) 
permeability coefficient compared with forward filtration except for the F80. For 
the F6 and F60, reverse filtration is 6-7% higher, whereas in the F8 and F80, it 
results in a 3-9% lower ultrafiltration rate (Table III-14).  
Table III-13: Ultrafiltration coefficient and membrane permeability in sterile dialyzers 
using three samples. 
Type n 
- 
KUF 
mL/h/mmHg 
k 
nm²/s/Pa 
x-intercept 
mmHg 
R² 
F6 18 5.86 ± 0.07  376 ± 4 -0.35 ± 3.65 0.997 
F8 19 7.53 ± 0.20 349 ± 9  -1.50 ± 6.55 0.988 
F60 23 144 ± 2 9231 ± 128 -1.01 ± 0.15 0.997 
F80 17 166 ± 5 7685 ± 231 -0.19 ± 0.31 0.987 
number of data points n; ultrafiltration coefficient KUF; membrane permeability k; 
correlation R² 
An in vitro induced protein layer on the membrane (maximum 2 samples) 
decreases the permeability by 15-30% (forward) and 3.9-12% (backward) in low 
flux and 58-60% (forward) and 65-73% (backward) in high flux dialyzers (Table 
III-15). For the F80, Fig. III-11 shows the reduction in slope of the ∆P-QUF plot 
of a dialyzer in which an in vitro protein layer was induced. After deriving the 
oncotic pressure from the x-intercept of this curve, a TMP-QUF plot is drawn. 
Table III-14: Forward and backward ultrafiltration coefficient in sterile dialyzers using 
three samples. 
Type Forward filtration Backfiltration  Reduction 
% 
Significance  
P 
 KUF 
mL/h/mmHg 
n 
- 
KUF 
mL/h/mmHg 
n 
- 
  
F6 5.86 ± 0.07  18 6.28 ± 0.04  18 -7.2 < 0.001 
F8 7.53 ± 0.20 19 6.87 ± 0.19 19 8.8 0.022 
F60 144 ± 2 23 153 ± 2 18 -6.3 0.003 
F80 166 ± 5 17 160 ± 6 19 3.6 0.464 
number of data points n; ultrafiltration coefficient KUF; significance level P 
Two dialyzers with in vivo induced proteins on the membrane were 14% (F6) - 
24% (F8) more permeable compared with the corresponding test samples in 
which an in vitro protein layer was performed. Because of the difficulty of 
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reproducing a protein layer in different dialyzer samples, the oncotic pressures 
were calculated separately for each single test series. These oncotic pressures are 
much higher in dialyzers with an in vitro induced protein layer (9-45mmHg) than 
in those with an in vivo protein layer (4 and 12mmHg) for forward filtration 
(Table III-16).  
Table III-15: Forward and backward ultrafiltration coefficient for dialyzers without 
versus with a protein layer. 
Type Forward filtration Backfiltration 
 KUF sterile KUF proteins Reduction KUF sterile KUF proteins Reduction 
 mL/h/mmHg mL/h/mmHg % mL/h/mmHg mL/h/mmHg % 
F6 6.05 ± 0.02 5.13 ± 0.02 15 5.69 ± 0.01 5.47 ± 0.11 3.9 
F8 8.03 ± 0.15 5.61 ± 0.06 30 7.29 ± 0.03 6.44 ± 0.04 12 
F60 144 ± 2 57.0 ± 1.0 60 153 ± 2 53.5 ± 3.2 65 
F80 163 ± 2 69.0 ± 12 58 176 ± 3 48.0 ± 7.1 73 
For the low flux F6 and F8, one sample was used (5 data points); for the high flux F60 and F80, 
two samples were used (15-20 data points). 
Table III-16: In vitro fitted oncotic pressures (mmHg) for both forward and 
backfiltration. 
Type In vitro oncotic pressures  
 Forward 
mmHg 
Backward 
mmHg 
F6 9 - 36 17 
F8 35 - 45 16 
F60 17 - 35 2 
F80 16 - 28 8 
4.4.5. Discussion 
In contrast with experiments published in literature in which the hydraulic 
permeability [221] and the influence of proteins [56] is investigated in an ex vivo 
setup using the clinical flow directions, we built a new in vitro setup in order to 
quantify the water permeability of the membrane as its real physical 
characteristic with greater accuracy. 
4.4.5.1. Sterile dialyzers  
The forward and reverse ultrafiltration coefficient KUF is considered independent 
of TMP up to 600mmHg for low flux and 60mmHg for high flux polysulphone 
dialyzers. For the low TMP range in high flux dialyzers, the small deviation from 
constant is due to the greater influence of the measuring error rather than the 
existence of hemoconcentration. 
Modeling of flow in a single hemodialyzer fiber 
 109
For the F6, the in vitro KUF exceeds the value given by the manufacturer by 6%, 
whereas the results for the F8 are comparable with the value given by the 
manufacturer (discrepancy only 0.4%). The KUF values for F60 and F80 differ 
significantly from the values given by the manufacturer (66-72%) (Table III-12 
and Table III-13). This discrepancy is expected because of differences in setup. 
Note, however, that our results for the F60 are almost similar (discrepancy 9%) 
to the results measured in an ex vivo setup [56] in which sodium chloride was used 
as blood substitute. 
Although a similar membrane permeability k is expected for the low respectively 
the high flux dialyzers, a slight difference can be observed (Table III-13). It 
seems that other dialyzer characteristics like geometry and manifold also 
influence the in vitro measured overall ultrafiltration coefficient. 
For the F6, F8 and F60 we found a significant difference between forward and 
reverse ultrafiltration flow presumably due to the asymmetrical structure of 
polysulphone membranes. In these three dialyzer types backfiltration renders a 
significant higher filtration except for the F8 (Table III-14).  
4.4.5.2. Protein layer  
The ultrafiltration coefficient of the low flux hollow fiber dialyzers in which an 
in vitro protein layer has been formed can be considered constant within 
normally encountered TMP range. The decrease of the forward permeability of 
the F6 results in KUF value, which is more comparable to the value given by 
Fresenius (Table III-12 and Table III-15). In the ex vivo study of Ronco et al. 
[221], in which the influence of a protein layer was rather limited, the measured 
ultrafiltration exceeds our findings by 5%. For the high flux hollow fiber 
dialyzers, the ultrafiltration is strongly decreased in presence of an in vitro 
protein layer both for forward and reverse flow. However, the results for the F60 
as well as for the F80 show an ultrafiltration coefficient, which is still 
significantly higher than the value given by the manufacturer (20-30%). The 
plasma ultrafiltration coefficient found by Bosch et al. [56] in their ex vivo setup 
shows a permeability reduction of almost 68% compared with their sodium 
chloride measurements. This reduction is quite similar to what we measure after 
inducing an in vitro protein layer on the dialyzer membrane. Comparing forward 
with backfiltration (Table III-15), higher permeabilities are registered for 
backfiltration for low flux dialyzers due to the washing out of the proteins from 
the blood compartment. The influence of in vivo deposited proteins is less 
significant than the effect of an in vitro formed protein layer. We speculate that 
this is due to the fact that the clinically used samples were flushed with a 
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physiological solution before testing. A small increase in permeability can also 
be observed in the ex vivo experiments of Bosch et al. when sodium chloride 
flows in the blood compartment after the dialyzer had first been exposed to 
plasma [56]. On the other hand, the oncotic pressure still present in our samples 
with an in vivo induced protein layer is absent in their ex vivo study. 
Although the same procedure was performed to induce the in vitro protein layer, 
accurate reproduction of such a layer appears extremely difficult due to the 
recirculation of a mixture of plasma of several non-anemic donors. As a 
consequence, the forward oncotic pressures (28±21mmHg for low flux and 
20±9mmHg for high flux dialyzers) exhibit a large standard deviation. 
Overall, a protein layer on the membrane is the main limiting factor with respect 
to the overall permeability. 
4.4.6. Conclusion 
The presented in vitro setup allows quantifying the hydraulic permeability of 
hollow fiber dialyzers with a different and more specific method than in previous 
ex vivo studies [56]. For sterile as well as dialyzers with an induced protein layer, 
the ultrafiltration coefficient KUF is constant over a TMP range up to 600mmHg 
for low flux and up to 60mmHg for high flux dialyzers. In sterile dialyzers, 
backfiltration deviates from forward filtration up to 9%. In the F6 and F60, the 
reverse permeability is higher, whereas in the F8, it is lower than the forward 
permeability. An in vitro protein layer on the membrane induces an important 
reduction of membrane permeability. The permeability values presented in this 
study differ from the values provided by the manufacturer due to the fact that 
they use a setup closer resembling to the actual clinical setting. We used a 
specific setup, which yields the hydraulic permeability for aqueous solutions. 
These permeabilities are suitable for a numerical model to simulate forward and 
backfiltration. 
4.4.7. Acknowledgements 
The present study was supported by Fresenius Medical Care (Germany). The 
authors also wish to express their gratefulness to the medical staff of the renal 
unit of the hospital 'AZ Zusters van Barmhartigheid' (Ronse) for supplying the 
filtration fluid and the clinically used dialyzer samples, to the Blood Transfusion 
Centre (Red Cross Belgium) for supplying plasma pockets, as well as to our 
colleague P Segers for his review. 
Modeling of flow in a single hemodialyzer fiber 
 111
4.5. Influence of dialyzer membrane type on membrane 
permeability 
4.5.1. Objective and methods 
The permeability characteristics of different membrane types were investigated 
with the previous described in vitro setup (paragraph 4.4.3.1) and using 
bicarbonate dialysate as filtration fluid. The studied membrane types (Table 
III-17) were modified cellulose membranes (saponified modified cellulose and 
cellulose triacetate) and synthetic membranes (polysulphone and acrylonitrile). 
The morphological differences between the different membrane types are 
illustrated in Fig. III-12.  
Table III-17: Manufacturer's data for the different tested hollow fiber dialyzers. 
 Membrane  
Dialyzer Type  Surface 
m² 
Thickness 
mm 
KUF 
mL/h/mmHg 
Spiraflo NC 2085 G SMC 1.95 0.0085 6.4 
Sureflux 210E CTA 2.1 0.015 20 
FX60 PSu 1.4 0.030 40 
F70 S PSu 1.6 0.040 50 
AN 69 Filtral 20 AN 2.05 0.050 62 
ultrafiltration coefficient KUF; saponified modified cellulose SMC; cellulose 
triacetate CTA; polysulphone PSu; acrylonitrile AN 
 
Fig. III-12: Morphological differences between different membrane types [123]. 
Cellulose membrane Synthetic membrane
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4.5.2. Results 
Mean values and standard deviations of the forward ultrafiltration coefficient KUF 
(mL/h/mmHg), the permeability of the sterile membrane k (nm²/s/Pa), the x-
intercept (mmHg) and the correlation R² are given in Table III-18 for the 
dialyzers under study. One sample of each dialyzer was evaluated, except for the 
FX60 were two samples were tested. 
Table III-18: Ultrafiltration coefficient, membrane permeability, and x-inercept in 
sterile dialyzers. 
Dialyzer n 
- 
KUF 
mL/h/mmHg 
k 
nm²/s/Pa 
x-intercept 
mmHg 
R² 
Spiraflo NC 2085 G 8 6.36 ± 0.58 57.8 ± 5.3 7.23 ± 5.05 0.944 
Sureflux 210E 9 16.2 ± 0.5 241 ± 8 7.60 ± 2.80 0.993 
FX60 30 131 ± 3 5852 ± 139 0.77 ± 0.39 0.985 
F70 S 10 122 ± 5 6331 ± 251 0.28 ± 0.35 0.988 
AN 69 Filtral 20 10 54 ± 3 2728 ± 128 2.86 ± 1.82 0.983 
number of data points n; ultrafiltration coefficient KUF; membrane permeability k; correlation R² 
The results for the Spiraflo are comparable with the KUF value given by the 
manufacturer (discrepancy only 0.6%), while the manufacturer’s data exceeds 
our results for the Sureflux (by 24%) and the AN69 (by 15%). The KUF values 
for the FX60 and F70S are significantly higher than the values given by the 
manufacturer (69 and 59%, respectively) (Table III-17 and Table III-18).  
Accounting for the membrane thickness and surface area, the membrane 
permeability k was found not significantly different (P=0.484) for both 
polysulphone membranes in the FX60 and F70S. 
Backfiltration yields a significant larger ultrafiltration coefficient (16%) 
compared with forward filtration for the FX60 (Table III-19). No significant 
differences were however found between forward and backfiltration for the 
Spiraflo (P=0.470), the Sureflux (P=0.306), the F70S (P=0.092), and the AN69 
(P=0.326).  
An in vitro induced protein layer on the membrane decreases the forward 
ultrafiltration coefficient by 14% (Spiraflo), 51% (FX60), 22% (F70S), and 41% 
(AN69) (Table III-20). The protein layer hampers backfiltration, resulting in a 
decrease of KUF by 6% (Spiraflo), 39% (FX60), 51% (F70S), and 18% (AN69) 
compared to sterile dialyzers. In the Sureflux, however, no significant decrease in 
forward (P=0.717) and reverse (P=0.647) ultrafiltration was observed after 
protein deposition at the membrane.  
 
Modeling of flow in a single hemodialyzer fiber 
 113
Table III-19: Forward and reverse ultrafiltration coefficient in sterile dialyzers  
Type Forward filtration Backfiltration  Reduction P 
 KUF 
mL/h/mmHg 
n 
- 
KUF 
mL/h/mmHg 
n 
- 
%  
Spiraflo NC 2085 G 6.36 ± 0.58 8 5.82 ± 0.45 10 8.5 0.470
Sureflux 210E 16.2 ± 0.5 9 15.3 ± 0.6 9 5.6 0.306
FX60 131 ± 3 30 152 ± 8 20 -16.0 0.006
F70 S 122 ± 5 10 112 ± 7 8 5.9 0.092
AN 69 Filtral 20 54 ± 3 10 56 ± 1 10 3.7 0.326
number of data points n; ultrafiltration coefficient KUF; significance P 
Table III-20: Forward and reverse ultrafiltration coefficient for dialyzers without versus 
with a protein layer. 
Type Forward filtration Backfiltration 
 KUF sterile KUF proteins Red KUF sterile KUF proteins Red 
 mL/h/mmHg mL/h/mmHg % mL/h/mmHg mL/h/mmHg % 
Spiraflo NC  6.36 ± 0.58 5.47 ± 0.31 14 5.82 ± 0.45 5.47 ± 0.31 6 
Sureflux  16.2 ± 0.5 15.8 ± 0.3 2 15.3 ± 0.6 15.5 ± 0.3 -1 
FX60 131 ± 3 64 ± 2 51 152 ± 8 92 ± 3 39 
F70 S 122 ± 5 93 ± 6 22 112 ± 7 55 ± 4 51 
AN 69  54 ± 3 32 ± 2 41 56 ± 1 46 ± 3 18 
ultrafiltration coefficient KUF ; reduction Red 
4.5.3. Discussion 
The present study was set out to evaluate the permeability differences between 
several types of dialyzer membranes. Furthermore, the influence of a protein 
layer on the overall permeability was investigated. Therefore, in vitro 
permeability measurements were performed in sterile dialyzers and in dialyzers 
in which a protein layer was induced on the membrane. 
The main conclusions can be summarized as follows: first, the forward 
ultrafiltration coefficients differ from the value reported by the manufacturer, 
except for the Spiraflo; second, backfiltration increases significantly the 
ultrafiltration coefficient for the asymmetrical polysulphone membrane of the 
FX60; third, with the cellulose triacetate membrane (Sureflux), protein 
deposition on the membrane does not alter permeability; and fourth, the decrease 
of membrane permeability caused by a protein layer is most expressed with the 
synthetic membranes (PSu and AN dialyzers). 
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As found previously for low flux dialyzers (paragraph 4.4.4), the backfiltration 
coefficient for the low flux Spiraflo dialyzer with a protein layer is not much 
decreased (6%) compared to the sterile dialyzer. Furthermore, the mid flux 
Sureflux (KUF=20mL/h/mmHg) showed no variation at all for the backfiltration 
coefficient after deposition of a protein layer. This confirms the phenomenon that 
plasma proteins are washed out with backfiltration. 
It was shown that dialyzers with hydroxyl groups on the membrane surface (e.g. 
regenerated or unmodified cellulose) are the strongest complement activators due 
to binding of complement factor (C3b). Partial substitution of these hydroxyl 
groups by either acetyl groups (CTA Sureflux) or benzyl groups (SMC Spiraflo) 
results in a considerable reduction of complement activation. Moreover, an even 
lower increase in concentration of intra-dialytic circulating complement factors is 
observed consecutively in the AN69 and polysulphone dialyzer membrane types. 
The deposition of a protein layer on the membrane was found to suppress 
complement activation. The present study illustrates a low influence of a protein 
layer on the low flux cellulose membranes, while protein adsorption was found 
more pronounced in the biocompatible high flux synthetic membranes. This 
phenomenon is not only due to the pore structure of the membrane (i.e. 
difference in ultrafiltration coefficient), because the previous investigated low 
flux polysulphone dialyzers (paragraph 4.4.4), also showed a higher influence on 
permeability by protein adsorption. 
It was not unexpected that differences were found between our results and the 
ultrafiltration coefficients as measured by the manufacturers. While the latter 
determined KUF values using anemic blood or blood-like fluids with counter 
current flows, we determined the water permeability of the membrane as its 
physical property not influenced by any flow setting. 
It should be remarked however, that our results for the tests with a protein layer 
on the membrane might differ from reality, because inducing in vitro a protein 
layer on the membrane does not represent the clinical situation. When the 
patient’s blood is exposed to the membrane, a rapid adsorption of proteins occurs 
within seconds. The initial protein deposition takes place in a specific sequence 
(i.e. albumin, immunoglobulin, fibrinogen, fibronectin, factor XII, and high 
molecular weight kininogen). The protein adsorption is however followed by 
desorption caused by the subsequent arrival of proteins with higher affinity. 
Instead of this active process of adsorption and desorption, the in vitro induced 
protein layer must be considered as a static layer and might result in deviating 
permeability properties compared to reality. 
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4.5.4. Conclusion 
The permeability of different membrane types was investigated in vitro. The 
obtained ultrafiltration coefficients differ from the values reported by the 
manufacturers due to the different study objective and experimental setup.  
Moreover, protein adsorption on the membrane results in diverging influences on 
membrane permeability when considering different types of membranes. 
Permeability decrease was more pronounced in the biocompatible synthetic 
membranes compared to the modified cellulose membranes. 
4.6. Influence of the filtration fluid on membrane 
permeability†  
4.6.1. Objective and methods 
A crossover study was performed to investigate the influence of the filtration 
fluid used in the permeability measurements. The hydraulic permeability of the 
polysulphone F80 dialyzer (Fresenius Medical Care, Bad Homburg, Germany) 
was derived using either RO water or bicarbonate dialysis fluid as filtration fluid. 
The tests were performed for forward (4 tests) and backfiltration (2 tests) in one 
sterile dialyzer sample. The in vitro setup as described in paragraph 4.4.3.1 was 
used. 
4.6.2. Results 
For each test series, mean values and standard deviations of the ultrafiltration 
coefficient KUF (mL/h/mmHg), the permeability of the sterile membrane k 
(nm²/s/Pa), the x-intercept (mmHg) and the correlation R² are given in Table 
III-21 for forward and backfiltration using either RO water or dialysis fluid. 
The mean ultrafiltration coefficient with RO water and dialysate is 195±1 and 
188±1mL/h/mmHg, respectively, for forward filtration, and 196±1 and 
188±2mL/h/mmHg, respectively, for backfiltration. 
 
 
                                                     
† The contents of this section was adapted from the report published in 2002 
Assessment of flow and particle transport through a hollow fiber dialyzer 
S. Eloot, D. De Wachter, and P. Verdonck 
This study was financially supported by Fresenius Medical Care – Bad Homburg – Germany 
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Table III-21: Permeability characteristics using RO water and dialysate. 
Test 
No. 
n 
- 
Fluid Filtration KUF 
mL/h/mmHg
k 
nm²/s/Pa 
x-intercept 
mmHg 
R² 
1 10 RO Forward 194 ± 1 8982 ± 27 0.04 ± 0.03 0.99 
2 10 Dialysate Forward 189 ± 1 8750 ± 42 0.08 ± 0.09 0.99 
3 8 RO Forward 195 ± 1 9045 ± 42 0.17 ± 0.06 0.99 
4 9 Dialysate Forward 187 ± 1 8670 ± 15 0.13 ± 0.02 0.99 
5 9 RO Reverse 196 ± 1 9078 ± 22 0.02 ± 0.03 0.99 
6 10 Dialysate Reverse 188 ± 2 8688 ± 105 0.18 ± 0.15 0.99 
number of data points n; ultrafiltration coefficient KUF; permeability k; correlation R² 
A significant difference was found for the forward (<0.001) and reverse 
(P=0.003) ultrafiltration coefficient derived from measurements using RO water 
and dialysate. For one type of filtration fluid, no significant differences could be 
observed between the successive test series with RO water (P=0.341) and with 
dialysate (P=0.326). This implies that, due to the crossover protocol of the tests, 
the filtration fluid has no irreversible influence on the membrane characteristics. 
As a consequence, the permeability difference is owing to the type of filtration 
fluid.  
Finally, no significant difference was found between the forward and reverse 
ultrafiltration coefficient in the F80 dialyzer with RO water (P=0.198) and 
dialysate (P=0.771). 
4.6.3. Discussion 
In the present study, the influence of the filtration fluid on the membrane 
permeability of a high flux polysulphone dialyzer (F80) was investigated in a 
crossover study. A significant difference was found for the forward as well as 
backfiltration coefficient when testing with RO water or dialysate. 
A possible explanation for the influence of the filtration fluid on membrane 
permeability might be the difference in hydration volume of protons. Small 
protons like hydrogen (H+) induce a higher surrounding electric field such that 
more water molecules are dragged together with the protons during membrane 
flow. Large protons like sodium and bicarbonate, as present in dialysis fluid, are 
characterized by a smaller hydration volume, which results in a lower 
permeability. 
As no difference was found between the forward and reverse ultrafiltration 
coefficients for the F80, the present results are in good agreement with previous 
measurements (paragraph 4.4.4). It should be remarked, however, that the 
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absolute values found previously for the ultrafiltration coefficient are 
significantly smaller than those described here for forward (P=0.037) and 
backfiltration (P=0.021). One of the possible reasons might be found in a 
different proportional mixing while preparing the dialysate solution. In our 
experiments, the final mixing was only controlled for conductivity and not for 
proportionality. As described earlier (paragraph 4.3), the mixing quantity and 
quality can result in different characteristics, such as viscosity. A bicarbonate 
concentration deviating from prescribed, changes the proton concentration and, 
as a consequence, might be responsible for a different permeability.  
4.6.4. Conclusion 
The choice of the filtration fluid used in the in vitro permeability tests (either 
reverse osmosis water or dialysate) affects the membrane permeability results in 
hollow fiber dialyzers.  
Because the composition of the filtration fluid in a clinical dialysis is not a priori 
known, care should be taken when defining the membrane permeability. For the 
numerical simulations, the results of the in vitro test with dialysate as filtration 
fluid were applied. Therefore, the properties of the filtration fluid were defined 
equal to those of dialysate (i.e. density 1008g/L and viscosity 0.687mPa·s).  
4.7. Numerical model for blood, dialysate and ultrafiltration 
flow† 
4.7.1. Abstract 
A three-dimensional finite volume model of the blood-dialysate interface over 
the complete length of the dialyzer is developed. Different equations govern 
dialyzer flow and pressure distribution (Navier-Stokes) and radial transport 
(Darcy). Blood is modeled as a non-Newtonian fluid with a viscosity varying in 
radial and axial direction determined by the local hematocrit, the diameter of the 
capillaries and the local shear rate. The dialysate flow is assumed as an 
incompressible, isothermal laminar Newtonian flow with a constant viscosity. 
The permeability characteristics of the membrane are calculated from laboratory 
tests for forward and backfiltration. The oncotic pressure induced by the plasma 
proteins is implemented as well as the reduction of the overall permeability 
                                                     
† The contents of this section was published in Artif Organs 2002;26(7):590-599 
Computational flow modeling in hollow-fiber dialyzers 
S. Eloot, D. De Wachter, I. Van Tricht, and P. Verdonck 
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caused by the adhesion of proteins to the membrane. From the calculated 
pressure distribution, the impact of flow, hematocrit and capillary dimensions on 
the presence and localization of backfiltration can be investigated. 
4.7.2. Numerical model 
A three-dimensional finite volume microscopic model of the blood-dialysate 
interface over the complete length of a dialyzer is developed (Fluent 5.4 - 
Sheffield UK). Assuming the fibers spaced in a hexagonal lattice and based on 
symmetry, a twelfth part of one single fiber can be isolated (Fig. III-13). The 
parameter settings of the three-dimensional module (Fig. III-14) were assessed 
for a high flux polysulphone Fresenius F60, characterized by a fiber diameter of 
200µm, membrane thickness of 40µm (1µm inner layer and 39µm bulk layer) 
and dialysate compartment dimensions (maximum radius 230µm) calculated 
from fiber density. The membrane module has an active length of 230mm while 
in and outlet tubes (each 12.5mm long) are foreseen in both fluid compartments 
simulating the header and potting region. For the implementation in the 
numerical model, properties of the three compartments, blood, dialysate and the 
semi-permeable membrane in between, are derived from in vitro and in vivo 
tests. 
 
Fig. III-13: Hexagonal lattice of the hollow fiber dialyzer (cross section). 
4.7.2.1. Membrane permeability 
The permeability characteristics of the membrane are obtained from laboratory 
tests in which a dialysate flow was forced through the membrane. The 
ultrafiltration coefficient (m³/s/Pa) is calculated from flow (m³/s) and 
transmembrane pressure (Pa) measurements. Furthermore, the hydraulic 
membrane permeability (m²/s/Pa) is derived from the ultrafiltration coefficient, 
membrane surface and thickness. The tests are done for forward and 
Modeling of flow in a single hemodialyzer fiber 
 119
backfiltration using sterile dialyzers (overall permeability 7950nm²/s/Pa) as well 
as samples in which a protein layer is induced on the membrane (overall 
permeability 2400nm²/s/Pa) simulating a clinical session [142]. The permeabilities 
of a sterile inner layer and bulk layer are implemented as a series of two 
resistances, whereas the influence of a protein layer on the overall membrane 
permeability is incorporated as a higher resistive inner layer.  
 
Fig. III-14: 3D visualization of an isolated unit, showing blood, membrane, and dialysate 
compartment. 
4.7.2.2. Dialysate fluid properties  
From bicarbonate dialysate samples taken in vivo from the supply and the drain 
of the dialyzer, dynamic viscosity and density were determined using a capillary 
Ubbelohde viscometer and a density-hydrometer-aerometer, respectively. As it 
was found that both properties are not influenced by the dialysis session, the 
dialysate flow is assumed as an incompressible, isothermal laminar Newtonian 
flow with a constant viscosity (0.687mPa·s) and density (1008kg/m³). 
4.7.2.3. Non-Newtonian blood behavior  
An extended literature review was needed to perform an accurate modeling of the 
non-Newtonian blood flow. While plasma or another Newtonian fluid is used in 
the blood compartment for the majority of the models described in literature 
[222,223], the presented model accounts for the influence on viscosity of the local 
hematocrit, the small diameter of the capillaries and the local shear rate. 
The shear thinning behavior as well as the dependence of the blood viscosity µ 
on plasma viscosity µp and the local hematocrit H, is described by Quemada [63]: 
 ( )2p Hk211
µ
µ
⋅⋅−
=  Eq. III-31 
Parameter k is function of the intrinsic viscosities k0(H), characterizing the red 
blood cell aggregation at zero shear stress, k∝(H), describing the orientation and 
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deformation of red blood cells at important shear stress, and the shear rate γ. For 
a fixed hematocrit, viscosity decreases with increasing shear rate, whereas for a 
fixed shear rate, viscosity increases with hematocrit. 
Blood flowing through small capillaries exhibits a redistribution of the red blood 
cells in such a way that a plasma-skimming layer can be observed near the wall 
while red blood cells are concentrated in the centre. Fahraeus and Lindqvist [147] 
described the effect of this non-uniform cell distribution on the flow by defining 
an apparent blood viscosity for use in the Haegen-Poiseuille equation. The radial 
variation of the hematocrit was deduced by Lerche et al. [66] using a parameter n, 
which describes the degree of plasma skimming: non-uniformity of cell 
distribution increases with decreasing n. This parameter is determined iteratively 
as a function of the hematocrit using an axi-symmetrical numerical model such 
that the obtained viscosity for flow in a small tube matches literature results of 
the apparent viscosity (Fig. III-15). 
Since plasma density (1030kg/m³) differs from the density of platelets and blood 
cells (1090kg/m³), the density of blood ρblood varies with the local hematocrit H:  
 H1090H)(11030ρ blood ⋅+−⋅=  Eq. III-32 
 
 
Fig. III-15: The Lerche parameter n as a function of hematocrit 
4.7.2.4. Governing equations 
In the blood and dialysate compartment, conservation of mass and momentum 
are described by the three-dimensional steady incompressible Navier-Stokes and 
continuity equations, using the local and constant viscosity and density for blood 
and dialysate, respectively. The transmembrane water transport, function of the 
membrane permeability and the local oncotic pressure, is described by the Darcy 
equation for porous media.  
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4.7.2.5. Boundary conditions 
In the blood and dialysate compartment, a constant inlet velocity is given, while 
outlet conditions can be specified either as outlet pressures or as a flow 
percentage distribution in both compartments to apply the desired ultrafiltration 
flow. Oncotic pressure, which is exerted by the plasma proteins and opposes the 
hydrostatic transmembrane pressure, is implemented as a discontinuous pressure 
drop at the skin-bulk interface. Moreover, as hemoconcentration takes place in 
axial direction, the oncotic pressure is varying with hematocrit. Because the 
smallest blood-membrane-dialysate entity was isolated, all other boundaries are 
symmetry planes. 
4.7.3. Results 
Assuming a constant blood and dialysate inlet flow of 250 and 500mL/min, 
respectively, outlet pressures of 10kPa and 5Pa respectively and initial oncotic 
pressure of 3.33kPa, the pressure distribution renders an overall ultrafiltration 
flow of 45mL/min while no backfiltration occurs (Fig. III-16 and Fig. III-18).  
 
Fig. III-16: Radial pressure distribution at blood inlet (x) and outlet (+) section 
As blood, with an initial viscosity of 3mPa·s, flows through the dialyzer, the 
water removal causes hemoconcentration. As a consequence, the hematocrit 
shows an axial variation from its initial value 0.30 at blood entrance up to 0.42 at 
the outlet, resulting in a mean viscosity increase from 3mPa·s to 4.5mPa·s. The 
plug flow of blood cells at the axis (maximum viscosity 7.5-11.8mPa·s) and the 
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plasma layer near the membrane wall (viscosity 1.3mPa·s) demonstrates the 
radial variation of the blood viscosity (Fig. III-17).  
The oncotic pressure, varying with the local hematocrit, increases from its initial 
value 3.33kPa up to 4.20kPa. The ultrafiltration flow is decreased with 28% 
because of the oncotic pressure opposing the hydraulic driving pressure. 
The shear stress, zero at blood and dialysate axes, is maximal at the blood-
membrane interface decreasing from 0.97Pa at blood inlet to 0.78Pa at the outlet, 
while it is slightly increasing at the dialysate-membrane interface from 0.23 up to 
0.26Pa at dialysate outlet. 
 
Fig. III-17: Radial viscosity distribution at blood inlet (x) and outlet (+) section 
Due to ultrafiltration, one may expect a deviation from the linear flow-pressure 
drop profile described by Haegen-Poiseuille as well as from the parabolic 
velocity profile. Nevertheless, for an ultrafiltration flow of 45mL/min in a 
dialyzer module of 230mm, the pressure distribution in the blood compartment 
deviates only slightly from linearity (maximum 0.28-0.33% at blood inlet and 
outlet respectively) (Fig. III-18), while the same is true for the parabolic velocity 
profile (R² = 0.997-0.993 at blood inlet and outlet respectively) (Fig. III-19). 
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Fig. III-18: Axial pressure distribution in blood (x) and dialysate (+) compartment 
 
 
Fig. III-19: Spatial velocity profile in blood and dialysate compartment at blood inlet (x) and 
outlet (+) section 
4.7.4. Discussion 
The presented 3D microscopic model allows the investigation of the impact of 
flow, blood viscosity and hematocrit, on the presence and localization of 
backfiltration for given capillary dimensions. Varying the dimensions of the 
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dialysate compartment subsequently, the impact of anisotropic fiber density 
and/or fiber twisting, as reported in macroscopic models [118,120,224], can be 
investigated. Moreover, the influence of a non-uniform blood and/or dialysate 
flow [111,118-120,224,225], resulting in locally different ultrafiltration flows, can be 
visualized at discrete radial positions. 
In the one-dimensional model of Legallais et al. [222], hydraulic and diffusive 
permeabilities of the membrane are obtained from experimental results found in 
literature [56,226]. In contrast with experiments where the hydraulic permeability 
[56,221,226] and the influence of proteins [56] is investigated in an ex vivo setup using 
the clinical flow directions, a new in vitro setup was built for this study in order 
to quantify the water permeability of the membrane as its real physical 
characteristic with greater accuracy. Nevertheless, the plasma ultrafiltration 
coefficient found by Bosch et al. [56] in their ex vivo setup shows a permeability 
reduction of 68% compared with their sodium chloride measurements, quite 
similar to what we measure after inducing an in vitro protein layer on the 
dialyzer membrane (reduction of 70%). 
Legallais et al. [222] assumed the Newtonian fluid plasma to flow in the blood 
compartment with a viscosity depending on the actual protein concentration [227]. 
In the presented model, the shear-thinning behavior of blood as well as the 
hematocrit dependency of its viscosity is incorporated using the Quemada model 
[63]. The influence of the non-uniform cell distribution is taken into account by 
using the Fahraeus-Lindqvist model, which was originally derived for 
impermeable tubes.  
Oncotic pressure, induced by the plasma proteins in the blood compartment, is 
not considered in models using saline solutions. For plasma [222], the oncotic 
pressure dependence on protein concentration is expressed by Landis et al. [228]. 
In this study, using blood, the local oncotic pressure is calculated accounting for 
the local hematocrit. As water is removed from the blood compartment over the 
length of the dialyzer and hemoconcentration occurs, the local hematocrit 
increases with the red blood cell concentration and the oncotic pressure increases 
with protein (albumin) concentration.  
Nevertheless the Haegen-Poiseuille equation is derived for flow in impermeable 
tubes, most one and two-dimensional numerical models [222] assume a linear 
pressure drop over the length of the dialyzer. Our three-dimensional model gives 
the opportunity to investigate whether this assumption is valid. It is found (Fig. 
III-18 and Fig. III-19) that deviation from linearity is negligible (0.3%) for flow 
in dialyzers with a limited active length (230mm), hereby confirming the 
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theoretical results by Wupper et al. [195]. However, using the analytical expression 
of Karode [196], a deviation from linearity of 6% is found at blood inlet and outlet 
for a common active dialyzer length (0.23m). 
After validation of the model by an ex vivo study mimicking the clinical setup, a 
profound parameter study can be performed to investigate the impact of 
ultrafiltration flow and capillary dimensions on blood viscosity.  
Although the presented model is the result of combining several flow, transport 
and fluid property aspects, some limitations of the model can be remarked. 
Concentration polarization, which should be considered for flow in permeable 
tubes, is not considered. Moreover, the accumulation of particles at the 
membrane is idealized by assuming the presence of a homogeneous monolayer of 
proteins (100µm) at the inner layer of the membrane. As a result, the axial 
variation of boundary layer thickness [203] and the shearing effect arising from 
backfiltration [200,201] as well as the shear stress acting on the boundary layer itself 
[202], are not considered. Therefore, with respect to the flow of highly 
concentrated fluids like blood, the consideration of concentration polarization 
and multiphase flow simulating inertial effects and slip between the particles and 
the carrier liquid [142] could be a point of further improvement.  
4.7.5. Conclusion 
Our numerical model incorporates the blood, dialysate and membrane flow in 
hollow fiber dialyzers allowing an accurate investigation of the fluid properties 
and the presence and localization of backfiltration can be performed. The 
hydraulic permeability of the dialyzer is based on a different and more accurate 
method than in previous ex vivo studies and blood is modeled as a non-
Newtonian fluid with properties varying in radial as well as axial direction. The 
simulation shows that deviation from a linear pressure drop - flow relationship is 
negligible for flow in dialyzers with a limited active length. 
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4.7.7. Correction to the manuscript 
The Lerche parameter n as described in paragraph 4.7.2.3, was derived with a 
two-dimensional axi-symmetrical model using the finite element software 
SEPRAN (Eindhoven, The Netherlands). Calculations with a three-dimensional 
model using the finite volume software Fluent (Sheffield, UK), resulted however 
in a different equation for the Lerche parameter n as a function of hematocrit H: 
 
0.206-H
11.0148n +=  Eq. III-33 
The calculations performed with Fluent were checked for grid convergence and 
for the applicability of Poiseuille’s law for zero hematocrit values.  
This new formulated relation is illustrated in Fig. III-20, together with the former 
reported relation. No significant differences were found for the resulting blood 
properties between both methods. In what follows, results are given using the 
adapted equation for the Lerche parameter. 
 
Fig. III-20: The Lerche parameter n as a function of hematocrit H: previous reported relation 
with a 2D model (thin line) [141] versus corrected relation (bold line) with a 3D model. 
4.8. Validation of the numerical model 
4.8.1. Objective 
The main objective of this study was to investigate whether the numerical model 
is able to predict ultrafiltration profiles and viscosity increases. From this respect, 
in vivo and ex vivo experiments were performed measuring flow and fluid 
properties. 
0
1000
2000
3000
0,2 0,25 0,3 0,35 0,4 0,45 0,5
hematocrit H (-)
pa
ra
m
et
er
 n
 (-
)
0
100
200
300
400
500
0,25 0,3 0,35 0,4 0,45 0,5
pa
ra
m
et
er
 n
 (-
)
Modeling of flow in a single hemodialyzer fiber 
 127
4.8.2. In vivo determination of blood properties 
4.8.2.1. Patients and methods 
The characteristics of blood flowing through a dialyzer were examined by the 
Critline system (described in Chapter I, paragraph 5.2). The sensors are placed 
at the inlet and outlet blood line for on line registration of hematocrit, blood 
volume, and oxygen saturation. 
The tests were completed for two stable dialysis patients. They were dialyzed 
during 4 hours with a low flux F6 and high flux F60 dialyzer, respectively 
(Fresenius Medical Care, Bad Homburg, Germany). The patients had an arterio-
venous fistula as vascular access, and the use of two needles assured a low 
recirculation rate (limited to 2-5%). 
A Bellco Multimat dialysis machine controlled blood and dialysate flows as well 
as ultrafiltration. The dialysate flow was kept constant at 500mL/min, while 
blood flow was changed stepwise (150-250-350mL/min) for an ultrafiltration rate 
of 0.5, 2, and 2.5L/h, respectively.  
4.8.2.2. Experimental results 
The difference between the inlet and outlet hematocrit is for the different blood 
and ultrafiltration flows given in Table III-22. 
Table III-22: Hematocrit increase for different blood and ultrafiltration flows. 
  Patient 1: low flux F6 Patient 2: high flux F60 
QB 
mL/min 
QUF 
L/h 
Hinlet 
% 
Houtlet 
% 
Incr. 
% 
Hinlet 
% 
Houtlet 
% 
Incr. 
% 
150 0.5 30.1 31.6 5.0 30.8 31.2 1.3 
250 0.5 30.1 31.1 3.3 30.7 31.1 1.3 
350 0.5 30.0 30.9 3.0 30.6 30.9 1.0 
150 2 30.3 37.8 25 30.8 37.9 23 
250 2 30.6 34.8 14 30.8 34.5 12 
350 2 30.7 33.7 9.8 30.8 32.8 6.5 
150 2.5 30.7 39.9 30 31.0 40.6 31 
250 2.5 30.8 36.6 19 31.1 36.2 16 
350 2.5 30.9 35.1 14 31.3 34.5 10 
blood flow QB; ultrafiltration flow QUF; hematocrit H; increment Incr 
The mean inlet hematocrit was 30.5±0.3% (patient 1: F6) and 30.9±0.2% (patient 
2: F60), while outlet hematocrit values were 34.6±3.1% (F6) and 34.4±3.4% 
(F60). By flowing through the dialyzer, blood thickening resulted in a hematocrit 
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increase of 3-30% (F6) and 1-31% (F60), depending on the blood and 
ultrafiltration flows. 
With a constant dialysate and blood flow, and increasing the ultrafiltration flow 
from 0.5L/h up to 2.5L/h in the F6 and F60, the outlet hematocrit was increased 
by 26 and 30% (QB=150mL/min), 18 and 16% (QB=250mL/min), and 14 and 
12% (QB=350mL/min), respectively. The outlet hematocrit is an exponential 
relation of ultrafiltration rate (Fig. III-21), with a mean hematocrit of 29.9±0.1% 
(F6) and 29.7±0.4% (F60) for a zero ultrafiltration flow. Those values are not 
significant different from the hematocrit measured at the dialyzer inlet. 
 
Fig. III-21: Outlet hematocrit as a function of ultrafiltration flow, for a blood flow of 150mL/min 
(thin line), 250mL/min (dashed line), and 350mL/min (bold line), with the F6 (left panel) and the 
F60 (right panel). 
Keeping the dialysate and ultrafiltration flow constant, and decreasing the blood 
flow rate from 350 to 150mL/min in the F6 and F60, outlet hematocrit values 
increased by 2.3 and 1.0% (QUF=0.5L/h), 12 and 16% (QUF=2L/h), and 14 and 
18% (QUF=2.5L/h), respectively. The outlet hematocrit varies according a second 
order relation for decreasing blood flows, and is illustrated in Fig. III-22.  
Considering constant flows, hematocrit increase was not significantly different in 
the high flux (F60) compared to the low flux (F6) dialyzer (P=0.657), except for 
the lowest applied ultrafiltration rate of 0.5L/h (P=0.014). We think however that 
this has more to do with the accuracy of the Critline system (not reported by the 
manufacturer) than with the dialyzer type. 
The mean inlet oxygen saturation was 90.2±1.4% (F6) and 92.2±0.4% (F60), 
while the outlet was varied 1-2% resulting in a mean value of 91.0±1.3% (F6) 
and 90.8±0.4% (F60).  
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Fig. III-22: Outlet hematocrit as a function of blood flow, for an ultrafiltration flow of 0.5L/h 
(thin line), 2L/h (dashed line), and 2.5L/h (bold line), with the F6 (left panel) and the F60 (right 
panel). 
4.8.2.3. Conclusion 
The present in vivo study aimed at determining the variation of blood properties, 
i.e. hematocrit. The influence on hematocrit of different flow settings was 
investigated using Critline sensors on the inlet and outlet blood line. 
The most important conclusion is that for a constant dialysate flow, the 
hematocrit increase due to dialyzer flow is more pronounced for lower blood 
flows and higher ultrafiltration rates.  
4.8.3. Ex vivo determination of flow and fluid properties 
4.8.3.1. Materials and Methods 
A scheme of the ex vivo setup is shown in Fig. III-23. A Bellco Formula dialysis 
machine prepared the dialysis fluid and controlled the dialysate, blood and 
ultrafiltration flow. Blood/dialysate flow combinations of 150/300mL/min, 
250/500mL/min, and 350/800mL/min were investigated for an overall 
ultrafiltration flow rate of 0.5L/h and 2L/h, respectively. Blood and dialysate 
flow rates were checked by gravimetrical flow measurements at the dialyzer 
outlet (Fig. III-23). Pressure was assessed at blood inlet and outlet, using fluid 
filled pressure transducers (Ohmeda, Gent, Belgium). 
The tests were performed using a high flux dialyzer F60 (Fresenius Medical 
Care, Bad Homburg, Germany). The main characteristics of the dialyzer are 
shown in Table III-12 (paragraph 4.4.3.3). 
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Fig. III-23: Ex vivo setup for flow and fluid investigation 
As patient’s blood substitute, bovine blood from the slaughterhouse was used. 
The blood was anticoagulated using 15 units of heparin per milliliter blood. 
Furthermore, it was filtered and maintained at a constant temperature (37°C) 
using a Bellco Simplex circulating system. The main blood characteristics of 
human and bovine blood are given in Table III-23. 
Table III-23: Blood characteristics of human and bovine blood. 
Blood H 
% 
RBC 
E+6 / µL 
DRBC 
µm 
WBC 
E+3 / µL 
Hb 
g/dL 
human 36 - 51 4.8 - 5.4 7 - 8 4 - 11 14 - 16 
bovine 24 - 46 5 - 10 4 - 8 4 - 12 8 - 15 
hematocrit H; number of red blood cells RBC; red blood cell diameter DRBC; 
number of white blood cells WBC; hemoglobin Hb 
Blood was sampled at the inlet and outlet blood line. Samples of 10mL were used 
for viscosity measurements with a plate and cone viscometer (Chapter I, 
paragraph 5.3). Dynamic viscosity was determined for shear rates of 100, 200, 
400, and 500s-1, while reproducibility was checked measuring the whole 
viscosity range, increasing the shear rate from 10 up to 800s-1. A second series of 
samples of 2.5mL were taken for hematocrit and mean cell volume (MCV) 
determination in the medical laboratory, while a third series of samples (2.5mL) 
were taken to control oxygen saturation and blood acidification (pH). 
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4.8.3.2. Experimental results 
With the different flow settings, the mean pH of the inlet blood sample was 
7.33±0.01, while outlet pH was 7.27±0.01. As a consequence, no blood 
acidification took place during the four hours of testing (small standard deviation 
for the inlet samples), nor when blood was flowing through the dialyzer (outlet 
pH only 0.7% lower than inlet pH). 
The inlet and outlet mean cell volume (MCV) was both found 51µm³. An 
important difference was found with the normal human MCV values (83-98µm³). 
Because the Critline system for hematocrit determination is calibrated for an 
MCV of 91µm³, which is a typical value for a dialysis patient population, 
Critline monitoring during the ex vivo experiments did not offer reliable results. 
With respect to the oxygen saturation, no significant difference was observed 
between the inlet and outlet samples (P=1.000). Owing to the constant oxygen 
saturation value during the four hours of testing, blood oxygenation was 
superfluous. 
Table III-24 shows the hematocrit increase for bovine blood flowing through the 
F60 dialyzer for different flow settings. When decreasing the blood and dialysate 
flow, the hematocrit increase was found to vary from 1.6 to 3.4% (QUF=0.5L/h), 
even more pronounced for the higher ultrafiltration rates of 2L/h (i.e. 7.6 to 
27%). 
 Table III-24: Hematocrit increase of bovine blood for different flow settings. 
QB 
mL/min 
QD 
mL/min 
QUF 
L/h 
Hinlet 
% 
Houtlet 
% 
Incr 
% 
150 300 0.5 43.7 45.2 3.4 
250 500 0.5 43.7 44.6 2.1 
350 800 0.5 43.7 44.4 1.6 
150 300 2 43.2 55.0 27 
250 500 2 43.2 48.9 13 
350 800 2 43.2 46.5 7.6 
blood flow QB; dialysate flow QD; ultrafiltration flow QUF; hematocrit H; 
increment Incr 
Fig. III-24 illustrates the variation of dynamic viscosity with increasing shear rate 
for samples taken at the inlet and outlet blood line with a blood and dialysate 
flow of 150 and 300mL/min and with an ultrafiltration rate of 0.5L/h and 2L/h, 
respectively. Viscosity can be assumed constant for shear rates in the range 300-
600s-1. For higher shear rates, viscosity was slightly increasing again due to the 
non-appropriate cone dimensions for measurements at high shear rates. 
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Fig. III-24: Dynamic viscosity variation for increasing shear rates with QB/QD =150/300mL/min: 
inlet sample (squares), outlet sample with QUF=0.5L/h (triangles) and QUF=2L/h (rhombs). 
Table III-25 shows the dynamic viscosity at a shear rate of 500s-1 of samples 
taken at the inlet and outlet blood line for different flow settings. The mean inlet 
viscosity was 4.73±0.09mPa·s, while viscosity was increased by 5-121% by 
flowing through the dialyzer. Because this important viscosity increase appeared 
unrealistic, inlet and outlet blood viscosities were also calculated using the 
formula derived for bovine blood by Mockros et al. [140] (Table III-25): 
 ( )H0.0235expµµ p ⋅⋅=  Eq. III-34 
With µp the plasma viscosity (1.3mPa·s) and H the hematocrit (%).  
Table III-25: Viscosity increase of bovine blood for different flow settings. 
   Ex vivo measurements Calculation with Eq. III-34 
QB 
mL/min 
QD 
mL/min 
QUF 
L/h 
µinlet 
mPa·s 
µoutlet 
mPa·s 
Incr 
% 
µinlet 
mPa·s 
µoutlet 
mPa·s 
Incr 
% 
150 300 0.5 4.90 5.30 8.1 3.57 3.69 3.5 
250 500 0.5 4.74 5.02 5.9 3.57 3.64 2.1 
350 800 0.5 4.67 4.91 5.3 3.57 3.63 1.6 
150 300 2 4.70 10.4 121 3.53 4.63 31 
250 500 2 4.69 6.70 43 3.53 4.02 14 
350 800 2 4.68 5.91 26 3.53 3.81 7.9 
blood flow QB; dialysate flow QD; ultrafiltration flow QUF; dynamic viscosity µ; increment Incr 
Significant differences were found between the viscosity rise obtained from the 
ex vivo tests and derived theoretically (Table III-25). Furthermore, an exponential 
relation could be drawn between viscosity (Table III-25) and hematocrit (Table 
III-24): µ=0.25·exp(0.068·H) and R²=0.996 (Fig. III-25). This equation is 
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significantly deviating from the one reported by Mockros et al. [140], and results in 
an underestimation of the plasma viscosity.  
Both phenomena suggest that the outlet blood viscosity was influenced not only 
by ultrafiltration, but maybe by clotting related factors as well. It was revealed 
that a protein layer on the membrane of critical thickness (20nm) plays an 
important role in the activation of the coagulation system [229]. Although the 
bovine blood was heparinized, it still might induce reactions that are not seen 
with clinical dialysis. As a consequence, care should be taken when extrapolating 
the bovine blood viscosity results to patient’s data.  
 
Fig. III-25: Dynamic viscosity as a function of hematocrit (F60) 
The pressure drop in the blood compartment can be calculated using the law of 
Haegen-Poiseuille (Eq. I-5) in a single fiber, counting with a fiber diameter of 
200µm, a fiber length of 0.255m (including potting) and a mean viscosity derived 
from the measured inlet and outlet viscosities (Table III-25). A comparison of the 
measured pressure drop with theory is, for the different flow settings, given in 
Table III-26. The measured pressure drop varied from a theoretical 
underestimation (3-17%) towards an overestimation (4-34%) for consecutive 
measurements. This phenomenon suggests that fiber clogging progressively 
occurred, increasing the pressure drop in the blood compartment. 
Table III-26: Theoretical and measured pressure drops in the blood compartment 
QB 
mL/min 
QD 
mL/min 
QUF 
L/h 
∆Ptheory 
mmHg 
∆Pex vivo 
mmHg 
deviation 
% 
150 300 0.5 68 56 -17 
250 500 0.5 108 96 -11 
350 800 0.5 148 143 -3 
150 300 2 100 104 4 
250 500 2 126 148 18 
350 800 2 164 219 34 
blood flow QB; dialysate flow QD; ultrafiltration flow QUF; pressure drop ∆P 
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4.8.3.3. Conclusion 
With the present ex vivo study, fluid (i.e. pressure and flow) and flow properties 
(i.e. hematocrit, viscosity, oxygen saturation and pH) were investigated in a high 
flux polysulphone dialyzer.  
The most striking conclusion is that the hematocrit and blood viscosity increases 
were most pronounced for lower blood flows and higher ultrafiltration rates. 
With respect to absolute values, care must be taken when considering bovine 
blood viscosity results for evaluation of a clinical session. Furthermore, fiber 
clogging during the ex vivo tests showed an important influence on pressure 
measurements. 
4.8.4. Comparison between experimental and numerical results 
4.8.4.1. Objective and methods 
The numerical model, as described in paragraph 4.7, was used to simulate 
selected in vivo and ex vivo experiments. The main input flow parameters were 
blood and dialysate inlet flow, and the overall ultrafiltration rate (using outflow 
boundaries - Chapter I, paragraph 5.6.2). The input fluid properties were inlet 
hematocrit, plasma viscosity (1.3mPa·s), inlet blood density, and inlet dialysate 
viscosity and density. 
For the considered simulations, different output parameters were investigated. 
The hematocrit and blood viscosity augmentations were calculated from mean 
inlet and outlet values and compared to the in vivo, ex vivo, and theoretical 
results. The pressure drop in the blood compartment was compared to the 
measured pressure difference as well as to the theoretical results using the 
Haegen-Poiseuille equation. 
4.8.4.2. Results 
Table III-27 and Table III-28 show the results of the numerical simulations for 
the blood properties (i.e. hematocrit and viscosity increase, respectively), 
compared to the results obtained with the in vivo, ex vivo, and theoretical method. 
No considerable difference was found between the hematocrit increases as found 
with the numerical simulations, the theoretical calculation, and the ex vivo 
experiments. With respect to the viscosity variation however, the numerical 
results are distinctly different from the experimental results, while similarity was 
found between simulations and theory. 
The experimentally measured, and numerically and theoretically derived pressure 
drops in the blood compartment are given in Table III-29. The simulation results 
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deviate significantly from the ex vivo measured (P=0.028) as well as from the 
theoretical derived pressure drops (P=0.008).  
Table III-27: Hematocrit increase for different flow settings. 
QB 
mL/min 
QD 
mL/min 
QUF 
L/h 
∆Hin vivo 
% 
∆Hex vivo 
% 
∆Hsimulation 
% 
∆Htheory 
% 
250 500 0.5 1.3 2.1 3.6 3.4 
150 300 2  27 28 28 
250 500 2 12 13 15 15 
350 800 2  7.6 11 11 
blood flow QB; dialysate flow QD; ultrafiltration flow QUF; hematocrit increase ∆H 
Table III-28: Blood viscosity increase for different flow settings. 
QB 
mL/min 
QD 
mL/min
QUF 
L/h 
∆µex vivo 
% 
∆µsimulation 
% 
∆µMockros 
% 
250 500 0.5 5.9 7.2 2.1 
150 300 2 121 32 31 
250 500 2 43 13 14 
350 800 2 26 9.8 7.9 
blood flow QB; dialysate flow QD; ultrafiltration flow QUF; 
viscosity increase ∆µ 
Table III-29: Pressure drops in the blood compartment for different flow settings. 
QB 
mL/min 
QD 
mL/min 
QUF 
L/h 
∆Pex vivo 
mmHg 
∆Psimulation 
mmHg 
∆Ptheory 
mmHg 
250 500 0.5 96 76 108 
150 300 2 104 28 100 
250 500 2 148 49 126 
350 800 2 219 68 164 
blood flow QB; dialysate flow QD; ultrafiltration flow QUF; pressure drop ∆P 
4.8.4.3. Discussion 
With respect to the blood property variation when flowing through the dialyzer, 
good similarity was found for the hematocrit increases as obtained with the 
different experimental and numerical methods. While matching was found 
between the numerical and theoretical results for blood viscosity, the ex vivo 
measured viscosities overestimated theoretical reality, probably due to the 
experimental test method (paragraph 4.8.3.2). As a consequence, accounting for 
the complex calculation of the varying blood properties, the implemented 
viscosity model was found appropriate. 
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With the ex vivo measurements, the pressure drop was assessed over the entire 
dialyzer, including energy losses at the dialyzer inlet and outlet manifold. This 
can however not explain the important difference with the numerical simulations. 
Furthermore, the discrepancy between the simulated and theoretical results 
suggests a non-appropriate calculation of the pressure drop with the CFD model. 
Because the blood-membrane interface is not defined as a no-slip wall, velocities 
at the interface are calculated by interpolation of the velocities of the adjacent 
cells. Keeping the parabolic Poiseuille velocity profile in mind, it is obvious that 
the velocity at the interface is more deviating from zero for increasing cell 
widths. As a consequence, velocities, and with it, flow and pressure drops were 
calculated inaccurate. Because the available computer capacity restricted the 
number of cells in the originally developed CFD model (paragraph 4.7), no 
refinement could be established near the blood-membrane interface (Fig. III-26). 
Recently, however, the mesh of the fiber model was refined, especially near the 
important boundaries blood-membrane and membrane-dialysate (Fig. III-26).  
 
Fig. III-26: Radial illustration of the original mesh (left panel) and the improved mesh (right 
panel) of the blood-dialysate interface 
Using the original mesh, simulations with an infinite membrane resistance 
resulted in a deviation of the blood-side pressure drop of 10% compared to the 
theoretical Poiseuille calculation. Mesh refinement reduced this error to 4.5%. In 
order to avoid long lasting simulations, further refinement was not considered. 
The hereafter reported results were calculated with the new-implemented mesh. 
4.8.4.4. Conclusion  
A number of simulations were performed to evaluate the validity of the 
microscopic CFD model by comparing the numerical results with experimental 
and theoretical results. While good similarity was found for the blood property 
blood
dialysate
bulk skin + protein layer
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variation over the dialyzer fiber, important discrepancies were found with respect 
to the pressure drop in the blood compartment. To remedy this calculation 
inaccuracy, the numerical mesh was refined for further applications. 
4.9. Influence of ultrafiltration on blood-side pressure drop 
4.9.1. Objective and aim 
With the refined mesh of the F60 dialyzer fiber, pressure profiles in the blood 
compartment were evaluated for increasing dialyzer lengths and an overall 
ultrafiltration flow of 2L/h. Results were compared to the theoretical calculation 
using Poiseuille’s law for flow in circular non-permeable tubes. 
4.9.2. Results 
Fig. III-27 illustrates the blood-side pressure drop for increasing dialyzer lengths. 
The theoretical (squares) as well as the numerically derived (triangles) results are 
shown.  
Due to forward filtration, blood flow decreases over the dialyzer length resulting 
in a smaller pressure drop than calculated theoretically. For a standard dialyzer 
with 230mm active fiber length, a deviation of 9.6% was found, while fiber 
elongation by a factor 1.5 or 2 results in a pressure drop that is 15% lower than 
given by Poiseuille’s law.  
Finally, it should be remarked that care must be taken when interpreting those 
percentage deviations, as a deviation of 4.5% was already found with the 
simulations for a non-permeable assumed membrane.  
 
Fig. III-27: Blood-side pressure drop (mmHg) as calculated theoretically (squares) and 
numerically (triangles) 
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4.9.3. Conclusion 
Because ultrafiltration causes the blood-side pressure drop to deviate from 
linearity, an interesting question is to which extent a linear approximation is still 
suitable. For a standard active fiber length of 230mm it was found with the 
described numerical model that deviations are below 10%, even for an overall 
ultrafiltration flow of 2L/h. However, care must be taken when considering 
longer dialyzer lengths. 
 Chapter IV Mass transport in a 
hemodialyzer 
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1. Chapter overview 
This chapter starts with the description of the different transport processes 
(diffusion, convection and adsorption), and the differences in solute removal of 
solutes with a different molecular weight in hemodialyzers with different 
membrane characteristics.  
Three different approaches were applied to investigate and describe solute 
removal, i.e. a theoretical, experimental, and numerical analysis. While each 
method has its proper drawbacks, by combining those three techniques we tried 
to provide the complete picture. 
The theoretical analysis was set out to investigate the influence on solute removal 
of dialyzer flow directions, total flow rates, and flow distributions. With respect 
to the latter, a general description is given and further applied to the low flux 
F6HPS dialyzer using the results of the SPECT measurements, as described in 
Chapter II. 
In the experiments, mass transport of small and middle molecules was studied in 
different flow and dialyzer combinations using F6HPS dialyzers. The 
investigated parameters were dialyzer flow directions, flow rates, and dialyzer 
positioning (i.e. two dialyzers placed in series or in parallel). 
Finally, a numerical model was developed to describe flow and mass transport in 
a single dialyzer fiber. After model calibration and validation, the impact on 
solute removal of a variable fiber length and diameter was assessed for small and 
middle molecules. Further on, the model is used to examine the effect of 
dialysate flow maldistribution by implementing the experimental SPECT results 
of chapter II. This allows a comparison between solute transport in a low flux F6, 
as derived theoretically, and in a high flux F60 dialyzer, as calculated 
numerically.   
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2. Introduction 
Besides the removal of the excess body water from the patient, dialysis therapies 
also aim at removing the toxic by-products of the metabolism.  
In hemodialysis, the major transport phenomenon is diffusion, driven solely by a 
concentration gradient without any filtration. To restore the fluid balance in the 
patient, however, a transmembrane pressure must be applied such that convection 
comes into play. The basics of both transport phenomena were discussed more in 
detail in Chapter I, paragraphs 3.4 and 3.5. 
In the description of mass transfer in hemodialyzers, it is important to make a 
distinction between small and middle molecule transport. Furthermore, besides 
the difference in filtration capacity, low and high flux dialyzers also differ with 
respect to solute clearances. 
2.1. Small versus middle molecule removal 
Small solutes are generally defined as molecules with a molecular weight (MW) 
below 300-500Da [84,229]. There is also ambiguity concerning the transition of 
middle to large solutes. Upper limits for the middle molecules of 12000 and 
15000Da are reported throughout the literature. Table IV-1 shows the 
classification of small, middle, and large molecules as defined by the European 
Uremic Toxin Work Group (EUTox) 
Table IV-1: Categorization of small, middle and large molecules. 
Classification of solutes Molecular weight range 
Small molecules 
e.g. urea (60), creatinine (113), phosphate (134) 
< 500 
Middle molecules 
e.g. vitamin B12 (1355), vancomycin (1448), inulin (5200), 
endotoxin fragments (1000-15000), β2-microglobulin (11818) 
500 – 15000 
Large molecules 
e.g. myoglobin (17000), EPO (34000), albumin (66000) 
> 15000 
 
The removal of middle molecules gained more and more attention over the past 
years due to its important role in uremic toxicity [110,230]. Traditionally, however, 
dialysis efficiency in the clinical practice is only focused on the removal of urea. 
The removal rate is then indicated as K·t/V or Urea Reduction Ratio (URR) [231], 
two dialysis adequacy parameters that are calculated on a regular basis (e.g. 
weekly, monthly…) [232]. 
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Because the diffusion rate of solutes was found inversely proportional to the 
square root of the solute molecular weight, only low molecular weight (LMW) 
molecules are removed by diffusion. Middle molecular weight solutes (MMW) 
are mainly removed by convection, and the contribution of convection to total 
solute removal increases with increasing molecular size [93]. 
When ultrafiltration becomes non-negligible, diffusion and convection interfere 
continuously with each other. Convection causes an accumulation of large 
solutes (i.e. larger than the membrane cut-off) at the membrane surface, 
influencing the diffusion length and the concentration gradient over the 
membrane. On the other hand, diffusion changes the local solute concentrations, 
which has an impact on their netto convective transport. As a consequence, it is 
impossible to specify the exact contribution of convection to the overall dialyzer 
clearance. It is however certain that the ultrafiltration flow has a larger impact on 
large solutes, which are not easily diffusing through the membrane [93]. 
Finally, the larger middle molecules (e.g. β2 microglobulin – MW11818) can 
also be removed by adsorption at the membrane. This phenomenon is however 
dependent on the membrane type, and is especially observed with 
polymethylmethacrylate (PMMA) [233,234] and some polyacrylonitrile (PAN) 
membranes. With the latter membrane, it is usually noticed that adsorption is 
overruling in the early stages of the dialysis treatment, while convection becomes 
dominant in the later stage [73,233]. Furthermore, solute removal by adsorption and 
convection are both enhanced by the use of high ultrafiltration flows [234,235].  
2.2. Solute removal in low flux versus high flux dialyzers 
Because of the different driving forces for small and middle molecule transport, 
i.e. concentration and pressure differences, the membrane properties play a key 
role in dialyzer efficiency.  
2.2.1. Diffusive transport 
The reciprocal of the mass transfer coefficient K0 in the equation for diffusive 
mass transport (Chapter I, Eq. I-10) can be seen as the resistance to diffusion. 
The latter is the sum of blood-side, membrane, and dialysate-side resistance. 
Because the membrane is far most the highest resistor, reducing this would result 
in a better dialysis efficiency. As a consequence, using membranes with smaller 
thickness and/or higher porosity enhances mass transfer. From this respect, 
membranes from modified cellulose have a significant lower membrane 
thickness (5-11µm) compared to synthetic membranes (40-50µm). The latter 
Mass transport in a hemodialyzer 
 143
group, however, can be produced with higher porosity (i.e. larger pores or 
increased number of pores), resulting in a high ultrafiltration coefficient 
(KUF>15mL/h/mmHg).  
Fig. IV-1 shows the difference in ranges of in vitro diffusive clearances for low 
flux and high flux membranes. Although Fig. IV-1 is based on data of 13 low 
flux and 7 high flux dialyzers of comparable surface area, the ranges of urea and 
creatinine clearances are quite narrow. This indicates that the different dialyzers, 
produced with different types of membranes, have relatively similar low 
molecular weight clearances. 
 
Fig. IV-1: Typical in vitro clearances of low and high flux dialyzers of 1.3-1.35m² [123]. All tests 
were performed without ultrafiltration and with QB and QD equal to 200 and 500mL/min. 
2.2.2. Convective transport 
The formula for total clearance K’, as reported in Chapter I (Eq. I-13) was drawn 
for the special case of unhindered solute transport through the membrane. For 
middle molecules, the convective term should be extended with the sieving 
coefficient S (-) [101,236,237]: 
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A sieving coefficient equal to unity corresponds to unhindered transport through 
the membrane, while S equal to zero implies that the membrane is impermeable 
for the considered solute, resulting in zero diffusion as well. 
It is obvious that the smaller pores in the low flux membranes hamper the 
transport of middle molecules over the membrane. This results in a sieving 
coefficient of only 0.7 and 0.1 for vitamin B12 (MW1355) and inulin (MW 
5200), respectively, in the low flux Fresenius polysulphone dialyzers (Fig. IV-2). 
The high flux polysulphone membranes, however, allow free passage of 
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molecules with a molecular weight less than or equal to inulin. Even β2-
microglobulin (MW11818), a molecule of the higher middle molecule range, is 
removed with a sieving coefficient approaching 0.65 (Fig. IV-2). 
 
Fig. IV-2: Schematic illustration of the sieving coefficient profiles (S) of low and high flux 
polysulphone dialyzers as a function of molecular weight [123]. 
In analogy as was earlier reported with respect to the ultrafiltration coefficient 
(Chapter III, paragraph 4.5.3), in vivo values for the sieving coefficient are 
different from the in vitro derived values. This is also due to the different 
composition of the patient’s blood and the different flow conditions. Depending 
on the membrane type, different combinations of diffusion, convection and 
adsorption can occur, such that the sieving coefficient may differ significantly in 
between different dialyzers. Furthermore, as the relative contribution of 
convection and adsorption to overall solute removal can change during the 
dialysis session, the sieving coefficient may also decrease, increase or remain 
constant when blood-membrane contact time increases. 
2.3. Conclusion 
Small molecules are solely removed by diffusion while middle molecules are 
mainly dragged by the ultrafiltration flow (convection). Furthermore, each 
membrane is characterized by different contributions of diffusion and convection 
to the overall solute removal. As a consequence, some membranes will be found 
more appropriate for the removal of a specific solute than others. It is the 
clinician’s challenge to find the optimal dialyzer for each patient individually. 
In general, the performance of a dialyzer depends on different aspects, which can 
be summarized as follows: first, the proficiency to remove urea and other small 
molecules that are normally eliminated by the native kidneys; second, the 
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ultrafiltration flux for water removal, determined by the transmembrane pressure 
and the ultrafiltration coefficient of the membrane; third, the corresponding 
removal of the middle molecules expelled with the filtration fluid, and fourth, the 
ability to retain important proteins, such as albumin, and other large molecules. 
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3. Theoretical analysis of mass transport 
3.1. Influence of flow direction on mass transport 
In a hemodialyzer, mass is transported over the semi-permeable membrane in 
between the blood and dialysate compartment. In the following, a mathematical 
relation is derived to determine the unknown blood and dialysate outlet 
concentrations as a function of the a priori known inlet concentrations. The 
spatial variation of mass transport in a dialyzer is described for the case blood 
and dialysate are flowing respectively in counter current and co-current direction 
(Fig. IV-3). 
 
Fig. IV-3: Scheme of counter current (left panel) and co-current dialyzer flows (right panel). 
3.1.1. Counter current dialyzer flows 
For small molecules that are easily transported by diffusion through the dialyzer 
membrane without any adsorption, the mass balance without considering 
ultrafiltration is given by: 
 
( ) ( ) dxC-CPKC-CdAK
dCQdCQ
DBF0DB0
DDBB
⋅⋅⋅−=⋅⋅−=
⋅−=⋅
 Eq. IV-2 
QB and QD represent blood and dialysate flow rates (m³/s), dC the solute 
concentration difference in flow direction (mol/m³) in blood (subscript B) and in 
dialysate (subscript D), K0 the overall mass transfer coefficient (m/s), A the mass 
exchange area (m²), PF the summation of the perimeters of all fibers (m), and x 
the axial direction (m) (Fig. IV-3, left panel). 
With α defined as the ratio of blood to dialysate flow, the concentration variation 
in blood and dialysate can be written in the x-direction: 
 ( ) ( )α1dCdC
Q
Q
dCdCdCCCd BB
D
B
BDBDB −⋅=⋅−=−=−  Eq. IV-3 
QB
CBi
QD CDiQD+QUF
CDo
QB-QUF
CBo
x
LF
dx QB
CBi
QD CDi QD+QUF
CDo
QB-QUF
CBo
x
LF
dx
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Substitution in Eq. IV-2 gives: 
 ( ) ( ) dxC-CPK
α1
CCd
Q DBF0
DB
B ⋅⋅⋅−=−
−⋅  Eq. IV-4 
By integration of Eq. IV-4 from 0 to x, the transmembrane concentration 
difference at a distance x in the dialyzer, is found: 
 ( ) ( ) ( ) ( ) ( )xβexp0∆CxCxCx∆C DB ⋅−⋅=−=  Eq. IV-5 
With the parameter β (1/m) defined as a function of α (-): 
 ( )α-1
Q
PK
β
B
F0 ⋅⋅=  Eq. IV-6 
To eliminate the a priori unknown transmembrane concentration difference at 
x=0, Eq. IV-5 is substituted in the blood-side and dialysate-side formula of Eq. 
IV-2, respectively: 
  ( ) ( )
( ) ( )

⋅⋅−⋅⋅⋅−=⋅
⋅⋅−⋅⋅⋅−=⋅
dxxβexp0∆CPKdCQ-
dxxβexp0∆CPKdCQ
F0DD
F0BB  Eq. IV-7 
Such that integration over the entire fiber length LF gives the following 
expressions: 
 ( ) ( )[ ]
( ) ( )[ ]


⋅−−⋅−
⋅−=−
⋅−−⋅−=−
FDoDi
FBoBi
Lβexp1
α1
α0∆CCC
Lβexp1
α1
0∆CCC
 Eq. IV-8 
Substitution of the concentrations (Eq. IV-8) in the definition of ∆C(0)=CBi-CDo, 
provides: 
 ( ) ( ) ( )( )F
DiBi
Lβexpα1
α1CC
0∆C ⋅−⋅−
−⋅−=  Eq. IV-9 
Finally, by substituting Eq. IV-9 in Eq. IV-8, the concentrations at the dialyzer 
outlet are described as a function of the known inlet concentrations: 
 ( ) ( )( )
( ) ( )( )


⋅−⋅−
⋅−−⋅⋅−+=
⋅−⋅−
⋅−−⋅−−=
F
F
DiBiDiDo
F
F
DiBiBiBo
Lβexpα1
Lβexp1
αCCCC
Lβexpα1
Lβexp1
CCCC
 Eq. IV-10 
In order to obtain the blood and dialysate concentrations at an arbitrary distance 
x, LF should be substituted by (x) and (LF-x), respectively, in the equation for CBo 
and CDo (Eq. IV-10). 
Chapter IV 
 148
In the case of non-negligible ultrafiltration, the mass balance is extended:  
 ( ) ( )
( ) UFUFDBF0
DDBB
CdQSdxC-CPK
CQdCQd
⋅⋅±⋅⋅⋅−=
⋅−=⋅
 Eq. IV-11 
CUF represents the solute concentration in the plasma ultrafiltrate in case of 
forward filtration (negative sign), or in the dialysate in case of backfiltration 
(positive sign), and S represents the sieving coefficient (-) [101,236,237].  
It should be remarked that blood flow (QB) in Eq. IV-11 is decreasing over the 
dialyzer length in the x-direction, resulting in a corresponding increase of 
dialysate flow (QD) in the opposite x-direction. Furthermore, if forward as well as 
backfiltration occurs, Eq. IV-11 should be used for each part of the dialyzer with 
the corresponding inlet concentrations. As a consequence, in order to determine 
the concentration distribution in a dialyzer in which forward and backfiltration 
take place simultaneously, Eq. IV-11 should be solved iteratively. 
Using the concentration variations (Eq. IV-10) as drawn from the mass balance 
equation (Eq. IV-2), a relation between the diffusive dialysance D (defined in 
Chapter I, Eq. I-11) and the mass transfer coefficient K0 can be derived: 
 ( )
( ) BF
F
B
DiBi
BoBi Q
Lβexpα1
Lβexp1Q
CC
CC ⋅⋅−⋅−
⋅−−=⋅−
−=D  Eq. IV-12 
Substituting the expressions for α and β in Eq. IV-12, the mass transfer area 
product K0·A is found as was reported earlier [85]: 
 
D
B
B
B
D
B
B
0
Q
Q
Q
Q
ln
1
Q
Q
Q
AK
⋅−
−⋅
−
=⋅
D
D  
Eq. IV-13 
3.1.2. Co-current dialyzer flows 
In analogy with the preceding derivation, the concentration profiles for the case 
of co-current flows can be derived from the mass balance equation (Eq. IV-2), 
neglecting ultrafiltration (Fig. IV-3, right panel): 
 ( ) ( )
( ) ( )


−
⋅−−⋅⋅−−=
−
⋅−−⋅−−=
α1
Lβexp1
αCCCC
α1
Lβexp1
CCCC
F
DiBiDiDo
F
DiBiBiBo
 Eq. IV-14 
With the parameter α as defined in Eq. IV-3 and β equal to: 
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 ( )α1
Q
PKβ
B
F0 +⋅⋅=  Eq. IV-15 
The diffusive dialysance is for the co-current situation transformed into: 
 ( )
B
F
B
DiBi
BoBi Q
α1
Lβexp1Q
CC
CC ⋅−
⋅−−=⋅−
−=D  Eq. IV-16 
And substitution of α and β in Eq. IV-16, gives the following expression for the 
mass transfer area product: 
 


 ⋅



⋅
−+⋅−
⋅=⋅ D
DB
DB
DB
DB
0 QQ
QQ
1ln
QQ
QQ
AK  Eq. IV-17 
3.1.3. Diffusive mass transport with counter current and co-
current flow directions  
3.1.3.1. Objective and methods 
Concentration variations along the dialyzer length were calculated and visualized 
using Eq. IV-10 and Eq. IV-14 for counter current and co-current flow directions, 
respectively. Furthermore, the influence of solute molecular weight was 
demonstrated theoretically. 
The main input parameters were related to flow (blood and dialysate flow rates), 
solute (diffusive dialysance and inlet concentration), and dialyzer dimensions 
(active fiber length, fiber diameter, and number of fibers). The considered 
Fresenius low flux F6 and high flux F60 dialyzers have 9200 fibers with an 
internal diameter of 200µm and active fiber length of 0.23m. The solute 
parameters are given in Table IV-2 for a blood flow of 250mL/min and dialysate 
flow of 500mL/min. 
Table IV-2: Diffusive dialysance and inlet concentrations of urea and vitamin B12 for 
counter current and co-current blood (250mL/min) and dialysate (500mL/min) flows in 
F6 / F60 dialyzers. 
  Counter current flows Co-current flows 
Solute MW 
Da 
D 
mL/min 
CBi 
mmol/L 
D 
mL/min 
CBi 
mmol/L 
Urea 60 201 / 213 16.7 172 / 182 16.7 
Vit B12 1355 61 / 126 0.037 51 / 95 0.037 
molecular weight MW; diffusive dialysance D [238,239]; blood inlet concentration CBi [240]. 
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3.1.3.2. Results and discussion 
The dialyzer concentration profiles of the small molecule urea in the high flux 
F60 are illustrated in Fig. IV-4 for counter current (left panel) and co-current 
flows (right panel). Because urea dialysance is only slightly lower in the low flux 
F6 dialyzer, concentration profiles will be quite similar compared to those found 
in the F60. 
 
Fig. IV-4: Urea concentration profiles in blood (bold line) and dialysate (thin line) in a high flux 
F60 dialyzer with counter current (left panel) and co-current flow directions (right panel). 
It is obvious from Fig. IV-4 that the driving force for diffusive transport (i.e. the 
concentration difference between blood and dialysate) is maintained over the 
entire dialyzer length for counter current flows. With the co-current flow 
configuration, however, the driving force is decreasing with dialyzer length. 
Because the diffusive dialysance of the middle molecule vitamin B12 is 
significant lower when using a low flux F6 compared to a high flux F60, 
concentration profiles will be different (Fig. IV-5). The blood concentration 
decrease and, with it, the dialysate concentration increase, are less pronounced in 
the low flux F6. 
3.1.3.3. Conclusion 
The mass balance equation in a hemodialyzer was applied to derive the 
concentration profiles in blood and dialysate. Furthermore, the influence of the 
mutual flow directions was investigated and the use of counter current flows was 
found most effective as the driving force for diffusive transport is well 
maintained over the entire dialyzer length.  
 
0
5
10
15
20
0 0,05 0,1 0,15 0,2 0,25
dialyzer axial x-position (m)
co
nc
en
tra
tio
n 
(m
m
ol
/L
)
0
5
10
15
20
0 0,05 0,1 0,15 0,2 0,25
dialyzer axial x-position (m)
co
nc
en
tra
tio
n 
(m
m
ol
/L
)
Mass transport in a hemodialyzer 
 151
 
Fig. IV-5: Vit B12 concentration profiles in blood (bold line) and dialysate (thin line) in a high 
flux F60 (full lines) and low flux F6 (dotted lines) with counter current (left panel) and co-
current flow directions (right panel). 
3.2. Influence of flow rate on mass transport 
When investigating the impact of flow on solute removal, one can consider the 
total dialyzer flow as controlled by the dialysis machine. It was however 
confirmed in Chapter II, that dialysate channeling (e.g. in the F6HPS dialyzer) 
causes maldistribution of flow. From this respect, the influence of total flows as 
well as flow distribution will be explained in this section and further applied on 
the F6HPS dialyzer. 
3.2.1. Influence of total flow rates on solute removal 
3.2.1.1. General description 
From the relation between the diffusive dialysance (D) and the mass transfer area 
coefficient (K0·A) (Eq. IV-12), the extraction ratio E (-) can be derived [108]. The 
larger the extraction ratio, the more efficient mass transfer is for a constant blood 
flow: 
 ( )
( )
( )[ ]
( )[ ]α1ηexp
α1ηexp1
Lβexpα1
Lβexp1
Q
E
B −⋅−
−⋅−=⋅−⋅−
⋅−−== α
D  Eq. IV-18 
With α and η two parameters describing flow and mass transfer, respectively: 
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The variation of the extraction ratio E with the flow parameter α (0.3-1) and the 
mass transfer parameter η (0.3-3) is illustrated in Fig. IV-6. For a constant 
dialysate flow of 500mL/min, dialysis seems more efficient for smaller α and 
larger η. This implies the use of lower blood and/or higher dialysate flows, and 
dialyzers with a larger K0·A value. It should be remarked, however, that for 
economical reasons, a dialysate flow of 2-2.5 times the blood flow is currently 
clinically applied (α=0.4-0.5). 
 
Fig. IV-6: Variation of the extraction ratio E as a function of the flow parameter α (left panel) 
and the mass transfer parameter η (right panel). Left panel: η=0.5 (thin dotted line), η=1 (thin 
line), η=2 (bold dotted line), and η=3 (bold line). Right panel: α=0.3 (thin dotted line), α=0.6 
(thin line), α=0.9 (bold line). 
Considering flow and mass transport of urea and vitamin B12 in a low flux F6 
and high flux F60 dialyzer, typical values for the parameters α, η and E are given 
in Table IV-3. 
Table IV-3: Parameters describing flow and mass transfer in F6/F60 dialyzers. 
Solute QB 
mL/min 
QD 
mL/min 
α 
(-) 
D 
mL/min 
K0·A 
mL/min 
η 
(-) 
E 
(-) 
Urea 200 500 0.4 180 / 185 619 / 709 3.09 / 3.55 0.90 / 0.93 
 250 500 0.5 201 / 213 558 / 684 2.23 / 2.74 0.80 / 0.85 
 300 500 0.6 222 / 242 570 / 736 1.90 / 2.45 0.74 / 0.81 
 350 500 0.7 243 / 270 606 / 821 1.73 / 2.35 0.69 / 0.77 
Vit B12 200 500 0.4 60 / 118  76 / 207 0.38 / 1.04 0.30 / 0.59 
 250 500 0.5 61 / 126 75 / 205 0.30 / 0.82 0.24 / 0.50 
 300 500 0.6 62 / 134 74 / 210 0.25 / 0.70 0.21 / 0.45 
 350 500 0.7 63 / 142 74 / 217 0.21 / 0.62 0.18 / 0.41 
blood flow QB; dialysate flow QD; flow parameter α; diffusive dialysance D; mass transfer area 
coefficient K0·A; mass transfer parameter η; extraction ratio E. 
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3.2.1.2. Application for the F6HPS dialyzer 
For overall blood and dialysate flows of 300 and 500mL/min, Table IV-4 gives 
the flow and mass transport parameters in the F6HPS dialyzer. An extraction 
ratio E of 0.79 and 0.31 was found for the small molecule urea and the middle 
molecule vitamin B12, respectively. Those values are however maximum values, 
and are only obtained in the case both flows are homogeneously distributed over 
the dialyzer cross section. The influence of the non-homogeneous flow 
distribution as found with the SPECT measurements is studied more in detail in 
the following paragraph. 
Table IV-4: Parameters describing flow and mass transfer in the F6HPS dialyzer. 
Solute QB 
mL/min 
QD 
mL/min
α 
(-) 
D 
mL/min
K0·A 
mL/min 
η 
(-) 
E 
(-) 
Urea 300 500 0.6 237 689 2.30 0.79 
VitB12 300 500 0.6 92 122 0.41 0.31 
blood flow QB; dialysate flow QD; flow parameter α; diffusive dialysance D; mass 
transfer coefficient K0·A; mass transfer parameter η; extraction ratio E. 
3.2.2. Influence of dialyzer flow distribution on solute removal 
3.2.2.1. General description 
When flow is not homogeneously distributed in a hemodialyzer, Eq. IV-18 
cannot be directly applied. Many flow maldistributions however occur due to 
flow channeling or preferential supply by the manifolds, and can be regarded as 
parallel maldistributions. Considering the dialyzer to be composed of a number 
of rectangular bars, the local extraction ratio e(ξ) can be derived from Eq. IV-18 
and Eq. IV-19 [108]: 
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With qB(ξ) and qD(ξ) the local blood and dialysate flow, k0·a(ξ) the local mass 
transfer area coefficient K0·A, and ξ a spatial variable (0 ≤ ξ ≤ 1). 
The overall dialyzer extraction ratio is then defined as a function of total mass 
transport J (mol/s): 
 
B
i
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∑ ⋅
=⋅=  Eq. IV-21 
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In a cylindrical dialyzer, local parameters will depend on the cylindrical 
coordinates r and θ (Fig. IV-7). In what follows, two different cases are 
discussed. First, a general formulation of the extraction ratio is given for a non-
homogeneous but axi-symmetrical flow distribution. And second, the extraction 
ratio is derived for the flow distribution as found in the F6HPS dialyzer 
(described in Chapter II). 
 
Fig. IV-7: Cylindrical skin (width dr) in a cross section of the dialyzer. 
3.2.2.2. Axi-symmetrical non-homogeneous flow distribution 
To illustrate the impact of the non-homogeneous flow on the extraction ratio E, 
the local blood and dialysate flows qB(r) and qD(r) are described as a function of 
two parameters A and B [-5, 5], indicating the degree of inhomogeneity: 
 







⋅−⋅−⋅⋅
⋅

−⋅⋅⋅−⋅=
⋅−⋅−⋅⋅
⋅

−⋅⋅⋅−⋅=
π
Q2π)5(QB
5
2
2
1
π
rBπ)5(Q
5
2(r)q
π
Q2π)5(QA
5
2
2
1
π
rAπ)5(Q
5
2(r)q
DD2
D
D
BB2
B
B
 Eq. IV-22 
Eq. IV-22 was obtained accounting for different conditions: first, the first 
derivative of those functions must be zero for r=0; second, the sum of all local 
flow rates has to match the overall flow; and third, qB(r) and qD(r) may not 
become equal to zero.  
The local dialysate flow profile is for a different inhomogeneity parameter B and 
overall dialysate flow of 500mL/min illustrated in Fig. IV-8. The local blood 
flow has a similar profile. 
θr
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Fig. IV-8: Local flow qD(r) as function of radial distance r and inhomogeneity parameter B. 
Overall dialysate flow is 500mL/min 
In each cylindrical skin (width dr), a first order approximation of blood and 
dialysate flow is 2·π·r·qB(r)·dr and 2·π·r·qD(r)·dr, respectively (Fig. IV-7). The 
membrane in between both flows has an area of 2·π·r·a0·dr, where a0 (-) 
represents a constant equal to Afiber·ρfiber (Afiber is the mass transfer area of a 
sinlge fiber and ρfiber is the fiber packing).  
Total mass transport J (mol/s) can be written as: 
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Such that the extraction ratio E becomes: 
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To study the extraction ratio for a given solute, the parameter k0·a0 is first 
calculated based on the solute clearance for a particular homogeneously 
distributed blood and dialysate flow. For a QB/QD of 300/500mL/min, urea and 
vitamin B12 clearances (D = E/QB = J/CBi) of 237 and 92mL/min, respectively, 
0
50
100
150
200
250
300
350
0 0,2 0,4 0,6 0,8 1
normalized radial distance r (-)
qD(r) 
(ml/min/m²)
Chapter IV 
 156
were reported by the manufacturer. Using Eq. IV-23 results in a k0·a0 value of 
202 and 38 for urea and vitamin B12. 
The extraction ratio E (Eq. IV-24) can now be determined for any given overall 
blood and dialysate flow, and for inhomogeneity parameters A and B in the range 
–5 to 5. Fig. IV-9 en Fig. IV-10 show the extraction ratio E(A,B) for urea and 
vitamin B12, respectively, normalized by the extraction ratio for a 
homogeneously distributed flow E(0,0), with an overall blood and dialysate flow 
of 300 and 500mL/min.  
 
Fig. IV-9: Contour curves for the extraction ratio E(A,B) for urea, normalized for the extraction 
ratio with homogeneous flow distribution E(0,0). 
For an axi-symmetrical non-homogeneous flow distribution, the influence of 
inhomogeneities on solute clearance and extraction ratio is rather limited. The 
worst case is obtained in the situation where high blood (dialysate) flows counter 
low dialysate (blood) flows. While the optimum efficiency is obviously obtained 
for (A,B) equal to (0,0), the optimum is shifting from (0,0) if one of both 
parameters is deviating from zero (Fig. IV-9).  
Comparing the results for urea and vitamin B12, it can be remarked that for a 
smaller k0·a0 value, as found with vitamin B12 (Fig. IV-10), contour curves are 
more symmetrical with respect to the axis A and B. As a consequence, if one of 
the parameters is deviating from zero, the optimum is reached for values of the 
other parameter more approaching zero. 
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Fig. IV-10: Contour curves for the extraction ratio E(A,B) for vitamin B12, normalized for the 
extraction ratio with homogeneous flow distribution E(0,0). 
Finally, in reality the value of k0 is not constant because of the differences in 
boundary layer resistances near the membrane for different flow rates. As a 
consequence, it would be more accurate when substituting an appropriate relation 
k0(qB,qD) in Eq. IV-23 and Eq. IV-24. 
3.2.2.3. In vitro measured non-homogeneous flow distribution 
With the experimental SPECT measurements, as reported in Chapter II, local 
blood and dialysate flow velocities were calculated in two perpendicular axial 
sections of the dialyzer, yz and xz-plane, divided in 16 slices of each 2.33mm in 
width (Fig. IV-11). Blood velocities were found to be uniform, while dialysate 
velocities were depending on the radial position. 
 
Fig. IV-11: Schematic illustration of the dialyzer with the axial sections yz and xz. 
The local extraction ratio was calculated using Eq. IV-20, where local blood and 
dialysate flows were drawn from the local velocities that were averaged over the 
different considered axial positions. The mass transfer area coefficient was 
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derived in two different ways. First, k0·a was calculated according clearance data 
reported by the manufacturer, and assuming homogeneous flows. Second, the 
influence of non-uniform flows was considered by applying mass transfer area 
coefficients for the local blood and dialysate flow. The clearance dependency on 
dialysate flow was used, as found in literature reported by Leypoldt at al. [128] for 
urea and by Eloot et al. [241] for vitamin B12 (see also paragraph 4.2). Diffusive 
dialysance D was found to be enhanced by 12% and 41% for urea and vitamin 
B12, respectively, when increasing dialysate flow from 500 up to 800mL/min. 
The results of both methods are illustrated in Fig. IV-12 for urea and Fig. IV-13 
for vitamin B12. The left panels show the local extraction ratio based on the 
velocities found in the yz-plane, while the right panels show the results for the 
xz-plane. The extraction ratio for the case of absolutely homogeneous flows is 
indicated in dotted line. 
 
Fig. IV-12: Local extraction ratio for urea in the yz-plane (left panel) and xz-plane (right panel) 
for homogeneous flows (dotted line), and non-homogeneous flows with constant (squares) and 
varying (crosses) mass transfer area coefficient. 
 
Fig. IV-13: Local extraction ratio for vitamin B12 in the yz-plane (left panel) and xz-plane (right 
panel) for homogeneous flows (dotted line), and non-homogeneous flows with constant (squares) 
and varying (crosses) mass tansfer area coefficient. 
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With non-homogeneous dialysate flows, regions of preferential flow paths result 
in enhanced mass transfer efficiency compared to mean mass transport found 
with homogeneously distributed flows. Although low dialysate velocities are 
localized near the dialyzer axis, those impeded dialysate flows have a non-
negligble impact on the overall extraction ratio. 
Integration of the local extraction ratio over the yz and xz-plane renders an 
overall planar extraction ratio that can be compared to the dialyzer extraction 
ratio as reported by the manufacturer (Table IV-5). The latter is 0.79 and 0.31 for 
urea and vitamin B12 mass removal, respectively.  
For the non-uniform dialysate flow, accounting with the varying k0·a value, the 
extraction ratio for urea is decreased by 1.6 and 3.5% in the yz and xz-plane, 
respectively, while it is decreased by only 1% for vitamin B12 in both planes. It 
should be remarked however that the local k0·a values for the increased local 
dialysate flows might be too optimistic as not all fibers are bathing in a 
surrounding dialysate flow in case of flow channeling. As a consequence, mass 
transfer deteriorations as found using a constant k0·a value might be more 
realistic. 
Table IV-5: Dialyzer extraction ratio E for urea and vitamin B12 in the case of 
homogeneous and non-homogeneous flow distribution. 
  Homogeneous Non-homogeneous distribution 
   Constant k0·a Varying k0·a 
Solute Section  E (-) E (-) decrease (%) E (-) decrease (%)
Urea YZ 0.790 0.749 5.2 0.777 1.6 
 XZ 0.790 0.721 8.7 0.762 3.5 
VitB12 YZ 0.310 0.300 3.2 0.307 1.0 
 XZ 0.310 0.295 4.8 0.307 1.0 
extraction ratio E, mass transfer area coefficient K0·A 
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4. Experimental analysis of mass transport 
Two experimental test sessions were carried out to investigate diffusive dialyzer 
clearance of small (paragraph 4.1) and middle molecules (paragraph 4.2) in 
different low flux dialyzer configurations. 
4.1. Diffusive clearance of small molecules in different 
dialyzer flow configurations† 
4.1.1. Abstract 
Clearance of low (LMW) and small middle molecular weight (MMW) solutes 
was investigated in vitro for different dialyzer configurations and mutual flow 
directions. Single pass tests were performed with two low flux Fresenius F6HPS 
hemodialyzers placed in series (12 tests) and in parallel (6 tests), and results were 
compared with those for one single dialyzer (2 tests). Either high concentrated 
(45mS/cm) bicarbonate dialysis fluid (surrogate LMW) or trisodiumphosphate 
(surrogate MMW) concentration (31mS/cm) was used as blood substitution fluid. 
Standard blood and dialysate flows of 250 and 500mL/min, respectively, were 
prescribed. Clearance was derived from conductivity measurements in blood and 
dialysate compartment, correcting for the overall ultrafiltration rate of 0.1-0.5L/h.  
In a single dialyzer, changing the counter current flow to co-current deteriorates 
diffusive clearance by 14% (LMW) and 18% (MMW). Compared to one single 
dialyzer using counter current flow, clearance increases by 3 and 8% (LMW) and 
by 15 and 18% (MMW) using two dialyzers in parallel and in series, 
respectively. As a consequence, the benefit of using a second dialyzer is more 
prominent for larger molecules. Moreover, pressure profiles drawn for the 
different configurations show the impact of limited convection on diffusive 
clearance.  
4.1.2. Introduction 
Adequate dialysis can be characterized by clearance index K·t/Vurea equal to 1.2-
1.4 [231,242]. This indicator is larger for better clearance, K, longer dialysis time, t, 
and/or for a smaller patient distribution volume, Vurea. In general, an increase in 
                                                     
† The contents of this section was published in Int J Artif Organs 2004;27(3):205-213. 
Diffusive clearance of small and middle-sized molecules in combined dialyzer flow configurations  
S. Eloot, JY. De Vos, R. Hombrouckx, and P. Verdonck 
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K·t/Vurea by 0.1 is associated with a substantially decreased risk of death from 
cardiac, cerebrovascular, and infectious diseases [90]. This clearance index, 
however, measures only the removal of low molecular weight (LMW) 
substances, which occurs predominantly by diffusion, and does not consider 
clearance of larger molecules. Babb et al. [91] was the first to introduce the term 
‘middle molecular weight’ (MMW) solutes, playing an important role in uremic 
toxicity, especially in processes related to inflammation, atherogenesis and 
malnutrition. Moreover, he defined their clearance as the product of overall mass 
transfer coefficient, K0 (proportional to solute diffusivity and inversely 
proportional to diffusion distance), and membrane area, A. Both parameters 
(K·t/Vurea and K0·A) are linked by the Michaels equation [85], which states that 
diffusive clearance, K, is a function of blood and dialysate flow rates and of the 
dialyzer specific parameter K0·A.  
To investigate impact of dialyzer membrane area, A, Scribner [243] connected 
three hemodialyzers in series in order to create a 3m² unit. Doubling the surface 
area using two dialyzers in parallel does not result in a doubling of urea clearance 
[244]. Several strategies have been proposed in the past to increase dialysis 
efficiency, K, so as to allow shorter dialysis treatment time, t, while maintaining 
adequacy. Paired filtration dialysis, using two units in series (hemofilter and 
hemodialyzer), was first introduced in the 80’s and was later optimized by Ronco 
et al. [245]. Jaffrin [246] described clearance in such hemodiafiltration models for 
the case in which the hemofilter is located upstream from the dialyzer using mid-
re-infusion or post dilution, as well as for the case the hemodialyzer is placed 
upstream the hemofilter. Utilizing two high flux hemodialyzers placed in series, 
with blood flows of 500mL/min, von Albertini et al. [247] evaluated shortened 
dialysis sessions (i.e. 115 minutes). Although they reported good biochemical 
control in the patients, precautions were taken with respect to hypotension due to 
the fast body fluid removal. With an analogous hemodiafiltration strategy, 
Velasquez et al. [248] found a 28% increase in K·t/Vurea, compared with 
conventional hemodialysis.  
In the present study, the diffusive clearance in parallel and serial placed low flux 
dialyzers was measured in vitro for different flow configurations. The aim was to 
better understand the underlying mechanism in dialyzer performance, rather than 
to find a method to minimize dialysis session time neither to ameliorate dialysis 
adequacy with obese patients. In particular, diffusion of small molecules was 
investigated and compared with the kinetics of a middle molecular weight solute, 
which is small enough to be mainly transported by diffusion. With this in mind, 
the influence of mutual flow directions was studied in low flux dialyzers placed 
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in series and in parallel. By splitting the blood and/or dialysate lines over both 
dialyzers, the influence of mutual flow rates was also investigated. Without 
considering the individual contributions of each dialyzer, the overall solute 
removal in each configuration was then compared with the results for a single 
dialyzer. 
4.1.3. Materials and Methods 
An experimental in vitro setup (Fig. IV-14) was developed, mimicking clinical 
dialysis using a Formula 2000 dialysis machine (Bellco Spa, Mirandola, Italy). 
As a consequence, blood, dialysate and ultrafiltration flow inside low flux 
F6HPS dialyzers (Fresenius Medical Care, Bad Homburg, Germany) were easily 
adjusted within physiological range. Overall blood and dialysate flow rates were 
chosen constant at 250 and 500mL/min, respectively, while an ultrafiltration rate 
was prescribed of 0.5 and 0.1L/h for the measurements with the LMW and 
MMW molecules, respectively. 
 
Fig. IV-14: Scheme of the in vitro setup. Blood substitution fluid (full line) and dialysis fluid 
(dotted line) are flowing single pass through the F6HPS dialyzer(s). 
Bicarbonate dialysis fluid of 14mS/cm conductivity was flowing in the dialysate 
compartment, while a concentrated solution of successively LMW and MMW 
molecules was used single pass in the blood compartment. These blood-
substituting fluids were heated up to 37°C by recirculation using a Simplex 
machine (Bellco Spa, Mirandola, Italy). To investigate clearance of LMW 
Bellco 
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molecules, standard bicarbonate dialysis fluid was mixed with A84 (acid) and 
B84 (bicarbonate) concentrates (producer: Sterima nv, Bissegem, Belgium; 
distributor: Fresenius Medical Care, Wilrijk, Belgium) up to 45mS/cm 
conductivity and obeying the prescribed A to B volume ratio. As middle-sized 
molecules are defined in the ‘European Best Practice Guidelines for 
Haemodialysis’ [84] by a molecular weight in the range of 300-12000Da, the 
conductive trisodiumphosphate Na3PO4 (Vel Chemicals, Belgium) with a MW 
equal to 395Da was chosen as small middle molecule. This molecule was 
dissolved in bicarbonate dialysis fluid (41g Na3PO4 / L dialysis fluid) and the 
solution reached an overall conductivity of 31mS/cm.  
Potential precipitation as well as stability of both solutions was controlled in the 
blood substitute reservoir during the whole test session (i.e. 4h for tests with one 
type of solution) performing temperature and conductivity measurements with an 
LF340 conductivity probe (WTW, Weilheim, Germany). To quantify dialyzer 
clearance, two extra conductivity probes were foreseen on blood outlet and 
dialysate outlet line, respectively, in specially developed probe chambers (Fig. 
IV-14). All conductivity probes were calibrated before each test session by 
immersing the probes into a control standard solution of 0.01mol/L potassium 
chloride (KCl). Out of the measured conductivity values COND (mS/cm), 
corresponding concentrations C ((L AB / L dialysis fluid) for LMW and (g 
Na3PO4 / L dialysis fluid) for MMW molecules) were calculated from calibration 
curves derived in advance: 
 
13.620COND0.425COND0.043C     :PONa
0.02027COND0.00286COND0.00018C             :AB
2
43
2
−⋅−⋅=
+⋅−⋅=
 Eq. IV-25 
Analyzing experimental data, the dependence of ultrafiltration QUF (mL/min) on 
total blood-side clearance Kblood (mL/min) is assumed to be linear [249]:  
 UFblood QTrKK ⋅+=  Eq. IV-26 
The diffusive clearance, K, is a function of blood inlet and outlet concentrations, 
CBi and CBo, and inlet blood flow rate QB (mL/min): 
 
B
Bi
BoBi Q
C
CC
K ⋅−=  Eq. IV-27 
The transmittance coefficient Tr is defined as [250]:  
 



⋅=
BQ
K-1STr  Eq. IV-28 
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For the considered molecules, the sieving coefficient S (-) can be assumed equal 
to one such that Eq. IV-26 can be written as: 
 
UF
Bi
Bo
B
Bi
BoBi
blood QC
C
Q
C
CC
K ⋅+⋅−=  Eq. IV-29 
From dialysate outlet concentration, CDo, and inlet dialysate flow rate, QD 
(mL/min), total dialysate-side clearance Kdialysate (mL/min) is defined as [85]: 
 
UFD
Bi
Do
dialysate QQC
C
K +⋅=  Eq. IV-30 
Both fluid flow rates were derived from gravimetrically measured blood and 
dialysate outflow (Fig. IV-14), accounting for the corresponding ultrafiltration 
rate.  
For each test solution, 20 different dialyzer flow configurations were investigated 
in a cross over study by changing the number of dialyzers (1 or 2), the 
positioning of dialyzers (in series (IS) or in parallel (IP)), the mutual flow 
directions inside one dialyzer (co-current (CC) or counter current (CTC) flow), 
and by choosing a split or chain dialysate flow of 250 or 500mL/min, 
respectively (Fig. IV-15, Fig. IV-16, and Fig. IV-17). Conductivities for each 
single pass test with a certain configuration were registered after the probe values 
remained constant during 5 minutes. 
 
Fig. IV-15: Clearance tests with AB and trisodiumphosphate solution in a single dialyzer (S). 
Pressure profiles of blood substitution fluid (bold line) and dialysis fluid (thin line for AB 
solution tests; dotted line for Na3PO4 tests) are drawn. 
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Fig. IV-16: Tests with the AB and trisodiumphosphate solution flowing inside in series 
placed dialyzers (IS). Pressure profiles of blood substitution fluid (bold line) and dialysis 
fluid (thin line for AB solution tests; dotted line for Na3PO4 tests) are drawn. 
4.1.4. Experimental results 
An overview of blood clearances, Kblood, for both LMW and MMW molecules is 
given in Table IV-6 for the 20 different dialyzer flow combinations. The 
dialysate clearances, Kdialysate, which were calculated as verification, deviate no 
more than 5% from the clearances calculated at dialyzer blood side.  
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Fig. IV-17: In parallel placed dialyzers (IP) investigating the clearance of AB and 
trisodiumphosphate. Pressure profiles of blood substitution fluid (bold line) and dialysis fluid 
(thin line for AB solution tests; dotted line for Na3PO4 tests) are drawn. 
For standard clinical dialysis, using one single dialyzer with counter current 
flows, a clearance of 215mL/min and 176mL/min is found for small and middle-
sized molecules, respectively. However, the clearance decreases by 14% (LMW) 
and 18% (MMW) changing the counter current flow to co-current. 
The results of serial configurations (IS) are clustered in three virtual groups 
(Table IV-6 and Fig. IV-16). In a first group (IS1-4), blood and dialysate inflow 
are in different dialyzers and both flows pass through both devices. In the second 
group (IS5-8), blood and dialysate again pass through both dialyzers, but in this 
case, the inflow of blood and dialysate is in the same dialyzer. In the final 
subgroup (IS9-12), a chain blood flow is combined with a dialysate flow split 
over the two dialyzers. It can be observed from Table IV-6 that although flow 
directions are changed within one category, the effect on LMW and MMW 
clearances is limited (small standard deviation) (Table IV-6). The combination 
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IS1-4, with a chain blood and dialysate flow and each inlet in a different dialyzer, 
gives the best results (225 and 193mL/min for LMW and MMW molecules, 
respectively). Compared to twice counter current flows, the co-current flow 
configuration deteriorates clearance by 2% (LMW) and 8% (MMW). Having the 
inlet chain flows in the same dialyzer (IS 5-8), decreases the clearance by 16% 
for LMW as well as for MMW molecules (189 compared to 225mL/min for 
LMW, and 163 compared to 193mL/min for MMW). Splitting dialysate flow 
over two dialyzers (IS 9-12), results in a QB/QD ratio of 1 and yields results in 
between those of the former described categories (211 and 173mL/min for LMW 
and MMW molecule removal, respectively).  
Table IV-6: Overview of the blood clearances Kblood (mL/min), calculated for the low 
and middle molecular weight molecules.  
ID CTC - CC QD split LMW : AB solution MMW : Na3PO4 
S 1 CTC - 215  176  
S 2 CC - 184  145  
IS 1 CTC - CTC I 233 209 
IS 2 CC - CTC I 230 196 
IS 3 CTC - CC I 225 190 
IS 4 CC - CC I 213 
225 ± 8 
177 
193 ± 13 
IS 5 CTC - CTC I 185 166 
IS 6 CC - CTC I 190 162 
IS 7 CTC - CC I 193 165 
IS 8 CC - CC I 187 
189 ± 4 
158 
163 ± 4 
IS 9 CTC - CTC V 219 188 
IS 10 CC - CTC V 215 170 
IS 11 CTC - CC V 213 171 
IS 12 CC - CC V 198 
211 ± 9 
161 
173 ± 11 
IP 1 CTC - CTC V 221  202  
IP 2 CC - CTC V 207  171  
IP 3 CC - CC V 176  154  
IP 4 CTC - CTC I 213  180  
IP 5 CC - CTC I 204  170  
IP 6 CC - CC I 190  156  
Column 2 indicates whether the flow in the dialyzers is CTC (counter current) or CC (co-
current), column 3 indicates whether dialysis fluid flow is split (V) over the dialyzers or not (I). 
In the case two dialyzers are placed in parallel, for a blood flow rate of 
125mL/min in each dialyzer, we can distinguish between a split (IP 1-3) and a 
chain (IP 4-6) dialysate flow of 250 and 500mL/min, respectively (Table IV-6 
and Fig. IV-17). A split dialysate flow is better in the case of twice counter 
current flows, while clearance results are equal and even worse for co-current 
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flow in one or two dialyzers, respectively. Although the use of two dialyzers in 
parallel results in clearance increase by 3% (LMW) and 15% (MMW) compared 
with one single dialyzer for counter current flows, two dialyzers placed in series 
ameliorates the clearance even more (8% and 18% for LMW and MMW, 
respectively). 
4.1.5. Discussion 
4.1.5.1. The experimental method 
The technique of monitoring conductivity is a practical method to derive solute 
clearance, and is already clinically used at the dialysate-side to derive urea 
clearance [251]. The choice of potential blood substitution fluids in vitro is, 
however, limited. A and B concentrates, composed by molecules with a 
molecular weight in the range of 20-180Da, as well as Na3PO4 (MW=395Da), 
could be dissolved efficiently in dialysis fluid resulting in a stable mixture with 
appropriate conductivity (45 and 31mS/cm, respectively). By dissolving the 
molecules of interest in bicarbonate dialysis fluid of 14mS/cm, no unwanted ion 
exchanges took place between blood and dialysate compartment.  
To investigate, in particular, diffusive clearance in different dialyzer 
configurations, low flux dialyzers as well as a limited ultrafiltration rate was 
proposed. Kerr et al. [252] did not find any differences between membrane types of 
six different low flux dialyzers with respect to urea and phosphate clearance in 
clinical practice. As a consequence, the results found here for a polysulphone 
membrane (thickness 40µm, fiber inner diameter 200µm, ultrafiltration 
coefficient 8.5mL/h/mmHg) may be extrapolated for other membrane types (i.e. 
cuprammonium, hemophan,…). To avoid substantial backfiltration as would 
occur e.g. in the case of zero overall ultrafiltration, the ultrafiltration rate was set 
to 0.5L/h for the tests with the 45mS/cm AB concentration. However, for the 
trisodiumphosphate solution with analogous conductivity and ultrafiltration rate 
values, concentration polarisation resulted in a blockage of the membrane. The 
blood substitute concentration was therefore diluted to a conductivity of 
31mS/cm and an ultrafiltration flow of only 0.1L/h was applied. 
The flow rate in the blood compartment was chosen in the range of clinical 
European practice, i.e. 250mL/min [31]. Since a low flux dialyzer is used, 
clearance is not limited by the relative low applied blood flow. Although mass 
transfer in large area devices is increased for high dialysate flow rates [253], 
Sigdell and Tersteegen [32] found, in the case of zero ultrafiltration, a practically 
feasible limit for any clinical dialysis situation of a dialysate flow twice as high 
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as blood flow. Therefore, dialysate flow rate was chosen constant at 500mL/min. 
To ensure that split flows were well balanced over both dialyzers, dialysis lines 
were taken perfectly symmetric and the used dialyzers were samples from the 
same lot number to obtain comparable individual dialyzer resistances. Moreover, 
the crossover studies were concluded with clearance measurements using the 
single dialyzer configuration, showing no differences with previously performed 
measurements. 
4.1.5.2. Which configuration to choose 
Although it is obvious that the configuration using two dialyzers placed in series 
or in parallel with counter current flows gives the best and second best clearance 
results, it is very interesting to have an idea about the advantage of making the 
extra cost by consuming a second dialyzer. With respect to the small molecules, 
the concentration reduction increases only from 89 up to 93% and 90% if a 
second dialyzer is added in series or in parallel, respectively. 
Trisodiumphosphate removal, however, rises from 68 up to 81% with both 
configurations. As a consequence, although small molecules are cleared more 
efficiently in all configurations, middle-sized molecules gain more advantage of 
an increased surface area by using a second dialyzer, as described earlier by 
Henderson et al. [254]. It should be remarked however that with respect to 
practical usage, the parallel configuration is preferable as deaeration of the 
dialyzers is easier to perform. In case water quality is in doubt, dialyzers in 
parallel should be considered, as backfiltration is less likely to occur. 
With counter current flows, clearance increases by 3-8% (LMW) and 15-19% 
(MMW) adding a second dialyzer in parallel or in series, respectively. However, 
increasing blood and dialysate flow rates from QB300-QD600mL/min up to 
QB400-QD800mL/min, Allen et al. [253] found a urea clearance increase of about 
25%. As a consequence, dealing with an adequate vascular access and as long as 
the water use is economically sensible, increasing blood and dialysate flow rates 
results in better clearances.  
4.1.5.3. Comparison of in vitro results with clinical data 
With respect to mutual blood and dialysate flow directions, co-current flow 
decreases clearance of small molecules (ureum, creatinine) even more in vivo 
(21-26%) [255] compared to in vitro (-14%). Compared with a single dialyzer, 
Fritz et al. [256] found urea (single pool) spK·t/Vurea increase of 14.4% and 16.8% 
for parallel and serial placed dialyzers, respectively, in large hemodialysis 
patients. Using two high flux F80A (Fresenius, Bad Homburg, Germany) 
dialyzers in parallel with a split blood and a split dialysate flow rate of each 200 
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and 400mL/min, respectively, urea spK·t/Vurea increases by 15% while the 
clearance of MMW molecules (surrogate iohexol of MW 821D) increases by 
39% [244]. Both clinical studies report equal LMW clearance improvements for 
the parallel setup, while less expressed ameliorations are found in our in vitro 
study. The discrepancy might be due to the fact that high flux dialyzers are used 
in vivo to obtain sufficient body fluid loss, while we were especially interested in 
pure diffusive clearances using low flux dialyzers. This assumption implies that 
the higher the convection, the higher the clearance, even more expressed for 
larger molecules [100,129]. 
4.1.5.4. Correlation of clearance with pressure distribution 
To explain the discrepancies between the results for a serial and parallel setup, as 
well as for the different virtual groups, pressure distribution and ultrafiltration 
profile per dialyzer are pointed out for each test setup. The pressure drop, ∆P, in 
the blood compartment is described theoretically by Poiseuille’s law for laminar 
flow in a circular tube: 
 
B4 QDπ
Lµ128∆P ⋅⋅
⋅⋅=  Eq. IV-31 
With µ the dynamic viscosity of the blood substitute solution at 37°C (0.78·E-3 
Pa·s), L the length of a hollow fiber (0.23m), D the fiber inner diameter (200µm) 
and QB the mean blood flow rate in a single fiber (m3/s) (total number of fibers is 
9200). For an overall blood flow rate of 250mL/min the pressure drop is 
15.5mmHg. As the velocity profile in the non-circular inner space of the 
dialysate compartment differs from a parabolic one, Poiseuille’s law is not 
applicable. The dialysis fluid pressure drop was therefore taken from a previous 
developed numerical model of the same dialyzer [141] where a pressure drop of 
7.5mmHg was found for an overall dialysate flow rate of 500mL/min. Dealing 
with laminar blood and dialysate flows, pressure drops are proportional with the 
corresponding flow rates and are, as a consequence, divided by two as blood or 
dialysate lines are split over two dialyzers. The transmembrane pressure TMP 
(mmHg) is defined as a function of ultrafiltration flow QUF (mL/h) and the 
ultrafiltration coefficient KUF (8.5mL/h/mmHg for the F6HPS): 
 
UF
UF
K
QTMP =  Eq. IV-32 
This results in a TMP of 58.8mmHg and 11.8mmHg for QUF equal to 0.5L/h and 
0.1L/h, respectively. For dialyzers placed in series or in parallel, overall TMP 
values are divided by two as the ultrafiltration coefficient is doubled. Assuming a 
fictitious inlet blood pressure of 100mmHg, the blood-side pressure drop over 
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both dialyzers is drawn as a linear function of axial distance (bold line in Fig. 
IV-15, Fig. IV-16, and Fig. IV-17). Moreover, the linear pressure drop in the 
dialysate compartment (thin (AB) and dotted line (Na3PO4) in Fig. IV-15, Fig. 
IV-16, and Fig. IV-17) is derived from the corresponding transmembrane 
pressure, which is the mean difference between blood and dialysate pressure. The 
area in between both curves is then a measure for the ultrafiltration flow rate 
such that backfiltration may occur whenever the dialysate pressure exceeds the 
blood pressure (Fig. IV-15, Fig. IV-16, and Fig. IV-17).  
This theoretical derivation of pressure profiles allows us to calculate the 
ultrafiltration flow per dialyzer for the different configurations (Table IV-7). It 
can be remarked that for the test setups belonging to the same virtual group, the 
overall ultrafiltration rate is divided over both dialyzers according to the same 
ratio. For serial placed dialyzers, there is a correlation of dialyzer clearance with 
pressure and ultrafiltration distributions. Moreover, the clearance of small as well 
as middle-sized molecules increases as the difference in amount of ultrafiltration 
per dialyzer increases (Table IV-7 and Fig. IV-16). As a consequence, the 
occurrence of backfiltration in one of the dialyzers, which is more likely to 
happen in smaller dialyzer fibers [129] or/and for dialyzers placed in series 
compared with the parallel configuration [257], ameliorates the overall clearance. 
This phenomenon, previously proven for larger molecules [100,129], seems to have 
a similar effect for smaller molecules.  
Table IV-7: Ultrafiltration flow (forward positive and backward negative) in the 
individual dialyzers for the single, serial and parallel configurations. 
 LMW : AB solution MMW : Na3PO4 
ID Quf dialyzer1 
mL/min 
Quf dialyzer2 
mL/min 
 
QUF total 
L/h 
Quf dialyzer1 
mL/min 
Quf dialyzer2 
mL/min 
QUF total 
L/h 
S1 8.33 - 0.5 1.67 - 0.1 
S2 8.33 - 0.5 1.67 - 0.1 
IS 1-4 5.80 2.53 0.5 2.46 -0.79 0.1 
IS 5-8 4.73 3.60 0.5 1.40 0.27 0.1 
IS 9-12 5.26 3.07 0.5 1.93 -0.26 0.1 
IP 1-3 4.17 4.17 0.5 0.83 0.83 0.1 
IP 4-6 4.70 3.63 0.5 1.37 0.30 0.1 
 
Considering dialyzers in a parallel setup, it can be remarked that an equal 
ultrafiltration distribution favors overall molecule clearance (Table IV-7 and Fig. 
IV-17), except for co-current flows. Moreover, the more dialysate flow exceeds 
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blood flow (IP4-6), co-current flow configurations become even more adequate, 
as published before [100]. 
4.1.6. Conclusion 
The developed in vitro setup investigates the influence of dialyzer and flow 
configurations on the diffusive clearance of small and middle-sized molecules. 
The benefits of using an extra dialyzer are quite limited for small molecules. For 
small MMW solutes, however, the diffusive clearance is significantly 
ameliorated when the surface area is doubled. The best configuration consists of 
serially placed dialyzers with chain blood and dialysate flows entering different 
dialyzers. Interpreting pressure profiles for the different configurations, it seems 
that the ultrafiltration distribution in dual dialyzers plays an even more important 
role than the mutual blood and dialysate flow directions. As a consequence, 
although convection and diffusion are described as two separate phenomena, in 
practice we cannot distinguish the single contributions given by the two transport 
mechanisms.  
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4.2. Diffusive clearance of middle molecules in different 
dialyzer flow configurations† 
4.2.1. Abstract 
Some studies found that the removal of middle molecules has a long-term effect 
on mortality and, even more, is enhanced by high flux dialysis. In order to 
enhance middle molecule removal in a low flux dialyzer, the present study aimed 
at investigating the combined impact of dialyzer flows and membrane surface 
area.  
Blood and dialysate flows were varied within the clinical range 300-500mL/min 
and 500-800mL/min, respectively, while ultrafiltration rate was kept constant at 
0.1L/h. Single pass tests were performed in vitro in a single Fresenius F6HPS 
                                                     
† The contents of this section was submitted for publication 
Middle molecule removal in low-flux polysulphone dialyzers: impact of flow and surface area on 
whole-body and dialyzer clearances 
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dialyzer (3 tests) and in serially (5 tests) and parallel (3 tests) connected 
dialyzers. The blood substitute fluid consisted of dialysis fluid in which 
radioactive labeled vitamin B12 (MW1355) was dissolved. Dialyzer clearance as 
well as whole-body clearance was calculated from radioactivity concentrations of 
samples taken at the inlet and outlet blood line. 
Adding a second dialyzer in series or parallel ameliorated significantly overall 
dialyzer and whole-body clearance, except for the highest applied blood flows of 
500mL/min. Better solute removal was also obtained with higher dialysate flows, 
while the use of higher blood flows seemed only advantageous when using a 
single dialyzer. Analysis of the ultrafiltration profiles in the different 
configurations illustrated that enhancing the internal filtration rate ameliorates 
convective transport of middle molecules.  
In conclusion, adequate solute removal results from a number of interactions, as 
there are, blood and dialysate flows, membrane surface area, filtration profile, 
and concentration profiles in the blood and dialysate compartment.  
4.2.2. Introduction 
The adequacy of chronic dialysis therapy is determined by the amount of solute 
removal from the patient. Although not necessarily toxic in its free form, urea is 
still currently used as the standard marker for small molecule removal, and the 
clearance index K·t/Vurea is calculated and compared to the target number 1.2-1.4 
[231]. Small molecule removal is mainly achieved by diffusion and is influenced 
by blood and dialysate flows, membrane thickness and dialyzer surface area. 
Although refuted by the HEMO study [258], several other studies [110,230] reported 
the long-term effect of larger uremic solutes on mortality and morbidity. Using 
vitamin B12 as a surrogate marker for middle molecule transport, the mortality 
risk lowered by approximately 5% in patients treated with a 10% higher 
K·t/VvitB12, independent of K·t/Vurea [259]. For middle molecules, which are 
substantially larger than urea (MW≥500Da) [229] and predominantly removed by 
convection, Babb et al. [91] defined the square meter hypothesis, stating that 
increasing dialyzer surface area only becomes advantageous for higher molecular 
weight solutes. Moreover, middle molecules are characterized by a kinetic 
behavior not resembling that of urea during hemodialysis using low flux 
membranes [260].  
The present study aimed to investigate the diffusive solute removal of middle 
molecules (i.e. vitamin B12) by performing in vitro experiments in low flux 
dialyzers mimicking clinical dialysis. Due to its importance for small molecule 
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removal [261], the impact of an increased blood and/or dialysate flow was studied. 
Furthermore, surface area was substantially enlarged by performing in vitro 
clearance tests with two low flux dialyzers placed either in series or in parallel. 
As dialyzer clearances do not reveal directly any changes within the uremic 
patient, a theoretical description of vitamin B12 compartmental kinetics was 
performed. An analysis of the impact of dialyzer flow and membrane area on the 
whole-body clearance allows formulating some recommendations to improve 
middle molecule removal, and, with it, patient survival rate. 
4.2.3. Materials and Methods 
4.2.3.1. Experiments 
In an experimental in vitro setup, solute removal was investigated in different 
flow configurations using low flux F6HPS dialyzers (Fresenius Medical Care, 
Bad Homburg, Germany). Mimicking clinical dialysis using a Formula 2000 
dialysis machine (Bellco Spa, Mirandola, Italy), blood and dialysate flows were 
easily set in the range 300-500mL/min and 500-800mL/min, respectively. 
Ultrafiltration rate was limited and prescribed at 0.1L/h. During the experiments, 
blood flow was measured gravimetrically at the outflow, accounting for the 
applied ultrafiltration rate, while dialysate and ultrafiltration flow were read from 
the dialysis machine display. 
Conductivity, concentration, and temperature of the dialysis fluid were monitored 
and adjusted by the dialysis machine in order to keep them constant. Vitamin 
B12 (MW1355) was chosen as an in vitro surrogate marker in the blood 
compartment to investigate clearance of middle molecules. For the preparation of 
the blood substitution fluid, three vitamin B12 capsules of each 20µg and labeled 
with Cobalt-57 (0.1 µCi/capsule) (Amersham Health, UK) were dissolved in a 
reservoir containing 30L dialysis fluid. The mixed solution was maintained 
thermostatic at 37°C by recirculation using a Simplex machine (Bellco Spa, 
Mirandola, Italy). Cobalt-57 is a radionuclide with a half-life of 271.7 days, and 
energy of 122.1keV. An adequacy test was performed to ascertain that no free 
Cobalt was present in the blood substitute solution. After the test session, all 
waste fluids were stored in tanks and, together with the dialysis lines and 
dialyzers, put in isolation during one year. 
For each configuration and under steady flow conditions, 2mL samples were 
taken at the inlet and outlet blood line. After the test session, all samples were 
placed during 20min in a Cobra gamma-multichannel-counter equipped with a 
3x3" NaI(Tl) crystal set at 122±18keV (Canberra-Packard, USA). Total numbers 
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of counts of 1521±217 and 952±210 were recorded for the inlet and outlet 
samples, respectively. From the detected number of counts per minute CPM, 
sample solute concentrations C (ng/L) were calculated using the following 
calibration curve: 
 CPM3,98C ⋅=  Eq. IV-33 
4.2.3.2. Dialyzer clearance 
Total blood-side clearance Kblood (mL/min) is function of diffusive clearance K 
(mL/min), and varies linearly with the ultrafiltration flow QUF (mL/min) [250]: 
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with Tr the transmittance coefficient [262], defined as a function of flow 
conditions and membrane properties [263], CBi and CBo the blood inlet and outlet 
concentrations, and QB the blood inlet flow (mL/min). The sieving coefficient S 
(-) is the proportionality factor between the solute flux and fluid flux across the 
membrane. Although often considered constant for a given solute-membrane 
combination, S varies depending on the ultrafiltration flux. For the low 
ultrafiltration flow of 1.67mL/min applied here, the sieving coefficient can be 
approximated equal to one, even for vitamin B12 with a molecular weight of 
1355Da [226,264]. Eq. IV-34 can then be rewritten as: 
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The overall mass transfer area coefficient K0·A (mL/min) represents the 
theoretical maximal clearance for a particular solute-dialyzer combination [265] 
and determines the solute clearance for a given set of blood and dialysate flows. 
For counter current flows and a negligible ultrafiltration rate, K0·A is defined as 
[85]: 
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Whereas diffusive clearance K and mass transfer area coefficient K0·A depend 
directly on the blood flow, an adequate comparison between solute removal in 
different flow configurations is performed by considering the extraction ratio E 
(%) [108], defined as the diffusive clearance normalized by blood flow: 
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B
⋅−=⋅=  Eq. IV-37 
4.2.3.3. Whole-body clearance 
From a clinical point of view it is more appropriate to investigate whole-body 
clearance, which is a better measure of overall treatment efficacy [266]. Therefore, 
two-pool kinetic modeling was performed using input from literature and the in 
vitro tests (Fig. IV-18).  
 
Fig. IV-18: Two-pool model to assess the whole-body clearance with respect to the middle 
molecule vitamin B12. 
Total distribution volume (Vtot=40L) consisted of two distinct volumes: the 
perfused or extracellular compartment (V1=13.3L) and the non-perfused or 
intracellular compartment (V2=26.7L) [267]. Ultrafiltration QUF=1.67mL/min (cf. 
in vitro) was assumed to occur in both compartments (-dV1/dt and -dV2/dt) in 
proportion to the compartmental volume ratio. 
Each compartment was theoretically characterized by a homogeneous solute 
concentration with pre-dialysis concentration C1_pre=C2_pre=1.997µg/L (cf. in 
vitro). Solute generation rate and access and cardiopulmonary recirculation have 
a negligible influence on whole-body clearance and were neglected in this study. 
During dialysis, solute removal is driven by the patient’s concentration (C) and 
the concentration difference between both compartments (C2-C1), and is 
proportional with dialyzer clearance (K) and inter-compartmental clearance 
(K12=125mL/min [267]), respectively. Dialyzer clearance K was different for each 
configuration (cf. in vitro), and was assumed to be constant throughout the entire 
dialysis session.  
K
CBi
CDi
CDo
CBo
dialyzer
QB
QD
QB - QUF
QD + QUF
V1, C1V2, C2
K12
Vtot = 40L
26.7L 13.3L
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The time variation of the compartment concentration was, for a particular solute, 
determined by solving a series of mass balance equations for both compartments 
[268,269]: 
 ( ) ( )
( ) ( )


−⋅−=
−⋅+⋅=
1212
22
12121
11
CCK
dt
CVd
CCKCK
dt
CVd
 Eq. IV-38 
Equations were solved for a complete dialysis session time of 240min, using the 
JSim software (National Simulation Resource, Seattle, W). 
In analogy with the well-known urea reduction rate, URR, the middle molecule 
reduction rate in the patient, MRR (%), is defined as a function of pre (C1_pre) 
and immediate post-dialysis vitamin B12 concentration (C1_post) in the perfused 
compartment: 
 
100
C
CC
MRR
1_pre
1_post1_pre
B12vit ⋅
−=  Eq. IV-39 
4.2.3.4. Study parameters 
In a crossover study, 11 different flow configurations were investigated (Table 
IV-8 and Fig. IV-19): 3 configurations using a single dialyzer (S1-S3), 5 
configurations with two dialyzers placed in series (IS1-IS5), and 3 using a 
parallel dialyzer configuration (IP1-IP3). The test with the first configuration was 
repeated to check reproducibility. The main parameters under study were the 
blood and dialysate flows, varying within the clinical range of 300-500mL/min 
and 500-800mL/min, respectively. All tests were performed with counter current 
flows. In each parallel configuration dialysate flow was distributed to both 
dialyzers. With the serially connected dialyzers, however, the influence of 
splitting the dialysate lines (X) or not (I) was investigated. 
4.2.3.5. Ultrafiltration profiles 
When using two dialyzers in series or in parallel, the applied ultrafiltration rate 
(1.67mL/min) was divided over both dialyzers. In order to better understand the 
intrinsic contribution of convection to the overall clearance, a previously 
described theoretical method [239] was used to calculate the pressure distribution 
and, with it, the ultrafiltration profile in each dialyzer configuration. From the 
latter, the ultrafiltration flow in each single dialyzer was derived, accounting for 
an ultrafiltration coefficient, KUF, of 8.5mL/h/mmHg for the F6HPS.  
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Fig. IV-19: Overview of the different investigated dialyzer flow configurations: three 
configurations using a single dialyzer (S1-3), three configurations using a linked dialysate flow 
in two dialyzers in series (IS1-3), two configurations using a split dialysate flow in two 
dialyzers in series (IS4-5), and three configurations using parallel placed dialyzers (IP1-3). 
4.2.3.6. Statistical analysis 
Values are reported as mean ± standard deviation. Correlations between 
parameters were investigated by performing linear regression analysis (Pearson). 
Statistical analysis was carried out using the Student t-Test on normally 
distributed populations, with P<0.05 as the limit of significant difference 
(Sigmastat, Jandel Corporation, US).  
4.2.4. Experimental results 
An overview of dialyzer clearance (K), mass transfer area coefficient (K0·A), 
extraction rate (E), and whole-body clearance (MRR) is shown in Table IV-8 for 
the different flow configurations. Besides the overall flow rates, blood and 
dialysate flows in each dialyzer were also added (noted as qB and qD) in order to 
give a better idea about mutual flow rates in each dialyzer within a serial and 
parallel configuration. The theoretical blood flows of 300 and 500mL/min 
corresponded to a measured flow rate of 296±2 and 500±2mL/min, respectively. 
For standard clinical dialysis, using a single dialyzer with a counter current blood 
and dialysate flow of 300 and 500mL/min, respectively, we found a blood-side 
clearance Kblood of 76mL/min, extraction ratio E of 25%, and middle molecule 
whole-body clearance MRR of 47%. Fig. IV-20 shows E and MRR as a function 
of clearance Kblood: E and MRR increase monotonically for higher clearances 
according Eq. IV-37 and Eq. IV-39. Strong correlation was found between 
dialyzer clearance K and whole-body clearance MRR (P<0.001, R=0.984). 
IS 1-3 IS 4-5 IP 1-3S 1-3
2
1
2
1
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Because the extraction ratio E is, in contrast with Kblood and MRR, smaller for 
larger blood flows (500mL/min), E was only correlated with Kblood when 
considering a constant blood flow of 300 or 500mL/min (P<0.001, R=0.999 and 
P=0.0016, R=0.998, respectively). 
Table IV-8: Efficiency parameters for the different studied flow configurations. 
 Overall flow Flow in 1 dialyzer     Ultrafiltration 
 QB 
mL/min 
QD 
mL/min 
qB 
mL/min 
qD 
mL/min
Kblood 
mL/min
K0·A  
mL/min
E 
% 
MRR 
% 
QUF 1 
mL/min 
QUF 2 
mL/min 
Single dialyzer         
S1 300 500 300 500 76 94 25 47 1.67 n.a. 
S2 300 800 300 800 107 142 36 57 1.67 n.a. 
S3 500 800 500 800 174 241 34 71 1.67 n.a. 
Dialyzers in series         
IS1 300 500  (I) 300 500 128 193 42 63 1.76 -0.09 
IS2 300 800  (I) 300 800 162 263 54 69 1.92 -0.25 
IS3 500 800  (I) 500 800 182 257 36 72 2.36 -0.69 
IS4 300 800  (X) 300 400 170 286 57 71 1.71 -0.04 
IS5 500 800  (X) 500 400 142 183 28 66 2.15 -0.47 
Dialyzers in parallel         
IP1 300 500  (X) 150 250 119 174 40 61 0.84 0.84 
IP2 300 800  (X) 150 400 145 220 49 66 0.84 0.84 
IP3 500 800  (X) 250 400 167 228 33 70 0.84 0.84 
overall blood flow QB; overall dialysate flow QD; flow is not split (I); flow is split over both 
dialyzers (X); blood flow in one dialyzer qB; dialysate flow in one dialyzer qD; blood-side 
clearance Kblood; overall mass transfer area coefficient K0·A; extraction ratio E; middle molecule 
reduction rate MRR; ultrafiltration rates in each dialyzer QUF1 and QUF2. 
 
Fig. IV-20: Correlations between extraction ratio E (%) and middle molecule reduction rate 
MRR (%), and clearance K (mL/min): E with QB 300mL/min (circles) and 500mL/min 
(rhombs), MRR with QB 300mL/min (crosses) and 500mL/min (triangles). 
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The mass transfer area coefficient K0·A in a single dialyzer increased from 
94mL/min for QB/QD 300/500mL/min up to 142 and 214mL/min when 
increasing QB and QD, respectively (Table IV-8). For each flow setting, except 
for the serial configuration with QB/QD 300/500mL/min, the use of two dialyzers 
did not result in a doubling of mass transfer area coefficient, as would be 
expected theoretically. Although not significant (P=0.083), doubling of 
membrane area resulted in a lower K0·A, most expressed with the parallel setup 
(7-53% decrease), and the 500/800mL/min flow setting (46-62% decrease). 
The benefit of adding a second dialyzer in series or in parallel is shown in Table 
IV-9 by means of percentage increase (%) of the extraction ratio E and the 
reduction rate MRR, compared to the single dialyzer setup. For standard clinical 
overall flow rates (QB/QD=300/500mL/min), the highest efficiency increase was 
obtained for the serially connected dialyzers. It is worth noticing, however, that 
solute removal effectiveness became negligible and even disadvantageous for a 
blood/dialysate flow of 500/800mL/min in a serial and parallel dialyzer 
configuration.  
Table IV-9: Influence of adding an extra dialyzer in series or in parallel for a similar 
overall blood and dialysate flow. 
Overall flow (mL/min) Configuration E increase MRR increase 
QB QD comparison % % 
300 500 S1 → IS1 69 32 
  S1 → IP1 58 28 
300 800 S2 → IS2 50 21 
  S2 → IS4 57 23 
  S2 → IP2 34 15 
500 800 S3 → IS3 4 2 
  S3 → IS5 -19 -8 
  S3 → IP3 -4 -1 
overall blood flow QB; overall dialysate flow QD; (S1)…(S3): see Fig. 
IV-19; extraction ratio E; middle molecule reduction rate MMR 
Increasing dialysate flow from 500mL/min up to 800mL/min favored middle 
molecule reduction rate MRR in the single dialyzer (+21%) as well as in the 
serial (+11/+13%) and parallel (+9%) configurations (Table IV-10). In series 
placed dialyzers rendered a better performance if dialysate flow was split over 
both dialyzers (+13% with IS4), compared to the use of a linked dialysate flow 
(+11% with IS2). Increasing blood flow from 300mL/min to 500mL/min 
deteriorated the extraction ratio E in a single (-4%), serial (-33/-51%), and 
parallel (-31%) dialyzer configuration (Table IV-11). The middle molecule 
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reduction rate MRR, however, was significantly increased in a single dialyzer 
(+24%), while it was slightly increased in a serial configuration with no split 
dialysate lines (+4%) and in a parallel configuration (+6%) (Table IV-11). 
Table IV-10: Influence of augmenting the overall dialysate flow from 500mL/min up to 
800mL/min, for a constant blood flow of 300mL/min. 
Configuration E increase MRR increase 
comparison % % 
S1 → S2 44 21 
IS1 → IS2 27 11 
IS1 → IS4 34 13 
IP1 → IP2 22 9 
 (S1)…(IP1): see Fig. IV-19; SR: extraction ratio 
E; middle molecule reduction rate MRR. 
The ultrafiltration rates corresponding to each dialyzer in a serial and parallel 
setup are shown in Table IV-8. For the investigated parallel configurations, 
ultrafiltration was equally divided over both dialyzers, independently of blood 
and dialysate flow, and no backfiltration occurred. Dialyzers placed in series, on 
the contrary, were characterized by a resulting forward filtration in the first and 
backfiltration in the second dialyzer (for numbering see Fig. IV-19). Moreover, 
efficiency parameters increased as the difference in amount of ultrafiltration per 
dialyzer increased, except when higher blood flows (500mL/min) and/or a split 
dialysate flow was applied. 
Table IV-11: Influence of augmenting the overall blood flow from 300mL/min up to 
500mL/min, for a constant dialysate flow of 800mL/min. 
Configuration E increase MRR increase 
comparison % % 
S2 → S3 -4 24 
IS2 → IS3 -33 4 
IS4 → IS5 -51 -7 
IP2 → IP3 -31 6 
(S2)…(IP2): see Fig. IV-19; extraction ratio E; 
middle molecule reduction rate MRR. A negative 
increase corresponds to a decrease. 
4.2.5. Discussion 
The present study aimed to study the combined influence of flow and area 
parameters on dialyzer and whole-body clearance of middle molecules in a low 
flux dialyzer. For this purpose, in vitro experiments were performed using 
radioactive labeled vitamin B12 as a surrogate middle molecule marker 
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(MW1355). The latter was dissolved in dialysis fluid in order to impede any 
other net solute transport between blood and dialysate compartment. To 
investigate in particular diffusive clearance with different dialyzer and flow 
combinations, low flux dialyzers (KUF = 8.5mL/h/mmHg) as well as a limited 
ultrafiltration rate (1.67mL/min) was applied. Whole-body clearance was derived 
from a theoretical description of middle molecule kinetics using a two-pool 
model. 
The most striking results of this study are summarized as follows. First, adding a 
second dialyzer in series or parallel ameliorates overall dialyzer and whole-body 
clearance, except for the highest applied blood flows of 500mL/min (Table 
IV-9). Most advantage of the surface area doubling was obtained with dialyzers 
placed in series (Table IV-8). Second, whole-body clearance is, compared to the 
extraction ratio, less effectuated if an additional dialyzer (Table IV-9) or a higher 
dialysate flow (Table IV-10) is used. And third, while an augmented dialysate 
flow ameliorates whole-body clearance as well as extraction ratio (Table IV-10), 
the latter is even negatively influenced when using an increased blood flow of 
500mL/min (Table IV-11). 
4.2.5.1. Influence of increased surface area 
Doubling the surface area, using two identical dialyzers in parallel, was found to 
ameliorate vitamin B12 (MW1355) MRR with 40%, while an increase of MRR 
by 38% was found previously for the surrogate iohexol (MW821) [244]. While the 
urea reduction rate, URR, increases only 3.7% and 5.2% for parallel and serially 
connected dialyzers using a split dialysate line [256], Mandolfo et al. [261] found an 
increase of β-2 microglobulin (MW11800) reduction rate by 39% enlarging the 
surface area with 57%. These results imply that molecules with a higher 
molecular weight gain more advantage of an increased surface area, compared to 
the smaller molecules [254]. Our results are in very good agreement with those 
findings. 
There is a considerable difference in overall mass transfer coefficient, K0, 
between a single (A=1.3m²) and dual (A=2.6m²) dialyzer configuration. This 
phenomenon is more explicit for the parallel dialyzer setup, as the higher blood 
and dialysate flows in the serial setup ameliorate mass transfer. The 
discrepancies with respect to K0 are even more important using blood flows of 
500mL/min (46/62% decrease in the serial and 53% decrease in the parallel 
setup). As a linked counter current dialysate flow is used for serially connected 
dialyzers, spent dialysate enters the first dialyzer and diminishes the 
transmembrane concentration gradient, and with it, the diffusive transport in the 
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first dialyzer (IS3, IS5). Furthermore, in the parallel dialyzer configuration (IP3), 
using fresh dialysate in each dialyzer, the solute removed from the blood cannot 
be drained efficiently with the lower dialysate flow of 400mL/min. In agreement 
with earlier performed studies [244,253], improvement in effective performance due 
to surface area increase is lower than theoretically assumed. 
4.2.5.2. Influence of dialysate flow 
Increasing overall dialysate flow from 500 to 800mL/min resulted in an 
improved middle molecule reduction rate in all configurations. It is known from 
previous studies that the clearance of small solutes largely depends on dialysate 
flow [128,253], while the clearance of middle molecules, and especially low 
molecular weight proteins, largely depends on convective transport induced by 
high ultrafiltration rates [249]. In general, the clearance responsiveness to dialysate 
flow variations decreases with increasing molecular weight [270], but still seems to 
be important for MW of 1355Da (vitamin B12) as shown in the present study. 
Splitting the dialysate lines in the serial configuration (IS4-5) results in a lower 
dialysate flow in each dialyzer (factor 2). Such a reduced dialysate flow can limit 
mass transport, as equilibration between plasma water and dialysate 
concentrations may occur prior to dialysate drainage from the dialyzer [254]. It can 
be seen however from our results, that the advantage of using fresh dialysate at 
each dialyzer inlet is more important than the impact of a lower dialysate flow 
(IS4 versus IS2), except for the highest applied blood flows (IS5 versus IS3). 
Furthermore, it should be remarked that applying lower dialysate flows, 
deviating from the common clinical practice of 2-2.5 times the blood flow [32], is 
still appropriate when using dialyzers with a higher fiber packing or with fibers 
with a micro wave design [121,261], instead of using the here presented F6HPS 
dialyzer. 
Both findings, improving mass transport by using a higher dialysate flow [253] or 
using a modified dialyzer design [261,271], are dealing with a decrease in dialysate-
side mass transfer resistance. The latter was found to be proportional with 1/QD0.8 
[272] and seems to match for our experimental data. The decrease in resistance, 
and, with it, the increase in overall mass transfer, is due to the presence of 
turbulence in the dialysate pathway [253], the decrease in boundary layer 
resistance, and/or the reduction in flow channeling with improved fiber bundle 
perfusion [117,119,120,128].  
4.2.5.3. Influence of blood flow 
In combination with a dialysate flow of 800mL/min, an increase of blood flow 
from 300 to 500mL/min resulted in a lower extraction ratio in all configurations, 
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while only a remarkable MRR increase was observed when using a single 
dialyzer. With a low flux polysulfone dialyzer (F6HPS), the lower membrane 
permeability limits mass transport of larger solutes. Under these circumstances, 
increasing overall blood flow has a reduced effect on solute clearance. This 
limitation of dialyzer efficiency is even more pronounced when using a dialysate 
flow equal to blood flow (IS5). While we found a decreased extraction rate in a 
single dialyzer of 4% with QB/QD 500/800mL/min (compared to 
300/800mL/min), others have shown that vitamin B12 extraction rate decreased 
by 71% using the mid flux Filtral AN69 dialyzer with QB/QD 500/500mL/min 
(compared to 100/500mL/min) [222,226]. 
Next to the membrane limiting aspect, which is important in our case of 
predominantly diffusive transport, the use of increased blood flows is more 
advantageous in case convection comes into play. An increased blood flow exerts 
higher shear rates at the wall, such that the polarization layer thickness is 
diminished. Moreover, the rate of ultrafiltration as well as the sieving coefficient 
is, on its turn, considerably influenced by the thickness of this layer [273]. Due to 
the interaction between diffusion and convection, total clearance is significantly 
less than the sum of diffusive and convective clearances. This is due to the fact 
that convective mass transport, proportional to local solute concentrations, is 
reduced by diffusion. Moreover, the decrease in local blood flow, induced by 
ultrafiltration, causes the blood-side resistance gradually to increase, and, with it, 
the diffusive clearance to decrease. This problem is even more complicated for 
solutes with a molecular weight exceeding 2000Da [226], as these are partially 
rejected by the dialysis membrane. 
4.2.5.4. Ultrafiltration profiles 
Although the overall applied ultrafiltration was limited, the pressure drop profiles 
in blood and dialysate may induce an important amount of forward filtration, 
cancelled by a corresponding rate of backfiltration. This Starling cycle effect of 
ultrafiltration-backfiltration, also referred to as internal filtration, was earlier 
found to increase the clearance by 2mL/min in the absence of overall 
ultrafiltration [246]. Moreover, for a fixed TMP, an increased internal filtration, by 
using fibers with smaller inner diameter [274] or by using longer fibers [131], 
increases the convective contribution to overall mass transport. The latter 
phenomenon can explain why the serial setup (doubling of length) is more 
advantageous with respect to dialyzer and whole-body clearances, compared to 
the parallel setup. 
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4.2.5.5. Model limitations 
Finally, it should be noted that care must be taken when using calculated vitamin 
B12 clearances to assess whole-body middle molecule removal, as in vitro 
measured clearances may differ from clinical results. This is due to in vivo 
membrane fouling by protein deposition [56,142], protein binding of the solute [275], 
and non-equilibrated solute distribution between blood cells and plasma. 
Furthermore, it is unclear to what extent the kinetics and dialyzer clearance of 
vitamin B12 are similar to those of other middle molecules. Because vitamin B12 
is not useful as an in vivo surrogate due to extensive protein binding [276], its 
kinetic behavior within the patient was derived theoretically using in vitro and 
literature data. Although most of our findings were reported earlier in numerous 
studies, our study is unique in coupling the different influencing parameters. 
4.2.6. Conclusion 
The present study investigated dialyzer and whole-body clearances of middle 
molecules in low flux dialyzers. The benefits of using an increased membrane 
surface area and/or increased blood and dialysate flow were investigated using a 
radioactive tracer. The best configuration consisted of serially connected 
dialyzers, as this gains most advantage of doubling the membrane surface area. A 
better extraction ratio is also obtained with higher dialysate flows. The use of 
higher blood flows, however, seemed only advantageous when using a single 
dialyzer, as other aspects like blood-dialysate flow ratio, internal filtration, and 
blood-dialysate concentration profiles, come into play when using serially or 
parallel connected dialyzers. For small ultrafiltration rates using low flux 
dialyzers, enhancing the rate of internal filtration by elongating the fibers using 
two dialyzers in series, ameliorates the convective transport of middle molecules. 
In conclusion, adequate solute removal results from a number of parameters, 
which continuously interact with each other. 
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5. Numerical analysis of mass transport† 
5.1. Influence of dialyzer geometry on mass transport 
5.1.1. Abstract 
While dialyzer manufacturers only provide information about mass removal 
under well-defined flow and solute conditions in commercially available 
dialyzers, this study aimed at evaluating dialyzer performance numerically for 
different dialyzer geometries. 
A three-dimensional finite volume model of a single fiber in a high flux 
polysulphone dialyzer (Fresenius F60) was developed. Different equations 
describe blood and dialysate flow (Navier-Stokes), radial filtration flow (Darcy), 
and solute transport (convection-diffusion). Fluid and membrane properties were 
derived from in vitro and in vivo tests as well as from literature data. Urea 
(MW60) was used as marker to simulate small molecule removal, while middle 
molecule transport was modeled using vitamin B12 (MW1355) and inulin 
(MW5200). Fiber diameter and length were changed in a wide range for 
evaluation of solute removal efficiency. The latter was found enhanced for larger 
fiber lengths and/or smaller diameters. Furthermore, the impact of fiber 
dimensions was more pronounced for the middle molecules compared to urea. 
5.1.2. Background 
During the progression of renal failure, a host of solutes, normally cleared by the 
healthy kidneys, is retained in the body of the uremic patient. This retention gives 
rise to a progressive deterioration of physiologic functions and of the clinical 
condition [277]. Hemodialysis is one of the possible treatments to remove those 
solutes from the blood when the human kidneys have lost their native function. 
During this therapy, blood is pumped out of the body into an extracorporeal 
circuit that contains a hollow fiber dialyzer. The latter is built of thousands of 
small fibers with a diameter of approximately 200µm and a total area of 0.8-
2.5m². Blood and dialysate are circulated counter currently at the interior and 
exterior of the fibers, respectively. Those fibers are constructed from a semi-
permeable membrane, which permits the diffusive and/or convective passage of 
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uremic solutes but restricts the transfer of blood proteins and cells from the blood 
towards the dialysate compartment. 
Recently, the European Uremic Toxin Work Group (EUTox) published a 
comprehensive list of all uremic solutes known to date [229]. Based on their 
physicochemical characteristics, one can distinguish between three major groups 
of uremic retention solutes: small water-soluble compounds (MW<500), the 
protein-bound solutes (MW also mostly <500), and the so-called middle 
molecules (MW>500). Of the 90 compounds identified, 68 belong to the low 
molecular weight range, whereby 23 of these are protein-bound. Of the 
remaining 22 middle molecules, 12 even exceeded MW15000. 
While the small molecules are dominantly removed by diffusion, larger 
molecules are better removed by convection. Although diffusion is the major 
transport process in hemodialysis, a transmembrane pressure is applied in order 
to restore the fluid balance in the patient by ultrafiltration. Furthermore, both 
transport processes interfere continuously with each other, such that it is 
impossible to specify theoretically the exact contribution of diffusion and 
convection to the overall dialyzer clearance. 
Since the validated basic work of Villarroel et al. [278], describing diffusive and 
convective solute transport in hemodialyzers, numerous other studies were done 
to optimize the theoretical description [222,223,226,264,279-281]. While some of them 
did not count for the flow variation along the dialyzer length [264,279-281], others 
[222,223] assumed a linear ultrafiltration profile, but neglected the non-Newtonian 
blood characteristics. 
The present study aimed at investigating solute transport accounting for the local 
flow and fluid properties, using a three-dimensional numerical model. After 
calibration and validation of the model, the impact of dialyzer dimensions on 
dialyzer clearance was studied. Small (i.e. urea MW60) as well as middle 
molecules (i.e. vitamin B12 MW1355 and inulin MW5200) were used as markers 
for dialyzer performance.  
5.1.3. Materials and Methods 
5.1.3.1. Geometry and domain characterization 
A three-dimensional numerical model was developed of the blood-membrane 
interface in a single fiber over the entire dialyzer length. The parameter settings 
were assessed for a high flux polysulphone Fresenius F60 dialyzer (Fresenius 
Medical Care, Bad Homburg, Germany), consisting of 9200 fibers. Each fiber is 
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characterized by an inner diameter of 200µm, membrane thickness of 40µm, and 
active length of 230mm.   
Abstraction was made of the fiber packing (733 fibers/cm²) in the dialyzer to 
isolate a twelfth part of a single fiber with its surrounding membrane and 
dialysate compartment (Fig. IV-21). For the implementation in the numerical 
model, properties of the three domains, i.e. blood, dialysate, and the semi-
permeable membrane, were derived from literature and experimental 
investigations [141].  
 
 
Fig. IV-21: Schematic illustration of a hollow fiber dialyzer on macroscopic (dialyzer) and 
microscopic (fiber) level. Blood and dialysate inlet (subscript i) and outlet (subscript o) flows 
and concentrations are indicated as QBi, QBo, QDi, QDo, CBi, CBo, CDi, and CDo. 
Membrane permeability characteristics were obtained from filtration tests 
through the membrane [142]. The tests were performed for forward and 
backfiltration using sterile dialyzers as well as samples in which a protein layer 
was induced on the membrane simulating a clinical session. The permeabilities 
of the skin (inner layer) and bulk (outer layer) of the polysulphone membrane 
were implemented as a series of two resistances. Furthermore, the influence of a 
protein layer on the overall permeability of the membrane was incorporated as a 
higher resistive inner layer, based on an overall membrane permeability of 
3650nm²/s/Pa. 
From dialysate samples taken in vivo from the supply and the drain of the 
dialyzer, dynamic viscosity and density were determined. As both properties 
were not influenced by dialysis, dialysate flow was assumed as an 
incompressible, isothermal, laminar Newtonian flow with a constant viscosity 
(0.687mPa·s) and density (1008kg/m³). 
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An extensive literature study preceded an accurate modeling of the non-
Newtonian blood flow, characterized by a viscosity varying in radial and axial 
direction. The shear thinning behavior as well as the dependence of the blood 
viscosity on the local hematocrit was described by the Quemada model [63]. 
Furthermore, the redistribution of the red blood cells in capillary blood flow 
results in a plasma skimming layer near the wall, and was described by Fahraeus 
and Lindqvist [65,147]. The radial variation of the hematocrit was deduced by 
Lerche et al. [66]. Blood density was defined as a function of plasma density 
(1030kg/m³) and varied with the local hematocrit. An inlet hematocrit of 30% 
was considered. 
5.1.3.2. Governing equations 
The calculation of dialyzer transport consists of two phases (Fluent, Sheffield, 
UK). With the fluid dynamic computation, velocities and pressures were 
obtained in the entire domain, while mass transfer calculation rendered the solute 
concentration distribution. With respect to the three domains, different equations 
were used. 
In the blood and dialysate domain, conservation of mass and momentum were 
described by the Navier-Stokes equations: 
 
0uµ-puuρ
0u
=∆⋅∇+∇•⋅
=•∇
 Eq. IV-40 
With u the local mass average fluid velocity vector (m/s), ρ the local density 
(kg/m³), p the local pressure (Pa), ∇  is the gradient operator in three-dimensional 
Cartesian coordinates 
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The transmembrane transport, function of the membrane permeability k 
(m²/s/Pa), was described by the Darcy equation for porous media: 
 pku ∇⋅=  Eq. IV-41 
This equation is only valid when the local Reynolds number is small enough 
(Re<1), which is the case for small ultrafiltration rates. 
Knowing the velocities in all nodes of the finite volumes, the mass transfer can 
be calculated with the stationary convection-diffusion equation in the absence of 
a source or sink reaction: 
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 ( ) ( ) 0CDCuS S =∇⋅∇−∇•⋅  Eq. IV-42 
DS represents the solute diffusion coefficient (m²/s) and C the solute 
concentration (mol/m³). Although this equation is valid for all domains, note that 
the diffusion coefficient DS is different for the three domains. Furthermore, while 
the sieving coefficient S (-) can be eliminated in the blood and dialysate domain, 
S can deviate from unity in the membrane domain [101,236,237]. A sieving 
coefficient equal to unity corresponds to unhindered solute transport through the 
membrane (e.g. small molecules like urea), while S equal to zero implies that the 
membrane is impermeable to the considered solute (e.g. large proteins like 
albumin). 
5.1.3.3. Boundary conditions 
In the blood and dialysate inlet, a Poiseuille respectively uniform velocity profile 
was defined (Dirichlet boundary condition). Furthermore, a constant solute 
concentration was described at the blood inlet, while the inlet dialysate 
concentration was assumed zero. The outlet flow conditions were specified as a 
flow percentage distribution in both domains to apply the desired ultrafiltration 
flow. A Neumann boundary condition was defined for the concentrations at the 
outlets, stating that the concentration gradient is zero in flow direction: 0
n
C =∂
∂
  
Oncotic pressure, which is exerted by the plasma proteins and opposes the 
hydrostatic transmembrane pressure, was implemented as a discontinuous 
pressure drop at the skin-bulk interface. Moreover, as hemoconcentration takes 
place in axial direction, the oncotic pressure was varying with hematocrit. At the 
blood inlet, an oncotic pressure of 25mmHg was considered [30,101]. 
The domain boundaries were modeled either as symmetry or as wall where no-
slip occurs. At symmetry planes, Neumann conditions were applied to eliminate 
velocity components and concentration differences perpendicular to the 
symmetry plane. At fixed walls, no-slip conditions were applied, resulting in a 
Dirichlet boundary condition for the velocity ( u =0). 
5.1.3.4. Calibration and validation of the diffusivities 
While the solute diffusion coefficients in blood and dialysate were known from 
literature [282], membrane diffusivity was derived from the inlet and outlet blood 
(CBi and CBo) and dialysate (CDi and CDo) concentrations. Blood concentrations 
(mol/L) were assessed from the definition of the diffusive dialyzer clearance K 
(mL/min) for a given blood flow QB (mL/min): 
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K ⋅−=  Eq. IV-43 
The manufacturer typically reports K values for given blood/dialysate flow 
combinations (e.g. 300/500mL/min) [238,283]. Dialysate concentrations (mol/L) 
were calculated from the mass balance of the dialyzer, which is a function of 
blood and dialysate flows QB and QD (mL/min) [85] (Fig. IV-21): 
 ( ) ( ) DDiDoBBoBi QCCQCC ⋅−=⋅−  Eq. IV-44 
Although the concentration difference between blood and dialysate, ∆C, will 
decrease exponentially along the dialyzer length, a linear approximation is 
allowed for low and middle molecules [226]: 
 ( )
L
∆C∆C
dz
∆Cd oi −=  Eq. IV-45 
With ∆Ci and ∆Co the blood-dialysate concentration difference at the blood inlet 
and outlet, respectively.   
By multiplying both terms with the mass flux J (mol/s), as defined by Fick’s law:  
 ∆CAKJ 0 ⋅⋅=  Eq. IV-46 
And after integration of Eq. IV-45 and solving it for the mass flux J, clearance K 
can then be written as a function of the mass transfer coefficient K0 (m/s), the 
reciprocal of total resistance R0, and the logarithmic mean concentration 
difference ∆Clm [85]: 
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Furthermore, as the mass transfer coefficient K0 for radial diffusive mass transfer 
(x-direction) is equal to DS/∆x, membrane diffusivity DM (m²/s) can be derived 
from total resistance R0 and the convective mass transfer coefficients 1/RB and 
1/RD (m/s): 
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RRRR ++=++=  Eq. IV-48 
RB, RM, and RD represent the blood-side, membrane and dialysate-side resistance, 
respectively. ∆xB and ∆xD symbolize a characteristic distance for diffusion in the 
blood and dialysate domain, while ∆xM is the membrane thickness. As ∆xB and 
∆xD were not a priori known, the diffusion coefficient in the membrane for a 
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particular solute was derived iteratively until the clearance as found with the 
simulations matches the manufacturer’s data for a QB/QD ratio equal to 
250/500mL/min. The power of the numerical model was checked performing 
simulations for a QB and QD equal to 300 and 500mL/min, and comparing the 
numerically derived clearance value with the manufacturer’s data [238,283]. 
5.1.3.5. Parameter study 
The influence on dialyzer performance of different dialyzer dimensions was 
investigated for solutes of distinct molecular weight. All simulations were 
performed with an overall blood and dialysate flow of 250 and 500mL/min, 
while an ultrafiltration rate of 2L/h was maintained. 
The choice of the uremic solutes was mainly driven by the available clearance 
data from the manufacturer. Urea (MW60) was used as marker for small water-
soluble solutes, while vitamin B12 (MW1355) and inulin (MW5200) were used 
as middle molecule markers. The main input parameters for those solutes are 
given in Table IV-12. 
Table IV-12: Mass transport parameters for urea, vitamin B12, and inulin in a high flux 
polysulphone F60 dialyzer with QB/QD equal to 250/500mL/min. 
Solute MW 
Da 
K 
mL/min 
S 
- 
DB 
m²/s 
DD 
m²/s 
DM 
m²/s 
Urea 60 213 1 17.5·E-10 19.0·E-10 3.9·E-10 
Vitamin B12 1355 126 1 4.0·E-10 4.2·E-10 1.5·E-10 
Inulin 5200 61 1 1.65·E-10 1.74·E-10 0.54·E-10 
molecular weight MW; diffusive clearance K; sieving coefficient S; diffusion coefficient in 
blood, dialysate, and membrane DB, DD, and DM, respectively. 
The effect on solute clearance of the fiber and dialyzer dimensions was 
investigated for different radial and axial sizes. Fiber inner diameters of 150-200-
250µm were studied, with corresponding size scaling in the membrane and 
dialysate domain to maintain the relative fiber packing. The membrane 
characteristics, permeability and diffusivity, were however adapted to maintain 
the original properties. Keeping the total membrane area constant, the number of 
fibers was changed. The mean velocity in both compartments was calculated 
accounting for the radial dimensions, the total number of fibers, and the constant 
overall blood and dialysate flow of 250 and 500mL/min. 
Active fiber lengths of 180-230-280mm were examined, as well as a dialyzer 
fiber one and a half times as long (345mm) and two times as long (460mm) as 
the standard fiber of 230mm in length with an inner diameter of 200µm.  
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In order to perform a transparent evaluation of the influence of the different 
investigated parameters, the extraction ratio E (-), defined as clearance K 
normalized by blood flow QB, was calculated with each simulation [108]: 
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5.1.3.6. Statistical analysis 
Correlations between parameters were investigated by performing linear 
regression analysis (Pearson). A general linear model (GLM) multivariate 
procedure was used to investigate differences in curve slopes. The GLM 
multivariate procedure provides regression analysis and analysis of variance for 
multiple dependent variables by one or more factor variables. The limit of 
significant difference was set to P<0.05.  
5.1.4. Results 
5.1.4.1. Calibration and validation of the diffusivities 
The membrane diffusion coefficients, obtained by calibrating the numerical 
model with QB and QD equal to 250 and 500mL/min, are given in Table IV-12, 
together with the blood and dialysate diffusivities. Membrane diffusivities were 
adapted iteratively until the dialyzer clearance, calculated from the blood-side 
inlet and outlet concentrations, matched the data given by the manufacturer. 
Membrane diffusivities were found a factor 2.7-4.9 smaller than blood and 
dialysate diffusivities. Furthermore, urea diffusion in blood and dialysate is a 
factor 4 and 11 higher compared to vitamin B12 and inulin diffusion, 
respectively, while the diffusion of urea through the membrane is a factor 3-7 
higher compared to the diffusion of the studied middle molecules. 
Simulating mass transport for a QB and QD of 300 and 500mL/min, respectively, 
no significant differences were found between the clearance values as derived 
from the simulations and those reported by Fresenius Medical Care (Table 
IV-13). For a blood flow increased from 250 up to 300mL/min, urea clearance 
and extraction ratio were enhanced by 14%, resulting in an extraction ratio of 
0.96 (compared to 0.85). The middle molecule clearances of vitamin B12 and 
inulin were increased by 6 and 20%, corresponding with extraction ratios of 0.54 
and 0.29, respectively (compared to 0.51 and 0.24). 
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Table IV-13: Mass transport parameters for urea, vitamin B12, and inulin in a 
polysulphone F60 dialyzer with QB and QD equal to 250 or 300, and 500mL/min. 
  QB=250mL/min QB=300mL/min  
Solute MW 
Da 
K 
mL/min 
KFresenius 
mL/min 
Ksimulation 
mL/min 
Deviation 
% 
Urea 60 213 242 241 0.4 
Vitamin B12 1355 126 134 134 0 
Inulin 5200 61 73 73 0 
molecular weight MW; diffusive clearance K; Deviation between simulated 
and published data. 
5.1.4.2. Influence of molecular weight 
Fig. IV-22 shows the concentration profiles in the xz-plane (indicated on Fig. 
IV-21) for urea, vitamin B12, and inulin in a standard F60 dialyzer with overall 
blood and dialysate flows of 250 and 500mL/min, respectively. The radial 
concentration variation, most pronounced for inulin, illustrates the lower 
diffusivities in blood and dialysate compared to urea. Comparing outlet with inlet 
solute concentrations, an extraction ratio of 0.85, 0.51 and 0.24 were found for 
urea, vitamin B12, and inulin. 
 
Fig. IV-22: Concentration profiles in the xz-plane of the dialzyer fiber (diameter 200µm and 
length 230mm) for urea (top panel), vitamin B12 (middle panel), and inulin (bottom panel). The 
relative blood start concentration was 100, while blood and dialysate flows were 250 and 
500mL/min. 
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5.1.4.3. Influence of fiber diameter on solute transport 
The impact of radial dialyzer dimensions on solute clearance is shown in Fig. 
IV-23 and Table IV-14 for the solutes under study. For an overall blood and 
dialysate flow of 250 and 500mL/min, total fiber number was adapted in order to 
maintain total membrane area of 1.33m² (Table IV-14). Solute clearances K were 
found to vary parabolically with fiber inner diameter, most pronounced for larger 
molecular weight solutes (Fig. IV-23). Decreasing the fiber inner diameter from 
200 to 150µm ameliorates the extraction ratio with 5.5 and 21% for vitamin B12 
and inulin, respectively. No significant gain was however observed for urea. 
Table IV-14: Extraction ratio E (-) and percentage increase in solute removal for 
different fiber diameters, compared to the results for the standard dialyzer with 200µm 
fiber diameter. 
Fiber diameter 150µm 200µm 250µm 
 E % E E % 
Urea 0.85 0 0.85 0.84 -0.9 
Vit B12 0.54 5.5 0.51 0.50 -2.3 
Inulin 0.30 21 0.24 0.25 1.6 
# fibers  12271 9200 7360 
 
 
Fig. IV-23: Influence of fiber diameter on the solute clearance of urea (squares), vitamin B12 
(triangles) and inulin (rhombs). 
5.1.4.4. Influence on fiber length on solute transport 
The effect on solute removal of variations in dialyzer length is illustrated in Fig. 
IV-24 and Table IV-15.  A linear regression could be drawn for urea (R=0.928), 
vitamin B12 (R=0.995), and inulin (R=0.997). Furthermore, multiple linear 
regression showed that the slopes of the relations were not significantly different 
for the different solutes, except between vitamin B12 and inulin (P=0.022). 
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Fig. IV-24: Influence of fiber length on the solute clearance of urea (squares), vitamin B12 
(triangles) and inulin (rhombs). 
Enlarging the active dialyzer length by 50mm has not much influence on urea 
removal (E increased by only 0.9%), while a significant increase in extraction 
ratio was observed for vitamin B12 (14%) and inulin (25%). On the other hand, 
shortening the dialyzer by 50mm has similar influence on small and middle 
molecules (-14/-12%). Doubling the active fiber length enhances the extraction 
ratio by 13% (urea), 50% (vitamin B12), and even 89% (inulin). 
Table IV-15: Extraction ratio E (-) and percentage increase in solute removal for 
different fiber lengths, compared to the results for the standard dialyzer with 230mm 
active fiber length. 
Length 180mm 230mm 280mm 345mm 460mm 
 E % E E % E % E % 
Urea 0.74 -14 0.85 0.86 0.9 0.91 7.0 0.96 13 
Vit B12 0.45 -12 0.51 0.58 14 0.66 30 0.76 50 
Inulin 0.21 -13 0.24 0.30 25 0.37 51 0.46 89 
Area (m²) 1.04 1.33 1.62 2.00 2.66 
5.1.5. Discussion 
The aim of the present study was to investigate the impact of fiber and dialyzer 
dimensions on the removal of solutes of different molecular weight. Therefore, a 
three-dimensional microscopic model of the blood-membrane interface was 
developed and mass transfer parameters were calibrated using dialyzer clearance 
data published by the manufacturer. The extraction ratio for one small molecule 
(urea MW60) and two middle molecules (vitamin B12 MW1355 and inulin 
MW5200) were investigated in a high flux polysulphone dialyzer. Fiber diameter 
and length were varied in a wide range. 
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The major conclusions of this study are: first, membrane diffusivities were found 
up to five times smaller compared to blood and dialysate diffusivities; second, 
the extraction ratio was increased for smaller fiber diameters, most pronounced 
for the middle molecules; and third, solute removal varied linearly with 
increasing fiber lengths (and membrane area) up to twice the original length. 
With respect to the last conclusion, it could be suggested to use two dialyzers in 
series to obtain better dialyzer performance as an alternative of doubling the fiber 
length. Previous performed in vitro studies, investigating solute transport in 
different dialyzer flow configurations using low flux Fresenius F6HPS dialyzers, 
reported an increase of the extraction ratio by 8% and 68% for small (MW20-
180) and middle (MW1355) molecules, respectively [239,241]. The present study 
found increases in E by 13 and 50%, respectively. The extra pressure loss in 
between two dialyzers placed in series, compared to simply elongated fibers, 
might ameliorate the internal filtration and, with it, the convective contribution to 
overall transport. Because this phenomenon only becomes important for 
increasing molecular weights, it might explain why better removal was found for 
vitamin B12 (MW1355) in the in vitro experiments, compared to the numerical 
simulations. 
Because of the importance regarding the uremic syndrome, several theoretical 
studies have been performed previously describing transport phenomena in 
hemodialyzers. Although those studies were accounting for the module 
geometry, the membrane properties, and the operating conditions [264,279-281], most 
of them did not consider the real ultrafiltration profile along the dialyzer length. 
Because the assumption of a zero or constant ultrafiltration velocity was not 
realistic, Ross [223] analyzed the mass transport through a permeable tubular 
membrane using an ultrafiltration velocity depending on hydrostatic and oncotic 
pressure differences. Legallais et al. [222] incorporated a varying ultrafiltration, by 
assuming the pressure in both compartments to drop following the Haegen-
Poiseuille equation. Both groups did however not consider the non-Newtonian 
fluid behavior of blood. 
The present numerical model, however, solves the convection-diffusion equation 
based on the local flow results as found with Navier-Stokes. Furthermore, local 
flows and pressures were calculated taking into account hemoconcentration due 
to ultrafiltration by the implementation of a viscosity model for blood. 
It should be remarked however that only small and middle molecules, with a 
sieving coefficient equal to unity, are modeled adequately with the present 
model. To simulate middle molecule removal in low flux dialyzers or large 
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molecule removal in high flux dialyzers, some additional aspects should be 
implemented. Because relative larger molecules are mainly transported by 
convection, the influence of the sieving coefficient must be considered [222,223,284]. 
Furthermore, the accumulation of larger molecules near the membrane causes 
concentration polarization to develop [222,284].  
Finally, as diffusive and convective solute transport are influenced by blood and 
dialysate flows, the overall dialyzer performance might be different from 
calculated, if for instance dialysate flow channeling occurs [112,118,285]. This 
phenomenon might be even more pronounced when elongating the fibers.  
The present model however offers a useful tool to count for those 
maldistributions by implementing the local flow rates in the fiber model. 
Integration over the entire dialyzer renders the overall solute removal. 
5.1.6. Conclusion 
While the manufacturer only provides dialyzer clearance information for the 
commercially available dialyzers, the aim of the present study was to investigate 
the impact of geometry adaptations on solute removal of small and middle 
molecules. The developed three-dimensional finite volume model incorporates 
blood, dialysate, and membrane flow in hollow fiber dialyzers allowing an 
accurate investigation of solute transport. While theoretical models on dialyzer 
mass transport often make abstraction of the ultrafiltration flow that is varying 
over the dialyzer length, the present numerical model combines flow and mass 
transport at once. With the simulations for different dialyzer geometries, it was 
found that mass transfer is enhanced for longer or wider fibers. The model will 
be extended in the future for mass transport in the case convection becomes the 
dominant transport phenomena. 
5.2. Influence of flow distribution on mass transport 
5.2.1. Objective and methods 
The present study was set out to evaluate numerically the impact of flow 
maldistributions on solute transfer efficiency. Therefore, the results as obtained 
from the SPECT measurements with the F6HPS dialyzer (Chapter II) were used 
in the previous described numerical model for the F60 dialyzer (paragraph 5.1.3). 
The F6HPS and the F60 dialyzer only differ with respect to their membrane 
permeability, while flow maldistributions in a dialyzer are mainly affected by the 
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fiber shape (i.e. ondulations), fiber dimensions, and fiber packing density. As a 
consequence, it can be assumed that similar non-homogeneous dialysate flow 
distributions will also be observed in the F60.  
Mass transfer calculation was performed for urea and vitamin B12 in the case of 
maximum and minimum dialysate flow velocity, as found in the yz-plane 
(Chapter II). Instead of using the mean dialysate velocity of 12.1mm/s, a mean 
velocity of 20.5mm/s and 4.3mm/s was applied to simulate both extreme 
situations. Meanwhile, blood flow was considered homogeneously distributed, 
and a Poiseuille velocity profile with mean velocity of 17.3mm/s was used at the 
blood inlet, corresponding to a uniform overall blood flow of 300mL/min. 
Overall ultrafiltration was set to 2L/h, but was found not to influence the 
diffusive clearances of urea and vitamin B12. 
For both simulations of mass transfer in a single fiber, the extraction ratio e (-) in 
the single fiber was calculated and compared to the value obtained for a 
homogeneously assumed flow distribution. Furthermore, the extraction ratio for 
intermediate dialysate flows was derived by linear interpolation, such that an 
overall planar extraction ratio was obtained by integration over the yz-plane. 
5.2.2. Results and discussion 
The results for the extraction ratio e (-) in a single fiber of a high flux F60 
dialyzer are given in Table IV-16 for the extreme considered flow conditions. 
While the observed maximum dialysate velocity resulted in an extraction ratio 
increase of 1.3 and 12% for urea and vitamin B12, the minimum dialysate 
velocity deteriorated solute removal by 12 and 28%, respectively.   
Table IV-16: Extraction ratio in a single fiber e (-) and percentage increase with non-
homogeneous flow distributions compared to the results for a uniform dialysate flow. 
 Homogeneous Non-homogeneous flow 
Solute e  
(-) 
Dialysate velocity  
(mm/s) 
e  
(-) 
Increase 
% 
Urea 0.80 Max: 20.5 0.81 1.3 
 0.80 Min: 4.3 0.70 -12 
Vitamin B12 0.45 Max: 20.5 0.50 12 
 0.45 Min: 4.3 0.32 -28 
 
Fig. IV-25 illustrates the vitamin B12 concentration profile in one fiber 
considering maximum (top panel) and minimum (bottom panel) velocity. It is 
obvious from the figure that solute removal is hampered for lower flow rates, as 
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the solutes diffused through the membrane are not adequately drained by the 
dialysate flow.  
 
Fig. IV-25: Concentration profiles in the xz-plane of the dialzyer fiber (diameter 200µm and 
length 230mm) for vitamin B12 with dialysate inlet velocity equal to 20.5mm/s (top panel) and 
4.3mm/s (bottom panel). 
By calculating the extraction ratio for intermediate blood-dialysate flow 
combinations, the extraction profile over the entire cross section (the dialyzer yz-
plane in Chapter II) was derived for urea and vitamin B12 (Fig. IV-26). By 
integration over the considered plane, an overall planar extraction ratio of 0.77 
and 0.43 was obtained for urea and vitamin B12. This corresponds to an overall 
decrease in solute removal efficiency by 3.8 and 4.4%, respectively.  
Comparing the numerical findings with the previous described theoretical results 
(paragraph 3.2.2.3) shows that the numerically derived extraction ratio is less 
influenced for the lowest dialysate flows. The overall extraction ratios are 
however in better agreement. 
With the theoretical derivation, it was found that the extraction ratio was 
decreased by 5.2% (urea) and 3.2% (vitamin B12) in the F6HPS dialyzer when 
assuming a constant k0·a (Table IV-5). Because much lower decreases (range 1-
1.6%) were found with a variable k0·a value (Table IV-5), our numerical findings 
are an indication that the theoretical results for a constant k0·a value are more 
approaching reality, as stated before. 
Analyses with imaging techniques revealed that flow distribution was more 
homogeneous when using spacing yarns or undulated fibers. In vivo urea 
extraction ratio was found 24% lower in a standard polyacrylonitrile dialyzer 
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compared to a cellulose diacetate dialyzer with undulated fibers [121]. Compared 
to a polyacrylonitrile dialyzer with spacing yarns, extraction ratio was decreased 
by 19%. 
 
Fig. IV-26: Local extraction ratio for urea (crosses) and vitamin B12 (squares) as derived 
numerically for non-homogeneous flow distribution. The results are compared to those for 
uniform flows (dotted line). 
The fact that vitamin B12 clearances were found more affected by dialysate flow 
inhomogeneities in the high flux F60 compared to the low flux F6HPS, might be 
due to positive contribution of ultrafiltration for middle molecules compared to 
urea. 
5.2.3. Conclusion 
With the numerical model, local flow inhomogeneities can be investigated in 
detail. Deviations were found with theory when considering the extreme situation 
of minimum dialysate flow. The influence of flow maldistributions on the overall 
extraction ratio was however in good agreement comparing the results of both 
techniques. 
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1. Chapter overview 
This chapter starts with an introduction on the uremic syndrome and the uremic 
solutes retained in patients with renal failure. The categorization as well as the 
major characteristics of the uremic toxins are presented. Furthermore, the 
shortcomings of in vitro analyses are discussed together with the advantages of 
kinetic modeling. 
A two-pool kinetic model was developed and applied to investigate and 
distinguish between the intra-dialytic behavior of small and water-soluble 
compounds like urea and some guanidino compounds (paragraph 3) and that of 
protein-bound solutes like p-cresol and indoxyl sulphate (paragraph 4). 
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2. Introduction 
2.1. Uremic toxins 
The uremic syndrome results from the retention of solutes that are normally 
cleared by healthy kidneys and secreted into the urine. The gradual retention of a 
large number of organic metabolites of proteins, fatty acids, and carbohydrates 
characterizes the progression of renal failure. In parallel, clinical alterations 
occur, which are related to the cardiovascular, nervous, hematological, 
immunological, endocrine, bone, gastro-intestinal, skin, and pulmonary system 
[3]. Although the link between clinical deterioration and uremia was recognized 
already many decades ago, the responsible factors are still partially unknown. 
Molecular weight is traditionally used as the parameter to classify uremic toxins, 
resulting in three groups of retention solutes: the toxin class of low molecular 
weight (MW<500), middle molecular weight (500<MW<15000), and high 
molecular weight solutes (MW>15000). They can further be subdivided in 
protein-bound and nonprotein-bound solutes. Recently, an encyclopedic list of 
uremic retention solutes was composed by the European Uremic Toxin Work 
Group (EUTox), distinguishing between small molecules (MW<500), small 
protein-bound solutes (MW mostly <500), and middle molecules (MW>500) 
[229]. The main known uremic retention solutes are given in Table V-1 [277]. 
At present, about 90 uremic retention solutes have been identified. Forty-five of 
them are small molecules without known protein binding. Twenty-five 
compounds belong to the group of protein-bound solutes, with a molecular 
weight smaller than 500Da, except two (i.e Leptin and Retinal-binding protein). 
From the 22 recognized middle molecules, 12 have a molecular weight 
exceeding 15000Da [229]. 
Low molecular weight molecules are water-soluble and are relatively easy to 
remove using standard low flux dialysis membranes. Because the removal of 
small protein-bound solutes is hampered due to protein binding, their dialytic 
behavior is comparable to that of larger molecules. The so-called middle 
molecules can only be removed using high flux dialysis membranes with large 
pores, unless they are adsorbed on the membrane. 
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Table V-1: Main known uremic retention solutes 
Small water-soluble solutes Protein-bound solutes Middle molecules 
Asymmetric dimethylarginine 3-Deoxyglucosone Adrenomedullin 
Benzylalcolhol CMPF * Atrial natrioretic peptide 
β-Guanidinopropionic acid Fructoselysine β2-Microglobulin 
β-Lipotropin Glyoxal β-Endorphin 
Creatinine Hippuric acid Cholecystokinin 
Cytidine Homocysteine Clara cell protein 
Guanidine Hydroquinone Complement factor D 
Guanidinoacetic acid Indole-3-acetic acid Cystatin C 
Guanidinosuccinic acid Indoxyl sulfate Degranulation inhibiting protein I
Hypoxanthine Kinurenine Delta-sleep-inducing peptide 
Malondialdehyde Kynurenic acid Endothelin 
Methylguanidine Methylglyoxal Hyaluronic acid 
Myoinositol N-carboxymethyllysine Interleukin 1β 
Orotic acid P-cresol Interleukin 6 
Orotidine Pentosidine Kappa-Ig light chain 
Oxalate Phenol Lambda-Ig light chain 
Pseudouridine P-OH hippuric acid Leptin 
Symmetric dimethylarginine Quinolinic acid Methionine-enkepahlin 
Urea Spermidine Neuropeptide Y 
Uric acid Spermine Parathyroid hormone 
Xanthine  Retinal binding protein 
  Tumor necrosis factor alpha 
* CMPF: carboxy-methyl-propyl-furanpropionic acid 
In spite of this wide variety of uremic retention solutes, urea removal is still used 
as the standard marker for dialysis efficiency, with a target K·t/V of at least 1.2. 
The good correlation between the intra-dialytic kinetic behavior of urea and 
potassium might be the reason for the impact of K·t/V on patient survival, as 
hyperkalemia is an important cause of death among dialysis patients [286,287]. This 
might imply that urea removal remains a valuable parameter with impact on 
patient survival.  
The intra-dialytic kinetic behavior of numerous other toxins is however different 
from that of urea. While it is quite obvious that this is the case for the protein-
bound [286,288] and middle molecules, an intra-dialytic kinetic behavior not 
conform that of urea was also found for a number of small molecules. Examples 
of this are the purines xanthine and hypoxanthine [286,288], and phosphate [289,290].  
Urea, the main marker of dialysis adequacy, was however proven to exert not 
much toxity by itself [291,292], in contrast with other small and water-soluble 
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compounds. The purines have been linked to resistance to vitamin D [293,294], 
while phosphate is related to cardiovascular damage, probably due to the 
deposition of calcium in the vessel wall [295]. Furthermore, several guanidino 
compounds have been related to neurotoxicity [296,297] and inhibition of the 
leukocyte function [298]. One of them, asymmetric dimethylarginine (ADMA) has 
been strongly related to cardiovascular mortality as a possible result of inhibition 
of nitric oxide synthase [299,300].  
2.2. The importance of kinetic modeling 
Up to now, numerous studies have been performed analyzing the behavior of 
uremic solutes, other than urea. They show however some important drawbacks 
[301]. To evaluate the biological impact of certain uremic solutes, artificially 
generated surrogates are studied instead of the genuine compound that is retained 
in uremia [302]. Likewise, concentrations applied in the in vitro studies are often 
diverging from the uremic levels. Furthermore, the role of metabolism in the 
decrease of concentration and the interference of different toxic compounds are 
neglected in in vitro studies. 
Kinetic modeling (explained in detail in Chapter I, paragraph 5.5) is a promising 
tool to counter some of those shortcomings. Using patient blood and/or plasma 
concentration data during and after dialysis, much can be learned about the inter 
and intra-compartmental behavior of the solutes under study. Because 
metabolism and solute interferences influence patient’s blood data, appropriate 
mathematical formulations can be implemented to model those phenomena. 
Recently, kinetic modeling has been used extensively to optimize the description 
of urea kinetics and to derive appropriate dialysis adequacy parameters [303,304]. In 
spite of this, however, besides urea, only a few uremic solutes have been 
kinetically investigated (e.g. creatinine, vitamin B12, β2-microglobulin) 
[267,268,305]. Those solutes were all modeled using a two-pool model, only differing 
in volume partitioning and inter-compartmental clearance [267]. The most striking 
results were found for phosphate, behaving as distributed in three and even in 
four different pools [290].  
The latter is an indication that uremic toxins, even if they are small and water-
soluble, might behave totally different from the marker molecule urea. 
Furthermore, if solutes are characterized by complex kinetics, the number of 
compartments and/or the blood sampling time points must be well chosen in 
order to describe the kinetic model properly, and to obtain reliable results. 
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In what follows, two studies will be reported, considering the kinetics of small 
and water-soluble compounds (i.e. several guanidino compounds) (paragraph 3) 
and those of protein-bound solutes (paragraph 4).  
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3. Intra-dialytic kinetic behavior of small water-
soluble uremic toxins, the case of the 
guanidino compounds† 
3.1. Abstract 
Although patients with renal failure retain a large variety of solutes, urea is 
virtually the only currently applied marker for adequacy of dialysis. Only a 
limited number of other compounds have up till now been investigated regarding 
their intra-dialytic kinetics. Scanty data suggests that large solutes show a kinetic 
behavior that is different from urea. The question investigated in this study is 
whether other small water-soluble solutes such as some guanidino compounds 
show a kinetic behavior comparable or dissimilar to that of urea.  
This study included 7 stable conventional hemodialysis patients without native 
kidney function undergoing low flux polysulphone dialysis (F8 and F10HPS). 
Blood samples were collected from the inlet and outlet blood lines immediately 
before the dialysis session, after 5, 15, 30, 120 minutes, and immediately after 
discontinuation of the session. Plasma concentrations of urea, creatinine (CTN), 
creatine (CT), guanidinosuccinic acid (GSA), guanidinoacetic acid (GAA), 
guanidine (G), and methylguanidine (MG) were used to calculate corresponding 
dialyzer clearances. A two-pool kinetic model was fitted to the measured plasma 
concentration profiles, resulting in the calculation of the perfused volume (V1), 
the total distribution volume (Vtot), and the inter-compartmental clearance (K12); 
solute generation and overall ultrafiltration were determined independently.  
No significant differences were observed between V1 and K12 for urea (6.4±3.3L 
and 822±345mL/min, respectively) and for the guanidino compounds. However, 
with respect to Vtot, GSA was distributed in a smaller volume (30.6±4.2L) 
compared to urea (42.7±6.0L) (P<0.001), while CTN, CT, GAA, G, and MG 
showed significantly higher volumes (54.0±5.9L, 98.0±52.3L, 123.8±66.9L, 
89.7±21.4L, 102.6±33.9L, respectively; P=0.004, =0.033,  =0.003, <0.001, 
=0.001, respectively). These differences resulted in divergent effective solute 
                                                     
† The contents of this section is accepted for publication in Kidney Int 
Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the 
guanidino compounds 
S. Eloot, A. Torremans, R. De Smet, B. Marescau, D. De Wachter, PP. De Deyn, N. Lameire,                     
P. Verdonck, and R. Vanholder 
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removal: 67% (urea), 58% (CTN), 42% (CT), 76% (GSA), 37% (GAA), 43% 
(G), and 42% (MG).  
In conclusion, the kinetics of the guanidino compounds under study are different 
from that of urea; hence, urea kinetics are not representative for the removal of 
other uremic solutes, even if they are small and water-soluble like urea. 
3.2. Introduction 
Urea kinetic modeling has become one of the cornerstones of estimation of 
dialysis adequacy. In uncontrolled studies, urea removal parameters have been 
related to morbidity and mortality of dialysis patients [90]. Two recent controlled 
studies, however, showed that giving more dialysis, defined as a higher clearance 
of smaller solutes like urea, did not improve survival [258,306].  
For that reason, it might be considered that molecules with a kinetic behavior 
different from that of urea play an equal if not more important role in the patho-
physiologic deterioration of patients with renal dysfunction. Differences in 
kinetic behavior can be conceived for some uremic retention solutes that are 
difficult to remove due to their high molecular weight and/or lipophilic 
properties. However, the kinetic behavior of small water-soluble molecules may 
also differ from that of urea, possibly accounting for the failure of urea clearance 
to predict outcome, once a certain threshold has been exceeded. 
The guanidino compounds are a large group of solutes, resulting from protein 
and amino acid metabolism. Among them, only some small and water-soluble 
guanidino compounds were considered in this study: four well known [307-309] 
uremic retention solutes (creatinine, guanidinosuccinic acid, guanidine, and 
methylguanidine) together with guanidinoacetic acid and creatine, which show a 
decreased serum concentration in the patients included in this study and in non-
dialyzed patients with chronic renal insufficiency [309]. Guanidino compounds can 
interfere with neuronal [310], cardiovascular [311], leukocyte [312], platelet [313], and 
erythrocyte function [314]. Of note, several of the guanidino compounds have 
concentrations relative to normal that are proportionately much higher than urea 
[229,308,309]. 
Considering this important contribution of the guanidino compounds to clinical 
disturbances related to the uremic syndrome, the present study has been 
undertaken to quantify their kinetics. Therefore, a two-pool model was applied 
for kinetic calculations based on fitting profiles of plasma concentrations during 
hemodialysis. The kinetic parameters, i.e. perfused volume, total distribution 
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volume, and inter-compartmental clearance, were compared to the values 
obtained for urea. 
3.3. Patients and methods 
3.3.1. Patients and dialysis strategies 
The study was performed in seven stable dialysis patients (three women and four 
men) without residual renal function. The study was approved by the local ethical 
committee, and written informed consent was obtained. The patients were 68±11 
years old and had spent 78±32 months on dialysis. Conventional hemodialysis 
was performed during 253±16 minutes using low flux polysulphone dialyzers: F8 
(n=3) and F10HPS (n=4) (Fresenius Medical Care, Bad Homburg, Germany). 
The main characteristics of the patients and their dialysis sessions are shown in 
Table V-2.  
Table V-2: Main characteristics of the patients 
Patient 
 
No. 
Sex Age   
 
years 
Time on 
dialysis  
months 
Blood 
flow 
mL/min
Body 
weight*
kg 
H*
 
% 
Total serum 
protein* 
g/L 
UF 
 
L 
Session 
duration 
min 
Dialyzer
1 F 79 76 287 73.8 40 67.2 3.1 240 F8 
2 F 53 80 349 95.6 41 72.0 3.2 240 F8 
3 M 73 30 318 71.8 37 72.4 4.5 270 F10HPS
4 F 81 97 326 69.8 36 65.9 2.3 240 F10HPS
5 M 56 113 330 70.1 34 57.0 3.5 270 F10HPS
6 M  73 42 350 75.8 33 57.6 4.3 240 F10HPS
7 M 60 106 350 88.4 40 62.2 4.7 270 F8 
MEAN - 68 78 330 77.9 37 64.9 3.7 253 - 
SD - 11 32 23 10.1 3 6.3 0.9 16 - 
* pre-dialysis ; hematocrit H; ultrafiltration UF; standard deviation SD. 
The composition of the dialysate was: 38.5mmol/L bicarbonate, 138mmol/L 
sodium, 104mmol/L chloride, 4mmol/L acetate, 1.25mmol/L calcium, and 
0.5mmol/L magnesium. The dialysate potassium concentration was adapted to 
the needs of the patients and ranged from 1 to 3mmol/L. A constant dialysate 
flow rate of 500mL/min was applied using a Fresenius FO1 or FO3 dialysis 
machine. Blood flow rates of 330±23mL/min and ultrafiltration rates of 
0.85±0.19L/h were obtained (Table V-2). Mean K·t/Vurea in this population was 
1.77±0.17 by routine monthly assessment according to the single-pool Daugirdas 
formula [303], immediately prior to the study. 
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3.3.2. Blood and dialysate sampling 
For each patient, blood samples were taken at the inlet and outlet blood lines 
immediately before the onset of dialysis, after 5, 15, 30, 120 minutes, and 
immediately after discontinuation of the dialysis session, without slowing down 
the blood pump. Blood samples were immediately centrifuged during 10 minutes 
at 1900g (CR 412, Jouan, Saint-Herblain, France), after which the plasma was 
stored at -80°C until analysis. From the outlet dialysate line, dialysate was 
sampled after 5, 15, 30, 120 minutes after the start of dialysis, and immediately 
before the end of dialysis.  
From a preliminary study in two patients, taking samples at 14 time points during 
the dialysis session, it was concluded that all investigated solutes were 
characterized by a two-pool kinetic behavior. As a consequence, the number of 
data points could be limited to those reported here. 
3.3.3. Analyses 
Total protein was determined photometrically by the biuret method (Genesys 
10vis, Spectronic, Unicam, Rochester, USA). Hematocrit was measured with the 
capillary centrifugation technique. Urea concentrations were determined with the 
method of Ceriotti et al. [315]. The concentrations of creatinine (CTN), creatine 
(CT), guanidinosuccinic acid (GSA), guanidinoacetic acid (GAA), guanidine 
(G), and methylguanidine (MG) were determined with a Biotronic LC 6001 
amino acid analyzer (Biotronik, Maintal, Germany) adapted for guanidino 
compound determination [316].  
3.3.4. Kinetic model 
A flow chart of the two-pool model used in the present study is shown in Fig. 
V-1. The total distribution volume (Vtot) was assumed to consist of two distinct 
volumes: the perfused volume (V1) and the non-perfused (V2). Each 
compartment was theoretically characterized by a homogeneous solute 
concentration with variable inputs and outputs. The solute transport between two 
compartments was considered to be driven by concentration gradients 
(diffusion), and/or pressure gradients (convection).  
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Fig. V-1: Flow chart of the two-pool kinetic model. V1: perfused volume; V2: non-perfused 
volume; Vtot: total distribution volume; C1: concentration in perfused compartment; C2: 
concentration in non-perfused compartment; CBi: concentration at blood inlet; CBo: 
concentration at blood outlet; CDi: concentration at dialysate inlet; CDo: concentration at 
dialysate outlet; Kblood: dialyzer clearance; K12: inter-compartmental clearance; GS: solute 
generation rate; QB: dialyzer blood flow; QD: dialyzer dialysate flow; QUF: ultrafiltration flow. 
As a compartment does not necessarily coincide with an anatomical entity [269], 
the perfused volume was not taken a priori equal to the plasma volume, but was 
assumed not being smaller than the pre-dialysis plasma volume, Vplasma. The 
latter was calculated from total blood volume as 1/13 of total body weight (BW-
kg), followed by subtraction of the contribution of the pre-dialysis hematocrit H: 
 H)(1
13
BWVplasma −⋅=  Eq. V-1 
From the inlet and outlet plasma concentrations, CPi and CPo, the blood flow, QB, 
and the ultrafiltration rate, QUF, total blood-side clearance Kblood (mL/min) was 
calculated considering diffusive as well as convective contribution to overall 
clearance [85]: 
 
UF
Pi 
Po 
B
Pi
Po Pi
blood QC
C
Q
C
CC
K ⋅+⋅−=  Eq. V-2 
For each solute, clearances at different time points throughout the dialysis 
session remained stable (standard deviation less than 3%) so that the mean of 
these individual clearances was used. 
The solute generation rate GS (mmol/min) in the interdialytic period, Tinter (min), 
was assumed equal to the amount of solutes collected in the dialysate [268]. 
Therefore, it was calculated as a function of the solute concentration, CD 
(mmol/L), in the collected dialysate volume, VD (L): 
Kblood
CPi
CDi
CDo
CPo
dialyzer
QB
QD
QB - QUF
QD + QUF
V1, C1V2, C2
K12
G
Vtot
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inter
DD
S T
CV
G
⋅=  Eq. V-3 
This method of calculating the generation rate excludes the amount of solutes 
that is metabolized after generation in the non-perfused volume. Furthermore, no 
significant differences in the kinetic parameters were found considering 
generation as taking place in the perfused or non-perfused compartment. 
Therefore, although CTN is known as being generated in the muscles, solute 
generation rate was generally considered to take place in the perfused 
compartment, a rationale also followed in previous studies [267]. A similar 
rationale was followed as well for the other guanidino compounds studied. 
Ultrafiltration QUF (0.85±0.19L/h) was taken into account to calculate convective 
clearance (Eq. V-2) and to vary total distribution volume in time. Ultrafiltration 
was assumed to occur in both compartments, dV1/dt and dV2/dt, in proportion to 
the compartment volume ratio. 
The time variation of the compartment concentration was, for a particular solute, 
determined by solving a series of mass balance equations for both compartments 
[268,269]:  
 ( ) ( )
( ) ( )


−⋅−=
−⋅+⋅−=
1212
22
12121bloodS
11
CCK
dt
CVd
CCKCKG
dt
CVd
 Eq. V-4 
The pre-dialysis concentration in the perfused and non-perfused compartment 
was assumed equal to the pre-dialysis plasma solute concentration. The model, 
developed with JSim 1.5 (National Simulation Resource, Seattle, W), iteratively 
solved the mass balance equations for the complete dialysis session time (either 
240 or 270min). The perfused volume, V1 (L), total distribution volume, Vtot (L), 
as well as the inter-compartmental clearance, K12 (mL/min), were calculated 
from fitting the solution to the measured plasma concentrations.  
The JSIM Mathematical Modeling Language (MML), following standard 
mathematical nomenclature, was used to define the equations of the problem to 
be solved. The applied software used the Dopri5 method to solve the differential 
equations [317] and the Simplex method was used to minimize the standard errors 
on the fitting. 
In a preliminary study, our data was also fitted calculating only two kinetic 
parameters (Vtot and K12), as proposed by the HEMO study [304]. The a priori 
assumption of V1/V2 equal to 1 by 2 for urea, as used in the HEMO method, 
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resulted in larger standard errors on the fitting compared to our method. As a 
consequence of this observation and the fact that no a priori assumptions can be 
made with respect to the guanidino compounds, we have decided to consider the 
perfused volume as one of the three fitting parameters. 
In conclusion, dialyzer clearance (Kblood) and solute generation rate (GS) were 
calculated from plasma and dialysate concentrations, respectively. Together with 
the ultrafiltration rate (QUF), they were used as known input parameters in the 
kinetic model. The sampled concentrations were fitted with a bi-exponential 
curve determining the perfused volume (V1), the total distribution volume (Vtot), 
and the inter-compartmental clearance (K12). The volume of the non-perfused 
compartment (V2) was calculated from the fitted parameters V1 and Vtot. 
3.3.5. Effective solute removal 
In analogy with the definition for the urea reduction ratio, URR, the reduction 
ratio RR (%) of the guanidino compounds can be defined as a function of pre 
(C1_pre) and immediate post-dialysis concentration (C1_post) in the perfused 
compartment: 
 
100
C
CC
RR
1_pre
1_post1_pre ⋅−=  Eq. V-5 
Due to redistribution in the body compartments following dialysis, the effective 
reduction ratio will be smaller than calculated with Eq. V-5 if a multi-
compartmental distribution is present. Therefore, concentration profiles in both 
compartments were calculated during the 60 minutes following discontinuation 
of the dialysis session using the same kinetic model as mentioned above. 
Dialyzer clearance was set equal to zero, while solute generation was assumed to 
occur continuously in the perfused compartment, according to the same 
conditions as accepted before. Solute concentration after 60 minutes (C1_60post), 
was calculated from the immediate post-dialysis concentration in the perfused 
volume (C1_post) and the previously obtained kinetic characteristics. C1_60post 
allowed calculating the effective reduction ratio RReff (%) for the different 
solutes: 
 
100
C
CC
RR
1_pre
1_60post1_pre
eff ⋅
−=  Eq. V-6 
To define the removal from the non-perfused compartment, which corresponds to 
removal from tissues and organs where biological/biochemical activity is 
displayed, the effective relative decline of concentration (slope: delta SC2eff) was 
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calculated from the pre (C2_pre) and immediate post-dialysis concentration in the 
non-perfused volume (C2_post), normalized to a total dialysis session duration ttotal 
of 240 minutes: 
 
100
t
240
C
CC
SC delta
total2_pre
2_post2_pre
eff 2 ⋅


 −=  Eq. V-7 
3.3.6. Statistical analysis 
Data are expressed as mean ± standard deviations. Correlations between 
parameters were investigated by performing linear regression analysis (Pearson). 
Statistical analyses were carried out using the Student t-Test for unpaired 
samples on normally distributed populations, with P<0.05 as the limit of 
significant difference.  
3.4. Results 
For the different studied compounds, Fig. V-2 illustrates the concentration 
profiles in the perfused and non-perfused compartments as fitted on the measured 
data points during dialysis in one of the patients evaluated in the present study. 
As compared to urea, the concentration profiles in the perfused volume for most 
of the guanidino compounds show a more pronounced bi-exponential profile. 
This corresponds to larger non-perfused volumes (see below), and is indicated by 
a steep exponential decline (according Kblood/V1) when dialysis starts, followed 
by a gentle exponential slope (determined by K12/Vtot) (e.g. CT, GAA, G, and 
MG). The relative distance in between both curves is a measure for the inter-
compartmental clearance: closer curves corresponds to a higher rate of solute 
exchange in between both pools such that concentration equilibriums are reached 
more easily (e.g. G and MG). More importantly, the relative slope of the 
concentration curve of the non-perfused compartment (bold line) offers an idea 
about the effective clearance from the patients’ tissues (delta SC2eff). The latter is 
more efficient for steeper slopes (e.g. urea, CTN, and GSA) (see below) (The 
reader must pay attention to the different scales on the y-axis as applied for the 
different solutes). 
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Fig. V-2: Concentration profiles (mmol/L) during the dialysis session of urea and the different 
investigated guanidine compounds in a representative patient. The asterisks * plot the measured 
data, while the thin and bold line are the fitted concentration profiles in the perfused (V1), and 
non-perfused compartment (V2), respectively. The angle in between the dotted lines is a 
measure for the solute removed from the non-perfused compartment (delta SC2eff). 
In Table V-3, solute generation rate (GS), dialyzer clearance (Kblood), and the 
fitted kinetic parameters [perfused volume (V1), total distribution volume (Vtot), 
and inter-compartmental clearance (K12)] are shown for the different investigated 
solutes.  
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Table V-3: Kinetic modeling parameters 
Compound GS 
mmol/24h 
V1 
L 
Vtot 
L 
Vtot / BW 
L/kg 
Kblood 
mL/min 
K12 
mL/min 
Urea 310 ± 86 6.4 ± 3.3 42.7 ± 6.0 0.55 ± 0.09 261 ± 17 822 ± 345 
CTN 9.83 ± 3.90 7.6 ± 3.4 54.0 ± 5.9 0.70 ± 0.09 264 ± 14 618 ± 113 
CT 0.557 ± 0.354 4.2 ± 1.3 98.0 ± 52.3 1.38 ± 0.72 257 ± 21 588 ± 84 
GSA 0.087 ± 0.037 5.7 ± 1.9 30.6 ± 4.2 0.39 ± 0.05 235 ± 29 625 ± 138 
GAA 0.019 ± 0.006 8.1 ± 5.1 123.8 ± 66.9 1.65 ± 0.93 266 ± 16 715 ± 288 
G 0.021 ± 0.004 8.4 ± 6.2 89.7 ± 21.4 1.17 ± 0.34 267 ± 25 918 ± 362 
MG 0.046 ± 0.028 8.0 ± 3.7 102.6 ± 33.9 1.32 ± 0.39 278 ± 15 1025 ± 498
solute generation rate GS; perfused volume V1; total distribution volume Vtot; total distribution 
volume normalized for body weight Vtot/BW; dialyzer clearance Kblood; inter-compartmental 
clearance K12; creatinine CTN; creatine CT; guanidinosuccinic acid GSA; guanidinoacetic acid 
GAA; guanidine G; methylguanidine MG. 
For urea and creatinine, mean total distribution volumes were equal to 42.7±6.0L 
and 54.0±5.9L, while the perfused compartment volumes were 6.4±3.3L and 
7.6±3.4L, respectively. The perfused and total distribution volumes of the 
guanidino compounds were 4.2±1.3L and 98.0±52.3L (CT), 5.7±1.9L and 
30.6±4.2L (GSA), 8.1±5.1L and 123.8±66.9L (GAA), 8.4±6.2L and 89.7±21.4L 
(G), and 8.0±3.7L and 102.6±33.9L (MG). Total distribution volumes 
normalized for patient’s body weight were 0.55±0.09L/kg (urea), 0.70±0.09L/kg 
(CTN), 1.38±0.72L/kg (CT), 0.39±0.05L/kg (GSA), 1.65±0.93L/kg (GAA), 
1.17±0.34L/kg (G), and 1.32±0.39L/kg (MG).  
No significant differences were observed between the volumes of the perfused 
compartment among all the compounds under study. With respect to the total 
distribution volumes, there were, however, significant differences between the 
values for urea and those for CTN (P=0.004), CT (P=0.033), GSA (P<0.001), 
GAA (P=0.003), G (P<0.001), and MG (P=0.001) (Table V-4). While most 
guanidino compounds showed a total distribution volume exceeding that of urea, 
GSA was distributed in a smaller volume. Analogous significant differences were 
observed for the total distribution volume normalized for body weight between 
urea and CTN (P=0.008), CT (P=0.017), GSA (P=0.001), GAA (P=0.003), G 
(P<0.001), and MG (P<0.001). In addition to the differences with urea, total 
distribution volumes of CTN and GSA were significantly lower compared to the 
other guanidino compounds. Moreover, Vtot for GSA was remarkably lower 
(P<0.001) than for CTN. As a consequence, CT, GAA, G, and MG showed a 
similar behavior, while other compounds (urea, CTN, and GSA) each had a 
specific behavioral pattern.  
Intra-dialytic kinetic behavior of uremic solutes 
 219
No significant differences were observed between the inter-compartmental 
clearances among the investigated compounds, except between the K12 for G and 
GSA (P=0.017). With respect to the dialyzer clearance of the different solutes, 
only some singular significant differences were found (Table V-4). 
Table V-4: Levels of significance for the differences between modeled parameters of 
the different compounds. 
 Urea CTN CT GSA GAA G MG 
Urea Vtot \ Kblood NS NS NS NS NS 0.026 
CTN 0.004 Vtot \ Kblood NS 0.040 NS NS NS 
CT 0.033 NS Vtot \ Kblood NS NS NS 0.044 
GSA < 0.001 < 0.001 0.017 Vtot \ Kblood 0.030 NS 0.005 
GAA 0.003 0.005 NS 0.003 Vtot \ Kblood NS NS 
G < 0.001 0.001 NS < 0.001 NS Vtot \ Kblood NS 
MG 0.001 0.001 NS < 0.001 NS NS Vtot \ Kblood
P-levels for dialyzer clearance Kblood above the diagonal and for total distribution volume Vtot 
below the diagonal; no significant differences were found for the perfused compartment V1; no 
significant differences were found for the inter-compartmental clearance K12, except between G 
and GSA (P=0.017).  
The pre and post-dialysis concentrations in the perfused volume, as well as the 
reduction ratios RR and RReff, as calculated with Eq. V-5 and Eq. V-6, are 
specified in Table V-5. With the immediate post-dialysis concentration, RR 
values were 75±4% (urea), 69±4% (CTN), 59±12% (CT), 82±5% (GSA), 
53±12% (GAA), 56±6% (G), and 55±8% (MG). Applying the perfused volume 
concentration corresponding to the 60th minute post-dialysis, however, RReff 
values of 67±4% (urea), 58±6% (CTN), 42±16% (CT), 76±6% (GSA), 37±14% 
(GAA), 43±7% (G), and 42±12% (MG) were found. There was a significant 
difference between the RR and RReff values for urea and those for CTN (P=0.024 
and 0.006), CT (P=0.033 and 0.017), GSA (P=0.014 and 0.006), GAA (P=0.005 
and 0.003), G (P<0.001 both), and MG (P<0.001 both). While all other guanidino 
compounds showed RR and RReff values lower than urea, GSA was removed 
more efficiently compared to urea.  
Solute removal from the non-perfused compartment (delta SC2eff), indicated by 
the slope of the corresponding concentration curve in Fig. V-2, as explained 
above, is also shown in Table V-5 for the different investigated compounds. 
Solute removal of GSA (delta SC2eff=73±4%) was significantly more pronounced 
as compared to urea (65±7%) (P=0.019), while GAA (34±15%), G (41±8%), and 
MG (40±12%) were significantly less efficiently removed from the non-perfused 
compartment (P=0.005, <0.001, and <0.001, respectively). 
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Table V-5: Molecular weight (MW), reduction ratio (RR), corrected reduction ratio 
(RReff), and the concentration decline in the non-perfused compartment (delta SC2eff) for 
the different compounds. 
Compound MW 
Da 
C1_pre 
µmol/L 
C1_post 
µmol/L 
C1_60post 
µmol/L 
RR 
% 
RReff 
% 
delta SC2eff 
% 
Urea 60 24 ± 9 * 6.1 ± 2.6 * 8.0 ± 3.3 * 75 ± 4 67 ± 4 65 ± 7 
CTN 113 1015 ± 286 312 ± 93 427 ± 138 69 ± 4 † 58 ± 6 † 55 ± 3 † 
CT 131 50 ± 42 24 ± 14 35 ± 22 59 ± 12 † 42 ± 16 † 52 ± 28 
GSA 175 12.0 ± 4.4 2.1 ± 0.9 2.8 ± 1.1 82 ± 5 † 76 ± 6 † 73 ± 4 † 
GAA 117 1.7 ± 0.6 0.8 ± 0.1 1.1 ± 0.2 53 ± 12 † 37 ± 14 † 34 ± 15 † 
G 59 1.8 ± 0.3 0.8 ± 0.1 1.0 ± 0.2 56 ± 6 † 43 ± 7 † 41 ± 8 † 
MG 73 3.7 ± 2.0 0.2 ± 0.1 2.3 ± 1.4 55 ± 8 † 42 ± 12 † 40 ± 12 † 
* Urea concentration in mmol/L; † P<0.05 compared to urea; pre-dialysis plasma concentration 
C1_pre; post-dialysis plasma concentration C1_post; plasma concentration 60 minutes after dialysis 
C1_60post; creatinine CTN; creatine CT; guanidinosuccinic acid GSA; guanidinoacetic acid GAA; 
guanidine G; methylguanidine MG. 
No correlations were found between urea and the guanidino compounds for the 
different model parameters (V1, Vtot, Kblood, and K12), nor for the derived 
parameters (RR, RReff, and delta SC2eff). RR, RReff, and delta SC2eff percentages, 
however, were found to correlate inversely with the total distribution volumes 
(R= -0.97 - P<0.001 for RR and RReff, and R= -0.94 - P=0.002 for delta SC2eff) 
(Fig. V-3). As a consequence, solute removal of CT, GAA, G, and MG, 
characterized by similar and large total distribution volumes, occurred with a 
comparable efficiency, which was smaller than that of urea, CTN, and GSA.  
 
 
Fig. V-3: Correlations between total distribution volume and reduction ratio RR (+), effective 
reduction, RReff (x), and effective relative concentration decline, delta SC2eff (o). 
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Considering the mean parameter values as shown in Table V-3, dialyzer 
clearance, Kblood, and inter-compartmental clearance, K12, were negatively 
correlated with solute molecular weight, and correlation coefficients R were 
equal to –0.78 and –0.79 (P=0.037 and P=0.033) (Fig. V-4). The perfused and 
total distribution volume, however, did not correlate with solute molecular 
weight. 
 
Fig. V-4: Correlations between solute molecular weight and dialyzer clearance Kblood (+), and 
inter-compartmental clearance K12 (x). 
3.5. Discussion 
The present study sets out to evaluate the kinetic characteristics of several 
guanidino compounds and to compare them with a standard marker of dialysis 
adequacy, urea. For this purpose, a two-pool kinetic model was applied, as 
plasma concentrations during dialysis showed a bi-exponential profile. For each 
solute, both differential equations were solved using three parameters to fit the 
measured data: the perfused compartment volume, V1, total distribution volume, 
Vtot, and the inter-compartmental clearance, K12. The differences in kinetic 
behavior can be determined by assessing the relationship between dialyzer 
clearance, inter-compartmental clearance, and compartment volumes for each 
solute.  
The most striking results of this study are: first, most of the studied guanidino 
compounds show a kinetic behavior that is different from that of urea; second, 
the distribution volume of CT, GAA, G, and MG is substantially larger than that 
of urea, while the distribution volume of GSA is significantly smaller; third, 
these differences occur in spite of similar dialyzer and inter-compartmental 
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clearance values; fourth, urea does not correlate with the guanidino compounds 
for any of the kinetic parameters. 
Although the plasma and organ systems of patients with renal failure contain a 
large amount of retention compounds [229], many of which have a potential for 
toxicity, data on solute removal pattern during dialysis have been collected only 
for a limited number of compounds. In addition, these studies not always contain 
a comparison regarding the kinetic behavior. Our study essentially emanated 
from the question whether urea, which is a currently applied marker for dialysis 
adequacy, shows a kinetic behavior that is comparable to that of guanidino 
compounds. This question was especially addressed since the guanidino 
compounds are, like urea, degradation products from proteins and amino acids, 
with an almost similar dialyzer clearance and molecular weight, and the same 
hydrophilic physico-chemical characteristics.  
Most serum guanidino compound concentrations are increased in hemodialysis 
patients [307,308] and in non-dialyzed patients with chronic renal failure [309]. Mean 
uremic GSA and MG serum levels are up to respectively 200 and 100 times 
higher compared to controls, while guanidine and creatinine concentrations are 
approximately 10 times increased [229,308,309]. For urea, the corresponding increase 
is only 6-fold [229]. The highest absolute concentrations were found for urea, 
creatinine and creatine. A high solute concentration, however, does not 
necessarily imply a strong biologic toxicity. While, urea and creatinine have a 
rather limited biologic toxicity, several guanidino compounds, on the contrary, 
are related to neurotoxicity [318], cardiovascular [311] and hematological 
complications [313,314], and alterations of leukocyte function [312]. GSA has been 
associated to uremic bleeding diathesis [313] and contributes to the toxic 
phenomena affecting the function of the central nervous system [319]. Moreover, it 
has, together with G, been held responsible for hemolysis [314,320]. MG and G 
have been suggested to relate to uremic polyneuropathy [320] and are considered 
to be epileptogenic [321]. Despite their potential for toxicity, guanidino compound 
kinetics during dialysis have never been the subject of investigation.  
In one study, it was indirectly suggested that guanidino compounds display a 
different intra-dialytic behavior compared to urea, suggesting differences in 
compartmental behavior [322]. The present study corroborates this impression by 
direct calculations.  
As can be observed from Table V-3 and Fig. V-2, guanidinoacetic acid, 
methylguanidine, and guanidine show a remarkable similarity for the four model 
parameters: perfused and non-perfused volume, and dialyzer and inter-
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compartmental clearances. Although their dialyzer clearance is similar to (for 
GAA and G) or even higher (for MG) than that of urea, the effective removal, 
expressed by RReff, is significantly lower than for urea (Table V-5). This 
potential for different removal behavior is mainly attributable to the significantly 
larger non-perfused volume for GAA, G and MG. As a consequence, GAA, G 
and MG concentrations diminish only slightly in the non-perfused compartment, 
as indicated by their significantly smaller delta SC2eff values, in spite of similar 
speed of redistribution between both pools. It should be remarked, however, that 
CT and GAA, the precursor of CT, both play an important role with respect to 
the energy metabolism. As a consequence, the larger distribution volume as 
found for both solutes must be considered as a positive feature in avoiding 
unwanted solute deficiency caused by dialysis. 
Guanidinosuccinic acid, on the contrary, is distributed in a much smaller volume, 
while it is, however, characterized by an analogous dialyzer clearance as urea. 
Although inter-compartmental solute transport is significantly slower than for 
guanidine (G), GSA shows a kinetic behavior approaching that of a single pool 
model (Fig. V-2). As a consequence, effective clearance is highly adequate, even 
as compared to urea. 
Up till now, few kinetic analyses have been undertaken for other molecules than 
urea. Some of those have concentrated on β2-microglobulin, which has a 
relatively high molecular weight, as compared to urea and the studied guanidino 
compounds [305,323]. Not surprisingly, molecules like β2-microglobulin show a 
kinetic behavior different from urea, essentially attributable to the resistance 
imposed by their molecular weight on the transfer from one compartment to 
another. Surprisingly, in the present study, we found an aberrant kinetic behavior 
for the guanidino compounds, which are small and water-soluble like urea. 
In previous studies, applying less refined tools for the estimation of intra-dialytic 
behavior, it has been shown that urea removal did not correlate with removal of 
several protein bound compounds [286,288]. In addition, a similar discrepancy was 
shown for urea and three small water-soluble compounds, phosphate [289,290], 
xanthine, and hypoxanthine [286,288]. The latter three solutes are known to interfere 
with biological/biochemical functions [293,294], in contrast to urea, for which few 
interactions are known, even at the clinical level [258]. Our data add to the 
perception that urea is not representative as a marker for the removal of other 
uremic solutes. According to the present data, this is even true for equally small 
and water-soluble compounds. 
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Why do small water-soluble compounds behave differently from urea? Virtually 
none of uremic retention solutes kinetically behave like urea, even not creatinine, 
as also demonstrated by our own data. Previous studies, a priori assuming a total 
distribution volume equal to that of urea [267], found inter-compartmental CTN 
transport about half as efficient as that of urea. Without preliminary assumptions, 
we found a significantly larger total distribution volume for CTN, while no 
difference was found between the inter-compartmental clearances. Both 
approaches for CTN kinetic modeling, however, imply a lower effective 
clearance, which is reflected by significantly lower RReff and delta SC2eff values 
(Table V-5), as compared to urea. In a seminal study, Langsdorf et al. [324] 
demonstrated that removal of creatinine and uric acid, two small water-soluble 
compounds, from intracellular to extracellular, was hampered in dialysis patients 
as compared to urea. These data suggest that the transfer of molecules through 
the cell membrane is restricted by other uremic solutes, perhaps due to the 
induction of structural changes. 
Originally, urea kinetics were mainly modeled using a single pool model that 
allows an easy derivation of the dialysis adequacy parameter K·t/V [325]. At a later 
stage, corrections were introduced accounting for the varying distribution volume 
during dialysis due to ultrafiltration [326]. According to recent data [267,268,327,328], 
the interpretation of urea kinetics is most accurate when a two-pool kinetic model 
is applied. Although most previously performed two-pool urea kinetic studies 
used different a priori assumptions with respect to total distribution volume and 
inter-compartmental clearance, our approach, based on fitting those parameters, 
results in analogous conclusions. First, we found a mean urea total distribution 
volume of 55% of mean body weight (Table V-2), which closely corresponds 
with the theoretical value of total body water (56-58% of BW) [269,327]. Second, 
our inter-compartmental urea clearance (822±345mL/min) is in good agreement 
with previous publications reporting K12 values ranging from 700 up to 
960mL/min [267,268]. Furthermore, it should be remarked that our calculated 
effective reduction ratio is comparable to the results of previous clinical studies 
[329].  
Finally, the question should be raised whether the presented data indicate that 
follow-up of urea removal in dialysis patients is irrelevant? Two recent studies 
showed no differences in survival while two different levels of urea removal 
were pursued [258,306]. Although observational, other studies, however, highlight 
the value of estimating urea removal as an index of dialysis adequacy [90,330]. 
Therefore, the conclusion of the present study is rather that, apart from urea, we 
should consider that many other changes occur in uremia and dialysis, and that 
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not all of them are representatively reflected by urea kinetics, even when 
considering other small water-soluble compounds such as the guanidino 
compounds. 
3.6. Conclusion 
Because urea is virtually the only clinically applied marker for adequacy of 
dialysis, few analyses have been concentrated on the intra-dialytic kinetic 
behavior of other uremic solutes. While scanty data suggests that large solutes 
show a kinetic behavior different from urea, the question investigated in this 
study is whether other small water-soluble compounds such as the guanidino 
compounds studied here show a kinetic behavior that is comparable or not to that 
of urea. As creatinine, creatine, guanidinoacetic acid, guanidine and 
methylguanidine have a significantly larger distribution volume compared to 
urea, those compounds are removed less efficiently from the body than urea. 
Guanidinosuccinic acid, on the contrary, characterized by a significantly smaller 
distribution volume, is removed more efficiently than urea. In conclusion, the 
kinetics of the guanidino compounds under study are different from that of urea; 
hence, urea kinetics are not representative for the removal of other uremic 
solutes, even small and water-soluble uremic solutes. 
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4. Intra-dialytic kinetic behavior of protein- 
bound uremic toxins† 
4.1. Introduction 
The role that protein-bound solutes play in the uremic syndrome has been partly 
neglected because their identification in uremic serum is not easy [331,332]. The 
measurement of protein-bound solutes in serum is mainly based on high 
performance liquid chromatography (HPLC) on reverse phase columns. To 
determine the total concentration of compounds (bound and unbound fraction), 
serum deproteinization is needed in order to release the ligands from the protein-
binding sites [333]. 
Protein-bound compounds share some important characteristics. They may have 
an impact on the biological activity of protein-bound drugs and other protein-
bound solutes by increasing the free fraction of ligands. Furthermore, they are 
not efficiently removed by classical dialysis, even when using large pore dialysis 
membranes [334]. As a consequence, they are retained in renal failure and affect 
major biochemical/biological functions involved in the uremic syndrome [292]. 
Two recent studies reported the correlation of protein-bound uremic solutes with 
indications of clinical condition [335,336]. 
To have better insight in the kinetic behavior of protein-bound solutes, the 
present preliminary study has been undertaken to quantify the kinetics of major 
protein-bound substances. With a two-pool model, kinetic calculations were 
performed fitting plasma concentrations during hemodialysis. Three kinetic 
parameters were derived, i.e. perfused volume, total distribution volume, and 
inter-compartmental clearance.  
4.2. Patients and Methods 
4.2.1. Patients and dialysis strategies 
Five stable dialysis patients without residual renal function included this study. 
The local ethical committee approved the study, and written informed consent 
was obtained. The patients were 71±11 years old and were 71.9±2.8kg of body 
                                                     
† The results for indoxyl sulphate were adapted from the submitted publication 
Removal mechanisms of protein bound uremic toxins by super flux cellulose triacetate dialyzers: a 
crossover prospective analysis  
R. De Smet, S. Eloot, M.A. Waterloos, A. Dhondt, N. Lameire, and R. Vanholder 
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weight. Conventional hemodialysis was performed during 258±16 minutes using 
the low flux polysulphone F10HPS dialyzer (Fresenius Medical Care, Bad 
Homburg, Germany). Dialysate was prepared conform to the criteria of purity, as 
proposed by the European Best Practice Guidelines [214]. A constant dialysate 
flow of 500mL/min was applied, while blood flows were 331±14mL/min and 
ultrafiltration flows were 0.86±0.23L/h. The patients had a pre-dialysis 
hematocrit of 35±2% and total serum protein of 63.2±7.3g/L. The mean K·t/Vurea 
in the period preceding the experiment was 1.78±0.20 [303]. 
4.2.2. Blood and dialysate sampling 
For each patient, blood was sampled from the inlet and outlet blood lines 
immediately before the onset of dialysis, after 5, 15, 30, 120 minutes, and post 
dialysis. Blood samples were centrifuged at 1900g (CR 412, Jouan, Saint-
Herblain, France), after which the serum was stored at -80°C until analysis. From 
the outlet dialysate line, dialysate was sampled after 5, 15, 30, 120 minutes after 
the start of dialysis, and immediately prior to the end of dialysis.  
4.2.3. Analyses 
Total protein was determined photometrically by the biuret method (Genesys 
10vis, Spectronic, Unicam, Rochester, USA). Hematocrit was obtained with the 
capillary centrifugation technique.  
Table V-6: Main characteristics of several protein-bound solutes. 
    Protein binding 
Compound MW 
Da 
Normal conc
mg/L 
Uremic conc 
mg/L 
Normal  
% 
Uremic 
% 
Hippuric acid 179 < 5.0 247.0 ± 112 56 - 68 34 
Indoxyl sulphate 251 0.6 ± 5.4 53.0 ± 91.5 90 - 99.9 89 
IAA (µg/L) 175 17.5 ± 17.5 875 ± 560 93.6 81 
P-cresol 108 0.6 ± 1.0 20.1 ± 10.3 99.9 88 
CMPF 240 7.7 ± 3.3 61.0 ± 16.5 99.9 99.9 
molecular weight MW; indole-3-acetic acid IAA; 3-carboxy-4-methyl-5-propyl-2-
furanpropionic acid CMPF. Normal and uremic concentrations adapted from Vanholder 
et al. [229]; normal and uremic protein binding adapted from McTique et al. [337] and De 
Smet et al. [unpublished data]. 
Analyses of several protein-bound compounds were performed on dialysate and 
diluted (1:3) plasma: hippuric acid, indoxyl sulphate, indole-3-acetic acid (IAA), 
p-cresol, and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF). The 
main characteristics of those compounds are shown in Table V-6. 
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Total (bound and unbound) concentrations were determined by deproteinization 
based on heat denaturation, and consecutive ultrafiltration. The obtained 
ultrafiltered samples were submitted to high performance liquid chromatography 
(HPLC) as described previously [288]. 
4.2.4. Kinetic model 
The two-pool model as described in paragraph 3.3.4 and illustrated in Fig. V-1, 
was used to derive the kinetic behavior of the protein-bound compounds under 
study.  
Blood-side dialyzer clearance (Kblood) and solute generation rate (GS) were 
calculated from plasma and dialysate concentrations, respectively. The 
ultrafiltration rate (QUF) was applied on both volumes proportionally. The 
sampled concentrations were fitted with a bi-exponential curve determining the 
perfused volume (V1), the total distribution volume (Vtot), and the inter-
compartmental clearance (K12).  
4.2.5. Solute removal 
In analogy with the urea reduction ratio (URR), the reduction ratio RR (%) of the 
protein-bound solutes was determined from the pre-dialysis and immediately 
post-dialysis plasma concentration in the perfused compartment, C1_pre and 
C1_post, respectively (Eq. V-5). 
4.2.6. Statistical analysis 
Data are expressed as mean ± standard deviations. Correlations between 
parameters were investigated by performing linear regression analysis (Pearson). 
Statistical analyses were carried out using the Student t-Test for unpaired 
samples on normally distributed populations, with P<0.05 as the limit of 
significant difference.  
4.3. Results 
Fig. V-5 illustrates the plasma concentration profiles for the five patients of 
p-cresol (left panel) and CMPF (right panel) as measured in vivo with the five 
patients. It is obvious from Fig. V-5 that both protein-bound solutes do not 
follow a bi-exponential concentration decline. As a consequence, both solutes 
could not be modeled using the proposed two-pool kinetic model. P-cresol was 
found to fluctuate in the beginning of the dialysis session, but showed an intra-
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dialytic decrease from 7.8±1.6mg/L to 5.8±1.5mg/L. Even more, CMPF plasma 
concentrations were increased from 6.5±2.3mg/L pre-dialysis up to 7.1±2.3mg/L 
post dialysis. 
 
Fig. V-5: Intra-dialytic concentrations of p-cresol (left panel) and CMPF (right panel). 
For hippuric acid, indoxyl sulphate, and IAA plasma concentrations, reliable 
kinetic results were obtained with the two-pool model. The fitted kinetic 
parameters i.e. perfused volume (V1), total distribution volume (Vtot), and inter-
compartmental clearance (K12), as well as the solute generation rate (GS) and 
dialyzer clearance (Kblood), are shown in Table V-7. The values are compared 
with those found for the small and water-soluble compound urea [338]. 
Table V-7: Kinetic modeling parameters for three protein-bound solutes compared to 
urea. 
Compound GS 
mg/24h 
V1 
L 
Vtot 
L 
Vtot / BW 
L/kg 
Kblood 
mL/min 
K12 
mL/min 
Urea  18600±5160 6.4 ± 3.3 42.7 ± 6.0 0.55 ± 0.09 261 ± 17 822 ± 345
Hippuric acid 347 ± 9 5.2 ± 1.7 29.8 ± 2.6 0.42 ± 0.03 184 ± 9 426 ± 303
Indoxyl sulphate 54 ± 21 3.9 ± 0.5 25.6 ± 7.5 0.36 ± 0.10 31 ± 9 288 ± 320
IAA 7.4 ± 4.0 4.5 ± 1.9 42.8 ± 9.9 0.60 ± 0.15 69 ± 8 526 ± 671
solute generation rate GS; perfused volume V1; total distribution volume Vtot; total distribution 
volume normalized for body weight Vtot/BW; dialyzer clearance Kblood; inter-compartmental 
clearance K12; indole-3-acetic acid IAA. 
The mean total distribution volumes were equal to 29.8±2.6L (hippuric acid), 
25.6±7.5L (indoxyl sulphate), and 42.8±9.9L (IAA), while the perfused volumes 
were respectively 5.2±1.7L, 3.9±0.5L, and 4.5±1.9L.  
No significant differences were observed between the perfused volumes among 
the protein-bound solutes under study. Even compared to the results as found for 
urea, no differences were seen.  
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With respect to the total distribution volumes, however, there were significant 
differences between Vtot and Vtot/BW for IAA and those for hippuric acid 
(P=0.022 and P=0.025) and indoxyl sulphate (P=0.001 and P=0.005, 
respectively). Compared to urea, hippuric acid and indoxylsulphate were 
characterized by a significant smaller total distribution volume (P=0.001 both), 
while IAA is distributed in a volume comparable to that of urea.  
Considering the inter-compartmental clearance K12, the only significant 
difference was found between the value for indoxyl sulphate and that for urea 
(P=0.022), the value for indoxyl sulphate being lower. 
No correlations were found between the kinetic parameters for the different 
investigated protein-bound compounds, nor between the parameters for urea and 
those for the protein-bound solutes. 
The reduction rates for the different protein-bound compounds are given in Table 
V-8 and are compared to the urea reduction ratio URR [338]. The post-dialysis 
concentration for hippuric acid, indoxyl sulphate, and IAA were taken at the 
kinetic model, whereas for p-cresol and CMPF the in vivo measured data was 
used for the calculation of RR. 
Table V-8: Reduction ratio for protein-bound solutes. 
Compound C1_pre 
mg/L 
C1_post 
mg/L 
RR 
% 
Urea  1440 ± 540 366 ± 156 75 ± 4 
Hippuric acid 89.5 ± 38.6 20.1 ± 90.6 78 ± 3 
Indoxyl sulphate 32.0 ± 13.8 21.2 ± 9.7 34 ± 6 
IAA 2.5 ± 1.0 1.5 ± 0.7 43 ± 7 
P-cresol  7.8 ± 1.6 5.8 ± 1.5 26 ± 6 
CMPF 6.5 ± 2.3 7.1 ± 2.3 -13 ± 20 
pre-dialysis plasma concentration C1_pre; post-dialysis plasma 
concentration C1_post ; reduction ratio RR. 
All protein-bound solutes were characterized by a reduction ratio that is 
significantly smaller compared to urea, except hippuric acid. The RR for CMPF 
was even found negative, although with a large standard deviation. While most 
solutes under study showed a reduction ratio that is significantly different from 
each other, a comparable RR was found for urea and hippuric acid, indoxyl 
sulphate and IAA, and indoxyl sulphate and p-cresol.  
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4.4. Discussion 
In the present study, the kinetic behavior of several protein-bound compounds 
was examined, and comparisons were made with the small and water-soluble 
molecule urea. Plasma concentrations during dialysis were evaluated and for 
those solutes following a bi-exponential profile, a two-pool kinetic model was 
applied to describe the kinetics. The measured concentration data was fitted 
using three parameters: perfused volume V1, total distribution volume Vtot, and 
inter-compartmental clearance K12.  
The major results of this study are: first, the removal of p-cresol is non efficient 
and concentrations vary arbitrarily at least during the first half hour of dialysis; 
second, CMPF is characterized by a concentration increase towards the end of 
dialysis; third, hippuric acid, indoxyl sulphate, and IAA show a bi-exponential 
concentration decline during dialysis, and, even more, the compartmentalization 
of IAA is comparable to that of urea; and fourth, hippuric acid is removed from 
the body according a reduction ratio similar to that of urea. 
P-cresol (4-methylphenol), which is partially hydrophilic and lipophilic, shows 
very tight binding to serum proteins (Table V-6), especially to albumin (factor 
1.78 from total serum protein). Evaluation of the intra-dialytic variation of total 
serum protein (Fig. V-6), however, cannot explain the behavior of p-cresol. 
 
Fig. V-6: Mean total serum protein (with SD) in samples from the inlet (rhombs) and outlet 
blood line (triangles), as a function of dialysis time. 
While normally eliminated by the healthy kidneys, serum concentrations are 
much increased in renal insufficiency, and even more, p-cresol generation was 
found increased in uremic patients [339]. Several findings suggested that p-cresol 
plays a role in the enhanced susceptibility to infection [340,341]. Because of its 
protein binding, it was however found that the biologic activity is especially 
exerted by the free p-cresol fraction [336,341]. As a consequence, instead of 
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focusing only on total p-cresol concentrations during dialysis, it is more 
appropriate to determine total as well as free fractions of the plasma samples. 
Combining those results with the change in total serum protein might learn us 
more about binding and p-cresol removal. 
The intra-dialytic increase in plasma concentrations of the strongly lipophilic 
solute CMPF can be explained, as reported earlier, by hemoconcentration 
according to the removal of plasma water [334,342]. Its totally different behavior 
during dialysis as compared to hippuric acid and indoxyl sulphate might be 
explained by the fact that CMPF is the strongest protein-bound compound [342]. 
Although CMPF and p-cresol are both strong protein binders, p-cresol plasma 
concentrations did not merely increase due to hemoconcentration. As a 
consequence, their different intra-dialytic behavior suggests an important role of 
free p-cresol, while no free fraction can be observed with CMPF. 
The reduction rates as found for indoxyl sulphate and hippuric acid correspond 
well with earlier reported values for uremic patients [334,343]. The kinetic behavior 
of hippuric acid, characterized by an RR of 78±3%, can be explained as follows. 
First, in spite of its protein binding, it is distributed in a significantly smaller 
volume compared to urea, approaching a single pool behavior. And second, 
although its distribution is similar to that of indoxyl sulphate, hippuric acid 
shows a markedly lower protein binding, resulting in a better clearance (Table 
V-7). In analogy, although IAA is distributed in a volume similar to that of urea, 
protein binding impeded adequate solute removal.  
In conclusion, some protein-bound compounds can be evaluated using a two-pool 
kinetic model (i.e. hippuric acid, indoxyl sulphate, indole-3-acetic acid IAA). 
Because the reduction ratio is depending on the degree of compartmentalization 
and protein binding, each protein-bound solute is characterized by a specific 
kinetic behavior. Furthermore, other protein-bound solutes, like p-cresol and 
CMPF, cannot at all be modeled with the proposed kinetic model and need 
further solute-specific investigation.  
4.5. Conclusion 
It is known from literature that protein-bound compounds affect major 
biochemical and biological functions involved in the uremic syndrome and are 
directly related to clinical conditions. Less is known, however, about their intra-
dialytic kinetic behavior and the processes impeding efficient solute removal. 
Therefore, major protein-bound solutes were preliminary investigated using a 
two-pool kinetic model. While the kinetics of hippuric acid, indoxyl sulphate, 
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and indole-3-acetic acid (IAA) could be explained with the proposed model, p-
cresol and carboxy-methyl-propyl-furanpropionic acid (CMPF) need further 
investigation. It can be concluded that the combination of compartmentalization 
and affinity for protein binding and/or release results in a solute-specific kinetic 
behavior. 
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1. Chapter overview 
This chapter starts with a presentation of the Genius single-pass batch system 
consisting of a dialysate container in which fresh as well as spent dialysate are 
stored. The principle of fluid separation and the impacting factors, i.e. 
temperature and solute concentrations, are explained. 
A theoretical, experimental, and numerical analysis was applied to investigate 
and describe fluid separation. 
The theoretical analysis was set out to predict mixing of fresh with spent 
dialysate for standardized as well as non-standardized dialysis, based on a limited 
number of data. Therefore, the heat and mass transfer in the entire Genius 
circuit was described theoretically and a number of parameters were derived 
empirically with in vitro and in vivo measurements. The theoretical derivation 
was validated with in vivo data. 
With an in vitro setup, the influence of both parameters, i.e temperature and 
concentration, was investigated experimentally. Suggestions were formulated to 
maintain dialysis adequacy when performing protracted dialysis. 
Finally, a numerical model was developed to visualize the temperature and 
concentration variations of the fresh and spent dialysate inside the container. This 
allows a better understanding of the relative impact on mixing of both 
parameters. 
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2. Introduction 
The Genius single-pass batch system (Fresenius Medical Care, Bad Homburg, 
Germany) was originally developed by Tersteegen and Van Endert [344]. The 
mobile system contains a closed loop dialysate circuit with a container of 75L of 
prepared dialysate. 
Fig. VI-1 shows a diagram of the Genius system. A double-sided roller pump 
(1) simultaneously generates blood and dialysate flow (maximum 300mL/min) in 
the dialyzer (2). The ultrafiltered fluid is collected in the filtrate recipient (3). In 
the isolated closed dialysate container of 75L (4), the spent dialysate (5) is 
drained at the bottom, while the fresh dialysate (6) is expelled from the top.  
It has been claimed that an adequate separation of spent and fresh dialysate is 
maintained during the entire dialysis session based on differences in fluid density 
[344]. Because density is mainly determined by temperature and concentration, 
both aspects are further investigated theoretically, with experiments, and 
numerically. 
 
Fig. VI-1: Flow chart of the Genius dialysis system. Double-sided roller pump (1), dialyzer 
(2), ultrafiltrate recipient (3), closed container with 75L dialysate (4), spent dialysate (5), fresh 
dialysate (6), arterial blood line (7), venous blood line (8), sampling port for fresh dialysate (9), 
sampling port for spent dialysate (10). 
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3. Theoretical analysis of Genius dialysis† 
3.1. Abstract 
Hemodialysis remains up till now the most frequently applied technique to 
remove uremic retention solutes from patients with severe chronic and acute 
renal failure. In contrast to the standard stationary dialysis setup using online 
dialysate production, the Genius single-pass batch system, containing a closed 
dialysate reservoir of 75 liters and a closed-loop circuit, offers a mobile 
configuration. The fresh dialysate is expelled at the top of the reservoir, while the 
spent dialysate is drained at the bottom. Although it has been claimed that fluid 
separation in the container between fresh and spent dialysate is maintained 
during an entire dialysis session of 4 hours, there are no studies that challenge 
this hypothesis under extreme conditions. Therefore, the present study was 
undertaken to investigate whether this separation is guaranteed under whatever 
clinical circumstance. This question was especially addressed since partial 
recirculation of spent dialysate results in a significant decrease of dialysis 
adequacy. Fluid separation is based on density differences. Because 
concentrations and temperatures affect density, a theoretical description of mass 
and heat transport in the Genius circuit was derived and validated performing in 
vivo and in vitro experiments. The derived theory was found adequate to predict 
dialysate mixing. Moreover, the key conclusion of this study was that dialysate 
mixing inside the container is more likely when temperature differences between 
fresh and spent dialysate are reduced. 
3.2. Background 
Kidney failure is a major and still expanding problem in our modern society. One 
of the most frequently applied therapies for removal of the solutes retained 
during renal failure is hemodialysis, a blood purification technique in which the 
patient’s blood is circulated extra-corporeally through an artificial kidney. In the 
latter, also called hemodialyzer, blood and dialysate are circulated counter 
currently on opposite sides of a semi-permeable membrane. This membrane 
permits the diffusive and/or convective passage of waste metabolites but restricts 
the transfer of blood proteins and cells from the blood towards the dialysate. 
                                                     
† The contents of this section was submitted for publication 
Temperature and urea concentrations as determinants of correct Genius operation. 
S. Eloot, A. Dhondt, J. Vierendeels, D. De Wachter, R. Vanholder, and P. Verdonck  
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During a regular hemodialysis session, the patient’s blood is pumped through the 
dialyzer using one or two cannulas as the patient’s vascular access. The dialysis 
machine continuously monitors the on-line production of dialysate, a mixture of 
reverse osmosis water with concentrated salts. Fresh dialysate is pumped into the 
dialyzer, where it is loaded with waste products, and subsequently the spent 
dialysate is eliminated from the dialyzer into the waste system. 
The Genius single-pass batch system for hemodialysis (Fresenius Medical Care, 
Bad Homburg, Germany), however, contains a closed loop dialysate circuit with 
a container of 75L of prepared dialysate. Originally developed by Tersteegen and 
Van Endert [344], the system is characterized by some important advantages, such 
as no need for dialysate preparation on the spot, the use of ultrapure dialysate, the 
efficient controllability of ultrafiltration, its user-friendliness, and its easy 
transportability. 
A diagram of the Genius system is presented in Fig. VI-1. In several aspects, the 
single-pass batch system differs from other currently used dialysis machines as it 
contains a closed reservoir in which fresh and spent dialysate are stored. A 
double-sided roller pump (1) simultaneously generates blood and dialysate flow 
in the dialyzer (2), so that blood inlet and dialysate outlet flow (fresh dialysate 
plus ultrafiltration flow) are the same (maximum 300mL/min). The excess body 
water that is ultrafiltered out of the blood plasma of the patient is collected in a 
filtrate recipient (3). Instead of a fixed water connection and on-line purification 
plant, the system contains an isolated closed dialysate container of 75L (4), and 
the dialysate is produced in a separate preparator to which the tank is connected 
prior to its use. The spent dialysate (5) is drained at the bottom of the container 
by flowing downward through a central glass tube, while the fresh dialysate (6) is 
expelled from the top. It has been claimed that an adequate separation of spent 
and fresh dialysate is maintained during the entire dialysis session based on 
differences in fluid density [344]. If mixing would occur, dialysis efficiency would 
decrease and partial recirculation of spent dialysate results in patient re-
intoxication by backdiffusion and/or backfiltration of uremic toxins. The earlier 
this mixing occurs, the more important the loss in adequacy. 
In the present study, we investigated whether and when the main advantage of 
the Genius system, i.e. the closed dialysate circuit and container, is turned into a 
disadvantage. Is fluid separation in the container guaranteed under any clinical 
circumstance? As concentration and fluid temperature mainly determine the 
density of the spent dialysate, it is conceivable that mixing might be induced with 
specific dialysis treatment conditions. To better understand all impacting factors 
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influencing the incidence of dialysate mixing in the container, in the present 
analysis, mass and heat transport will be described theoretically in the entire 
Genius circuit and a number of parameters will be derived empirically from in 
vitro and in vivo measurements. In vivo data was used to validate our theoretical 
approach. Finally, this study is concluded by a formulation of some 
recommendations in order to avoid dialysate mixing in the container, such that 
dialysis adequacy is maintained.  
3.3. Materials and methods 
3.3.1. Theoretical approach 
Since temperature and concentration may influence density differences between 
the spent and fresh dialysate inside the container, a good understanding of heat 
and mass transfer in the dialysis circuit is necessary to investigate or prevent 
dialysate mixing in the container. Therefore, heat and mass transfer in the entire 
dialysis circuit is analyzed theoretically in order to define the distribution of the 
temperatures and concentrations in the container. 
3.3.1.1. Heat transfer 
Heat transfer processes involve one or more of the following modes: conduction, 
convection and/or radiation. In the Genius dialysis setup, we can distinguish 
between energy transfer to and from the patient, in the dialyzer, in the dialysis 
tubings, and in the container.  
Patient’s blood and body temperature 
The temperature of blood extracted from the patient’s vascular access does not 
necessarily reflect body temperature (Tbody) because of possible access and 
cardiopulmonary recirculation. Therefore, the temperature of the blood fowing 
into the arterial blood line (Tart) must be corrected by the degree of recirculation 
R (%) of the blood flowing back from the venous blood line with a temperature 
Tven [345]: 
 
R1
RT
R1
1TT venartbody −⋅−−⋅=  Eq. VI-1 
Temperature balance in the dialyzer 
Inside a hollow fiber dialyzer, blood and dialysate flow in a counter current 
fashion at each side of a semi-permeable membrane. As a consequence, radial 
heat transport between both fluids will take place from the warmer to the colder 
fluid, according to the local temperature gradient. In the following mathematical 
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derivation, dialysate inflow temperature is assumed to exceed blood inflow 
temperature. For a negligible contribution of ultrafiltration to heat transport, the 
overall heat balance in the dialyzer could be described in the direction of flow as: 
 ( ) dxPT-ThdTcmdTcm FBDMBpBBDpDD ⋅⋅⋅−=⋅⋅−=⋅⋅ &&  Eq. VI-2 
With Dm& and Bm& , respectively, the applied dialysate and blood mass flow rates 
(kg/s), which vary slightly with temperature, cp the specific heat capacity of the 
fluids (J/kg/K), T the absolute temperature (K), hM the heat transfer coefficient 
through the membrane (W/m²/K), PF the summation of the perimeters of all 
dialyzer fibers (m) and x the considered axial direction (m).  
 
Fig. VI-2: Pressure, temperature, and concentration profiles in a hemodialyzer with the 
presentation of forward (0,xt) and backfiltration (xt,LF). 
Integration over the entire fiber length LF renders the unknown outlet 
temperatures (subscript o) as a function of the a priori known inlet temperatures 
(subscript i) (Fig. VI-2): 
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With the coefficients α (-) and β (1/m) defined as: 
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 Eq. VI-4 
To calculate the blood and dialysate temperatures at an arbitrary position in the 
dialyzer (Fig. VI-2), LF should be substituted by (x) in the equation for TBo and 
by (LF-x) in the equation for TDo (Eq. VI-3). 
Besides heat conduction over the dialyzer membrane, blood and dialysate 
temperatures are also influenced by the convection of plasma ultrafiltrate (in case 
of forward filtration) and dialysate (in case of backfiltration) through the 
membrane. If the local ultrafiltration rate becomes non-negligible, the overall 
heat balance in the dialyzer (Eq. VI-2) must be extended, accounting for the 
convective heat transfer: 
 ( ) ( )
( ) UFpUFUFUFFBDM
BpBBDpDD
TcρdQdxPT-Th 
TcmdTcmd
⋅⋅⋅±⋅⋅⋅−=
⋅⋅−=⋅⋅ &&
 Eq. VI-5 
With ρUF, cpUF, and TUF the density, specific heat capacity, and local temperature 
of the filtration fluid. The positive sign in the last right-hand term corresponds to 
forward filtration, while the negative sign is related to backfiltration. The 
ultrafiltration flow dQUF (m³/s) is driven by the local pressure gradient between 
the blood and dialysate compartment ∆p = pB-pD (Pa) (Fig. VI-2), and is further 
function of the membrane permeability coefficient kM (m²/s/Pa) and the 
membrane surface area dAM (m²): 
 
∆r
∆pdAkdQ MMUF ⋅⋅=  Eq. VI-6 
As ultrafiltration takes place in radial direction, ∆r is equal to the membrane 
thickness dM (m), and the ultrafiltration flow can be written as a function of the 
membrane characteristic dKUF, also called ultrafiltration coefficient (m³/s/Pa): 
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 ( ) ( )DBUFDB
M
MM
UF ppdKppd
dAkdQ −⋅=−⋅⋅=  Eq. VI-7 
The occurrence and localization of forward and backfiltration can be determined 
by considering the pressure distributions in blood and dialysate. Poiseuille’s law, 
valid for laminar flow in circular tubes, can be applied to determine the local 
pressure drop dpB in the blood compartment: 
 
dx
Dπnρ
mµ128dp 4
FFB
BB
B ⋅⋅⋅⋅
⋅⋅= &  Eq. VI-8 
With µB and ρB the dynamic blood viscosity (0.003Pa·s) and density 
(1054kg/m³), nF the total number of fibers in the dialyzer (-), and DF the fiber 
diameter (m). For the non-circular inner space of the dialysate compartment, an 
equivalent diameter Deq can be derived from dpD as found in a previous 
performed numerical study [141] and by using Eq. VI-8. Both pressure drops, dpB 
and dpD, reflect the slope of the pressure distribution at each side of the 
membrane (Fig. VI-2). The total area in between both curves is a measure for the 
overall ultrafiltration flow rate as set by the dialysis machine, QUFtot (m³/s), and is 
determined by the transmembrane pressure TMP (Pa) and the oncotic pressure 
∆π (Pa): 
 
UF
UFtotDoDiBoBi
K
Q
∆π
2
pp
2
pp
TMP =−+−+=  Eq. VI-9 
As a consequence, backfiltration may occur wherever the dialysate pressure 
exceeds the blood pressure (Fig. VI-2).  
Due to ultrafiltration, the blood mass flow rate, Bm& , in Eq. VI-8 is decreasing 
over the dialyzer length in the x-direction, resulting in a corresponding increase 
of dialysate mass flow rate Dm&  in the opposite x-direction. This phenomenon 
results in a pressure drop profile slightly deviating from linearity. The deviation 
was found, however, insignificant for forward ultrafiltration flow rates restricted 
to 2L/h [141].  
Neglecting the non-linearity of the pressure distributions, ultrafiltration can be 
written as a linear function of the position x: 
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Eq. VI-10 
If forward as well as backfiltration occurs, Eq. VI-5 should be used for each part 
of the dialyzer separated by the transition point, xt, where forward filtration 
switches to backfiltration. In the part of forward filtration, (0,xt), the inlet 
dialysate temperature is TD(xt), whereas for backfiltration, the inlet blood 
temperature is TB(xt). As a consequence, to determine the temperature 
distribution in a dialyzer in which forward and backfiltration take place 
simultaneously, Eq. VI-5 should be solved iteratively. 
Heat transfer in the tubings 
When blood and dialysate are pumped through the dialysis tubings, their 
temperature will decrease by heat loss to the ambient room temperature, Troom. 
The heat exchange phenomenon is described by: 
 ( ) TroomTp dATThdTcm ⋅−⋅=⋅⋅&  Eq. VI-11 
With hT the effective heat loss coefficient through the tubing wall (W/m²/K), and 
AT the heat exchange area (m²), which is equal to the product of the perimeter PT 
with the considered tubing length LT. The dialysate temperature at a distance LT 
of the tubing, T(LT), can be calculated from the solution of the differential Eq. 
VI-11, and is function of the dialysate temperature at zero distance T(0): 
 ( ) ( )[ ] 


 ⋅⋅
⋅−⋅−+= T
p
TT
roomroomT Lcm
PhexpT0TTLT &  Eq. VI-12 
Temperature distribution in the dialysate container 
Because the fresh dialysate can only be heated during the preparation procedure, 
prior to the dialysis session, spontaneous cooling of the dialysate starts 
immediately after the preparation, by heat exchange with the cooler room 
temperature, Troom. Furthermore, the temperature of the spent dialysate inside the 
container is influenced by the convective inflow (dV) of new additional spent 
dialysate if it has a different temperature from the already present spent dialysate, 
and by heat conduction from the warmer fresh to colder spent dialysate or vice 
versa. Because the thermal conductivity is only 0.6W/m/K [62], conduction can be 
considered not important compared to convection, and total change in heat in the 
volume of spent dialysate can be described as: 
Analysis of dialysis using a single-pass batch system  
 245
 ( ) ( ) ( ) ( ) ( ) ( )[ ]
( ) dVpdVroomCC
ppp
TcmTTA-h                 
tTtctm∆ttT∆ttc∆ttm
∆t
1
dt
dTcm
⋅⋅+−⋅⋅=
⋅⋅−+⋅+⋅+⋅=⋅⋅
&
&
 Eq. VI-13 
with hC the effective heat transfer coefficient (W/m²/K), AC the interface surface 
between fresh and spent dialysate (m²), cpdV and TdV the specific heat capacity 
(J/kg/K) and temperature (K) of the inflowing spent dialysate, and the mass 
( ) ( ) ∆tmtm∆ttm ⋅+=+ & . 
Because the specific heat capacity, cp, can be assumed constant in the clinical 
temperature range of 34-38°C, Eq. VI-13 can be solved for T(t + ∆t): 
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 Eq. VI-14 
in which the thermal transport velocity k (1/s) can be substituted by: 
 
( )( ) p
CC
c∆tmtm
Ahk ⋅⋅+
⋅= &&  Eq. VI-15 
Finally, the spent dialysate flows downward through the central glass tube 
entering the container cavity at the bottom side (Fig. VI-1). As a consequence, 
the temperatures of the surrounding fresh and/or spent dialysate inside the 
container, as well as the inflowing spent dialysate, are influenced by coupled heat 
transport (i.e., convection and conduction). Because of the limited heat exchange 
area of the central tube (≈0.09m²) compared to the total container surface 
(≈0.93m²), heat exchange near the central tube affects a much smaller dialysate 
volume inside the container, compared to the heat exchange near the wall. 
3.3.1.2. Mass transfer of solutes 
Although numerous other retention compounds [229,292] could be used to describe 
mass transport in a dialyzer, the small molecule urea was used as marker in the 
present study. During dialysis, the patient’s body urea concentration is 
diminishing (whole-body clearance) as urea is transported, mainly by diffusion, 
over the dialyzer membrane (dialyzer clearance) towards the dialysate 
compartment (Fig. VI-3). 
Whole-body clearance 
Since urea is a small water-soluble molecule, which is easily transferred among 
the intra and extra-cellular compartments in the patient, urea body levels were 
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assumed to obey single-pool kinetics [325,346]. The mass balance of such a model 
can be described in terms of a differential equation (Fig. VI-3): 
 ( ) ( )DiBiSBiurea CCDGdt
CVd −⋅−=⋅  Eq. VI-16 
Vurea, the patient’s urea distribution volume (L), is supposed to equal 58% of total 
body weight [347,348], CBi is the urea blood concentration at the dialyzer inlet 
(mol/L), GS the urea generation rate (mol/min), CDi the dialysate inlet urea 
concentration, and D the diffusive dialysance (L/min). The latter is a dialyzer 
characteristic and is defined as the ratio of the blood-side concentration change to 
the concentration driving force [86]: 
 
Bi
DiBi
BoBi Q
CC
CC
D ⋅−
−=  Eq. VI-17 
 
 
 
Fig. VI-3: Single-pool model to evaluate the whole-body and dialyzer clearance with respect to 
the small molecule urea. 
Eq. VI-16 should be numerically integrated. If, however, the change in 
distribution volume, dV/dt, due to ultrafiltration, can be neglected, and the inlet 
dialysate concentration can be assumed constant, the urea concentration variation 
in time, CBi(t), is an exponential function of the start concentration, CBi(0): 
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For an urea generation rate GS of 300mmol/24h [338], and a zero dialysate inlet 
concentration if no dialysate mixing occurs inside the container, CBi increases by 
only 0.08%, such that the right-hand term in Eq. VI-18 can be neglected. 
Mass transfer in the dialyzer 
The small and water-soluble molecule urea is easily transported by diffusion 
through the dialyzer membrane without any adsorption. The contribution of 
convection to the overall solute removal is negligible for small molecules like 
urea, such that the influence of ultrafiltration might be neglected. In analogy with 
the description of the heat balance inside a dialyzer, the mass balance is in the 
flow direction given by (Fig. VI-2): 
 ( )
( ) dxC-CPK
C-CdAKdCQdCQ
DBF0
DBM0DDBB
⋅⋅⋅−=
⋅⋅−=⋅−=⋅
 Eq. VI-19 
QB and QD represent the blood and dialysate flow rates (m³/s), C the urea 
concentration (mol/m³) in blood (subscript B) and in dialysate (subscript D), K0 
the overall mass transfer coefficient (m/s), AM the mass exchange area (m²), PF 
the summation of the perimeters of all fibers (m²), and x the axial direction (m).  
Integration over the fiber length LF, in the special considered case of equal blood 
and dialysate flow rates, results in the following expressions for the outlet blood 
and dialysate concentrations as a function of the inlet concentrations: 
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 Eq. VI-20 
With the coefficients δ and ε equal to: 
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In order to obtain the blood and dialysate concentrations at an arbitrary distance 
x, LF should be substituted by (x) in the equation for CBo and by (LF-x) in the 
equation of CDo (Eq. VI-20). 
Mass transfer inside the dialysate container 
Mass is often transferred simultaneously by two possible mechanisms: diffusion 
and convection. Diffusion is the result of concentration differences and occurs 
from a region of higher concentration to one of lower concentration. Convective 
mass transfer, however, is due to bulk motion of the fluid. In case of natural 
convection, this motion is induced by density differences, which result from 
concentration and temperature variations, while forced convection can take place 
due to mass inflow in the container. The general convection-diffusion equation is 
defined as: 
 ( )uuρuρn ureaureaureaurea −⋅+⋅=  Eq. VI-22 
With nurea the urea mass flux (kg/m²/s), ρurea the urea density (1323kg/m³), u the 
fluid velocity (m/s), and (uurea-u) the diffusional velocity of urea in the fluid 
(m/s). The second right-hand term in Eq. VI-22, describing diffusive transport 
(jurea), can be expressed by Fick’s law: 
 ( ) ( )
ds
ωd
Dρuuρj ureaureaureaureaurea ⋅⋅−=−⋅=  Eq. VI-23 
With Durea the diffusion coefficient of urea in dialysate (m²/s), ρ the total density 
(kg/m³), and dωurea/ds the urea mass fraction gradient in the s direction. 
The dimensionless Péclet number describes the relative importance of convection 
compared to diffusion, and is defined as the ratio of a convective term to a 
diffusive term: 
 
urea
C
D
Lu
Pe
⋅=  Eq. VI-24 
LC represents a characteristic length of the container (m) (eg. container height). 
To have an idea about the relative importance of buoyancy forces acting in the 
fluid, we can consider the dimensionless drag coefficient, DDC, defined as the 
ratio of the gravitational force to the inertial force: 
 ( )
2
C
uρ
gLρ'-ρ
DDC ⋅
⋅⋅=  Eq. VI-25 
With (ρ’- ρ) the density difference between the reservoir’s and inflowing spent 
dialysate, and u the local convective fluid velocity. 
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It should be remarked that the buoyancy force in a fluid results in a tendency for 
the upper regions to be composed of lower density material than the lower 
regions. This phenomenon, also referred to as mass stratification, may be discrete 
or continuous.  
Because no direct data was available of the densities inside the container, density 
of fresh and spent dialysate were calculated accounting for the temperature and 
concentration influence. Density of fresh dialysate was determined from the 
concentration of its components (paragraph 3.3.2.2) and was found 1004.37g/L at 
37°C. Spent dialysate consists of water, electrolytes and uremic solutes. 
Neglecting electrolyte, glucose and acid base shifts during dialysis, the amount of 
electrolytes can be considered similar as in fresh dialysate. The density of spent 
dialysate was determined based on the measured urea concentrations in dialysate, 
simultaneously measured concentrations of protein-bound solutes [unpublished 
data], and calculations using reported uremic solute serum concentrations [229]. 
3.3.2. Validation study 
3.3.2.1. In vitro experiments 
Dialysate temperature variation over the tubing length was measured in order to 
calculate empirically the effective heat transfer coefficient through the tubing 
wall, hT (Eq. VI-12). More specific, temperature was registered using two probes, 
which were placed consecutively at different mutual distances in the dialysate 
line (0.225, 1.05, and 2.01m) upstream from the dialyzer. Room temperature was 
measured simultaneously.  
3.3.2.2. In vivo experiments 
A uremic patient, regularly dialyzed with standard hemodialysis, was 
experimentally dialyzed twice with the Genius single-pass batch system [349]. A 
high-flux polysulfone 70S dialyzer (Fresenius Medical Care, Bad Homburg, 
Germany) was used in combination with a blood and dialysate flow of 
300mL/min. The composition of the dialysate was: 35mmol/L bicarbonate, 
140mmol/L sodium, 111.5mmol/L chloride, 5.5mmol/L glucose, 0.084mmol/L 
citrate, 1.25mmol/L calcium, 0.5mmol/L magnesium, and 1mmol/L potassium. 
Two dialysis sessions were performed using a dialysate start temperature either 
of 36.4°C or 37.6°C. The ultrafiltration volume was 3.6L (QUF 13.3mL/min) and 
4.2L (QUF 15.5mL/min) during the session with the low and higher dialysate start 
temperature, respectively. 
Dialysate temperatures were registered at 5, 30, 60, 90, 120, 150, 180, 210, 225, 
230, 235, 240, 255, and 270 minutes after the onset of dialysis at the entrance and 
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exit of the container. The patient’s body temperature was measured at the start 
and after 120 and 240 minutes. 
In order to determine urea mass transport, dialysate was sampled from the 
container exit and entrance line (numbers 9 and 10 in Fig. VI-1) after 5, 60, 180, 
210, 225, 230, 235, 240, 255, and 270 minutes. The samples were stored at -20°C 
until analysis. Blood samples were taken at the arterial blood line at the start of 
dialysis and after 240 and 270 minutes. After immediate centrifugation at 
3000rpm (CR 412, Jouan, Saint-Herblain, France), the serum samples were 
stored at -20°C until analysis. Urea concentrations (mmol/L) were determined by 
the Urease/Berthelot reaction and measured photometrically at 570nm (Genesys 
10 vis, Spectronic, Unicam, Rochester, NY, USA). 
3.3.2.3. Theoretical predictions 
Two major questions were investigated to check the validity of the theoretical 
approach. First, is it possible to determine the temperature and urea concentration 
at the container entrance based on the temperature and concentration measured at 
the container exit and accounting for the influence of dialysis? And second, is it 
possible to predict the temperature and concentration variations inside the 
container with the known entrance and exit temperatures and concentrations? In 
other words, is it possible to predict mixing? If so, the described theory would be 
applicable to calculate mixing for less current dialysis strategies (e.g. long slow 
dialysis) by performing a limited number of tests, and to determine which setups 
can be applied to prevent mixing as long as possible and to offer as adequate as 
possible dialysis. 
3.4. Results 
3.4.1. Prediction of temperature at the container entrance 
3.4.1.1. Measured data 
Fig. VI-4 illustrates the dialysate temperatures as measured at the container 
entrance (squares) and exit (triangles) at different time points during in vivo 
dialysis. The patient’s body temperature was measured at 0, 120, and 240 
minutes (rhombs). Those measured data were linearly interpolated (dotted line in 
Fig. VI-4) and a mean body temperature of 36.0±0.2°C (colder dialysis) and 
36.3±0.1°C (warmer dialysis) was found.  
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3.4.1.2. Calculated data 
As validation of the theory, the dialysate temperature at the container entrance 
was calculated theoretically based on the measured exit temperature and patient’s 
body temperature, and the results were compared to the measured data. 
 
Fig. VI-4: Blood and dialysate temperature time course at the inlet and outlet of the dialyzer for a 
dialysate start temperature of 36.4°C (left panel) and 37.6°C (right panel). Measured temperature 
of the patient’s body (rhombs), fresh dialysate at the container exit (triangles), and spent dialysate 
at the container entrance (squares). Calculated temperature of the patient’s body (dotted line), 
blood at dialyzer inlet (thin line), blood at dialyzer outlet (crossed line), and dialysate at the 
container entrance (bold line). 
In order to account for the influence of dialysis, the ultrafiltration profile in the 
dialyzer might play a role and was first calculated. For the Fresenius F70S 
dialyzer with 10800 fibers (inner diameter 200µm), the pressure drop in the 
blood compartment is 61mmHg. An equivalent fiber diameter of 259µm 
corresponds with a dialysate flow of 300mL/min and dialysate pressure drop of 
5mmHg. The F70S dialyzer is characterized by an ultrafiltration coefficient of 
122mL/h/mmHg, derived with the in vitro method earlier described by Eloot et 
al. [142]. An ultrafiltration flow of 13.3mL/min (cf. the colder dialysis session) 
results in a mean transmembrane pressure (TMP) of 6.7mmHg. Calculated 
pressure and flow distributions are illustrated in Fig. VI-5. For the applied blood, 
dialysate and ultrafiltration flows, forward filtration converts into backfiltration 
at 60% of the dialyzer length (xt = 0.138m). This results in a total amount of 
forward and backfiltration of 39.6mL/min and 26.3mL/min, respectively. Despite 
the considerable amount of forward and backfiltration, heat transfer owing to the 
ultrafiltrate flow inside the dialyzer was rather limited (less than 5% 
contribution) compared to the conductive heat flow. 
In order to quantify heat loss in the tubings, dialysate temperatures were 
measured in vitro at different distances LT in the dialysate line. For a dialysate 
mass flow of 5.04·E-3kg/s (corresponding to 300mL/min), a room temperature of 
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25.5±0.2°C, and a start dialysate temperature of 37.5±0.6°C, an effective heat 
transfer coefficient hT of 35.2±14.2W/m²/K was found using Eq. VI-12. 
 
Fig. VI-5: Pressure and flow along an F70S hemodialyzer for QB=QD=300mL/min and 
QUF=13.3mL/min. 
Accounting for the dialysate cooling when flowing through the dialysis tubings, 
we calculated the dialysate temperature at the dialyzer inlet (TDi). From the 
measured patient’s body temperature (Tbody) and accounting for the heat loss in 
the tubings, blood temperature at the dialyzer inlet (TBi) was calculated 
iteratively using Eq. VI-1 (Fig. VI-4, thin line). Assuming a realistic heat transfer 
coefficient hM in the dialyzer of 300W/m²/K, blood outlet temperature  (TBo) 
(crossed line) and dialysate outlet temperature (TDo) were determined using Eq. 
VI-3. The latter was further used to determine the dialysate temperature at the 
container entrance (bold line in Fig. VI-4), which was compared to the measured 
data (squares). Deviations between calculations and measurements were 
2.1±0.9% (number of data points n=14) and 1.0±0.9% (n=14) for the colder and 
warmer dialysis, respectively. 
3.4.2. Prediction of concentration at the container entrance  
3.4.2.1. Measured data 
The patient’s urea concentrations sampled at the arterial blood line are given in 
Table VI-1 for the colder and warmer dialysis session, while Fig. VI-6 shows the 
measured dialysate urea concentrations at the container entrance (crosses) and 
exit (rhombs).  
QD QD - QUF
QB QB - QUF
dx
61mmHg
0mmHg
dpB = 61mmHg
dpD= 5mmHg
p
0
x (m)
0.230.145 0
18.9mL/min
32.2mL/min
19.4mmHg
24.4mmHg
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3.4.2.2. Calculated data 
To validate the theory, the urea concentration at the container entrance was 
determined applying the data as measured at the container exit and in the 
patient’s blood, and the results were compared to the measurements. 
Table VI-1: Blood urea concentrations CBi (mmol/L). 
Time point 
minutes 
CBi for colder dialyis 
mmol/L 
CBi for warmer dialysis 
mmol/L 
0 15.67 16.67 
240 4.43 4.50 
270 4.70 4.83 
 
 
Fig. VI-6: Time course of urea concentration in blood and dialysate for a dialysate start 
temperature of 36.4°C (left panel) and 37.6°C (right panel). Measured urea concentrations of 
fresh dialysate at the container exit (rhombs), and spent dialysate at the container entrance 
(crosses). Calculated urea concentrations of blood at dialyzer inlet (thin line), blood at dialyzer 
outlet (dotted line), and spent dialysate (bold line).  
For the patient of 55kg body weight, the urea distribution volume is equal to 32L. 
From the urea blood concentration measured at the start of dialysis and after 240 
minutes, urea dialysance D was calculated using Eq. VI-18 (with CDi=0 and 
G≈0), and was found equal to 168mL/min and 174mL/min for the dialysis 
session with a dialysate start temperature of 36.4°C and 37.6°C, respectively. 
Furthermore, the blood inlet concentrations (CBi) during the entire dialysis 
session were derived (Eq. VI-18) and are illustrated in Fig. VI-6 (thin line). The 
dialysate concentrations at the dialyzer inlet (CDi) are equal to those measured at 
the container exit (see rhombs in Fig. VI-6). 
From the blood and dialysate concentrations at the dialyzer inlet (CBi and CDi), 
blood and dialysate outlet concentrations (CBo and CDo: dotted and bold line in 
Fig. VI-6, respectively) were derived using Eq. VI-20. As can be observed from 
Fig. VI-6, good agreement was found between measurements and calculations 
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(crosses and bold line, respectively), and the mean standard deviations were 
6.9±3.2% and 4.1±2.7% for the colder and warmer dialysis, respectively. 
3.4.3. Prediction of temperatures inside the container 
3.4.3.1. Measured data 
Fig. VI-7 illustrates the dialysate temperatures as measured at the container 
entrance (squares) and exit (triangles) at different time points during dialysis.  
 
Fig. VI-7: Temperature time course of fresh and spent dialysate outside and inside the container 
for a dialysate start temperature of 36.4°C (left panel) and 37.6°C (right panel). Measured 
temperature of fresh dialysate (triangles) and spent dialysate (squares). Calculated temperature of  
fresh dialysate (full line) and spent dialysate (dotted line). 
3.4.3.2. Calculated data 
The measured data was applied to calculate the spent and fresh dialysate 
temperatures inside the container. As the conductive heat transfer at the fresh and 
spent dialysate interface was limited to 7.5W, conduction was assumed 
negligible, and the temperature variations of fresh and spent dialysate were 
considered separately.  
As dialysate cooling inside the container progresses, the temperature of the fresh 
dialysate decreases exponentially with the thermal transport velocity k (Eq. 
VI-15). The latter was derived empirically from temperatures measured at the 
container exit during the first hour of the dialysis session to assure that no 
influence of the spent dialysate was considered. The thermal transport velocity 
was found equal to 0.60·E-3 1/min and 0.81·E-3 1/min for the tests with a start 
dialysate temperature of 36.4°C and 37.6°C, respectively, and for a surrounding 
room temperature of 25.5±0.2°C. The exponential relations are illustrated in Fig. 
VI-7 (full lines). 
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The temperature profile of the spent dialysate, however, was calculated from the 
measured dialysate temperature at the container entrance (squares) using Eq. 
VI-14, and is shown in Fig. VI-7 (dotted line). Although the measured dialysate 
entrance temperature (squares) exceeded the exit temperature (triangles) at 210 
and 225 minutes after the start of the colder and warmer dialysis, respectively, 
important heat transfer inside the container was only obtained at 225 minutes for 
the colder start dialysate (intersection of full and dotted line), while no significant 
heat transfer between the fresh and spent dialysate was observed starting with a 
higher dialysate temperature. This phenomenon is also reflected in the dialysate 
temperatures at the container exit (triangles), as they turn out to be constant when 
entrance and exit temperatures become equal at 210 minutes, while they continue 
decreasing exponentially for the warmer dialysis session. As a consequence, the 
described theoretical method forms a satisfactory approximation for 
determination of temperatures inside the container. 
3.4.4. Prediction of concentrations inside the container 
3.4.4.1. Measured data 
The concentrations at the container entrance and exit are shown in Fig. VI-6. 
Fresh dialysate was contaminated at 235 and 255 minutes after the start of 
dialysis for the colder and warmer dialysis session, respectively.  
3.4.4.2. Calculated data 
For a mean upward velocity of the spent dialysate front of 3.8·E-5m/s 
(2.3mm/min) and a diffusion coefficient of urea in water of 1.9·E-9m²/s, a Péclet 
number of 12000 was found inside the container (average height of 0.65m and 
virtual diameter of 0.40m). As a consequence, forced convection is much more 
pronounced compared to diffusion. It should be remarked, however, that, apart 
from the entrance zone where inflow velocities are in the order of 0.01m/s, 
kinetic energy is absorbed in the container, resulting in smaller fluid velocities 
and a much greater influence for the buoyancy forces (Eq. VI-25). As a 
consequence, buoyancy induced transport is the critical transport phenomenon 
for potential urea mixing.  
Fig. VI-8 shows the calculated densities of fresh and spent dialysate as measured 
at the container exit and entrance, respectively. The time point at which both 
densities equalize was determined from the intersection of the corresponding 
linear regressions. Equal densities at the entrance and exit were found at 200 and 
230 minutes for the colder and warmer dialysis, respectively. Those time points 
are 30.0±7.1 minutes before the expelled fresh dialysate was contaminated. This 
Chapter VI 
 256
retardation can be explained as follows: while the inflowing spent dialysate is 
climbing in the container towards regions of similar density, it will be further 
cooled down resulting in a relative density increase, such that it settles at a point 
in the container not as high as expected.  
 
Fig. VI-8: Density of fresh (rhombs) and spent dialysate (crosses) corresponding to the 
measurements at the container exit and entrance, respectively. Data is fitted by linear regression: 
R=0.987 and 0.910 for fresh and spent dialysate with colder dialysis (left panel) and R=0.997 and 
0.810 for fresh and spent dialysate with warmer dialysis (right panel). 
3.5. Discussion 
The aim of the present study was to develop a validated theoretical approach to 
predict dialysate mixing in the container of the Genius dialysis batch system. 
Because the adequacy of fluid separation is based on density differences, the 
main influencing factors, i.e. concentration and temperature, play a key role. 
Therefore, mass and heat transport in the different parts of the dialysis circuit 
were described. Validation of theory was performed in two steps. First, the 
concentrations and temperatures at the container entrance were calculated and 
compared to the measured data; and second, predictions of the concentrations 
and temperatures inside the container were compared to the measurements at the 
entrance and exit.  
Relating to the first step, several striking conclusions can be drawn from this 
study: 1) The spent dialysate temperature was calculated within close limits using 
fresh dialysate temperatures and only three measurements of body temperature. 
As a matter of fact, considering the small standard deviation, body temperature 
can be assumed constant in the theoretical calculation. 2) With respect to 
concentration, the assumption of a single pool model for urea distribution in the 
patient, described with good agreement the in vivo results. Furthermore, after 
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applying the mass balance in the dialyzer, dialysate concentrations at the 
container entrance were found conform to the measured data.  
Relating to the second step, major conclusions are: 1) Temperatures inside the 
container could be predicted theoretically, and the time point at which fresh and 
spent dialysate temperatures became identical is reflected in the temperature 
profile as measured at the container exit. 2) The densities at the container 
entrance and exit equalize at 30 minutes before contamination of the fresh 
dialysate. 
The density of the spent dialysate at the container entrance is changed by 
0.4g/L/K assuming constant concentration, while it is increased by 0.24g/L for 
each additional g/L urea assuming constant temperature. Because concentrations 
are non-controllable, temperature must be controlled in order to postpone 
dialysate mixing inside the container. It is obvious from Fig. VI-8 that dialysate 
of 36°C causes advanced mixing. Considering the measured concentration data at 
the container exit, it can be calculated by interpolation that mixing can be 
postponed until the 240th or 250th minute when using a start dialysate temperature 
of 36.7 and 37.3°C, respectively. 
Furthermore, because the thermal conductivity for heat conduction between the 
spent and fresh dialysate inside the container is 0.6W/m²/K, homogenization of 
the temperature distribution in the container was faster established for smaller 
temperature gradients between fresh and spent dialysate (i.e. start dialysate 
temperature approaching the patient’s temperature as with the colder dialysis). 
As diffusive dialysance remains constant for one set of dialyzer and operational 
conditions, dialysis adequacy decreases from the moment fresh dialysate is 
contaminated (CDi≠0). Clearance was found to decrease from 172mL/min to 
18mL/min at the 235th minute of the colder dialysis session, while it decreased 
from 179mL/min to 25mL/min at the 255th minute of the warmer dialysis session. 
As a consequence, the efficiency of dialysis decreases significantly if mixing 
occurs. 
Based on the key conclusion that dialysate mixing is enhanced for a smaller 
temperature difference between spent and fresh dialysate, some guidelines for 
clinical practice can be summarized. With a standard dialysis session during 240 
minutes, in a program of three times per week, and with standard blood and 
dialysate flow rates of 300mL/min, fresh dialysate contamination can be 
postponed by using a start dialysate temperature of at least 37°C. For non-
standardized dialysis, the described theory can be applied in advance to calculate 
mixing. 
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3.6. Conclusion 
The Genius single-pass batch system is a mobile dialysis system with numerous 
advantages if no mixing of fresh and spent dialysate occurs during dialysis. The 
present study was undertaken to investigate whether fluid separation is 
guaranteed under any clinical circumstance. Therefore, a theoretical description 
of mass and heat transport in the entire Genius circuit was derived and validated 
with in vivo and in vitro experiments. It was illustrated and explained that 
dialysate mixing is postponed when using fresh dialysate of higher temperature, 
i.e. higher than 37.3°C for mixing after the 250th minute of dialysis. Finally, the 
derived theory was found adequate to investigate in advance the risk factors of 
dialysate contamination and to determine precautions to take with a non-
standardized dialysis session. 
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4. Experimental analysis of Genius dialysis† 
4.1. Introduction 
One of the most intriguing features of the Genius system is that both fresh and 
spent dialysate are stored in the same container, with a separation among both 
compartments until the container is almost entirely filled with spent dialysate, as 
demonstrated before [349]. Although this remarkable characteristic is attributed to 
physical effects, related to the density of the dialysate, caused by its temperature 
and solute content, no studies are available in the literature evaluating the 
conditions that influence this separation either positively or negatively.  
Knowledge of these factors might be of importance especially since the Genius 
dialysis system has recently been recommended for daily protracted use in 
critically ill patients with acute renal failure [350,351]. In this specific population, 
the plasma and dialysate concentrations of uremic retention solutes tend to 
become low because of a combination of protracted dialysis and low solute 
generation due to wasting and/or malnutrition. Likewise, because of the long 
duration of the sessions, fresh dialysate may cool progressively and eventually 
may become cooler than the spent dialysate. Hence, in these conditions both 
factors that are supposed to stabilise the partitioning between both compartments 
are reduced or even absent.  
In the present in vitro study, we investigated the role of differences in density in 
the partitioning between spent and fresh dialysate. Density of spent dialysate was 
manipulated by varying its solute content and by warming spent dialysate at the 
container entrance. The relative contribution of both uremic solute concentration 
and temperature differences was analyzed. 
4.2. Materials and methods 
An experimental in vitro setup (Fig. VI-9) was developed mimicking clinical 
dialysis using the Genius system (Fresenius Medical Care, Bad Homburg, 
Germany). During the preparation procedure, the dialysate in the Genius 
container was heated to 37.6±0.2°C. A high flux F70S dialyzer was applied with 
                                                     
† The results of this section were adapted from the submitted publication 
In vitro dialysis with the Genius batch system: differentiating the effect of temperature and solute 
concentration on the partitioning of dialysate 
A. Dhondt, S. Eloot, D. De Wachter, R. De Smet, A.M. Waterloos,  G. Glorieux, N. Lameire,  
P. Verdonck, and R. Vanholder 
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blood and dialysate flows of 300mL/min. The sessions lasted 270 minutes and no 
ultrafiltration was imposed. 
 
Fig. VI-9: In vitro setup with the Genius dialysis system. 
An open tank replaced the patient, assuming a single pool kinetic behavior of the 
studied solute, i.e. urea, which is a good approximation as demonstrated in 
paragraph 3.4.2. The tank was filled with 30L fresh dialysate (simulating a 
patient of 52kg of body weight), in which an a priori known amount of urea was 
solved (10g, 20g, 30g, or 45g). This corresponds to a pre-dialysis urea 
concentration of 0.33, 0.67, 1.0, and 1.5g/L. Dialysate composition was similar to 
that described in paragraph 3.3.2.2. Hydrochloric acid, 9.87mL, was added for 
pH adjustment. To avoid recirculation, inlet and outlet blood lines were fixed in 
the tank as far as possible from each other and a blender mixed the fluid 
continuously.  
At the container entrance, the dialysate line was connected to a heat exchanger 
originating from a Centri 3 (Cobe, Zaventem, Belgium) in connection with a 
water bath heated by an immersion circulator (Julabo P, Belgolabo, Overijse, 
Belgium) (Fig. VI-9). The heat exchanger was adjusted manually to obtain the 
target temperatures. 
Dialysate temperature was measured digitally (Oregon scientific, Inc, Tualatin, 
OR, USA) both at the inlet and outlet dialysate line every 5 minutes during the 
first half hour of the session and subsequently every quarter until 210 minutes. 
1
2
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From then on measurements were again recorded more frequently: at 220, 225, 
230, 235, 240, 250, 260 and 270 min. The progressive cooling of the fresh 
dialysate, as measured at the container exit, follows initially a first order cooling 
process described as: 
 ( ) ( )[ ] ( )tkexpT0TTtT roomrrrm ⋅−⋅−+=  Eq. VI-26 
with Troom the room temperature (°C), T(0) the temperature at the start (°C), T(t) 
the actual temperature at time point t (°C), and k the thermal transport velocity 
determining the speed of cooling (1/s). To avoid influences by heat transfer from 
the tubings at room temperature at the dialysis start, and from the spent dialysate 
inside the container, k was determined considering data between 30 and 120 
minutes. 
Three different modalities were studied: first, spontaneous cooling of the 
dialysate without heating of the spent dialysate; second, heating of the spent 
dialysate such that container entrance and exit dialysate temperatures were 
continuously equal, and third, heating of the spent dialysate in order to obtain 
temperatures at the container entrance corresponding to those observed during in 
vivo experiments. The first 2 temperature patterns were applied with all 4 urea 
concentrations, the last one only with 0.33 and 0.67g/L urea. In total 10 different 
combinations were examined and each combination was tested 6 times.  
Dialysate was sampled in polystyrene tubes (Merck Eurolab, Leuven, Belgium) 
at different time points during the dialysis sessions: at the container entrance 
every 30 minutes and at the container exit at 5, 30, 60, 90 minutes, and 
subsequently every quarter until 210 min. From then on samples were again 
taken more frequently: at 220, 225, 230, 235, 240, 250, 260 and 270 minutes. All 
samples were tested for urea concentration. Urea (g/L) was determined by an 
enzymatic urease reaction (Roche Diagnostics, Mannheim, Germany).  
Data were expressed as means ± standard deviation (SD). One way analysis of 
variance (Kruskal-Wallis) followed by Mann Whitney test was applied 
(GraphPad Prism® 3.0, Graphpad Software, San Diego, California, USA). 
Significance was accepted if P<0.05. 
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4.3. Experimental results 
4.3.1. Temperature profiles 
Fig. VI-10, Fig. VI-11, and Fig. VI-12 display the mean temperatures measured 
at the container entrance and exit for different urea concentrations of the 
temperature schedule without heating, with heating until equal temperatures, and 
with heating as in vivo, respectively. 
 
Fig. VI-10: Temperature profile (mean ± SD) at the container exit (rhombs) and entrance 
(triangles) with no external heating and for a urea start concentration of 0.33g/L (left panel) and 
1.5g/L (right panel). 
With the three heating schedules, progressive cooling at the container exit was 
observed. The thermal transport velocity k was found equal to 0.96±0.12mmin-1 
for the experiments without external heating, 0.61±0.07mmin-1 for the 
experiments in which the spent dialysate was heated to obtain the same 
temperature as fresh dialysate, and 0.58±0.04mmin-1 for external heating 
simulating in vivo temperatures of spent dialysate.  
 
Fig. VI-11: Temperature profile (mean ± SD) at the container exit for a urea start concentration 
of 0.33g/L (rhombs) and 1.5g/L (triangles) with heating until equal temperatures. 
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Comparing the experiments without heating to these with heating until equal 
temperatures, a faster decline of container outlet temperature was noted in the 
schedule without heating (P<0.0001), pointing to the fact that the temperature of 
spent dialysate influences that of fresh dialysate. For the tests with heating as in 
vivo, a slower temperature decline was observed compared to the schedule 
without heating (P<0.0001), while no difference was observed compared to the 
schedule with heating until equal temperatures (P=0.127).  
 
Fig. VI-12: Temperature profile (mean ± SD) at the container exit (rhombs) and entrance 
(triangles) for a urea start concentration of 0.67g/L with heating as in vivo. 
4.3.2. Urea concentration profiles 
Fig. VI-13 shows urea concentrations at the container entrance (triangles) and 
exit (rhombs) in a representative experiment with urea start concentration 
0.67g/L without heating (left panel) and with heating to equal temperatures (right 
panel). 
 
Fig. VI-13: Urea concentrations at the container entrance (triangles) and exit (rhombs) in a 
representative experiment with urea start concentration of 0.67g/L without heating (left panel) 
and with heating until equal temperatures (right panel). 
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At the container entrance, a progressive decline in urea concentration was 
observed, reflecting the decreasing concentration in the tank used as patient 
substitute. At the container exit, an abrupt increase in urea concentration was 
remarked between 105 and 235 minutes.  
After the appearance of urea at the container exit, the concentration exceeded that 
measured at the entrance in the experiments with 0.67g/L urea without heating 
(Fig. VI-13) and with 1.0 and 1.5g/L urea irrespective of heating schedule. In the 
experiments where urea appeared earlier at the container exit, the concentration 
was equal or lower than that measured at the entrance.  
The mean time points at which urea appeared at the container exit are displayed 
per experimental setting in Table VI-2. Contamination occured progressively 
later with increasing urea concentrations: from 185±20 (0.33g/L urea) to 227±5 
min (1.5g/L) for the experiments without heating, from 122±11 (0.33g/L urea) to 
232±3 min (1.5g/L) for heating until equal temperatures, and from 175±12 
(0.33g/L urea) to 202±8 min (0.67g/L). 
For each urea concentration, except for 150mg/dL, contamination occurs earlier 
when the dialysate outlet is heated compared to the experiments without heating. 
In the experiments with heating as in vivo, intermediate results between the two 
temperature patterns were obtained.  
Table VI-2: Time points at which urea appeared at the container exit (minutes after 
dialysis start) 
g/L urea No heating Heating as in vivo  Heating until outlet= inlet 
0.33 185 ± 20 175 ± 12 122 ± 11 * & 
0.67 219 ± 5 + 202 ± 8 * + 162 ± 11 * +  & 
1.0 224 ± 2 + ° - 204 ± 14 * + °° 
1.5 227 ± 5 + ° - 232 ± 3 + °° # 
*: P<0.01 vs no heating, &: P<0.01 vs heating as in vivo, +: P<0.01 vs 33mg/dL urea,   
°: P<0.05 vs 67mg/dL urea, °°: P<0.01 vs 67mg/dL urea, #: P<0.01 vs 100mg/dL urea  
4.4. Discussion 
In the present study, the impact of differences in dialysate density on the 
separation between spent and fresh dialysate was investigated during in vitro 
dialysis with the Genius system. We demonstrated that both urea concentration 
and temperature play a role in the partitioning between spent and fresh dialysate. 
The higher the urea concentration in the container used as patient substitute and 
the higher the temperature difference between warm fresh and cool spent 
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dialysate, the later urea appeared at the container exit, which corresponds to the 
moment that adequate dialysis is no longer possible.  
A difference in density is necessary to maintain the partitioning between spent 
and fresh dialysate and both temperature and solute concentration can contribute 
to this density. With the highest urea concentration, however, no reinforcing 
effect on partitioning was obtained by a temperature difference. In addition, with 
the highest temperature difference also no reinforcing effect was obtained by 
increasing the urea concentration from 1.0 to 1.5g/L. Hence the second 
contributing factor becomes relatively irrelevant if one factor is altered to a 
sufficient extent to have an overriding effect.  
The more pronounced the exponential decrease of urea concentration at the 
container entrance, the better the substitute patient was cleared (higher K·t/V). 
This was especially found with 0.67g/L urea without heating (Fig. VI-13) and 
with 1.0 and 1.5g/L urea irrespective of heating schedule. It should be remarked 
however that in case of contamination, high urea concentrations are flowing back 
to the dialyzer, diminishing dialysis adequacy. 
On one hand, a reduced solute content of spent dialysate may be encountered in 
the application of daily protracted dialysis in the intensive care patient, as well as 
in the detoxification of non-renal patients after poisoning with highly toxic low 
molecular weight substances. In order to obtain a larger density difference, 
trisodiumcitrate (258D) could be infused at the inlet blood line, as applied for 
loco-regional anticoagulation. As almost 70% of citrate is dialyzed [352], an 
increase in solute concentration of spent dialysate of 0.76g/L is expected for a 
citrate blood inlet concentration of 4.3mmol/L [353]. 
On the other hand, it can be expected that during the progression of a protracted 
dialysis, fresh dialysate can become as warm as, or even cooler than spent 
dialysate. To ensure higher fresh dialysate temperatures, spent dialysate should 
be additionally cooled by the use of longer dialysate outlet tubings or a heat 
exchanger. Another possible solution is to prepare the fresh dialysate at a higher 
start temperature, which can lead however to hemodynamic instability due to 
heat transfer to the patient.  
In conclusion, it is demonstrated that with the Genius dialysis system both 
uremic solute concentration and temperature contribute to the separation between 
fresh and spent dialysate. The higher the urea concentration in the container used 
as patient substitute and the higher the temperature difference between the warm 
fresh and cool spent dialysate, the later urea appears at the container outlet. 
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4.5. Conclusion 
The present study was set out to evaluate the influence of solute concentration 
and temperature distribution on the occurrence of dialysate mixing inside the 
container of the Genius dialysis system. Therefore, in vitro tests were performed 
measuring urea concentrations and temperatures at the container entrance and 
exit. Fresh dialysate contamination was found enhanced by using a lower urea 
start concentration and for warmer spent dialysate temperatures. As a 
consequence, special precautions, e.g. cooling of spent dialysate, should be 
considered with protracted dialysis.  
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5. Numerical analysis of Genius dialysis 
5.1. Background 
While the former studies indicated the importance of temperature and solute 
concentration of the spent dialysate entering the Genius container, the present 
computational study was set out to visualize the variation of those parameters 
inside the container. A numerical evaluation was chosen, as this results in a better 
understanding of all impacting factors that influence the time point of mixing.  
When focusing on the density stratification inside the container, different 
transport phenomena come into play influencing local temperatures and solute 
concentrations. Besides the direct influence by the concentration and temperature 
of the inflowing spent dialysate, other phenomena influence the temperature 
distribution. First, the fluid in the container near the outer wall is subject to 
cooling by the colder room temperature; and second, the temperature of the spent 
dialysate flowing down in the central tube has an impact on the temperature of 
the fluid surrounding the central tube. 
Accounting for all those impacting factors, two different strategies as measured 
in vitro (paragraph 4) were simulated during a dialysis session of 300 minutes. 
The urea start concentration was defined corresponding to the tests with 1g/L 
urea (30g urea in a 30L dialysate tank). The case with spontaneous cooling as 
well as the case with heating of the spent dialysate until equal temperatures was 
considered.  
5.2. Materials and Methods 
5.2.1. Geometry and domain characterization 
A two-dimensional axi-symmetrical numerical model was developed of the 
Genius dialysis container. The model has a cylindrical shape with height 
340mm and internal diameter 400mm. On the top and bottom, the container 
geometry describes a half sphere with internal radius of 200mm. The wall 
thickness of the container is 40mm. 
The central tube contains an ultraviolet tube of 10mm radius, surrounded axi-
symmetrically by an inlet ring for spent dialysate of 7mm in width and a glass 
wall of 3mm thick. The inner and outer shell of the inlet tube ends 27mm and 
20mm above the bottom of the container, respectively. The fresh dialysate outlet 
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section at the container top and surrounding the central tube, consists of a ring of 
width 15mm. 
5.2.2. Governing equations 
5.2.2.1. Fluid dynamic equations 
The fluid flow is described by the unsteady incompressible continuity and 
momentum equations using a time step of 6s. Because the fluid properties 
(density ρ and viscosity µ) are temperature dependent, the energy equation was 
solved simultaneously.  
5.2.2.2. Convection-diffusion equation 
The transport of urea in the container, driven by pressure and concentration 
differences, is described by the convection-diffusion equation (paragraph 
3.3.1.2). The mass fraction of urea is defined as: 
 
Du
u
urea ρC
C
ω +=  Eq. VI-27 
with Cu the time-varying urea concentration (g/L) and ρD the dialysate density 
(g/L). 
5.2.2.3. Fluid property equations 
The fluid properties (density and viscosity) are dependent on the temperature and 
the solute concentration.  
The influence of dialysate viscosity on density was not taken into account, as the 
viscosity variation due to temperature differences is much greater than the 
variation due to density differences. The temperature T dependency (°C) of 
dialysate viscosity µ (Pa·s) is described by [62]: 
 ( )T3 0.98101.465µ ⋅⋅= −  Eq. VI-28 
The temperature dependency of the dialysate density ρD (kg/m³) is described as a 
function of the density ρ0 (1007 kg/m³) at temperature T0 (30°C), and the 
volumetric thermal expansion coefficient of dialysate β (β·ρ0=0.3kg/m³/K):  
 ( ))T(Tβ1ρρ 00D −⋅+⋅=  Eq. VI-29 
The density of the urea-dialysate mixture ρm (kg/m³) is calculated as a volumetric 
average with Vu and VD the volumes of urea and dialysate, respectively, and ρu 
the density of urea (1323kg/m³): 
Analysis of dialysis using a single-pass batch system  
 269
 ( )
uu
Duu
Du
DDuu
m Cρ
ρCρ
VV
ρVρV
ρ +
+⋅≅+
⋅+⋅=  Eq. VI-30 
5.2.2.4. Heat transfer equations 
The heat transfer inside the reservoir is governed by Fourier’s law of conduction 
and the mixing of warm and cold dialysate: 
 ( )u2pDm JTk2vρvtTcρ ⋅−∇⋅∇=



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∂⋅⋅ uhh  Eq. VI-31 
with k the heat conduction coefficient for water (0.6W/m/K), cpD the heat 
capacity of the dialysis fluid (4178 J/kg/K at 37°C), h the (total) enthalpy, hu the 
relative enthalpy for urea, and Ju the diffusional urea flux.  
At the outer wall of the container, heat loss is described in terms of natural (air) 
convection, described with Newton’s law of cooling:  
 ( )roomTThQ −⋅=  Eq. VI-32 
with Q the heat flux through the wall (W/m²), Troom the ambient room 
temperature (25°C), and h the convective heat transport coefficient as assumed 
constant (5W/m²/K). The latter was calculated accounting for the container 
dimensions, the temperature difference between dialysate at the container 
entrance and exit, and the thermal transport velocity k (1/s) as derived from the in 
vitro experiments (paragraph 4.2). 
At the glass interface of the central tube, heat transfer between the inflow tube 
and the container is described with Fourier’s law, as a function of the heat 
conduction coefficient k for glass (1.3W/m/K), the glass density ρG (2200kg/m³), 
and the heat capacity of glass cpG (840 J/kg/K).  
 ( )Tk
t
Tcρ pGG ∇⋅∇=∂
∂⋅⋅  Eq. VI-33 
5.2.3. Boundary conditions 
The container wall is modeled as a wall where no-slip occurs, while the container 
axis is defined as symmetry axis. On top of the container, the exit is defined as a 
zero outlet pressure, while the entrance is defined as a mass flow rate of 5g/s of 
the spent dialysate. This corresponds to an overall dialysate flow of 
approximately 300mL/min as used for the in vitro experiments. 
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The temperature measurements during the in vitro tests with spontaneous cooling 
showed an approximately constant temperature difference between the fresh and 
spent dialysate during the entire dialysis (Fig. VI-10). For the start concentration 
of 30g/30L, a mean temperature difference of 2.5°C was measured. As a 
consequence, the temperature of the spent dialysate as applied at the container 
entrance was calculated from the temperature of the fresh dialysate at the 
container exit, accounting for the 2.5°C difference. The fresh dialysate was 
characterized by a temperature of 36.2°C at the start of dialysis. 
For simulation of the tests with heating until equal temperatures, the temperature 
of the spent dialysate was taken instantaneously equal to those of the fresh 
dialysate. 
To calculate the urea concentration in the spent dialysate, the single pool model 
as described in paragraph 3.3.1.2 was used to simulate the substitute patient. 
Because the urea removal from the patient depends on the urea concentration in 
the dialysate at the dialyzer inlet (CDi), the differential equation was solved 
numerically (JSim, National Simulation Resource, Seattle, USA). From fitting 
the measured dialysate concentrations at the dialyzer outlet, a urea start 
concentration in the patient substitute of 33.91g/30L and 31.28g/30L was found 
for the tests with spontaneous cooling and heating, respectively. A diffusive 
dialysance D of 180mL/min and 214mL/min was obtained for the considered 
tests. 
The dialyzer outlet concentration of the dialysate (CDo) is the concentration at the 
container entrance and can be calculated using the formula for dialysate-side 
dialysance D (Eq. I-10) with QDi the dialysate flow in the dialyzer: 
 ( )
Di
D
DiBi
Do CQ
CC
C +−⋅= D  Eq. VI-34 
To obtain the concentrations and temperatures at the container exit, a velocity-
weighted integration was performed for use in further calculations. 
5.3. Results 
For each time step, heat and mass distributions can be visualized in a cross-
section of the container. Fig. VI-14 shows temperatures and concentrations in the 
container for the case of spontaneous cooling (left panel) and heating until equal 
temperatures (right panel) at 90 minutes after the start of dialysis. 
In both cases, the isotherms illustrate the cooling of the dialysate near the 
container wall. With spontaneous cooling, the temperature of the dialysate 
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surrounding the central tube is influenced by the inflowing spent dialysate. In the 
upper part of the container, the dialysate is cooled down due to the 2.5°C 
difference between fresh and spent dialysate. In the lowest part of the container, 
however, dialysate is heated as the inflowing spent dialysate temperature 
increases gradually when flowing downward through the central tube. For the 
tests with heating of spent dialysate, the inflowing dialysate is warmer than the 
surrounding dialysate over the entire height of the container, resulting in heat 
transfer towards the dialysate inside the container. 
While the separation between fresh and spent dialysate is well maintained for the 
tests with spontaneous cooling (Fig. VI-14, left panel), the separation was more 
diluted and laying higher when heating spent dialysate (Fig. VI-14, right panel). 
 
Fig. VI-14: Concentration C (g/L) and temperature T distribution (°C) at 90 minutes after the 
start of dialysis for a start concentration of 1.13g/L and 1.04g/L, respectively, in the case of 
spontaneous cooling (left panel) and in the case of heating of the spent dialysate (right panel). 
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5.4. Discussion 
The differences between the results for spontaneous cooling and dialysate 
heating can be explained as follows: independent of temperature and 
concentration, it is expected that a stratification based on density is present inside 
the container with the highest density at the bottom layers.  
From the start of dialysis, dialysate at the outer wall of the container is cooling, 
resulting in a sinking of the cooler dialysate by gravity. Hence a temperature 
gradient, similar to the density gradient, comes into being with at the bottom 
heavy cool and at the top the lighter warmer dialysate. The temperature of the 
dialysate near the central tube is also disturbed by heat transport to and from the 
inflowing warmer or colder dialysate. As a consequence, the temperature profile 
inside the container will not show smooth stratification in vertical direction. 
Because density increases for higher urea concentrations and lower temperatures, 
the isotherms as well determine the concentration profile inside the container.  
In the case of spontaneous dialysate cooling, the highest temperatures, and with 
it, relative higher urea concentrations will be observed in between the central 
tube and the container wall (left panel in Fig. VI-14). The inflowing dialysate 
intends to migrate towards zones of equal density and will rise upward along the 
central tube until it reaches a fluid layer with similar density (see arrow in Fig. 
VI-14, left panel). As a consequence, the speed of the spent dialysate front (most 
pronounced halfway the glass tube and the container wall) is higher than 
theoretically expected. In addition, this phenomenon is more prominent for lower 
urea start concentrations. 
In the experiments where spent dialysate is heated at the container entrance until 
equal temperatures as measured at the container exit, the spent dialysate 
reinfused at the bottom of the container might be warmer than the cool fresh 
dialysate already present at the bottom. Hence this drained warm spent dialysate 
will rise above the cooler and heavier fresh dialysate, unless solute content 
results in a higher density and counteracts this upward movement. Fig. VI-14 
shows that the inflowing spent dialysate (with a concentration of 0.40g/L at 90 
minutes) rises towards the virtual separation layer (see arrow in right panel). 
Furthermore, the maintenance of fresh dialysate sinking along the container wall 
results in a dilution of the urea concentrations in the lower regions. Due to this 
continuous dilution by fresh dialysate, the contaminated volume is larger than 
theoretically predicted. This clarifies why recirculation of spent dialysate occurs 
earlier when spent dialysate is heated at the container entrance compared with no 
heating unless high urea concentrations were applied (paragraph 4).  
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For the test with spontaneous cooling, temperature variation over the container 
height is around 2.4°C, while a concentration difference of 0.57g/L is found in 
the spent dialysate. When spent dialysate is heated, a temperature and 
concentration difference of 0.7°C and 0.40g/L is observed. Because the variation 
of density due to temperature and concentration variations can be described as 
dρ/dT equal to 0.4g/L/°C and dρ/dC equal to 0.24, it is obvious that temperature 
is the major impacting factor determining the time point of dialysate mixing. 
5.5. Conclusion 
It was stated before (paragraph 3 and 4) that urea mixing is enhanced for a spent 
dialysate temperature approaching the temperature of the fresh dialysate, and for 
lower urea concentrations in the spent dialysate. The present numerical technique 
offers a better insight in the relative importance of the impacting factors 
determining dialysate mixing inside the Genius container.  
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1. Conclusion 
While most studies for analyzing dialyzer performance are based on clinical data, 
a decoupling of dialyzer and patient was done in the scope of this dissertation. 
Therefore, separate analyses were performed to investigate either dialyzer or 
patient clearance using experimental techniques and developing theoretical and 
numerical models. 
1.1. Summary of quantifying dialyzer performance 
The efficiency of mass transport in a dialyzer is influenced by numerous 
parameters like membrane and fluid properties, dialyzer design and geometry, 
and flow distributions. Although solute removal is a phenomenon that takes place 
on microscale in a single fiber, information about flow distributions on 
macroscale was initially achieved by an experimental and numerical approach. A 
medical imaging technique (i.e. SPECT) was used to visualize dialyzer flow, and 
showed homogeneously distributed flow in the blood compartment while 
preferential flow paths with decreased fiber bundle resistance were observed in 
the dialysate flow. Those results were further applied for validating the numerical 
model of each compartment, which offers detailed information about local 
pressure and velocity. 
An experimental technique for the analysis of particle transport in impermeable 
microcapillaries, based on the electronic detection of particles, was found 
unsatisfactory for analyzing blood flow in a dialyzer fiber. Hence, for the 
investigation of the flow on microscale, a numerical model of a single fiber with 
its surrounding dialysate domain was developed. After validation with ex vivo 
experiments, the model was found useful to give a detailed description of fluid 
property variations, and according pressure and flow profiles.  
Furthermore, the micromodel was extended to study mass transport of small 
solutes (i.e. urea) and middle molecules with a sieving coefficient equal to unity 
in the dialyzer under study (i.e. vitamin B12 and inulin). After derivation of the 
diffusion coefficients in the three domains (blood, membrane and dialysate), a 
parameterstudy was performed varying radial and axial dimensions. Solute 
transfer was found more effective for larger fiber diameters and lengths. Besides 
the numerical approach, the influence on mass transfer of different impacting 
factors like flow direction, flow rate, and flow distribution, were investigated 
either theoretically or performing in vitro experiments. Although the latter 
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approaches confirmed earlier clinical findings, they were especially useful to 
define the individual influence of each parameter. In conlusion, solute removal 
was found enhanced for lower blood and higher dialysate flows, and in dialyzers 
with an increased mass transfer area coefficient. 
To draw the link between flow distributions and mass transfer, the results of the 
SPECT measurements were applied as flow input parameters, and overall 
dialyzer efficiency was calculated. Although large differences in dialysate 
velocities were observed with the experiments, the decrease in solute removal, 
compared to the case of homogeneously distributed flows, was found limited to 
10%. 
1.2. Summary of quantifying patient clearance 
Up till now, around 90 uremic solutes have been identified and classified 
according their molecular weight and their potential for protein binding. 
Although the large variety in uremic retention products, urea is still used as the 
marker for dialyis adequacy. While extensive research has been done on the 
kinetics of urea, not much is known about the intra-dialytic kinetic behavior of 
the other solutes. 
In the attempt to find a correlation between the kinetics of small and water-
soluble compounds, significant differences were found and no specific 
correlations could be drawn. For the analysis, a two-pool kinetic model was used 
and kinetic parameters like distribution volumes and inter-compartmental 
clearance were derived fitting on the intra-dialytic measured concentrations. 
Some guanidino compounds (e.g. CTN, CT, GAA, G and MG) are distributed in 
a larger volume compared to urea, hampering adequate solute removal from the 
deeper tissues of the patient’s body. Guanidinosuccinic acid (GSA) however was 
found distributed in a significantly smaller volume, resulting in a better reduction 
ratio. As a result, urea kinetics may not be used as a standard example of the 
kinetic behavior of other small and water-soluble compounds. 
The two-pool model was however found inappropriate to model the kinetics of 
some protein-bound solutes (e.g. p-cresol, CMPF), since concentrations were 
fluctuating or even increasing during dialysis. Furthermore, for those compounds 
that could be evaluated with the two-pool model, the degree of protein binding 
must be considered when interpreting the kinetic results.  
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1.3. Summary of analyzing batch dialysis 
As final application, the knowledge of different transport phenomena was 
merged for the investigation of dialysis adequacy using the Genius single-pass 
batch system. Since the system consists of a closed dialysate container in which 
the separation of fresh and spent dialysate is based on density differences, it was 
investigated whether fluid separation remains guaranteed under varying 
conditions. The impact of the two major parameters influencing fluid density, i.e. 
temperature and concentration, were studied with a theoretical, an experimental, 
and a computational approach.  
It was concluded from all three studies that dialysate mixing inside the container 
is enhanced for lower concentrations in the spent dialysate, and with more equal 
temperatures of fresh and spent dialysate. Since those aspects become important 
with a protracted dialysis session, suggestions are formulated in order to maintain 
dialysis adequacy. 
1.4. Final summary 
In the present dissertation, different experimental techniques were applied and 
mathematical and numerical models were developed to study the dialyzer and 
patient clearance. The combination of the developed tools allows a detailed 
investigation of solute transport in order to define the adequacy of dialysis. 
 
Conclusion and future work 
 279
2. Future work 
Although the described models are helpful to study mass removal from the 
patient with a particular dialyzer, some shortcomings can be drawn. 
Consequently, in the following paragraphs, suggestions are formulated for further 
impovement of the models to quantify dialyzer and patient clearances. 
2.1. Suggestions for optimizing the dialyzer model 
The method as applied for the macroscopic study of dialyzer flow can be utilized 
to investigate and/or optimize different designs of manifold or fiber bundle. 
The numerical micromodel, investigating mass transport between blood and 
dialysate, was up til now only applicable for the removal of solutes with a sieving 
coefficient equal to unity. As a consequence, the important contribution of 
convection of larger solutes should be implemented. Furthermore, solutes that are 
hampered in passing the membrane causes the occurrence of concentration 
polarization and influences overall mass removal. The description of those 
phenomena as well as their influence on flow and mass transport must be 
implemented accurately. 
Going even one step further, it might be of interest for the device manufacturers 
to develop a model of the membrane itself. In such a model, the membrane is not 
longer defined as a porous medium with an overall permeability. The model 
should be rather on nanoscale visualizing the flow inside the membrane pores. 
Consequently, the solutes are then modeled as individual particles with various 
shapes and specific deformations. Such a model would allow detailed 
information on the formation and movement of the boundary and protein layer. 
2.2. Suggestions for optimizing the patient model 
It would be advantageous to have different kinetic models to our disposal for the 
investigation of the kinetic behavior of a particular solute. Up till now only a 
two-pool model was optimized and applied within the scope of this dissertation. 
It was however found for protein-bound solutes that a different approach is 
required. Clinical studies, determining for instance the free and bound 
concentration separately on different and even more time points during dialysis, 
might reveal the behavior of those solutes, such that appropriate new models can 
be developed for kinetic modeling of other uremic solutes. 
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